Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-28T18:54:14.015Z Has data issue: false hasContentIssue false

Section 5 - Late Pregnancy – Maternal Problems

Published online by Cambridge University Press:  15 November 2017

David James
Affiliation:
University of Nottingham
Philip Steer
Affiliation:
Imperial College London
Carl Weiner
Affiliation:
University of Kansas
Bernard Gonik
Affiliation:
Wayne State University, Detroit
Stephen Robson
Affiliation:
University of Newcastle
Get access

Summary

Imagine asking yourself the question, “How would I describe a typical pregnant woman who uses drugs?” You might reply that she comes from a different social class, cannot think beyond the pregnancy, uses jargon, and doesn’t listen or care about the welfare of the child. However, my experience when asking drug-using women what they thought about the typical obstetrician is that they say the doctor was from a different social class, could not think beyond the pregnancy, used jargon, and didn’t listen or care about the welfare of the child.

Type
Chapter
Information
High-Risk Pregnancy
Management Options
, pp. 779 - 1522
Publisher: Cambridge University Press
First published in: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Cormier, RA, Dell, CA, Poole, N. Women and substance abuse problems. BMC Womens Health 2004; 4 (Suppl 1) :S8.Google Scholar
World Health Organization. Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. Geneva: WHO, 2014. www.who.int/iris/handle/10665/107130 (accessed September 2018).Google Scholar
Chasnoff, IJ, McGourty, RF, Bailey, GW, et al. The 4P’s Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005; 25: 368–74.Google Scholar
Calvo, N, Cannon-DeKreek, S. Two perspectives on use of 4P’s Plus© to screen pregnant women for alcohol and other drugs. The Source (National Abandoned Infants Assistance Resource Center) 2010; 20 (2). http://aia.berkeley.edu/ (accessed December 2015).Google Scholar
Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health, Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD: SAMSHA, 2012.Google Scholar
Home Office. Drug misuse statistics. https://www.gov.uk/government/collections/drug-misuse-declared (accessed March 2017).Google Scholar
National Institute on Drug Abuse. www.drugabuse.gov (accessed March 2017).Google Scholar
Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. HHS Publication No. (SMA) 18-5054. Rockville, MD: SAMHSA, 2018. https://store.samhsa.gov/product/Clinical-Guidance-for-Treating-Pregnant-and-Parenting-Women-With-Opioid-Use-Disorder-and-Their-Infants/SMA18-5054 (accessed September 2018).Google Scholar
Wouldes, TA, Lagasse, LL, Derauf, C, et al. Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend 2013; 127: 101–7.Google Scholar
Frank, DA, Augustyn, M, Knight, WG, Pell, T, Zuckerman, B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001; 285: 1613–25.CrossRefGoogle ScholarPubMed
Behnke, M, Eyler, FD, Warner, TD, et al. Outcome from a prospective, longitudinal study of prenatal cocaine use: preschool development at 3 years of age. J Pediatr Psychol 2006; 31: 41–9.Google Scholar
Hepburn, M. Drug use in pregnancy: a multidisciplinary responsibility. Hosp Med 1998; 59: 436.Google Scholar
Little, BB, Snell, LM, Trimmer, KJ, et al. Peripartum cocaine use and adverse pregnancy outcome. Am J Hum Biol 1999; 11: 598602.Google Scholar
Janisse, JJ, Bailey, BA, Ager, J, Sokol, RJ. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abus 2014; 35: 60–7.Google Scholar
Calderon-Margalit, R, Qiu, C, Ornoy, A, Siscovick, DS, Williams, MA. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol 2009; 201: 579.e1–8.Google Scholar
Wright, TE, Schuetter, R, Tellei, J, Sauvage, L. Methamphetamines and pregnancy outcomes. J Addict Med 2015; 9: 111–17.Google Scholar
Smith, LM, Lagasse, LL, Derauf, C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118: 1149–56.Google Scholar
World Health Organization. Recommendations for the Prevention and Management of Tobacco Use and Second-Hand Smoke Exposure in Pregnancy. Geneva: WHO, 2013.Google Scholar
Scottish Executive. Scottish Index of Multiple Deprivation 2006 Technical Report. Edinburgh: Scottish Executive, 2006.Google Scholar
NHS National Services Scotland, Information Services Division. ISD Scotland. www.isdscotland.org (accessed March 2017).Google Scholar
Shipton, D, Tappin, DM, Vadiveloo, T, et al. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ 2009; 339: b4347.Google Scholar
Chasnoff, IJ, Wells, AM, McGourty, RF, Bailey, LK. Validation of the 4P’s Plus screen for substance use in pregnancy validation of the 4P’s Plus. J Perinatol 2007; 27: 744–8.Google Scholar
Baeza-Loya, S, Viswanath, H, Carter, A, et al. Perceptions about e-cigarette safety may lead to e-smoking during pregnancy. Bull Menninger Clin 2014; 78: 243–52.Google Scholar
Schauer, GL, Malarcher, AM, Babb, SD. Prevalence and correlates of switching to another tobacco product to quit smoking cigarettes. Nicotine Tob Res 2015; 17: 622–7.CrossRefGoogle ScholarPubMed
Suter, MA, Mastrobattista, J, Sachs, M, Aagaard, K. Is there evidence for potential harm of electronic cigarette use in pregnancy? Birth Defects Res Part A Clin Mol Teratol 2015; 103: 186–95.CrossRefGoogle ScholarPubMed
Roth, LK, Taylor, HS. Risks of smoking to reproductive health: assessment of women’s knowledge. Am J Obstet Gynecol 2001; 184: 934–9.Google Scholar
Huxley, RR, Woodward, M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011; 378: 1297–305.Google Scholar
Raymond, EG, Mills, JL. Placental abruption: maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand 2009; 72: 633–9.Google Scholar
Gardosi, J, Madurasinghe, V, Williams, M, Malik, A, Francis, A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108.CrossRefGoogle ScholarPubMed
Hackshaw, A, Rodeck, C, Boniface, S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update 2011; 17: 589604.CrossRefGoogle ScholarPubMed
Weber, MA, Ashworth, MT, Risdon, RA, et al. The role of post-mortem investigations in determining the cause of sudden unexpected death in infancy. Arch Dis Child 2008; 93: 1048–53.CrossRefGoogle ScholarPubMed
Task Force on Sudden Infant Death Syndrome; Moon, RY. SIDS and other sleep-related infant deaths: expansion of recommendations for a safe infant sleeping environment. Pediatrics 2011; 128: e1341–67.CrossRefGoogle ScholarPubMed
Moon, RY, Fu, L. Sudden infant death syndrome: an update. Pediatr Rev 2012; 33: 314–20.Google Scholar
Office for National Statistics. Unexplained deaths in infancy, England and Wales 2015. Release date August 2017. www.ons.gov.uk/releases/unexplaineddeathsininfancyenglandandwales2015 (accessed September 2018).Google Scholar
American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. SIDS and other sleep-related infant deaths: updated 2016 recommendations for a safe infant sleeping environment. Pediatrics 2016; 138(5) pii: e20162938. doi: 10.1542/peds.2016-2938.Google Scholar
West, R. Time for a change: putting the Transtheoretical (Stages of Change) Model to rest. Addiction 2005; 100: 1036–9.CrossRefGoogle ScholarPubMed
Pomerleau, CS, Zucker, AN, Stewart, AJ. Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers. Nicotine Tob Res 2001; 3: 5160.Google Scholar
Lumley, J, Chamberlain, C, Dowswell, T, et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009; (3): CD001055.Google Scholar
National Institute for Health and Care Excellence. Smoking: Stopping in Pregnancy and After Childbirth. Public Health Guideline 26. London: NICE, 2010. https://www.nice.org.uk/guidance/ph26 (accessed March 2017).Google Scholar
Cooper, S, Lewis, S, Thornton, JG, et al. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy: clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technol Assess 2014; 18 (54): 1128.Google Scholar
National Collaborating Centre for Women’s and Children’s Health (UK). Pregnancy and Complex Social Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors. London: RCOG Press, 2010.Google Scholar
Fahy, SJ, Cooper, S, Coleman, T, Naughton, F, Bauld, L. Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS Stop Smoking Services for Pregnant Women. BMC Health Serv Res 2014; 14: 107.Google Scholar
Hajek, P, West, R, Lee, A, et al. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction 2001; 96: 485–94.Google Scholar
Cahill, K, Hartmann-Boyce, J, Perera, R. Incentives for smoking cessation. Cochrane Database Syst Rev 2015; (5): CD004307.CrossRefGoogle Scholar
Mamluk, L, Edwards, HB, Savović, J, et al. Low alcohol consumption and pregnancy and childhood outcomes: time to change guidelines indicating apparently ‘safe’ levels of alcohol during pregnancy? A systematic review and meta-analyses. BMJ Open 2017: e015410. doi: 10.1136/bmjopen-2016-015410.CrossRefGoogle Scholar
Department of Health. Alcohol guidelines review. Report from the guidelines development group to the UK Chief Medical Officers. London: Department of Health, 2016.Google Scholar
Royal College of Obstetricians and Gynaecologists. Alcohol and Pregnancy. Patient information leaflet. London: RCOG, 2015 (revised January 2018). www.rcog.org.uk/en/patients/patient-leaflets/alcohol-and-pregnancy (accessed September 2018).Google Scholar
Esser, MB, Hedden, SL, Kanny, D, et al. Prevalence of alcohol dependence among US adult drinkers, 2009–2011. Prev Chronic Dis 2014; 11: E206.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: APA, 2013.Google Scholar
Sarkola, T, Eriksson, CJ, Niemelä, O, Sillanaukee, P, Halmesmäki, E. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse. Acta Obstet Gynecol Scand 2000; 79: 359–66.Google Scholar
Bearer, CF. Markers to detect drinking during pregnancy. Alcohol Res Health 2001; 25: 210–18.Google Scholar
Joya, X, Friguls, B, Ortigosa, S, et al. Determination of maternal–fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal 2012; 69: 209–22.Google Scholar
Chang, G, Wilkins-Haug, L, Berman, S, et al. Alcohol use and pregnancy: improving identification. Obstet Gynecol 1998; 91: 892–8.Google ScholarPubMed
Russell, M, Martier, SS, Sokol, RJ, et al. Screening for pregnancy risk-drinking. Alcohol Clin Exp Res 1994; 18: 1156–61.CrossRefGoogle ScholarPubMed
Sokol, RJ, Martier, SS, Ager, JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989; 160: 863–8.Google Scholar
Bush, B, Shaw, S, Cleary, P, Delbanco, TL, Aronson, MD. Screening for alcohol abuse using the CAGE questionnaire. Am J Med 1987; 82: 231–5.CrossRefGoogle ScholarPubMed
Bottoms, SF, Martier, SS, Sokol, RJ. Refinements in screening for risk drinking in reproductive-aged women: The “NET” results. Alcoholism 1989; 13: 339.Google Scholar
Bush, K, Kivlahan, DR, McDonell, MB, Fihn, SD, Bradley, KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158: 1789–95.Google Scholar
Burns, E, Gray, R, Smith, LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction 2010; 105: 601–14.Google Scholar
Schenker, S. Medical consequences of alcohol abuse: is gender a factor? Alcohol Clin Exp Res 1997; 21: 179–81.Google ScholarPubMed
Bailey, BA, Sokol, RJ. Pregnancy and alcohol use: evidence and recommendations for prenatal care. Clin Obstet Gynecol 2008; 51: 436–44.CrossRefGoogle ScholarPubMed
Patra, J, Bakker, R, Irving, H, et al. Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA): a systematic review and meta-analyses. BJOG 2011; 118: 1411–21.CrossRefGoogle ScholarPubMed
Day, NL, Leech, SL, Richardson, GA, et al. Prenatal alcohol exposure predicts continued deficits in offspring size at 14 years of age. Alcohol Clin Exp Res 2002; 26: 1584–91.Google Scholar
Andersen, AM, Andersen, PK, Olsen, J, Grønbæk, M, Strandberg-Larsen, K. Moderate alcohol intake during pregnancy and risk of fetal death. Int J Epidemiol 2012; 41: 405–13.CrossRefGoogle ScholarPubMed
Floyd, RL, O’Connor, MJ, Sokol, RJ, Bertrand, J, Cordero, JF. Recognition and prevention of fetal alcohol syndrome. Obstet Gynecol 2005; 106: 1059–64.Google Scholar
Albertsen, K, Andersen, AM, Olsen, J, Grønbæk, M. Alcohol consumption during pregnancy and the risk of preterm delivery. Am J Epidemiol 2004; 159: 155–61.CrossRefGoogle ScholarPubMed
Anderson, BL, Dang, EP, Floyd, RL, et al. Knowledge, opinions, and practice patterns of obstetrician-gynecologists regarding their patients’ use of alcohol. J Addict Med 2010; 4: 114–21.Google Scholar
Hannigan, JH, Armant, DR. Alcohol in pregnancy and neonatal outcome. Semin Neonatol 2000; 5: 243–54.Google Scholar
Lemoine, P, Harousseau, H, Borteyru, JP, Menuet, JC. Children of alcoholic parents: observed anomalies: discussion of 127 cases. Ther Drug Monit 2003; 25: 132–6.Google Scholar
Jones, KL, Smith, DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973; 302: 9991001.Google Scholar
May, PA, Gossage, JP. Estimating the prevalence of fetal alcohol syndrome: a summary. Alcohol Res Health 2001; 25: 159–67.Google ScholarPubMed
Bertrand, J, Floyd, LL, Weber, MK; Fetal Alcohol Syndrome Prevention Team, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC). Guidelines for identifying and referring persons with fetal alcohol syndrome. MMWR Recomm Rep 2005; 54 (RR-11): 114.Google ScholarPubMed
Astley, SJ, Clarren, SK. Diagnosing the full spectrum of fetal alcohol-exposed individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol 2000; 35: 400–10.Google Scholar
Victor, A, Wozniak, JR, Chang, PN. Environmental correlates of cognition and behavior in children with fetal alcohol spectrum disorders. J Hum Behav Soc Environ 2008; 18: 288300.Google Scholar
O’Leary, CM, Jacoby, PJ, Bartu, A, D’Antoine, H, Bower, C. Maternal alcohol use and sudden infant death syndrome and infant mortality excluding SIDS. Pediatrics 2013; 131: e770–8.CrossRefGoogle ScholarPubMed
Whitlock, EP, Polen, MR, Green, CA, Orleans, T, Klein, J; U.S. Preventive Services Task Force. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: 557–68.Google Scholar
Bertholet, N, Daeppen, JB, Wietlisbach, V, Fleming, M, Burnand, B. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med 2005; 165: 986–95.Google Scholar
Crawford-Williams, F, Fielder, A, Mikocka-Walus, A, Esterman, A. A critical review of public health interventions aimed at reducing alcohol consumption and/or increasing knowledge among pregnant women. Drug Alcohol Rev 2015; 34: 154–61.CrossRefGoogle ScholarPubMed
Bailey, BA, Sokol, RJ. Some pregnant women still don’t believe drinking is dangerous. Am J Drug Alcohol Abuse 2014; 40: 85–6.Google Scholar
Floyd, RL, Jack, BW, Cefalo, R, et al. The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures. Am J Obstet Gynecol 2008; 199 (6 Suppl 2): S333–9.Google Scholar
Holbrook, AM, Crowther, R, Lotter, A, Cheng, C, King, D. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999; 160: 649–55.Google Scholar
Suh, JJ, Pettinati, HM, Kampman, KM, O’Brien, CP. The status of disulfiram: a half of a century later. J Clin Psychopharmacol 2006; 26: 290302.Google Scholar
Godel, JC, Pabst, HF, Hodges, PE, et al. Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth. CMAJ 1992; 147: 181–8.Google Scholar
Castrén, O, Gummerus, M, Saarikoski, S. Treatment of imminent premature labour. Acta Obstet Gynecol Scand 1975; 54: 95100.Google Scholar
Haastrup, MB, Pottegård, A, Damkier, P. Alcohol and breastfeeding. Basic Clin Pharmacol Toxicol 2014; 114: 168–73.Google Scholar
Ho, E, Collantes, A, Kapur, BM, Moretti, M, Koren, G. Alcohol and breast feeding: calculation of time to zero level in milk. Biol Neonate 2001; 80: 219–22.Google Scholar
Giglia, RC, Binns, CW, Alfonso, HS, Scott, JA, Oddy, WH. The effect of alcohol intake on breastfeeding duration in Australian women. Acta Paediatr 2008; 97: 624–9.CrossRefGoogle ScholarPubMed
Jagodzinski, T, Fleming, MF. Postpartum and alcohol-related factors associated with the relapse of risky drinking. J Stud Alcohol Drugs 2007; 68: 879–85.CrossRefGoogle ScholarPubMed
O’Leary, CM, Bower, C. Guidelines for pregnancy: what’s an acceptable risk, and how is the evidence (finally) shaping up? Drug Alcohol Rev 2012; 31: 170–83.Google Scholar
Mukherjee, RAS, Hollins, S, Abou-Saleh, MT, Turk, J. Low level alcohol consumption and the fetus. BMJ 2005; 330: 375–6.Google Scholar
Jones, TB, Bailey, BA, Sokol, RJ. Alcohol use in pregnancy: insights in screening and intervention for the clinician. Clin Obstet Gynecol 2013; 56: 114–23.Google Scholar
Carson, G, Cox, LV, Crane, J, et al. Alcohol use and pregnancy consensus clinical guidelines. J Obstet Gynaecol Can 2010; 32 (8 Suppl 3): S1–31.Google Scholar
Bakhireva, LN, Savage, DD. Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects. Alcohol Res Health 2011; 34: 5663.Google Scholar
Blanc, M, Daeppen, JB. [Does disulfiram still have a role in alcoholism treatment?] Rev Med Suisse 2005; 1: 1728–30, 1732–3.Google Scholar
Farrell, M, Howes, S, Taylor, C, et al. Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. Addict Behav 1998; 23: 909–18.Google Scholar
Jonas, JM, Gold, MS. Cocaine abuse and eating disorders. Lancet 1986; 1: 390–1.Google Scholar
Cazerta, M, Claro, HG, Andrade, FCDA, de Oliveira, MAF. Assessing the impact of alcohol, tobacco and illegal drugs on miscarriage among pregnant women in São Paulo, Brazil. Revista Terapia Ocupacional Universidade de São Paulo 2013; 23: 223–9.Google Scholar
Ness, RB, Grisso, JA, Hirschinger, N, et al. Cocaine and Tobacco Use and the Risk of Spontaneous Abortion. N Engl J Med 1999; 340: 333–9.CrossRefGoogle ScholarPubMed
Hulse, GK, Milne, E, English, DR, Holman, CD. Assessing the relationship between maternal cocaine use and abruptio placentae. Addiction 1997; 92: 1547–51.CrossRefGoogle ScholarPubMed
Burkett, G, Yasin, SY, Palow, D, LaVoie, L, Martinez, M. Patterns of cocaine binging: effect on pregnancy. Am J Obstet Gynecol 1994; 171: 372–8.CrossRefGoogle ScholarPubMed
Messinger, DS, Bauer, CR, Das, A, et al. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004; 113: 1677–85.Google Scholar
Cordero, DR, Medina, C, Helfgott, A. Cocaine body packing in pregnancy. Ann Emerg Med 2006; 48: 323–5.Google Scholar
Jonsson, S, O’Meara, M, Young, JB. Acute cocaine poisoning. Am J Med 1983; 75: 1061–4.CrossRefGoogle ScholarPubMed
Cruickshank, CC, Dyer, KR. A review of the clinical pharmacology of methamphetamine. Addiction 2009; 104: 1085–99.Google Scholar
Perez, JA, Arsura, EL, Strategos, S. Methamphetamine-related stroke: four cases. J Emerg Med 1999; 17: 469–71.Google Scholar
Grotta Della, S, Lagasse, LL, Arria, AM, et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 2010; 14: 519–27.Google Scholar
Dueñas-Garcia, OF. False-positive amphetamine toxicology screen results in three pregnant women using labetalol. Obstet Gynecol 2011; 118: 360–1.Google Scholar
Moritz, ML, Kalantar-Zadeh, K, Ayus, JC. Ecstacy-associated hyponatremia: why are women at risk? Nephrol Dial Transplant 2013; 28: 2206–9.Google Scholar
Kiblawi, ZN, Smith, LM, Diaz, SD, et al. Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study. Subst Abus 2014; 35: 6873.Google Scholar
Draper, ES, Rankin, J, Tonks, AM, et al. Recreational drug use: a major risk factor for gastroschisis? Am J Epidemiol 2008; 167: 485–91.Google Scholar
Ladhani, NNN, Shah, PS, Murphy, KE. Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205: 219.e1–7.Google Scholar
McElhatton, PR, Bateman, DN, Evans, C, Pughe, KR, Thomas, SH. Congenital anomalies after prenatal ecstasy exposure. Lancet 1999; 354: 1441–2.Google Scholar
Becker, JB, Hu, M. Sex differences in drug abuse. Front Neuroendocrinol 2008; 29: 3647.Google Scholar
Rawson, RA, Gonzales, R, Obert, JL, McCann, MJ, Brethen, P. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J Subst Abuse Treat 2005; 29: 6774.CrossRefGoogle ScholarPubMed
Zorick, T, Nestor, L, Miotto, K, et al. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction 2010; 105: 1809–18.Google Scholar
Good, MM, Solt, I, Acuna, JG, Rotmensch, S, Kim, MJ. Methamphetamine use during pregnancy: maternal and neonatal implications. Obstet Gynecol 2010; 116: 330.Google Scholar
Slamberová, R, Charousová, P, Pometlová, M. Methamphetamine administration during gestation impairs maternal behavior. Dev Psychobiol 2005; 46: 5765.CrossRefGoogle ScholarPubMed
Degenhardt, L, Bruno, R, Topp, L. Is ecstasy a drug of dependence? Drug Alcohol Depend 2010; 107: 110.Google Scholar
McKetin, R, Copeland, J, Norberg, MM, et al. The effect of the ecstasy “come-down” on the diagnosis of ecstasy dependence. Drug Alcohol Depend 2014; 139: 2632.Google Scholar
Ayus, JC, Arieff, A, Moritz, ML. Hyponatremia in marathon runners. N Engl J Med 2005; 353: 427–8.Google Scholar
Moritz, ML, Ayus, JC. 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis 2010; 25: 91–6.Google Scholar
Crome, IB, Kumar, MT. Epidemiology of drug and alcohol use in young women. Semin Fetal Neonatal Med 2007; 12: 98105.Google Scholar
Schempf, AH, Strobino, DM. Illicit drug use and adverse birth outcomes: is it drugs or context? J Urban Health 2008; 85: 858–73.Google Scholar
Hudak, ML, Tan, RC; Committee on Drugs; Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129: e540–60.Google Scholar
Bass, PF. Neonatal abstinence syndrome. Contemp Pediatr 2015; 32: 26.Google Scholar
Wolff, K, Boys, A, Rostami-Hodjegan, A, Hay, A, Raistrick, D. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005; 61: 763–8.Google Scholar
Jones, HE, O’Grady, KE, Malfi, D, Tuten, M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008; 17: 372–86.Google Scholar
Young, JL, Martin, PR. Treatment of opioid dependence in the setting of pregnancy. Psychiatr Clin North Am 2012; 35: 441–60.CrossRefGoogle ScholarPubMed
Bell, JR, Butler, B, Lawrance, A, Batey, R, Salmelainen, P. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug Alcohol Depend 2009; 104: 73–7.Google Scholar
Mattick, RP, Breen, C, Kimber, J, Davoli, M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; (2): CD002207.Google Scholar
Concheiro, M, Jones, HE, Johnson, RE, Choo, R, Huestis, MA. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther Drug Monit 2011; 33: 619–26.Google Scholar
Welle-Strand, GK, Skurtveit, S, Jansson, LM, et al. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr 2013; 102: 1060–6.Google Scholar
Gaalema, DE, Heil, SH, Badger, GJ, Metayer, JS, Johnston, AM. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend 2013; 133: 266–9.Google Scholar
Jones, HE, Kaltenbach, K, Heil, SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320–31.Google Scholar
Finnegan, LP, Michael, H, Leifer, B, Desai, S. An evaluation of neonatal abstinence treatment modalities. NIDA Res Monogr 1984; 49: 282–8.Google Scholar
Jones, HE. Treating opioid use disorders during pregnancy: historical, current, and future directions. Subst Abus 2013; 34: 8991.Google Scholar
Pétursson, H. The benzodiazepine withdrawal syndrome. Addiction 1994; 89: 1455–9.Google Scholar
Dolovich, LR, Addis, A, Vaillancourt, JMR, et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case–control studies. BMJ 1998; 317: 839–43.Google Scholar
Enato, E, Moretti, M, Koren, G. The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can 2011; 33: 46–8.Google Scholar
McElhatton, PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8: 461–75.Google Scholar
Cruz, SL. The latest evidence in the neuroscience of solvent misuse: an article written for service providers. Subst Use Misuse 2011; 46 (Suppl 1): 62–7.CrossRefGoogle ScholarPubMed
Hannigan, JH, Bowen, SE. Reproductive toxicology and teratology of abused toluene. Syst Biol Reprod Med 2010; 56: 184200.Google Scholar
Bowen, SE. Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 2011; 46 (Suppl 1): 6872.Google Scholar

Further Reading

Bleyer, WA, Breckenridge, RT. Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA 1970; 213: 2049–53.Google Scholar
Clayton-Smith, J, Donnai, D. Human malformations. In Rimoin, DL, Connor, JM, Pyeritz, RE (eds), Emery and Rimoin’s Principles and Practice of Medical Genetics, 3rd edn. New York, NY: Churchill Livingstone, 1996, p. 383.Google Scholar
Einarson, A, Pistelli, A, DeSantis, M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008; 165: 749–52.Google Scholar
Holmes, LB. Teratogen-induced limb defects. Am J Med Genet 2002; 112: 297303.Google Scholar
Marks, PW. Management of thromboembolism in pregnancy. Semin Perinatol 2007; 31: 227–31.Google Scholar
Matheson, I, Samseth, M, Sande, HA. Ampicillin in breast milk during puerperal infections. Eur J Clin Pharmacol 1988; 34: 657–9.CrossRefGoogle ScholarPubMed
Slone, D, Shapiro, S, Miettinen, O. Case–control surveillance of serious illnesses attributable to ambulatory drug use. In Colombo, F, Shapiro, S, Slone, D, Tognoni, G (eds), Epidemiological Evaluation of Drugs. Amsterdam: Elsevier-North Holland Biomedical, 1977, pp. 5970.Google Scholar
Spinillo, A, Viazzo, F, Colleoni, R, et al. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004; 191: 217–24.Google Scholar
Teixeira, NA, Lopes, RC, Secoli, SR. Developmental toxicity of lithium treatment at prophylactic levels. Braz J Med Biol Res 1995; 28: 230–9.Google Scholar
Weiner, CP, Mason, C. Drugs for Pregnant and Lactating Women, 3rd edn. Philadelphia, PA: Churchill Livingstone, 2020.Google Scholar

References

Buhimschi, CS, Weiner, CP. Medications in pregnancy and lactation. In Queenan, JT, Spong, CY, Lockwood, CJ (eds), Management of High Risk Pregnancy. An Evidence Based Approach, 5th edn. Malden, MA: Blackwell, 2007, pp. 3858.CrossRefGoogle Scholar
Plentl, AA, Gray, MJ. Total body water, sodium space and total exchangeable sodium in normal and toxemic pregnant women. Am J Obstet Gynecol 1959; 78: 472–8.Google Scholar
Verkeste, CM, Slangen, BF, Dubelaar, ML, et al. Mechanism of volume adaptation in the awake early pregnant rat. Am J Physiol 1998; 274: H1662–6.Google Scholar
Frederickson, MC. Physiologic changes in pregnancy and their effect on drug distribution. Semin Perinat 2001; 25: 120–3.Google Scholar
Spaanderman, ME, Meertens, M, van Bussel, M, et al. Cardiac output increases independently of basal metabolic rate in early human pregnancy. Am J Physiol Heart Circ Physiol 2000; 278: H1585– 8.Google Scholar
Robson, SC, Hunter, S, Boys, RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256: H1060–5.Google Scholar
Robson, SC, Mutch, E, Boys, RJ, et al. Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance. Br J Obstet Gynaecol 1990; 97: 720–4.Google Scholar
Everson, GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992; 21: 751–76.Google Scholar
American College of Obstetrics and Gynecology. Nausea and vomiting of pregnancy (Practice Bulletin No. 52). Obstet Gynecol 2004; 103: 803–14.Google Scholar
Anderson, GD. Using pharmacokinetics to predict the effects of pregnancy and maternal–infant transfer of drugs during lactation. Expert Opin Drug Metab Toxicol 2006; 2: 947–60.CrossRefGoogle ScholarPubMed
Wood, M, Wood, AJ. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981; 29: 522–6.Google Scholar
Shepard, TH, Lemire, RJ (eds). Catalog of Teratogenic Agents, 12th edn. Baltimore, MD: Johns Hopkins University Press, 2007.Google Scholar
Chambers, C, Weiner, CP. Teratogenesis and environmental exposure. In Creasy, RK, Resnik, R, Iams, JD, et al. (eds), Creasy & Resnik’s Maternal Fetal Medicine. Principles and Practice, 6th edn. Philadelphia, PA: Saunders Elsevier, 2009, pp. 347–59.Google Scholar
Buhimschi, CS, Weiner, CP. Medications in pregnancy and lactation: Part 1. Teratology. Obstet Gynecol 2009; 113: 166–88.Google ScholarPubMed
Clayton-Smith, J, Donnai, D. Human malformations. In Rimoin, DL, Connor, JM, Pyeritz, RE (eds), Emery and Rimoin’s Principles and Practice of Medical Genetics, 3rd edn. New York, NY: Churchill Livingstone, 1996, p. 383.Google Scholar
Cabrera, RM, Hill, DS, Etheredge, AJ, et al. Investigations into the etiology of neural tube defects. Birth Defects Res C Embryo Today 2004; 72: 330–44.Google Scholar
Kozer, E, Nikfar, S, Costei, A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002; 187: 1623–30.Google Scholar
Vermillion, ST, Scardo, JA, Lashus, AG, et al. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177: 256–9.Google Scholar
Warkany, J. Warfarin embryopathy. Teratology 1976; 14: 205–9.Google Scholar
Vitale, N, De Feo, M, De Santo, LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 33: 1637–41.Google Scholar
Kaplan, LC. Congenital Dandy–Walker malformation associated with first trimester warfarin: a case report and literature review. Teratology 1985; 32: 333–7.Google Scholar
Carney, EW, Scialli, AR, Watson, RE, et al. Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Birth Defects Res C Embryo Today 2004; 72: 345–60.Google Scholar
Giroux, M, Teixera, MG, Dumas, JC, et al. Influence of maternal blood flow on the placental transfer of three opioids: fentanyl, alfentanil, sufentanil. Biol Neonate 1997; 72: 133–41.Google Scholar
Ageno, W, Crotti, S, Turpie, AG. The safety of antithrombotic therapy during pregnancy. Expert Opin Drug Saf 2004; 3: 113–18.Google Scholar
Young, AM, Allen, CE, Audis, KL. Efflux transporters of the human placenta. Adv Drug Deliv Rev 2003; 55: 125–32.Google Scholar
Schatz, M. The efficacy and safety of asthma medications during pregnancy. Semin Perinatol 2001; 25: 145–52.Google Scholar
Yerby, M. The use of anticonvulsants during pregnancy. Semin Perinatol 2001; 25: 153–8.Google Scholar
Sibai, BM. Antihypertensive drugs during pregnancy. Semin Perinatol 2001; 25: 159–64.CrossRefGoogle ScholarPubMed
Newport, DJ, Wilcox, MM, Stowe, ZN. Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Semin Perinatol 2001; 25: 145–58.Google Scholar
McCartney, MA, Scinto, PL, Wang, SS, et al. Developmental effects of phenytoin may differ depending on sex of offspring. Neurotoxicol Teratol 1999; 21: 119–28.Google Scholar
Boncinelli, E. Homeobox genes and disease. Curr Opin Genet Dev 1997; 7: 331–7.Google Scholar
Zakany, J, Duboule, D. The role of Hox genes during vertebrate limb development. Curr Opin Genet Dev 2007; 17: 359–66.Google Scholar
Faiella, A, Wernig, M, Consalez, GG, et al. A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 2000; 9: 227–36.CrossRefGoogle ScholarPubMed
Suzuki, A, Urushitani, H, Sato, T, et al. Gene expression change in the Müllerian duct of the mouse fetus exposed to diethylstilbestrol in utero. Exp Biol Med (Maywood) 2007; 232: 503–14.Google Scholar
Addis, A, Sharabi, S, Bonati, M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf 2000; 23: 245–53.Google Scholar
Weiner CP. Introduction. In Weiner CP, Mason C (eds), Drugs for Pregnant and Lactating Women, 3rd edn. Philadelphia, PA: Saunders Elsevier, 2020.Google Scholar
American College of Obstetricians and Gynecologists. Viral hepatitis in pregnancy (Practice Bulletin No. 86). Obstet Gynecol 2007; 110: 941–56.Google Scholar
Sinclair SM, Jones JK, Miller RK, et al. The Ribavirin Pregnancy Registry: an interim analysis of potential teratogenicity at the mid-point of enrollment. Drug Saf 2017; 40: 1205–18. https://doi.org/10.1007/s40264-017-0566-6.Google Scholar
Chambers, CD, Braddock, SR, Briggs, GG, et al. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 2001; 64: 252–61.Google Scholar
Mitchell, AA. Systematic identification of drugs that cause birth defects: a new opportunity. N Engl J Med 2003; 349: 2556–9.Google Scholar
Kennedy, DL, Uhl, K, Kweder, SL. Pregnancy exposure registries. Drug Saf 2004; 27: 215228.Google Scholar
Briggs, GG, Polifka, J; Research Committee, Organization of Teratology Information Specialists. Better data needed from pregnancy registries. Birth Defects Res A Clin Mol Teratol 2009; 85: 109–11.Google Scholar
Källén, BA. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom (Kyoto) 2005; 45: 4451.Google Scholar
Slone, D, Shapiro, S, Miettinen, O. Case–control surveillance of serious illnesses attributable to ambulatory drug use. In Colombo, F, Shapiro, S, Slone, D, Tognoni, G (eds), Epidemiological Evaluation of Drugs. Amsterdam: Elsevier-North Holland Biomedical, 1977, pp. 5970.Google Scholar
Buhimschi, CS, Weiner, CP. Medications in pregnancy and lactation: Part 2. Drugs with minimal or unknown human teratogenic effect. Obstet Gynecol 2009; 113: 417–32.Google Scholar
Landon, MB. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol 2007; 50: 9981006.Google Scholar
Tomlinson, AJ, Campbell, J, Walker, JJ, et al. Malignant primary hypertension in pregnancy treated with lisinopril. Ann Pharmacother 2000; 34: 180–2.Google Scholar
August, P, Mueller, FB, Sealey, JE, et al. Role of renin–angiotensin system in blood pressure regulation in pregnancy. Lancet 1995; 345: 896–7.Google Scholar
Easterling, TR, Carr, DB, Davis, C, et al. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol 2000; 96: 956–61.Google Scholar
Tabacova, SA, Kimmel, CA. Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review. Reprod Toxicol 2001; 15: 467–78.Google ScholarPubMed
Miller, RK, Jessee, L, Barrish, A, et al. Pharmacokinetic studies of enalaprilat in the in vitro perfused human placental lobule system. Teratology 1998; 58: 7681.Google Scholar
Burrows, RF, Burrows, EA. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy. Aust N Z J Obstet Gynaecol 1998; 38: 306–11.Google Scholar
Centers for Disease Control and Prevention (CDC). Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy: United States, Canada, and Israel, 1987–1995. MMWR Morb Mortal Wkly Rep 1997; 46: 240–2.Google Scholar
Maliheh, K, Abdorrazagh, K, Armen, K, et al. Angiotensin converting enzyme inhibitors and aortic arch obstructive malformations. Indian J Med Sci 2006; 60: 417–20.Google Scholar
Boix, E, Zapater, P, Picó, A, et al. Teratogenicity with angiotensin II receptor antagonists in pregnancy. J Endocrinol Invest 2005; 28: 1029–31.Google Scholar
Cooper, WO, Hernandez-Diaz, S, Arbogast, PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443–51.Google Scholar
Laube, GF, Kemper, MJ, Schubiger, G, Neuhaus, TJ. Angiotensin-converting enzyme inhibitor fetopathy: long-term outcome. Arch Dis Child Fetal Neonatal Ed 2007; 92: F402–3.Google Scholar
Redman, CW, Kelly, JG, Cooper, WD. The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol 1990; 38: 99.Google Scholar
Devlin, RG, Fleiss, PM. Captopril in human blood and breast milk. J Clin Pharmacol 1981; 21: 110–13.Google Scholar
American College of Obstetricians and Gynecologists. Use of psychiatric medications during pregnancy and lactation (Practice Bulletin No. 92). Obstet Gynecol 2008; 111: 1001–20.Google Scholar
American College of Obstetricians and Gynecologists. Treatment with selective serotonin reuptake inhibitors during pregnancy (Committee Opinion No. 354). Obstet Gynecol 2006; 108: 1601–3.Google Scholar
Cohen, LS, Altshuler, LL, Harlow, BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499507.Google Scholar
Reefhuis, J, Devine, O, Friedman, JM, Louik, C, Honein, MA; National Birth Defects Prevention Study. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ 2015; 351: h3190.Google Scholar
Howard, LM, Hoffbrand, S, Henshaw, C, et al. Antidepressant prevention of postnatal depression. Cochrane Database Syst Rev 2005; (2): CD004363.Google Scholar
Heikkinen, T, Ekblad, U, Palo, P, Laine, K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003; 73: 330–7.Google Scholar
Wen, SW, Yang, Q, Garner, P, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194: 961–6.Google Scholar
Malm, H, Klaukka, T, Neuvonen, PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106: 1289–96.Google Scholar
Einarson, TR, Einarson, A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005; 14: 823–7.Google Scholar
Hendrick, V, Stowe, ZN, Altshuler, LL, et al. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160: 993–6.Google Scholar
Louik, C, Lin, AE, Werler, MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 356: 2675–83.Google Scholar
Bérard, A, Iessa, N, Chaabane, S, et al. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol 2016; 81: 589604.Google Scholar
Masarwa R, Bar-Oz B, Gorelik E, et al. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Am J Obstet Gynecol 2019; 220: 57.e1–57.e13. https://doi.org/10.1016/j.ajog.2018.08.030.Google Scholar
Einarson, A, Pistelli, A, DeSantis, M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008; 165: 749–52.Google Scholar
Einarson, A. Risks/safety of psychotropic medication use during pregnancy: Motherisk Update 2008. Can J Clin Pharmacol 2009; 16: e58–65.Google Scholar
Chambers, CD, Johnson, KA, Dick, LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010–15.Google Scholar
Bellissima V, Visser GHA, Ververs T, et al. Antenatal maternal antidepressants drugs treatment affects S100B levels in maternal-fetal biological fluids in a dose dependent manner. Clin Chim Acta 2020; 501 :20–6. https://doi.org/10.1016/j.cca.2019.11.027.Google Scholar
Zeskind, PS, Stephens, LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113: 368–75.Google Scholar
Stowe, ZN, Hostetter, AL, Owens, MJ, et al. The pharmacokinetics of sertraline excretion into human breast milk: Determinants of infant serum concentrations. J Clin Psychiatry 2003; 64: 7380.Google Scholar
Hendrick, V, Fukuchi, A, Altshuler, L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001; 179: 163–6.Google Scholar
Back, DJ, Bates, M, Bowden, A, et al. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception 1980; 22: 495503.Google Scholar
Crawford, P, Chadwick, D, Cleland, P, et al. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids. Contraception 1986; 33: 23–9.Google Scholar
Crawford, P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002; 16: 263–72.Google Scholar
Patsalos, PN, Berry, DJ, Bourgeois, BF, et al. Antiepileptic drugs— Best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008; 49: 1239–76.Google Scholar
McAuley, JW, Anderson, GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 2002; 41: 559–79.Google Scholar
Leppik, IE, Rask, CA. Pharmacokinetics of antiepileptic drugs during pregnancy. Semin Neurol 1988; 8: 240–6.Google Scholar
Eberhard-Gran, M, Eskild, A, Opjordsmoen, S. Treating mood disorders during pregnancy: safety considerations. Drug Saf 2005; 28: 695706.Google Scholar
Petrenaite, V, Sabers, A, Hansen-Schwartz, J. Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 2005; 65: 185–8.Google Scholar
Battino, D, Tomson, T. Management of epilepsy during pregnancy. Drugs 2007; 67: 2727–46.Google Scholar
Franco, V, Mazzucchelli, I, Gatti, G, et al. Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. Ther Drug Monit 2008; 30: 544–7.Google Scholar
Azarbayjani, F, Danielsson, BR. Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? Epilepsia 2002; 43: 457–68.Google Scholar
Jäger-Roman, E, Deichl, A, Jakob, S, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108: 9971004.Google Scholar
Kjaer, D, Horvath-Puhó, E, Christensen, J, et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case–control study. BJOG 2008; 115: 98103.Google Scholar
Nakamura, H, Ushigome, F, Koyabu, N, et al. Proton gradient-dependent transport of valproic acid in human placental brush-border membrane vesicles. Pharm Res 2002; 19: 154–61.Google Scholar
Clayton-Smith, J, Donnai, D. Fetal valproate syndrome. J Med Genet 1995; 32: 724–7.Google Scholar
Lindhout, D, Omtzigt, JG, Cornel, MC. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992; 42: 111–18.Google Scholar
Kozma, C. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet 2001; 98: 168–75.Google Scholar
Witters, I, Van Assche, F, Fryns, JP. Nuchal edema as the first sign of fetal valproate syndrome. Prenat Diagn 2002; 22: 834–5.Google Scholar
Pynnönen, S, Kanto, J, Sillanpää, M, et al. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol Toxicol (Copenh) 1977; 4: 244–53.Google Scholar
Matalon, S, Schechtman, S, Goldzweig, G, et al. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 2002; 16: 917Google Scholar
Moore, SJ, Turnpenny, P, Quinn, A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000; 37: 489–97.Google Scholar
Webster, WS, Howe, AM, Abela, D, et al. The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin. Curr Pharm Des 2006; 12: 1431–48.Google Scholar
Hanson, JW, Smith, DW. The fetal hydantoin syndrome. J Pediatr 1975; 87: 285–90.Google Scholar
Iqbal, MM, Sohhan, T, Mahmud, SZ. The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation. J Toxicol Clin Toxicol 2001; 39: 381–92.Google Scholar
Myllynen, PK, Pienimäki, PK, Vähäkangas, KH. Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo. Eur J Clin Pharmacol 2003; 58: 677–82.Google Scholar
Cunnington, M, Ferber, S, Quartey, G; International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007; 48: 1207–10.Google Scholar
Fotopoulou, C, Kretz, R, Bauer, S, et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res 2009; 85: 60–4.Google Scholar
Chaudron, LH. When and how to use mood stabilizers during breastfeeding. Prim Care Update Ob Gyns 2000; 7: 113–17.Google Scholar
Frey, B, Schubiger, G, Musy, JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr 1990; 150: 136–8.Google Scholar
Shimoyama, R, Ohkubo, T, Sugawara, K, et al. Monitoring of phenytoin in human breast milk, maternal plasma and cord blood plasma by solid-phase extraction and liquid chromatography. J Pharm Biomed Anal 1998; 17: 863–9.Google Scholar
Kessler, RC, Berglund, P, Demler, O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593602.Google Scholar
Iqbal, MM, Sobhan, T, Ryals, T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 2002; 53: 3949.Google Scholar
Belfort, MA, Anthony, J, Saade, GR. Prevention of eclampsia. Semin Perinatol 1999; 23: 6578.Google Scholar
Duley, L, Gulmezoglu, AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev 2001; (1): CD002960.Google Scholar
Duley, L, Henderson-Smart, D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2003; (4): CD000127.Google Scholar
Yaris, F, Kadioglu, M, Kesim, M, et al. Newer antidepressants in pregnancy: Prospective outcome of a case series. Reprod Toxicol 2004; 19: 235–8.Google Scholar
Eros, E, Czeizel, AE, Rockenbauer, M, et al. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2002; 101: 147–54.Google Scholar
Blotière PO, Raguideau F, Weill A, et al. Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology 2019; 93: e167–80. https://doi.org/10.1212/WNL.0000000000007696.Google Scholar
Lim, EC, Seet, RC, Wilder-Smith, EP, et al. Dystonia gravidarum: a new entity? Mov Disord 2006; 21: 6970.Google Scholar
Kanto, J, Erkkola, R. The feto-maternal distribution of diazepam in early human pregnancy. Ann Chir Gynaecol Fenn 1974; 63: 489491.Google Scholar
Saxén, I. Cleft palate and maternal diphenhydramine intake. Lancet 1974; 1: 407–8.Google Scholar
Rosenberg, L, Mitchell, AA, Parsells, JL, et al. Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 1983; 309: 1282–5.Google Scholar
Gonzalez de Dios, J, Moya-Benavent, M, Carratala-Marco, F. “Floppy infant” syndrome in twins secondary to the use of benzodiazepines during pregnancy. Rev Neurol 1999; 29: 121–3.Google Scholar
St. Clair, SM, Schirmer, RG. First-trimester exposure to alprazolam. Obstet Gynecol 1992; 80: 843–6.Google Scholar
García-Algar, O, López-Vílchez, MA, Martín, I, et al. Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis. Clin Toxicol (Phila) 2007; 45: 295–8.Google Scholar
Fisher, JB, Edgren, BE, Mammel, MC, et al. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol 1985; 66: 34S35S.Google Scholar
McElhatton, PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8: 461–75.Google Scholar
Oo, CY, Kuhn, RJ, Desai, N, et al. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br J Clin Pharmacol 1995; 40: 231–6.Google Scholar
Kart Koseoglu, H, Yucel, AE, Kunefeci, G, et al. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 2001; 10: 818–20.Google Scholar
Ozalp, SS, Yalcin, OT, Tanir, HM. A hospital-based multicentric study results on gestational trophoblastic disease management status in a developing country. Eur J Gynaecol Oncol 2001; 22: 221–2.Google Scholar
Peters, BG, Bray, JJ, Masidonski, P, et al. Issues surrounding adjuvant chemotherapy for breast cancer during pregnancy. Oncol Nurs Forum 2001; 28: 639–42.Google Scholar
Enns, GM, Roeder, E, Chan, RT, et al. Apparent cyclophosphamide (Cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 1999; 86: 237–41.Google Scholar
Meirow, D, Epstein, M, Lewis, H, et al. Administration of cyclophosphamide at different stages of follicular maturation in mice: Effects on reproductive performance and fetal malformations. Hum Reprod 2001; 16: 632–7.Google Scholar
Paskulin, GA, Gazzola Zen, PR, de Camargo Pinto, LL, et al. Combined chemotherapy and teratogenicity. Birth Defects Res A Clin Mol Teratol 2005; 73: 634–7.Google Scholar
Ostensen, M. Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation. Am J Reprod Immunol 1992; 28: 148–52.Google Scholar
Amato, D, Niblett, JS. Neutropenia from cyclophosphamide in breast milk. Med J Aust 1977; 1: 383–4.Google Scholar
Hammond, MG, Hammond, CB, Parker, RT. Conservative treatment of endometriosis externa: The effects of methyltestosterone therapy. Fertil Steril 1978; 29: 651–4.Google Scholar
Penteado, SR, Fonseca, AM, Bagnoli, VR, et al. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women. Climacteric 2008; 11: 1725.Google Scholar
Borgatta, L, Murthy, A, Chuang, C, et al. Pregnancies diagnosed during Depo-Provera use. Contraception 2002; 66: 169–72.Google Scholar
Bianchi, S, Busacca, M, Agnoli, B, et al. Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study. Hum Reprod 1999; 14: 1335–7.Google Scholar
Shane, BS, Dunn, HO, Kenney, RM, et al. Methyl testosterone-induced female pseudohermaphroditism in dogs. Biol Reprod 1969; 1: 41–8.Google Scholar
Grote, K, Stahlschmidt, B, Talsness, CE, et al. Effects of organotin compounds on pubertal male rats. Toxicology 2004; 202: 145158.Google Scholar
Tuffli, GA. Testosterone and micropenis. J Pediatr 1974; 84: 927.Google Scholar
Duck, SC, Katayama, KP. Danazol may cause female pseudohermaphroditism. Fertil Steril 1981; 35: 230–1.Google Scholar
Minh, HN, Belaisch, J, Smadja, A. Female pseudohermaphroditism. Presse Med 1993; 22: 1735–40.Google Scholar
Kingsbury, AC. Danazol and fetal masculinization: a warning. Med J Aust 1985; 143: 410–11.Google Scholar
Rosa, FW. Virilization of the female fetus with maternal danazol exposure. Am J Obstet Gynecol 1984; 149: 99100.Google Scholar
Baheiraei, A, Ardsetani, N, Ghazizadeh, S. Effects of progestogen-only contraceptives on breast-feeding and infant growth. Int J Gynaecol Obstet 2001; 74: 203–5.Google Scholar
Ratchanon, S, Taneepanichskul, S. Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women. Obstet Gynecol 2000; 96: 926–8.Google Scholar
Kaya, H, Babar, Y, Ozmen, S, et al. Intratubal methotrexate for prevention of persistent ectopic pregnancy after salpingotomy. J Am Assoc Gynecol Laparosc 2002; 9: 464–7.Google Scholar
Kulier, R, Gulmezoglu, AM, Hofmeyr, GJ, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004; (2): CD002855.Google Scholar
Creinin, MD, Wiebe, E, Gold, M. Methotrexate and misoprostol for early abortion in adolescent women. J Pediatr Adolesc Gynecol 1999; 12: 71–7.Google Scholar
Gracia, CR, Brown, HA, Barnhart, KT. Prophylactic methotrexate after linear salpingostomy: a decision analysis. Fertil Steril 2001; 76: 1191–5.Google Scholar
Dilbaz, S, Caliskan, E, Dilbaz, B, et al. Predictors of methotrexate treatment failure in ectopic pregnancy. J Reprod Med 2006; 51: 8793.Google Scholar
Yedlinsky, NT, Morgan, FC, Whitecar, PW. Anomalies associated with failed methotrexate and misoprostol termination. Obstet Gynecol 2005; 105: 1203–5Google Scholar
Del Campo, M, Kosaki, K, Bennett, FC, et al. Developmental delay in fetal aminopterin/methotrexate syndrome. Teratology 1999; 60: 1012.Google Scholar
Sorosky, JI, Sood, AK, Buekers, TE. The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am 1997; 24: 591–9.Google Scholar
Ostensen, M, Motta, M. Therapy insight: the use of antirheumatic drugs during nursing. Nat Clin Pract Rheumatol 2007; 3: 400–6.Google Scholar
Koren, G, Soldin, O. Therapeutic drug monitoring of antithyroid drugs in pregnancy: The knowledge gaps. Ther Drug Monit 2006; 28: 1213.Google Scholar
Azizi, F. The safety and efficacy of antithyroid drugs. Expert Opin Drug Saf 2006; 5: 107–16.Google Scholar
Mestman, JH. Diagnosis and management of maternal and fetal thyroid disorders. Curr Opin Obstet Gynecol 1999; 11: 167–75.Google Scholar
American College of Obstetrics and Gynecology. Thyroid disease in pregnancy (Practice Bulletin No. 37). Int J Gynaecol Obstet 2002; 79: 171–80.Google Scholar
Chattaway, JM, Klepser, TB. Propylthiouracil versus methimazole in treatment of Graves’ disease during pregnancy. Ann Pharmacother 2007; 41: 1018–22.Google Scholar
Takata, K, Kubota, S, Fukata, S, et al. Methimazole-induced agranulocytosis in patients with Graves’ disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 2009; 19: 559–63.Google Scholar
McNab, T, Ginsberg, J. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves’ disease. Clin Invest Med 2005; 28: 127–31.Google Scholar
Azizi, F, Khamseh, ME, Bahreynian, M, et al. Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 2002; 25: 586–9.Google Scholar
Messer, PM, Hauffa, BP, Olbricht, T, et al. Antithyroid drug treatment of Graves’ disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) 1990; 123: 311–16.Google Scholar
Nakamura, S, Nishikawa, T, Isaji, M, et al. Aplasia cutis congenita and skull defects after exposure to methimazole in utero. Intern Med 2005; 44: 1202–3.Google Scholar
Karg, E, Bereg, E, Gaspar, L, et al. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol 2004; 21: 491–4Google Scholar
Johansen, K, Andersen, AN, Kampmann, JP, et al. Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982; 23: 339–41.Google Scholar
Cooper, DS. Antithyroid drugs: to breast-feed or not to breast-feed. Am J Obstet Gynecol 1987; 157: 234–5Google Scholar
Azizi, F, Bahrainian, M, Khamseh, ME, et al. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab 2003; 16: 1239–43.Google Scholar
Shepard, TH, Brent, RL, Friedman, JM, et al. Update on new developments in the study of human teratogens. Teratology 2002; 65: 153–61.Google Scholar
Suri, V, Sawhney, H, Vasishta, K, et al. Pregnancy following cardiac valve replacement surgery. Int J Gynaecol Obstet 1999; 64: 239–46.Google Scholar
Marks, PW. Management of thromboembolism in pregnancy. Semin Perinatol 2007; 31: 227–31.Google Scholar
Vitale, N, De Feo, M, Cotrufo, M. Anticoagulation for prosthetic heart valves during pregnancy: the importance of warfarin daily dose. Eur J Cardiothorac Surg 2002; 22: 656.Google Scholar
Hall, JG, Pauli, RM, Wilson, KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122–40.Google Scholar
Tyagi, A, Bhattacharya, A. Central neuraxial blocks and anticoagulation: a review of current trends. Eur J Anaesthesiol 2002; 19: 317–29.Google Scholar
Zakzouk, MS. The congenital warfarin syndrome. J Laryngol Otol 1986; 100: 215–19.Google Scholar
Wesseling, J, Van Driel, D, Smrkovsky, M, et al. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 2001; 63: 8395.Google Scholar
Dardick, KR. Warfarin during lactation. Conn Med 1980; 44: 693.Google Scholar
Orme, ML, Lewis, PJ, de Swiet, M, et al. May mothers given warfarin breast-feed their infants? Br Med J 1977; 1: 1564–5.Google Scholar
Carney, SM, Goodwin, GM. Lithium—A continuing story in the treatment of bipolar disorder. Acta Psychiatr Scand Suppl 2005; 426: 712.Google Scholar
Viguera, AC, Nonacs, R, Cohen, LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157: 179–84.Google Scholar
Gelenberg, AJ. Lithium efficacy and adverse effects. J Clin Psychiatry 1988; 49 (Suppl): 811.Google Scholar
Teixeira, NA, Lopes, RC, Secoli, SR. Developmental toxicity of lithium treatment at prophylactic levels. Braz J Med Biol Res 1995; 28: 230–9.Google Scholar
Pinelli, JM, Symington, AJ, Cunningham, KA, et al. Case report and review of the perinatal implications of maternal lithium use. Am J Obstet Gynecol 2002; 187: 245–9.Google Scholar
Giles, JJ, Bannigan, JG. Teratogenic and developmental effects of lithium. Curr Pharm Des 2006; 12: 1531–41.Google Scholar
Jacobson, SJ, Jones, K, Johnson, K, et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339: 530–3.Google Scholar
Cohen, LS, Friedman, JM, Jefferson, JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146–50.Google Scholar
van Gent, EM, Verhoeven, WM. Bipolar illness, lithium prophylaxis, and pregnancy. Pharmacopsychiatry 1992; 25: 187–91.Google Scholar
Poels EMP, Bijma HH, Galbally M, Bergink V. Lithium during pregnancy and after delivery: a review. Int J Bipolar Disord 2018; 6: 26. https://doi.org/10.1186/s40345-018-0135-7.Google Scholar
Newmark RL, Bogen DL, Wisner KL, et al. Risk-Benefit assessment of infant exposure to lithium through breast milk: a systematic review of the literature. Int Rev Psychiatry 2019; 31: 295–304. https://doi.org/10.1080/09540261.2019.1586657.Google Scholar
Viguera, AC, Newport, DJ, Ritchie, J, et al. Lithium in breast milk and nursing infants: Clinical implications. Am J Psychiatry 2007; 164: 342–5.Google Scholar
Eroglu, D, Oktem, M, Yanik, F, et al. Labor induction at term: a comparison of the effects of 50 microg and 25 microg vaginal misoprostol. Clin Exp Obstet Gynecol 2007; 34: 102–5.Google Scholar
Dodd, JM, Crowther, CA, Robinson, JS. Oral misoprostol for induction of labour at term: Randomised controlled trial. BMJ 2006; 332: 509–13.Google Scholar
Zikopoulos, KA, Papanikolaou, EG, Kalantaridou, SN, et al. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Hum Reprod 2002; 17: 3079–83.Google Scholar
American College of Obstetrics and Gynecology. New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy (Committee Opinion. No. 283). Obstet Gynecol 2003; 10: 1049–50.Google Scholar
Alfirevic, Z, Weeks, A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2006; (2): CD001338.Google Scholar
Vogel, D, Burkhardt, T, Rentsch, K, et al. Misoprostol versus methylergometrine: Pharmacokinetics in human milk. Am J Obstet Gynecol 2004; 191: 2168–73Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. Obstet Gynecol 2019; 133: e128–50. https://doi.org/10.1097/AOG.0000000000003072.Google Scholar
Back, DJ, Breckenridge, AM, Crawford, F, et al. The effect of rifampicin on norethisterone pharmacokinetics. Eur J Clin Pharmacol 1979; 15: 193–7.Google Scholar
Nora, JJ, Nora, AH. Can the pill cause birth defects (editorial)? N Engl J Med 1974; 291: 731–2.Google Scholar
Jellesen, R, Andersen, AM. Prenatal exposure to birth control pills: Risk of fetal death and congenital malformations. Ugeskr Laeger 2006; 168: 2437–42.Google Scholar
Pardthaisong, T, Gray, RH. In utero exposure to steroid contraceptives and outcome of pregnancy. Am J Epidemiol 1991; 134: 795803.Google Scholar
Yovich, JL, Turner, SR, Draper, R. Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects. Teratology 1988; 38: 135–44.Google Scholar
Abroms, L, Maibach, E, Lyon-Daniel, K, et al. What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med 2006; 3: e483.Google Scholar
Brinker, A, Kornegay, C, Nourjah, P. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the Accutane SMART program. Arch Dermatol 2005; 141: 563–9.Google Scholar
Schaefer, C, Meister, R, Weber-Schoendorfer, C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet 2010; 281: 221–7.Google Scholar
Charakida, A, Mouser, PE, Chu, AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf 2004; 3: 119–29.Google Scholar
Iagaru, A, McDougall, IR. Treatment of thyrotoxicosis. J Nucl Med 2007; 48: 379–89.Google Scholar
Pauwels, EK, Thomson, WH, Blokland, JA, et al. Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders. Eur J Nucl Med 1999; 26: 1453–7.Google Scholar
McClellan, DR, Francis, GL. Thyroid cancer in children, pregnant women, and patients with Graves’ disease. Endocrinol Metab Clin North Am 1996; 25: 2748.Google Scholar
Smithells, RW, Newman, CG. Recognition of thalidomide defects. J Med Genet 1992; 29: 716–23.Google Scholar
Kastritis, E, Palumbo, A, Dimopoulos, MA. Treatment of relapsed/refractory multiple myeloma. Semin Hematol 2009; 46: 143–57.Google Scholar
Srinivasan, R, Akobeng, AK. Thalidomide and thalidomide analogues for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 2009; (2): CD007350.Google Scholar
Panjwani, S. Early diagnosis and treatment of discoid lupus erythematosus. J Am Board Fam Med 2009; 22: 206213.Google Scholar
Teo, SK, Harden, JL, Burke, AB, et al. Thalidomide is distributed into human semen after oral dosing. Drug Metab Dispos 2001; 29: 1355–7.Google Scholar
Holmes, LB. Teratogen-induced limb defects. Am J Med Genet 2002; 112: 297303.Google Scholar
Rainsford, KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007; 42: 327.Google Scholar
Everson, GW, Krenzelok, EP. Chronic salicylism in a patient with juvenile rheumatoid arthritis. Clin Pharm 1986; 5: 334–41.Google Scholar
Li, DK, Liu, L, Odouli, R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: Population based cohort study. BMJ 2003; 327: 368.Google Scholar
Kozer, E, Costei, AM, Boskovic, R, et al. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res B Dev Reprod Toxicol 2003; 68: 7084.Google Scholar
James, AH, Brancazio, LR, Price, T. Aspirin and reproductive outcomes. Obstet Gynecol Surv 2008; 63: 4957.Google Scholar
Nadar, S, Blann, AD, Lip, GY. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. Am J Hypertens 2006; 19: 970–7.Google Scholar
Empson, M, Lassere, M, Craig, JC, et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002; 99: 135–44.Google Scholar
Di Nisio, M, Peters, L, Middeldorp, S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2005; (2): CD004734.Google Scholar
Farquharson, RG, Quenby, S, Greaves, M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100: 408–13.Google Scholar
Caritis, S, Sibai, B, Hauth, J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. N Engl J Med 1998; 338: 701–5.Google Scholar
Vainio, M, Kujansuu, E, Iso-Mustajarvi, M, et al. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002; 109: 161–7.Google Scholar
Bujold, E, Roberge, S, Nicolaides, KH. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn. 2014; 34: 642–8.Google Scholar
Acetylcysteine (Acetadote) for acetaminophen overdosage. Med Lett Drugs Ther 2005; 47: 70–1.Google Scholar
Sunshine, A, Olson, NZ, O’Neill, E, et al. Analgesic efficacy of a hydrocodone with ibuprofen combination compared with ibuprofen alone for the treatment of acute postoperative pain. J Clin Pharmacol 1997; 37: 908–15.Google Scholar
Wiebe, ER, Rawling, M. Pain control in abortion. Int J Gynaecol Obstet 1995; 50: 41–6.Google Scholar
Anderson, DF, Phernetton, TM, Rankin, JH. The placental transfer of acetylsalicylic acid in near-term ewes. Am J Obstet Gynecol 1980; 136: 814–18.Google Scholar
Martinez-Frias, ML, Rodriguez-Pinilla, E, Prieto, L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 1997; 56: 241–3.Google Scholar
Kirshon, B, Moise, KJ Jr, Wasserstrum, N. Effect of acetaminophen on fetal acid-base balance in chorioamnionitis. J Reprod Med 1989; 34: 955–9.Google Scholar
Golden, NL, King, KC, Sokol, RJ. Propoxyphene and acetaminophen: possible effects on the fetus. Clin Pediatr (Phila) 1982; 21: 752–4.Google Scholar
Adjei, AA, Gaedigk, A, Simon, SD, et al. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol 2008; 82: 155–65.Google Scholar
Collins, E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981; 58: 57S62S.Google Scholar
Thomas, RL, Parker, GC, Van Overmeire, B, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005; 164: 135–40.Google Scholar
Bar-Oz, B, Bulkowstein, M, Benyamini, L, et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf 2003; 26: 925–35.Google Scholar
Bleyer, WA, Breckenridge, RT. Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA 1970; 213: 2049–53.Google Scholar
Spigset, O, Hagg, S. Analgesics and breast-feeding: safety considerations. Paediatr Drugs 2000; 2: 223–38.Google Scholar
Mitchell, JL. Use of cough and cold preparations during breastfeeding. J Hum Lact 1999; 15: 347–9.Google Scholar
Watson-Jones, D, Gumodoka, B, Weiss, H, et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 2002; 186: 948–57.Google Scholar
Michelow, IC, Wendel, GD, Norgard, MV, et al. Central nervous system infection in congenital syphilis. N Engl J Med 2002; 346: 1792–8.Google Scholar
Ballard, RC, Berman, SM, Fenton, KA. Azithromycin versus penicillin for early syphilis. N Engl J Med 2006; 354: 203–5.Google Scholar
Boyer, KM, Gotoff, SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665–9.Google Scholar
Stauffer, UG. Tooth changes caused by tetracycline in the fetus, infant and child. Schweiz Med Wochenschr 1967; 97: 291–3.Google Scholar
Bothamley, G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24: 553–65.Google Scholar
Centers for Disease Control and Prevention (CDC). Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. MMWR Morb Mortal Wkly Rep 2001; 50: 960.Google Scholar
Ludlam, H, Wreghitt, TG, Thornton, S, et al. Q fever in pregnancy. J Infect 1997; 34: 75–8.Google Scholar
El-Tabbakh, GH, Elejalde, BR, Broekhuizen, F. Primary syphilis and nonimmune fetal hydrops in a penicillin-allergic woman. A case report. J Reprod Med 1994; 39: 412–14.Google Scholar
Smith, JR, Taylor-Robinson, D. Infection due to Chlamydia trachomatis in pregnancy and the newborn. Baillieres Clin Obstet Gynaecol 1993; 7: 237–55.Google Scholar
American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Sexually transmitted diseases in adolescents (Committee Opinion No. 30). Obstet Gynecol 2004; 104: 891–8.Google Scholar
Connell, W, Miller, A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 1999; 21: 311–23.Google Scholar
Gulmezoglu, AM. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 2002; (3): CD000220.Google Scholar
Klebanoff, MA, Hauth, JC, MacPherson, CA, et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004; 190: 363–70.Google Scholar
Klebanoff, MA, Hillier, SL, Nugent, RP, et al.; National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol 2005; 192: 470–7.Google Scholar
Okun, N, Gronau, KA, Hannah, ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005; 105: 857–68.Google Scholar
Hauth, JC, Goldenberg, RL, Andrews, WW, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732–6.Google Scholar
Carey, JC, Klebanoff, MA, Hauth, JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342: 534–40.Google Scholar
Goldenberg, RL, Klebanoff, M, Carey, JC, et al. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol 2001; 185: 485–6.Google Scholar
Klebanoff, MA, Carey, JC, Hauth, JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487–93.Google Scholar
Shennan, A, Crawshaw, S, Briley, A, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 2006; 113: 6574.Google Scholar
McGregor, JA, French, JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000; 55(5 Suppl 1): S1–19.Google Scholar
Pacifici, GM. Placental transfer of antibiotics administered to the mother: a review. Int J Clin Pharmacol Ther 2006; 44: 5763.Google Scholar
Elek, E, Ivan, E, Arr, M. Passage of penicillins from mother to foetus in humans. Int J Clin Pharmacol 1972; 6: 223–8.Google Scholar
Dashe, JS, Gilstrap, LC. Antibiotic use in pregnancy. Obstet Gynecol Clin North Am 1997; 24: 617–29.Google Scholar
Klastersky-Genot, MT. Effects of tetracycline, administered during pregnancy, on the deciduous teeth: a double blind controlled study. Acta Stomatol Belg 1970; 67: 107–24.Google Scholar
Czeizel, AE, Rockenbauer, M. Teratogenic study of doxycycline. Obstet Gynecol 1997; 89: 524–8.Google Scholar
Polachek, H, Holcberg, G, Sapir, G, et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 2005; 122: 61–5.Google Scholar
Berkovitch, M, Pastuszak, A, Gazarian, M, et al. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 535–8.Google Scholar
Peled, Y, Friedman, S, Hod, M, et al. Ofloxacin during the second trimester of pregnancy. DICP 1991; 25: 1181–2.Google Scholar
Heisterberg, L. Placental transfer of metronidazole in the first trimester of pregnancy. J Perinat Med 1984; 12: 43–5.Google Scholar
Nau, H. Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. Dev Pharmacol Ther 1987; 10: 174198.Google Scholar
Matheson, I, Samseth, M, Sande, HA. Ampicillin in breast milk during puerperal infections. Eur J Clin Pharmacol 1988; 34: 657–9.Google Scholar
Hendeles, L, Trask, P. Tetracycline and lactation. J Am Dent Assoc 1983; 107: 12, 14.Google Scholar
Giamarellou, H, Kolokythas, E, Petrikkos, G, et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989; 87: 49S51S.Google Scholar
Harmon, T, Burkhart, G, Applebaum, H. Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg 1992; 27: 744–6.Google Scholar
Passmore, CM, McElnay, JC, Rainey, EA, et al. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988; 26: 4551.Google Scholar
Wendel, PJ, Ramin, SM, Barnett-Hamm, C, et al. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol 1996; 175: 150–4.Google Scholar
Pongrojpaw, D, Somprasit, C, Chanthasenanont, A. A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. J Med Assoc Thai 2007; 90: 1703–9.Google Scholar
Aubé, M. Migraine in pregnancy. Neurology 1999; 53: S26–8.Google Scholar
Hay, TB, Wood, C. The effect of dimenhydrinate on uterine contractions. Aust N Z J Obstet Gynaecol 1967; 7: 81–9.Google Scholar
Andrade, SE, Raebel, MA, Brown, J, et al. Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf 2008; 17: 240–7.Google Scholar
ACOG Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 122: 1122–31.Google Scholar
Williamson, JD, Supiano, MA, Applegate, WB, et al.; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016; 315: 2673–82.Google Scholar
Borghi, C, Esposti, DD, Cassani, A, et al. The treatment of hypertension in pregnancy. J Hypertens Suppl 2002; 20: S52–6.Google Scholar
Kirsten, R, Nelson, K, Kirsten, D, Heintz, B. Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet 1998; 35: 936.Google Scholar
Livingstone, I, Craswell, PW, Bevan, EB, et al. Propranolol in pregnancy three year prospective study. Clin Exp Hypertens B 1983; 2: 341–50.Google Scholar
Scardo, JA, Vermillion, ST, Newman, RB, et al. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. Am J Obstet Gynecol 1999; 181: 862–6.Google Scholar
Hennessy, A, Thornton, CE, Makris, A, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT Trial. Aust N Z J Obstet Gynaecol 2007; 47: 279–85.Google Scholar
Vigil-De Gracia, P, Ruiz, E, López, JC, et al. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy 2007; 26: 163–71.Google Scholar
Duley, L, Henderson-Smart, DJ, Meher, S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006; (3): CD001449.Google Scholar
Caswell, HT, Marks, AD, Channick, BJ. Propranolol for the preoperative preparation of patients with thyrotoxicosis. Surg Gynecol Obstet 1978; 146: 908–10.Google Scholar
Sukenik, S, Biale, Y, Ben-Aderet, N, et al. Successful control of pheochromocytoma in pregnancy. Eur J Obstet Gynecol Reprod Biol 1979; 9: 249–51.Google Scholar
Bott-Kanner, G, Schweitzer, A, Reisner, SH, et al. Propranolol and hydrallazine in the management of essential hypertension in pregnancy. Br J Obstet Gynaecol 1980; 87: 110–14.Google Scholar
Elhassan, EM, Mirghani, OA, Habour, AB, et al. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J 2002; 79: 172–5.Google Scholar
Gunenc, O, Cicek, N, Gorkemli, H, et al. The effect of methyldopa treatment on uterine, umblical and fetal middle cerebral artery blood flows in preeclamptic patients. Arch Gynecol Obstet 2002; 266: 141–4.Google Scholar
Houlihan, DD, Dennedy, MC, Ravikumar, N, et al. Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance. J Perinat Med 2004; 32: 315–19.Google Scholar
Olsen, KS, Beier-Holgersen, R. Fetal death following labetalol administration in pre-eclampsia. Acta Obstet Gynecol Scand 1992; 71: 145–7.Google Scholar
Crooks, BN, Deshpande, SA, Hall, C, et al. Adverse neonatal effects of maternal labetalol treatment. Arch Dis Child Fetal Neonatal Ed 1998; 79: F150–1.Google Scholar
Hjertberg, R, Faxelius, G, Belfrage, P. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants. Acta Obstet Gynecol Scand 1993; 72: 611–15.Google Scholar
Bowman, ML, Bergmann, M, Smith, JF. Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid 1998; 8: 795–6.Google Scholar
Beardmore, KS, Morris, JM, Gallery, ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 2002; 21: 8595.Google Scholar
Munshi, UK, Deorari, AK, Paul, VK, et al. Effects of maternal labetalol on the newborn infant. Indian Pediatr 1992; 29: 1507–12.Google Scholar
Reichmuth, D, Lockey, RF. Present and potential therapy for allergic rhinitis: a review. BioDrugs 2000; 14: 371–87.Google Scholar
Chanda, M, Mackenzie, P, Day, JH. Hypersensitivity reactions following laminaria placement. Contraception 2000; 62: 105– 6.Google Scholar
Stafford, CT, Lobel, SA, Fruge, BC, et al. Anaphylaxis to human serum albumin. Ann Allergy 1988; 61: 85–8.Google Scholar
Miller, AA. Diphenhydramine toxicity in a newborn: a case report. J Perinatol 2000; 20: 390–1.Google Scholar
American College of Obstetrics and Gynecology. Management of herpes in pregnancy (Practice Bulletin No. 82). Obstet Gynecol 2007; 109: 1489–98.Google Scholar
Scott, LL, Hollier, LM, McIntire, D, et al. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 2002; 10: 71–7.Google Scholar
Little, SE, Caughey, AB. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis. Am J Obstet Gynecol 2005; 193: 1274–9.Google Scholar
Kimberlin, DF, Weller, S, Whitley, RJ, et al. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 1998; 179: 846–51.Google Scholar
Laerum, OD. Toxicology of acyclovir. Scand J Infect Dis Suppl 1985; 47: 40–3.Google Scholar
Sheffield, JS, Fish, DN, Hollier, LM, et al. Acyclovir concentrations in human breast milk after valaciclovir administration. Am J Obstet Gynecol 2002; 186: 100–2.Google Scholar
Silver, RK, MacGregor, SN, Sholl, JS, et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411–17.Google Scholar
Lieman, JM, Brumfield, CG, Carlo, W, et al. Preterm premature rupture of membranes: Is there an optimal gestational age for delivery? Obstet Gynecol 2005; 105: 1217Google Scholar
Walfisch, A, Hallak, M, Mazor, M. Multiple courses of antenatal steroids: Risks and benefits. Obstet Gynecol 2001; 98: 491–7.Google Scholar
Garite, TJ, Kurtzman, J, Maurel, K, et al.; Obstetrix Collaborative Research Network. Impact of a “rescue course” of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009; 200: 248.e1–9.Google Scholar
Egerman, RS, Mercer, BM, Doss, JL, et al. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol 1998; 179: 1120–3.Google Scholar
Gurbuz, A, Karateke, A, Ozturk, G, et al. Is 1-hour glucose screening test reliable after a short-term administration of antenatal betamethasone? Am J Perinatol 2004; 21: 415–20.Google Scholar
Elliott, JP, O’Keeffe, DF, Greenberg, P, et al. Pulmonary edema associated with magnesium sulfate and betamethasone administration. Am J Obstet Gynecol 1979; 134: 717–19.Google Scholar
Mushkat, Y, Ascher-Landsberg, J, Keidar, R, et al. The effect of betamethasone versus dexamethasone on fetal biophysical parameters. Eur J Obstet Gynecol Reprod Biol 2001; 97: 50–2.Google Scholar
Wapner, RJ, Sorokin, Y, Thom, EA, et al.; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: Evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 195: 633–42.Google Scholar
Fujii, Y, Uemura, A. Dexamethasone for the prevention of nausea and vomiting after dilatation and curettage: A randomized controlled trial. Obstet Gynecol 2002; 99: 5862.Google Scholar
Martin, JN, Thigpen, BD, Rose, CH, et al. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003; 189: 830–4.Google Scholar
Fonseca, JE, Mendez, F, Catano, C, et al. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2005; 193: 1591–8.Google Scholar
Addison, RS, Maguire, DJ, Mortimer, RH, et al. Metabolism of prednisolone by the isolated perfused human placental lobule. J Steroid Biochem Mol Biol 1991; 39: 8390.Google Scholar
Lockshin, MD, Sammaritano, LR. Corticosteroids during pregnancy. Scand J Rheumatol Suppl 1998; 107: 136–8.Google Scholar
Walker, BE. Induction of cleft palate in rats with antiinflammatory drugs. Teratology 1971; 4: 3942.Google Scholar
Park-Wyllie, L, Mazzotta, P, Pastuszak, A, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.Google Scholar
Carmichael, SL, Shaw, GM, Ma, C, et al.; National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197: 585.e1–7.Google Scholar
Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994; 12 (2): 1–24.Google Scholar
Spinillo, A, Viazzo, F, Colleoni, R, et al. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004; 191: 217–24.Google Scholar
Huang, WL, Harper, CG, Evans, SF, et al. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci 2001; 19: 415–25.Google Scholar
Whitelaw, A, Thoresen, M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000; 83: F154–7.Google Scholar
Rotmensch, S, Lev, S, Kovo, M, et al. Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study. Fetal Diagn Ther 2005; 20: 371–6.Google Scholar
Hayes, EJ, Paul, DA, Stahl, GE, et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol 2008; 111: 921–6.Google Scholar
American College of Obstetricians and Gynecologists, Committee Opinion: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2002; 99: 871–3.Google Scholar
Mulder, EJ, Derks, JB, Visser, GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol 1997; 104: 1239–47.Google Scholar
Costedoat-Chalumeau, N, Georgin-Lavialle, S, Amoura, Z, et al. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus 2005; 14: 660–4.Google Scholar
Hughes, I. Prenatal treatment of congenital adrenal hyperplasia: Do we have enough evidence? Treat Endocrinol 2006; 5: 16.Google Scholar
Brook, CG. Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia. Arch Dis Child Fetal Neonatal Ed 2000; 82: F176–81.Google Scholar
Leman, J, Burden, A. Treatment of severe psoriasis with infliximab. Ther Clin Risk Manag 2008; 4: 1165–76.Google Scholar
Teshima, CW, Thompson, A, Dhanoa, L, et al. Long-term response rates to infliximab therapy for Crohn’s disease in an outpatient cohort. Can J Gastroenterol 2009; 23: 348–52.Google Scholar
Allaart, CF, Breedveld, FC, Dijkmans, BA. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt Study. J Rheumatol Suppl 2007; 80: 2533.Google Scholar
O’Donnell, S, O’Morain, C. Use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment Pharmacol Ther 2008; 27: 885–94.Google Scholar
Mahadevan, U, Sandborn, WJ, Li, DK, et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133: 1106–12.Google Scholar
Roux, CH, Brocq, O, Breuil, V, et al. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 2007; 46: 695–8.Google Scholar
Stengel, JZ, Arnold, HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol 2008; 14: 3085–7.Google Scholar

References

Knight, M, Bunch, K, Tuffnell, D, et al.; MBRRACE-UK. Saving Lives, Improving Mothers’ Care: Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015–17. Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2019.Google Scholar
Roberts, CL, Ford, JB, Algert, CS, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 2011; 1: e000101.Google Scholar
National Institute for Health and Care Excellence. Hypertension in Pregnancy: Diagnosis and Management. NICE Guideline NG133. London: NICE, 2019. www.nice.org.uk/guidance/ng133 (accessed August 2020).Google Scholar
National Committee for Confidential Enquiry into Maternal Deaths. Saving Mothers 2017: annual report on confidential enquiries into maternal death in South Africa. Pretoria: Department of Health, 2018.Google Scholar
Capeless, EL, Clapp, JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynaecol 1989; 16: 1449–53.Google Scholar
Gerber, JG, Payne, HA, Murphy, RC, et al. Prostacyclin produced by the pregnancy uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest 1981; 67: 632–6.Google Scholar
Duvekott, JJ, Cheriex, EC, Pieters, FA, et al. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 1993; 169: 1382–92.Google Scholar
Wilson, M, Morganti, AA, Zervoudakis, I, et al. Blood Pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 1980; 68: 97104.Google Scholar
Brown, MA, Lindheimer, MD, de Sweit, M, Van Assche, A, Moutquin, JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20 (1): ixxiv.Google Scholar
Tranquilli, AL, Dekker, G, Magee, L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 2014; 4: 97104.Google Scholar
Franklin, SS, Thijs, L, Hansen, TW, et al. White-coat hypertension: new insights from recent studies. Hypertension 2013; 62: 982–7.Google Scholar
National Institute for Health and Care Excellence. Hypertension in Adults: Diagnosis and Management. Clinical Guideline CG127. London: NICE, 2011. https://www.nice.org.uk/guidance/cg127 (accessed December 2017).Google Scholar
Pickering, TG, Hall, JE, Appel, LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1. Circulation 2005; 111: 697716.Google Scholar
Stone, P, Cook, D, Hutton, J, et al. Measurements of blood pressure, edema and proteinuria in a pregnant population of New Zealand. Aust N Z J Obstet Gynaecol 1995; 35: 32–7.Google Scholar
National Institute for Health and Care Excellence. Antenatal Care for Uncomplicated Pregnancies. Clinical Guideline CG62. London: NICE, 2008. https://www.nice.org.uk/guidance/cg62 (accessed December 2017).Google Scholar
American College of Obstetricians and Gynecologists (ACOG). Hypertension in Pregnancy. Washington, DC: ACOG, 2013. http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy (accessed March 2017).Google Scholar
Magee, LA, Pels, A, Helewa, M, Rey, E, von Dadelszen, P; Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. SOGC Clinical Practice Guideline No. 307. J Obstet Gynaecol Can 2014; 36: 416–41.Google Scholar
Nathan, HL, Duhig, K, Hezelgrave, NL, et al. Blood pressure measurement in pregnancy. TOG 2015; 17: 91–8.Google Scholar
O’Brien, E, Petrie, J, Littler, W, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11 (Suppl 2): S43–62.Google Scholar
O’Brien, E, Pickering, T, Asmar, R, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure monitoring devices in adults. Blood Press Monit 2002; 7: 317.Google Scholar
O’Brien, E, Atkins, N, Stergiou, G, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure monitoring devices in adults. Blood Press Monit 2010; 15: 23–8. Erratum in: Blood Press Monit 2010; 15: 171–2.Google Scholar
Royal College of Obstetricians and Gynaecologists. Self-Monitoring of Blood Pressure in Pregnancy: Information for Healthcare Professionals. Version 1. London: RCOG, 2020. www.rcog.org.uk/globalassets/documents/guidelines/2020-03-30-self-monitoring-of-blood-pressure-in-pregnancy.pdf (accessed August 2020).Google Scholar
Lowe, SA, Bowyer, L, Lust, K, et al.; Society of Obstetric Medicine of Australia and New Zealand (SOMANZ). The SOMANZ guideline for the management of hypertensive disorders of pregnancy 2014. https://somanz.org/documents/HTPregnancyGuidelineJuly2014.pdf (accessed March 2017).Google Scholar
Holt, JL, Mangos, GJ, Brown, MA. Measuring protein excretion in pregnancy. Nephrology 2007; 12: 425–30.Google Scholar
Kyle, PM, Fielder, JN, Pullar, B, et al. Comparison of methods to identify significant proteinuria in pregnancy in the outpatient setting. BJOG 2008; 115: 523–7.Google Scholar
Saudan, PJ, Brown, MA, Farrell, T, et al. Improved methods of assessing proteinuria in hypertensive pregnancy. Br J Obstet Gynaecol 1997; 104: 1159–64.Google Scholar
Ramos, JG, Martins-Costa, SH, Mathias, MM, et al. Urinary protein/creatinine ratio in hypertensive pregnant women. Hypertens Pregnancy 1999; 18: 209–18.Google Scholar
Waugh, J, Hooper, R, Lamb, E, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess 2017; 21 (61): 190. doi: 10.3310/hta21610.Google Scholar
Webster, S, Waugh, JJS. Point-of-care testing in prenatal care. In Price, CP, St John, A, Kricka, LJ (eds), Point-of-Care Testing: Needs, Opportunity and Innovation, 3rd edn. Washington, DC: AACC Press, 2010, p. 471.Google Scholar
Brown, MA, Magee, LA, Kenny, LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens 2018; 13: 291310. https://doi.org/10.1016/j.preghy.2018.05.004.Google Scholar
Brown, MA, Buddle, ML. Inadequacy of dipstick proteinuria in hypertensive disease. Aust N Z J Obstet Gynaecol 1995; 35: 366–9.Google Scholar
Bell, SC, Halligan, AW, Martin, A, et al. The role of observer error in antenatal dipstick proteinuria analysis. Br J Obstet Gynaecol 1999; 106: 1177–80.Google Scholar
Waugh, JJ, Bell, SC, Kilby, MD, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy. BJOG 2005; 112: 412–17.Google Scholar
American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135: e237–60. https://doi.org/10.1097/AOG.0000000000003891.Google Scholar
O’Brien, E, Parati, G, Stergiou, G, et al.; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731–67.Google Scholar
Bateman, BT, Bansil, P, Hernandez-Diaz, S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol 2012; 206: 134.e1–8.Google Scholar
Roberts, CL, Bell, JC, Ford, JB, et al. The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens Pregnancy 2008; 27: 285–97.Google Scholar
Brown, MA, Mangos, G, Davis, G, et al. The natural history of white coat hypertension during pregnancy. BJOG 2005; 112: 601–6.Google Scholar
Bramham, K, Parnell, B, Nelson-Piercy, C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 2014; 348: g2301.Google Scholar
Davison, JM, Nelson-Piercy, C, Kehoe, S, Baker, P. Renal Disease in Pregnancy: 54th RCOG Study Group. London: RCOG, 2008.Google Scholar
Redman, GW, Sargent, IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592–4.Google Scholar
American College of Obstetricians and Gynecologists. Chronic hypertension in pregnancy. ACOG Practice Bulletin No. 203. Obstet Gynecol 2019; 133: e2650. https://doi.org/10.1097/AOG.0000000000003020Google Scholar
Henderson, JT, Whitlock, EP, O’Connor, E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 2014; 160: 695–70.Google Scholar
Askie, LM, Duly, L, Henderson-Smart, DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791–8.Google Scholar
Duley, L, Henderson-Smart, DJ, Meher, S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; (2): CD004659.Google Scholar
Rolnik, DL, Wright, D, Poon, LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377: 613–22. https://doi.org/10.1056/NEJMoa1704559.Google Scholar
Wright, D, Rolnik, DL, Syngelaki, A, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on the length of stay in the neonatal intensive care unit. Am J Obstet Gynecol 2018; 218: 612.e1–6. doi: 10.1016/j.ajog.2018.02.014.Google Scholar
Hofmeyr, GJ, Lawrie, TA, Atallah, AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014 (6): CD001059.Google Scholar
World Health Organization. Guideline: Calcium Supplementation in Pregnant Women. Geneva: WHO, 2013.Google Scholar
Barakat, R, Pelaez, M, Cordero, Y, et al. Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am J Obstet Gynecol 2016; 214: 649.e1649.e6498. https://doi.org/10.1016/j.ajog.2015.11.039.Google Scholar
Poston, L, Briley, AL, Seed, PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet 2006; 367: 1145–54.Google Scholar
Conde-Agudelo, A, Romero, R, Kusanovic, JP, Hassan, SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 204: 503.e1–12.Google Scholar
Groom, KM, McGowan, LM, MacKay, LK, et al. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial. Am J Obstet Gynecol 2017; 216: 296.e1–14. doi: 10.1016/j.ajog.2017.01.014.Google Scholar
Magee, LA, von Dadelszen, P, Rey, E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015; 372: 407–17.Google Scholar
Abalos, E, Duley, L, Steyn, DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014; (2): CD002252.Google Scholar
Butalia, S, Audibert, F, Côté, AM, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol 2018; 34: 526–31. doi: 10.1016/j.cjca.2018.02.021.Google Scholar
Duley, L, Meher, S, Jones, L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013 (7): CD001449.Google Scholar
American College of Obstetricians and Gynecologists. Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. ACOG committee opinion 692, April 2017.Google Scholar
Sibai, BM, Abdella, TN, Anderson, GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61: 571–6.Google Scholar
Hutcheon, JA, Lisonkova, S, Magee, LA, et al. Optimal timing of delivery in pregnancies with pre-existing hypertension. BJOG 2011; 118: 4954.Google Scholar
Royal College of Obstetricians and Gynaecologists. The Investigation and Management of the Small-for-Gestational-Age Fetus, 2nd edn. Green-top Guideline No. 31. London: RCOG, 2014.Google Scholar
Ananth, CV, Basso, O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality in first and higher order births: a population-based study. Epidemiology 2010; 21: 118–23.Google Scholar
Wallis, AB, Saftlas, AF, Hsia, J, et al. Secular trends in the rates of preeclampsia, eclampsia and gestational hypertension, United States, 1987–2004. Am J Hypertens 2008; 21: 521–6.Google Scholar
Saudan, P, Brown, MA, Buddle, ML, et al. Does gestational hypertension become pre-eclampsia? BJOG 1998; 105: 1177–84.Google Scholar
Buchbinder, A, Sibai, BM, Caritis, S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186: 6671.Google Scholar
Koopmans, CM, Bijlenga, D, Groen, H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomized control trial. Lancet 2009; 374: 979–88.Google Scholar
Vijgen, SMC, Koopmans, CM, Opmeer, BC, et al. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term. BJOG 2010; 117: 1577–85.Google Scholar
Broekhuijsen, K, van Baaren, GJ, van Pampus, MG, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015; 385: 2492–501. Erratum in: Lancet 2016; 387: 848.Google Scholar
Royal College of Obstetricians and Gynaecologists. Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. Green-top guideline No.7. London: RCOG, 2010.Google Scholar
Roberts, D, Dalziel, SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3): CD004454.Google Scholar
Leduc, D, Biringer, A, Lee, L, Dy, J; Society of Obstetricians and Gynaecologists of Canada. Induction of labour. SOGC Clinical Practice Guideline No. 296. J Obstet Gynaecol Can 2013; 35: 840–60.Google Scholar
Xenakis, EM, Piper, JM, Conway, DL, et al. Induction of labor in the nineties: conquering the unfavorable cervix. Obstet Gynecol 1997; 90: 235–9.Google Scholar
Thornton, CE, Dahlem, HG, Ogle, R, et al. Birth outcomes and induction success in hypertensive women: a population based data linkage study (2000–2011). Pregnancy Hypertens 2015; 5: 73.Google Scholar
Tranquilli, AL, Brown, MA, Zeeman, GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens 2013; 3: 44–7.Google Scholar
Brennan, LJ, Morton, JS, Davidge, ST. Vascular dysfunction in preeclampsia. Microcirculation 2014; 21: 414.Google Scholar
Roberts, JM, Bell, MJ. If we know so much about preeclampsia, why haven’t we cured the disease? J Reprod Immunol 2013; 99: 19.Google Scholar
Hytten, FE, Thomson, AM, Taggart, N, et al. Total body water in normal pregnancy. BJOG 1966; 73: 553–61.Google Scholar
Bosio, PM, McKenna, PJ, Conroy, R, et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 978–84.Google Scholar
Easterling, TR, Benedetti, TJ, Schmucker, RN, et al. Maternal hemodynamics in normal and preeclamptic pregnancies:a longitudinal study. Obstet Gynaecol 1990; 76: 1061–9.Google Scholar
Mabie, WC, Ratts, TE, Sibai, BM. The central hemodynamics of severe preeclampsia. Am J Obstet Gynecol 1989; 161: 1443–8.Google Scholar
Creasy, RK, Resnik, R, Iams, JD (eds). Creasy and Resnik’s Maternal–Fetal Medicine, 6th edn. Philadelphia, PA: Elsevier, 2009, pp. 661–2.Google Scholar
Strevens, H, Wide-Swensson, D, Hansen, A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003; 110: 831–6.Google Scholar
Spargo, BH, McCartney, C, Winemiller, R. Glomerular endotheliosis in toxemia of pregnancy. Arch Pathol 1959; 13: 593–9.Google Scholar
Burke, N, Flood, K, Murray, A, et al. Platelet reactivity changes significantly throughout all trimesters if pregnancy compared with the nonpregnant state: a prospective study. BJOG 2013; 120: 1599–604.Google Scholar
Giles, C, Inglis, TC. Thrombocytopenia and macrothrombocytosis in gestational hypertension. BJOG 1981; 88: 1115–19.Google Scholar
Yang, Z, Ye, R, Miao, L. Study of the liver changes by B-ultrasound and histopathology in severe pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1998; 33: 453–5.Google Scholar
Dani, R, Mendes, GS, Medeiros, JdeL, Péret, FJ, Nunes, A. Study of the liver changes occurring in pre-eclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol 1996; 91: 292–4.Google Scholar
Nelson-Piercy, C. Handbook of Obstetric Medicine, 2nd edn. London: Taylor & Francis, 2002.Google Scholar
Cipola, MJ. Control of cerebral blood flow. In The Cerebral Circulation. San Rafael, CA: Morgan & Claypool Life Sciences, 2009, chapter 5.Google Scholar
Roos, NM, Wiegman, MJ, Jansonius, NM, et al. Visual disturbances in (pre)eclampsia. Obstet Gynecol Surv 2012; 67: 242–50.Google Scholar
Neurdorfer, M, Spierer, O, Goder, M, et al. The prevalence of retinal and optical coherence tomography findings in pre-eclamptic women. Retina 2014; 34: 1376–83.Google Scholar
Digre, KB, Varner, MW, Schiffman, JS. Neuroophthalmologic effects of intravenous magnesium sulfate. Am J Obstet Gynaecol 1990; 163: 1848–52.Google Scholar
Robertson, WB. Uteroplacental vasculature. J Clin Path 1976; 10: 917.Google Scholar
Staff, AC, Dechend, R, Redman, CW. Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta 2013; 34: S73–8.Google Scholar
Bakker, R, Steegers, EA, Hofman, A, et al. Blood pressure in different gestational trimesters, fetal growth, and the risk of adverse birth outcomes: the generation R study. Am J Epidemiol 2011; 174: 797806.Google Scholar
MBRRACE-UK. Perinatal Mortality Surveillance Report: UK perinatal deaths for births from January to December 2014. Oxford: National Perinatal Epidemiology Unit, 2016. https://www.npeu.ox.ac.uk/downloads/files/mbrrace-uk/reports/MBRRACE-UK-PMS-Report-2014.pdf (accessed March 2017).Google Scholar
Churchill, D, Duley, L, Thornton, JG, et al. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks’ gestation. Cochrane Database Syst Rev 2013; (7): CD003106.Google Scholar
Nilsson, E, Salonen Ros, H, Cnattingius, S, et al. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG 2004; 111: 200–6.Google Scholar
Jebbink, J, Wolters, A, Fernando, F, et al. Molecular genetics of preeclampsia and HELLP syndrome: a review. Biochim Biophys Acta 2012; 1822: 1960–9.Google Scholar
Zusterzeel, PLM, te Morsche, R, Rajmakers, MTM, et al. Paternal contribution to the risk for pre-eclampsia. J Med Genet 2002; 39: 44–5.Google Scholar
Lie, RT, Rasmussen, S, Brunborg, H, et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316: 1343–7.Google Scholar
North, RA, McCowan, LM, Dekker, GA, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011; 342: d1875.Google Scholar
Wang, Z, Wang, P, Liu, H, et al. Maternal adiposity as an independent risk factor for pre-eclampsia: a meta-analysis of prospective cohort studies. Obes Rev 2013; 14: 508–21.Google Scholar
Duckitt, K, Harrington, D, et al. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565.Google Scholar
Jacobs, DJ, Vreeburg, SA, Dekker, GA, et al. Risk factors for hypertension during pregnancy in South Australia. Aust N Z J Obstet Gynaecol 2003; 43: 421–8.Google Scholar
Kho, EM, McCowan, LM, North, RA, et al. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J Reprod Immunol 2009; 82: 6673.Google Scholar
Robertson, L, Wu, O, Langhorne, P et al.; TREATS study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171–96.Google Scholar
Rodger, MA, Betancourt, MT, Clark, P, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010; 7 (6): e1000292Google Scholar
Alfirevic, Z, Roberts, D, Martlew, V. How strong is the association between thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101: 614.Google Scholar
Opdahl, S, Henningsen, AA, Tiitinen, A, et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod 2015; 30: 1724–31.Google Scholar
Poon, LC, Kametas, NA, Chelemen, T, et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 2010; 24: 104–10.Google Scholar
Myatt, L, Clifton, RG, Roberts, JM, et al. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population? BJOG 2013; 120: 1183–91.Google Scholar
Chappell, LC, Duckworth, S, Seed, PT, et al. Diagnostic accuracy of placental growth factor in women with pre-eclampsia. Circulation 2013; 128: 2121–31.Google Scholar
Powe, CE, Levine, RJ, Karumanchi, SA. Preeclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856–69.Google Scholar
National Institute for Health and Care Excellence. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio. NICE Diagnostics Guidance DG23. London: NICE, 2016. www.nice.org.uk/guidance/dg23 (accessed September 2019).Google Scholar
Brown, MA, Magee, LA, Kenny, LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens 2018; 13: 291310. doi: 10.1016/j.preghy.2018.05.004.Google Scholar
Duhig, KE, Shennan, AH. Recent advances in the diagnosis and management of pre-eclampsia. F1000Prime Reports 2015, 7: 24.Google Scholar
Metcalfe, A, Langlois, S, MacFarlane, J, et al. Prediction of obstetrical risk using maternal serum markers and clinical risk factors. Prenat Diagn 2014; 34: 172–9.Google Scholar
Kenny, LC, Black, MA, Poston, L, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertension 2014; 64:644–52.Google Scholar
Velauthar, L, Plana, MN, Kalidindi, M, et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55974 women. Ultrasound Obstet Gynecol 2014; 43: 500–7.Google Scholar
Tan, MY, Wright, D, Syngelaki, A, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol 2018;51: 743–50. doi: 10.1002/uog.19039.Google Scholar
Douglas, KA, Redman, CWG. Eclampsia in the United Kingdom. BMJ 1994; 309: 1395–400.Google Scholar
Knight, M; UKOSS. Eclampsia in the United Kingdom 2005. BJOG 2007; 114: 1072–8.Google Scholar
Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455–63.Google Scholar
Altman, D, Carroli, G, Duley, L, et al. Do women with pre-eclampsia and their babies benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877–90.Google Scholar
Duley, L, Gulmezoglu, AM, Henderson-Smart, DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010; (11): CD000025.Google Scholar
Van Pampus, MG, Wolf, H, Westenberg, SM, et al. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Gynecol Reprod Biol 1998; 76: 31–6.Google Scholar
Woudstra, DM, Chandra, S, Justus Hofmeyr, G, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010; (9): CD008148.Google Scholar
Ganzevoort, W, Rep, A, Bonsel, GJ, et al. A randomised controlled trial comparing two temporizing management strategies, one with and one without plasma volume expansion, for severe and early-onset pre-eclampsia. BJOG 2005; 112: 1358–68.Google Scholar
Jacobsen, AF, Skjeldestad, FE, Sandset, PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study. J Thromb Haemost 2008; 6: 905–12.Google Scholar
Lindqvist, P, Dahlback, B, Marsal, K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94: 595–9.Google Scholar
Kramer, MS, Berg, C, Abenhaim, H, et al. Incidence, risk factors, and temporal trends in severe postpartum haemorrhage. Am J Obstet Gynecol 2013; 209: 449.e1–7.Google Scholar
Dennis, AT. Management of pre-eclampsia: issues for anaesthetists. Anaesthesia 2012; 67: 1009–20.Google Scholar
van Veen, JJ, Nokes, TJ, Makris, M, et al. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol 2010; 148: 1525.Google Scholar
Aya, AG, Vialles, N, Tanoubi, I, et al. Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesth Analg 2005; 101: 869–75.Google Scholar
Davis, EF, Lazdam, M, Lewandowski, AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012; 129: e1552–61.Google Scholar

References

Kuklina, E, Callaghan, W. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995–2006. BJOG 2011; 118: 345–52.Google Scholar
Knight, M, Bunch, K, Tuffnell, D, et al., on behalf of MBRRACE-UK. Saving Lives, Improving Mothers' Care: Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015–17. Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2019. www.npeu.ox.ac.uk/mbrrace-uk/reports (accessed August 2020).Google Scholar
Creanga, AA, Syverson, C, Seed, K, Callaghan, WM. Pregnancy-related mortality in the United States, 2011–2013. Obstet Gynecol 2017; 1030: 366–73. https://doi.org/10.1097/AOG.0000000000002114.Google Scholar
Leary, PJ, Leary, SE, Stout, KK, Schwartz, SM, Easterling, TR. Maternal, perinatal, and postneonatal outcomes in women with chronic heart disease in Washington State. Obstet Gynecol 2012; 120: 1283–90.Google Scholar
Sermer, M, Colman, J, Siu, S. Pregnancy complicated by heart disease: a review of Canadian experience. J Obstet Gynaecol 2003; 23: 540–4.Google Scholar
Siu, SC, Sermer, M, Colman, JM, et al. Prospective multicenter study of pregnancy outcome in women with heart disease. Circulation 2001; 104: 515–21.Google Scholar
Stangl, V, Schad, J, Gossing, G, et al. Maternal heart disease and pregnancy outcome: a single-centre experience. Eur J Heart Fail 2008; 10: 855–60.Google Scholar
Siu, SC, Sermer, M, Harrison, DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96: 2789–94.Google Scholar
Ruys, TP, Roos-Hesselink, JW, Hall, R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart 2014; 100: 231–8.Google Scholar
Regitz-Zagrosek, V, Lundqvist, CB, Borghi, C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147–97. doi: 10.1093/eurheartj/ehr218.Google Scholar
Silversides, CK, Grewal, J, Mason, J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol 2018; 71: 2419–30. doi: 10.1016/j.jacc.2018.02.076.Google Scholar
Lindheimer, M, Katz, A. Sodium and diuretics in pregnancy. N Engl J Med 1973; 288: 891–4.Google Scholar
Seitchik, J. Total body water and total body density of pregnant women. Obstet Gynecol 1967; 29: 155–6.Google Scholar
Theunissen, I, Parer, J. Fluid and electrolytes in pregnancy. Clin Obstet Gynecol 1994; 37: 315.Google Scholar
Scott, DE. Anemia in pregnancy. Obstet Gynecol Annu 1972; 1: 219–44.Google Scholar
Pritchard, JA, Baldwin, RM, Dickey, JC, Wiggins, KM. Blood volume changes in pregnancy and the puerperium: 2. Red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. Am J Obstet Gynecol 1962; 84: 1271–82.Google Scholar
Bader, RA, Bader, ME, Rose, DF, Braunwald, E. Hemodynamics at rest and during exercise in normal pregnancy as studied by cardiac catheterization. J Clin Invest 1955; 34: 1524–36.Google Scholar
Desai, D, Moodley, J, Naidoo, DP. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol 2004; 104: 20–9.Google Scholar
Katz, R, Karliner, JS, Resnik, R. Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978; 58: 434–41.Google Scholar
Ueland, K, Novy, MJ, Peterson, EN, Metcalfe, J. Maternal cardiovascular dynamics: IV. The influence of gestational age on the maternal cardiovascular response to posture and exercise. Am J Obstet Gynecol 1969; 104: 856–64.Google Scholar
Sadaniantz, A, Kocheril, AG, Emaus, SP, Garber, CE, Parisi, AF. Cardiovascular changes in pregnancy evaluated by two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1992; 5: 253–8.Google Scholar
Wilson, M, Morganti, AA, Zervoudakis, I, et al. Blood pressure, the renin-aldosterone system, and sex steroids throughout normal pregnancy. Am J Med 1980; 68: 97104.Google Scholar
MacGillivray, I, Rose, GA, Rowe, B. Blood pressure survey in pregnancy. Clin Sci 1969; 37: 395407.Google Scholar
Kerr, M. Cardiovascular dynamics in pregnancy and labour. Br Med Bull 1968; 24: 1924.Google Scholar
Kim, T, Ryu, D. The effect of fundal pressure at caesarean section on maternal haemodynamics. Anesthesia 2006; 61: 434–8.Google Scholar
Oian, P, Maltau, JM, Noddeland, H, Fadnes, HO. Oedema-preventing mechanisms in subcutaneous tissue of normal pregnant women. Br J Obstet Gynaecol 1985; 92: 1113–19.Google Scholar
Oian, P, Maltau, J. Calculated capillary hydrostatic pressure in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1987; 157: 102–6.Google Scholar
Cotton, DB, Gonik, B, Spillman, T, Dorman, KF. Intrapartum to postpartum changes in colloid osmotic pressure. Am J Obstet Gynecol 1984; 149: 174–7.Google Scholar
Gonik, B, Cotton, D, Spillman, T, Abouleish, E, Zavisca, F. Peripartum colloid osmotic changes: effects of controlled fluid management. Am J Obstet Gynecol 1985; 151: 812–15.Google Scholar
Wilson, W, Taubert, KA, Gewitz, M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736–54.Google Scholar
National Institute for Health and Care Excellence. Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures. NICE Clinical guideline CG64. London: NICE, 2008 [updated 2016]. www.nice.org.uk/guidance/CG64 (accessed August 2020).Google Scholar
Gould, FK, Elliott, TS, Foweraker, J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006; 57: 1035–42.Google Scholar
Smaill, FM, Gyte, GM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2010 (1): CD007482.Google Scholar
McFaul, PB, Dornan, JC, Lamki, H, Boyle, D. Pregnancy complicated by maternal heart disease: a review of 519 women. Br J Obstet Gynaecol 1988; 95: 861–7.Google Scholar
Sugrue, D, Blake, S, MacDonald, D. Pregnancy complicated by maternal heart disease at the National Maternity Hospital, Dublin, Ireland, 1969–1978. Am J Obstet Gynecol 1981; 139: 16.Google Scholar
Durack, D. Prevention of infective endocarditis. N Engl J Med 1995; 332: 3844.Google Scholar
Nishimura, RA, Otto, CM, Bonow, RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patient with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e1159−95. https://doi.org/10.1161/CIR.0000000000000503.Google Scholar
Pocock, S, Chen, K. Inappropriate use of antibiotic prophylaxis to prevent infective endocarditis in obstetric patients. Obstet Gynecol 2006; 108: 280–5.Google Scholar
Gelson, E, Curry, R, Gatzoulis, MA, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol 2011; 117: 886–91.Google Scholar
Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761–81.Google Scholar
Burn, J, Brennan, P, Little, J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998; 351: 311–16.Google Scholar
Cheitlin, D, Alpert, JS, Armstrong, WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography Circulation 1997; 95: 1686–744.Google Scholar
Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Disease of the Heart and Great Vessels. 6th edn. Boston, MA: Little, Brown, 1964.Google Scholar
Sidlik, R, Sheiner, E, Levy, A, Wiznitzer, A. Effect of maternal congenital heart defects on labor and delivery outcome: a population-based study. J Matern Fetal Neonatal Med 2007; 20: 211–16.Google Scholar
Ostheimer, GW, Alper, MH. Intrapartum anesthetic management of the pregnant patient with heart disease. Clin Obstet Gynecol 197; 18: 81–97.Google Scholar
Briggs, G, Freeman, R, Yaffe, S. Drugs in Pregnancy and Lactation, 8th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2011.Google Scholar
Food and Drug Administration (FDA). Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling. Final Rule. Fed Regist 2014; 79 (233): 72063–103.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 212: pregnancy and heart disease. Obstet Gynecol 2019; 133: e320−56. https://doi.org/10.1097/AOG.0000000000003243.Google Scholar
Hameed, AB, Morton, CH, Moore, A. Improving health care response to cardiovascular disease in pregnancy and postpartum. California Department of Public Health, 2017. www.cmqcc.org/resource/improving-health-care-response-cardiovascular-disease-pregnancy-and-postpartum (accessed August 2020).Google Scholar
Thorne, S. Pregnancy and native heart valve disease. Heart 2016; 102: 1410−17. https://doi.org/10.1136/heartjnl-2014-306729.Google Scholar
Robertson, JE, Silversides, CK, Mah, ML, et al. A contemporary approach to the obstetric management of women with heart disease. J Obstet Gynaecol Can 2012; 34: 812–19.Google Scholar
Bernard, GR, Sopko, G, Cerra, F, et al. Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. JAMA 2000; 283: 2568–72.Google Scholar
Parson, P. Progress in research on pulmonary-artery catheters. N Engl J Med 2003; 348: 66–8.Google Scholar
Sandham, JD, Hull, RD, Brant, RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348: 514.Google Scholar
Asfour, V, Murphy, MO, Attia, R. Is vaginal delivery or caesarean section the safer mode of delivery in patients with adult congenital heart disease? Interact Cardiovasc Thorac Surg 2013; 17: 144–50.Google Scholar
World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 5th edn. Geneva: World Health Organization, 2015.Google Scholar
Thorne, S, Nelson-Piercy, C, MacGregor, A, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006; 32: 7581.Google Scholar
Goldberg, LM, Uhland, H. Heart murmurs in pregnancy: a phonocardiographic study and their development, progression and regression. Dis Chest 1967; 52: 381–6.Google Scholar
Harvey, W. Alterations of the cardiac physical examination in normal pregnancy. Clin Obstet Gynecol 1975; 18: 5163.Google Scholar
Northcote, R, Knight, P, Ballantyne, D. Systolic murmurs in pregnancy: value of echocardiographic assessment. Clin Cardiol 1985; 8: 327–8.Google Scholar
Etchells, E, Bell, C, Robb, K. Does this patient have an abnormal systolic murmur? JAMA 1997; 277: 564–71.Google Scholar
Xu, M, McHaffie, DJ. Nonspecific systolic murmurs: an audit of the clinical value of echocardiography. N Z Med J 1993; 106: 54–6.Google Scholar
Tan, J, de Swiet, M. Prevalence of heart disease diagnosed de novo in pregnancy in a West London population. Br J Obstet Gynaecol 1998; 105: 1185–8.Google Scholar
Bonow, RO, Carabello, BA, Kanu, C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84–231.Google Scholar
Weisse, A. Mitral valve prolapse: now you see it; now you don’t: recalling the discovery, rise and decline of a diagnosis. Am J Cardiol 2007; 99: 129–33.Google Scholar
Freed, LA, Levy, D, Levine, RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999; 341: 17.Google Scholar
Hepner, AD, Ahmadi-Kashani, M, Movahed, MR. The prevalence of mitral valve prolapse in patients undergoing echocardiography for clinical reason. Int J Cardiol 2007; 123: 55–7.Google Scholar
Lax, D, Eicher, M, Goldberg, S. Effects of hydration on mitral valve prolapse. Am Heart J 1993; 126: 415–18.Google Scholar
Rayburn, WF, LeMire, MS, Bird, JL, Buda, AJ. Mitral valve prolapse. J Reprod Med 1987; 32: 185–7.Google Scholar
Retchin, SM, Fletcher, RH, Earp, J, Lamson, N, Waugh, RA. Mitral valve prolapse: disease or illness? Arch Intern Med 1986; 146: 1081–4.Google Scholar
Avierinos, JF, Detaint, D, Messika-Zeitoun, D, Mohty, D, Enriquez-Sarano, M. Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community. Am J Cardiol 2008; 101: 662–7.Google Scholar
Zuppiroli, A, Rinaldi, M, Kramer-Fox, R, et al. Natural history of mitral valve prolapse. Am J Cardiol 1995; 75: 1028–32.Google Scholar
Drenthen, W, Pieper, PG, Roos-Hesselink, JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49: 2303–11.Google Scholar
Karamlou, T, Diggs, BS, McCrindle, BW, Welke, KF, et al. A growing problem: maternal death and peripartum complicatons are higher in women with grown-up congenital heart disease. Ann Thorac Surg 2011; 92: 2193–9.Google Scholar
Webb, G, Gatzoulis, M. Atrial septal defects in the adult: recent progress and overview. Circulation 2006; 114: 1645–53.Google Scholar
Alahuhta, S, Jouppila, P. Pregnancy after cardiac surgery in patients with secondary pulmonary hypertension due to a ventricular septal defect. Acta Obstet Gynecol Scand 1994; 73: 836–8.Google Scholar
Curry, RA, Fletcher, C, Gelson, E, et al. Pulmonary hypertension and pregnancy: a review of 12 pregnancies in nine women. BJOG 2012; 119: 752–61.Google Scholar
Duarte, AG, Thomas, S,Safdar, Z, et al. Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience. Chest 2013; 143: 1330–6.Google Scholar
Sliwa, K, van Hagen, IM, Budts, W, et al. Pulmonary hypertension and pregnancy outcomes: data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the Euproean Society of Cardiology. Eur J Heart Fail 2016; 18: 1119–28. https://doi.org/10.1002/ejhf.594.Google Scholar
Chakravarty, E, Khanna, D, Chung, L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol 2008; 111: 927–34.Google Scholar
Penning, S, Robinson, KD, Major, CA, Garite, TJ. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 2001; 184: 1568–70.Google Scholar
Wylie, BJ, Epps, KC, Gaddipati, S, Waksmonski, CA. Correlation of transthoracic echocardiography and right heart catheterization in pregnancy. J Perinat Med 2007; 35: 497502.Google Scholar
Bonnin, M, Mercier, FJ, Sitbon, O, et al. Severe pulmonary hypertension during pregnancy mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: 1133–7.Google Scholar
Maxwell, BG, El-Sayed, YY, Riley, ET, Carvalho, B. Peripartum outcomes and anaesthetic management of parturients with moderate to complex heart disease or pulmonary hypertension. Anesthesia 2013; 68: 52–9.Google Scholar
Hart, C. Nitric oxide in adult lung disease. Chest 1999; 115: 1407–17.Google Scholar
Yentis, SM, Steer, PJ, Plaat, F. Eisenmenger’s syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998; 105: 921–2.Google Scholar
Vongpatanasin, W, Brickner, ME, Hillis, LD, Lange, RA. The Eisenmenger syndrome in adults. Ann Intern Med 1998; 128: 745–55.Google Scholar
Smedstad, K, Cramb, R, Morison, D. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth 1994; 41: 502–12.Google Scholar
Hameed, A, Goodwin, T, Elkayam, U. Effect of pulmonary stenosis on pregnancy outcomes: a case–control study. Am Heart J 2007; 154: 852–4.Google Scholar
Drenthen, W, Pieper, PG, Roos-Hesselink, JW, et al. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart 2006; 92: 1838–43.Google Scholar
Hameed, A, Karaalp, IS, Tummala, PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37: 893–9.Google Scholar
Vriend, JW, Drenthen, W, Pieper, PG, et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 2005; 26: 2173–8.Google Scholar
Horlick, EM, McLaughlin, PR, Bensen, LN. The adult with repaired coarctation of the aorta. Curr Cardiol Rep 2007; 9: 323–30.Google Scholar
Krieger, EV, Landzberg, MJ, Economy, KE, Webb, GD, Opotowsky, AR. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol 2011; 107: 1529–34.Google Scholar
Beauschesne, LM, Connolly, HM, Ammash, NM, Warnes, CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 2001; 38: 1728–33.Google Scholar
Gelson, E, Gatzoulis, M, Steer, PJ, Lupton, M, Johnson, M. Tetralogy of Fallot: maternal and neonatal outcomes. BJOG 2008; 115: 398402.Google Scholar
Meijer, JM, Pieper, PG, Drenthen, W, et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 2005; 91: 801–5.Google Scholar
Patton, DE, Lee, W, Cotton, DB, et al. Cyanotic maternal heart disease in pregnancy. Obstet Gynecol Surv 1990; 45: 594600.Google Scholar
Canobbio, MM, Morris, CD, Graham, TP, Landzberg, MJ. Pregnancy outcomes after atrial repair for transposition of the great arteries. Am J Cardiol 2006; 98: 668–72.Google Scholar
Jain, VD, Moghbeli, N, Webb, G, et al. Pregnancy in women with congenital heart disease: the impact of a systemic right ventricle. Congenit Heart Dis 2011; 6: 147–56.Google Scholar
Bowater, SE, Selman, TJ, Hudsmith, LE, et al. Long-term outcome following pregnancy in women with a systemic right ventricle: is the deterioration due to pregnancy or a consequence of time? Congenit Heart Dis 2013; 8: 302–7.Google Scholar
Tobler, D, Fernandes, SM, Wald, RM, et al. Pregnancy outcomes in women with transposition of the great arteries and arterial switch operation. Am J Cardiol 2010; 106: 417–20.Google Scholar
Horiuchi, C, Kamiya, CA, Ohuchi, H, et al. Pregnancy outcomes and mid-term prognosis in women after arterial switch operation for dextro-transposition of the great arteries: tertiary hospital experiences and review of the literature. J Cardiol 2019; 73: 247–54. https://doi.org/10.1016/j.jjcc.2018.11.007.Google Scholar
Stoll, VM, Drury, NE, Thorne, S, et al. Pregnancy outcomes in women with transposition of the great arteries after an arterial switch operation. JAMA Cardiol 2018; 3: 1119–22. https://doi.org/10.1001/jamacardio.2018.2747.Google Scholar
Katsuragi, S, Kamiya, C, Yamanaka, K, et al. Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol 2013; 209: 452.e1–6.Google Scholar
Paranon, S, Acar, P. Ebstein’s anomaly of the tricuspid valve: from fetus to adult. Heart 2008; 94: 237–43.Google Scholar
Friedman, W, Heiferman, M. Clinical problems of postoperative pulmonary vascular disease. Am J Cardiol 1982; 50: 631–6.Google Scholar
Wilson, N. Rheumatic heart disease in indigenous populations: New Zealand experience. Heart Lung Circ 2010; 19: 282–8.Google Scholar
Elassy, S, Elmidany, A, Elbawab, H. Urgent cardiac surgery during pregnancy: a continous challenge. Ann Thorac Surg, 2014; 97: 1624–9.Google Scholar
Sartain, JB, Anderson, NL, Barry, JJ, Boyd, PT, Howat, PW. Rheumatic heart disease in pregnancy: cardiac and obstetric outcomes. Intern Med J 2012; 42: 978–84.Google Scholar
Gray, ED, Regelmann, WE, Abdin, Z, et al. Compartmentalization of cells surface antigens in peripheral blood and tonsils in rheumatic heart disease. J Infect Dis 1987; 155: 247252.Google Scholar
van Hagen, IM, Thorne, SA, Taha, N, et al. Pregnancy outcomes in women with rheumatic mitral valve disease: results from the registry of pregnancy and cardiac disease. Circulation 2018; 137: 806–16. https://doi.org/10.1161/CIRCULATIONAHA.117.032561.Google Scholar
Desai, DK, Adanlawo, M, Naidoo, DP, Moodley, J, Kleinschmidt, I. Mitral stenosis in pregnancy: a four-year experience at King Edward VIII Hospital, Durban, South Africa. BJOG 2000; 107: 953–8.Google Scholar
Silversides, CK, Colman, JM, Sermer, M, Siu, SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003; 91: 1382–5.Google Scholar
Lesniak-Sobelga, A, Tracz, W, Kostkiewicz, M, Podolec, P, Pasowicz, M. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases: maternal and fetal outcome. Int J Cardiol 2004; 94: 1523.Google Scholar
Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. J Am Coll Cardiol 2014; 63: 2438–88.Google Scholar
de Souza, JA, Martinez, EE, Ambrose, JA, et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol 2001; 37: 900–3.Google Scholar
Fawzy, ME, Kinsara, AJ, Stefadouros, M, et al. Long-term outcome of mitral balloon valvotomy in pregnant women. J Heart Valve Dis 2001; 10: 153–7.Google Scholar
Esteves, C, Munoz, JS, Braga, S, et al. Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol 2006; 98: 812–16.Google Scholar
Nercolini, D, da Rocha Loures Bueno, R, Eduardo Guérios, E, et al. Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis. Catheter Cardiovasc Interv 2002; 57: 318–22.Google Scholar
Sivadasanpillai, H, Srinivasan, A, Sivasubramoniam, S, et al. Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol 2005; 95: 1504–6.Google Scholar
Iscan, ZH, Mavioglu, L, Vural, KM, Kucuker, S, Birincioglu, L. Cardiac surgery during pregnancy. J Heart Valve Dis 2006; 15: 686–90.Google Scholar
Kinsara, AJ, Ismail, O, Fawzi, ME. Effect of balloon mitral valvoplasty during pregnancy and childhood development. Cardiology 2002; 97: 155–8.Google Scholar
Clark, SL, Phelan, JP, Greenspoon, J, Aldahl, D, Horenstein, J. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol 1985; 152: 984–8.Google Scholar
Waller, B, Howard, J, Fess, S. Pathology of mitral valve stenosis and pure mitral regurgitation: Part I. Clin Cardiol 1994; 17: 330–6.Google Scholar
John, AS, Gurley, F, Schaff, HV, et al. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 2011; 91: 1191–6.Google Scholar
Mahli, A, Izdes, S, Coskun, D. Cardiac operations during pregnancy: review of factors influencing fetal outcome. Ann Thorac Surg 2000; 69: 1622–6.Google Scholar
Rossouw, GJ, Knott-Craig, CJ, Barnard, PM, Macgregor, LA, Van Zyl, WP. Intracardiac operation in seven pregnant women. Ann Thorac Surg 1993; 55: 1172–4.Google Scholar
Weiss, BM, von Segesser, LK, Alon, E, Seifert, B, Turina, MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 1998; 179: 1643–53.Google Scholar
Carabello, BA. Aortic stenosis. N Engl J Med 2002; 346: 677–82.Google Scholar
Silversides, CK, Colman, JM, Sermer, M, Farine, D, Siu, SC. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol 2003; 91: 1386–9.Google Scholar
Yap, SC, Drenthen, W, Pieper, PG, et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008; 126: 240–6.Google Scholar
Spagnuolo, M, Kloth, H, Taranta, A, Doyle, E, Pasternack, B. Natural history of rheumatic aortic regurgitation. Criteria predictive of death, congestive heart failure, and angina in young patients. Circulation 1971; 44: 368–80.Google Scholar
Szekely, P, Turner, R, Snaith, L. Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J 1973; 35: 1293–303.Google Scholar
Vongpatansin, W, Hillis, L, Lange, R. Prosthetic heart valves. N Engl J Med 1996; 335: 407–16.Google Scholar
Yap, SC, Drenthen, W, Pieper, PG, et al. Outcome of pregnancy in women after pulmonary autograft valve replacement for congenital aortic valve disease. J Heart Valve Dis 2007; 16: 398403.Google Scholar
De Santo, LS, Romano, G, Della Corte, A, et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg 2005; 130: 1319.Google Scholar
Elkayam, U, Bitar, F. Valvular heart disease and pregnancy part II: prosthetic valves. J Am Coll Cardiol 2005; 46: 403–10.Google Scholar
Kearon, C, Hirsh, J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506–11.Google Scholar
Bouhout, I, Poirier, N, Mazine, A, et al. Cardiac, obstetric, and fetal outcomes during pregnancy after biological or mechanical aortic valve replacement. Can J Cardiol 2014; 30: 801–7.Google Scholar
Sillesen, M, Hjortdal, V, Vejlstrup, N, Sørensen, K. Pregnancy with prosthetic heart valves: 30 years nationwide experience in Denmark. Eur J Cardiothorac Surg 2011; 40: 448–54.Google Scholar
Cotrufo, M, De Feo, M, De Santo, LS, et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 2002; 99: 3540.Google Scholar
Sadler, L, McCowan, L, White, H, et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 2000; 107: 245–53.Google Scholar
Heuvelman, HJ, Arabkhani, B, Cornette, JM, et al. Pregnancy outcomes in women with aortic valve substitutes. Am J Cardiol 2013; 111: 382–7.Google Scholar
Salazar, E, Espinola, N, Román, L, Casanova, JM. Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J 1999; 137: 714–20.Google Scholar
North, RA, Sadler, L, Stewart, AW, et al. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 1999; 99: 2669–76.Google Scholar
van Hagen, IM, Roos-Hesselink, JW, Ruys, TP, et al. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation 2015; 132: 132–42. https://doi.org/10.1161/CIRCULATIONAHA.115.015242.Google Scholar
Oran, B, Lee-Parritz, A, Ansell, J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004; 92: 747–51.Google Scholar
Saeed, CR, Frank, JB, Pravin, M, et al. A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves. Clin Appl Thromb Hemost 2011; 17: 313–19.Google Scholar
De Santo, LS, Romano, G, Della Corte, A, et al. Mechanical aortic valve replacement in young women planning on pregnancy maternal and fetal outcomes under low oral anticoagulantion, a pilot observational study on a comprehensive pre-operative counseling protocol. J Am Coll Cardiol 2012; 59: 1110–15.Google Scholar
Vural, KM, Ozatik, MA, Uncu, H, et al. Pregnancy after mechanical mitral valve replacement. J Heart Valve Dis 2003; 12: 370–6.Google Scholar
Ginsberg, JS, Hirsch, J. Use of antithrombotic agents during pregnancy. Chest 1998; 114 (5 Suppl): 524S530S.Google Scholar
Bates, SM, Greer, IA, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): 691S736S.Google Scholar
Bardett-Fausett, MB, Vogtlander, M, Lee, RM, et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001; 185: 148–52.Google Scholar
Leffert, L, Butwick, A, Carvalho, B, et al. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg 2018; 126: 928–44. https://doi.org/10.1213/ANE.0000000000002530.Google Scholar
Milewicz, D, Dietz, H, Miller, D. Treatment of aortic disease in patients with Marfan syndrome. Circulation 2005; 111: e150–7.Google Scholar
Rossiter, JP, Repke, JT, Morales, AJ, Murphy, EA, Pyeritz, RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995; 173: 1599–606.Google Scholar
Curry, RA, Gelson, E, Swan, L, et al. Marfan syndrome and pregnancy: maternal and neonatal outcomes. BJOG 2014; 121: 610–17.Google Scholar
Dean, JC. Management of Marfan syndrome. Heart 2002; 88: 97103.Google Scholar
Meijboom, LJ, Vos, FE, Timmermans, J, et al. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005; 26: 914–20.Google Scholar
Meijboom, LJ, Drenthen, W, Pieper, PG, et al. Obstetric complications in Marfan syndrome. Int J Cardiol 2006; 110: 53–9.Google Scholar
Pearson, GD, Veille, JC, Rahimtoola, S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000; 283: 1183–8.Google Scholar
Fett, JD, Christie, LG, Carraway, RD, Murphy, JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005; 12: 1602–6.Google Scholar
Brar, SS, Khan, SS, Sandhu, GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007; 100: 302–4.Google Scholar
Mielniczuk, LM, Williams, K, Davis, DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 2006; 97: 1765–8.Google Scholar
Whiteman, VE, Salihu, HM, Weldeselasse, HE, et al. Temporal trends in cardiomyopathy in pregnancy and association with feto-infant morbidity outcomes. J Matern Fetal Neonatal Med 2012; 25: 627–31.Google Scholar
Bültmann, BD, Klingel, K, Näbauer, M, Wallwiener, D, Kandolf, R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005; 193: 363–5.Google Scholar
Fett, JD, Dowell, DL, Carraway, RD, Sundstrom, JB, Ansari, AA. One hundred cases of peripartum cardiomyopathy. . . and counting: what is going on? Int J Cardiol 2004; 97: 571–3.Google Scholar
Lamparter, S, Pankuweit, S, Maisch, B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 2007; 118: 1420.Google Scholar
Sliwa, K, Förster, O, Libhaber, E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441–6.Google Scholar
Sliwa, K, Fett, J, Elkayam, U. Peripartum cardiomyopathy. Lancet 2006; 368: 687–93.Google Scholar
Bello, N, Rendon, I, Arany, Z. The relationshiop between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013; 62: 1715–23.Google Scholar
Elkayam, U, Akhter, MW, Singh, H, et al. Pregnancy-associated cardiomyopathy clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050–5.Google Scholar
Amos, AM, Jaber, WA, Russell, SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006; 152: 509–13.Google Scholar
Chapa, JB, Heiberger, HB, Weinert, L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005; 105: 1303–8.Google Scholar
Duran, N, Günes, H, Duran, I, Biteker, M, Ozkan, M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 2008; 101: 137–40.Google Scholar
Habli, M, O’Brien, T, Nowack, E, et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008; 199: 415.e1–5.Google Scholar
Elkayam, U, Tummala, PP, Rao, K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344: 1567–71.Google Scholar
Fett, J, Christie, L, Murphy, J. Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 2006; 145: 30–4.Google Scholar
Sliwa, K, Forster, O, Zhanje, F, et al. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 2004; 93: 1441–3.Google Scholar
Lampert, MB, Weinert, L, Hibbard, J, et al. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 1997; 176: 189–95.Google Scholar
Shotan, A, Ostrzega, E, Mehra, A, Johnson, JV, Elkayam, U. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 1997; 79: 1061–4.Google Scholar
Blomström-Lundqvist, C, Scheinman, MM, Aliot, EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003; 108: 1871–909.Google Scholar
Romem, A, Romem, Y, Katz, M, Battler, A. Incidence and characteristics of maternal cardiac arrhythmias during labor. Am J Cardiol 2004; 93: 931–3.Google Scholar
Berlinerblau, R, Yessian, A, Lichstein, E, et al. Maternal arrhythmias of normal labor and delivery. Gynecol Obstet Invest 2001; 52: 128–31.Google Scholar
Rashba, EJ, Zareba, W, Moss, AJ, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation 1998; 97: 451–6.Google Scholar
Tan, H, Lie, K. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 2001; 22: 458–64.Google Scholar
Silversides, CK, Harris, L, Haberer, K, et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97: 1206–12.Google Scholar
Heradien, MJ, Goosen, A, Crotti, L, et al. Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? J Am Coll Cardiol 2006; 48: 1410–15.Google Scholar
Ersbøll, AS, Hedegaard, M, Søndergaard, L, Ersbøll, M, Johansen, M. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increased the risk of fetal growth restriction. BJOG 2014; 121: 618–26.Google Scholar
Wang, YC, Chen, CH, Su, HY, Yu, MH. The impact of maternal cardioversion on fetal haemodynamics. Eur J Obstet Gynecol Reprod Biol 2006; 126: 268–9.Google Scholar
Fuster, V, Rydén, LE, Asinger, RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001; 104: 2118–50.Google Scholar
James, AH, Jamison, MG, Biswas, MS, et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006; 113: 1564–71.Google Scholar
Ladner, H, Danielsen, B, Gilbert, W. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 2005; 105: 480–4.Google Scholar
Roth, A, Elkayam, U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008; 52: 171–80.Google Scholar
Karpati, P, Rossignol, M, Pirot, M, et al. High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology 2004; 100: 30–6.Google Scholar
Elkayam, U, Jalnapurkar, S, Barakkat, MN, et al. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation 2014; 129: 1695–702. https://doi.org/10.1161/CIRCULATIONAHA.113.002054.Google Scholar
Abramov, Y, Abramov, D, Abrahamov, A, Durst, R, Schenker, J. Elevation of serum creatine phosphokinase and its MB isoenzyme during normal labor and early puerperium. Acta Obstet Gynecol Scand 1996; 75: 255–60.Google Scholar
Shivvers, S, Wians, FH, Keffer, JH, Ramin, SM. Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol 1999; 180: 122.Google Scholar
Krahenmann, F, Huch, A, Atar, D. Troponin I measurement in the diagnosis of myocardial injury during pregnancy and delivery: two cases. Am J Obstet Gynecol 2000; 183: 1308–10.Google Scholar
Shade, GH, Ross, G, Bever, FN, et al. Troponin I in the diagnosis of acute myocardial infarction in pregnancy, labor, and post partum. Am J Obstet Gynecol 2002; 187: 1719–20.Google Scholar
Mhyre, JM, Tsen, LC, Einav, S, et al. Cardiac arrest during hospitalization for delivery in the United States, 1998–2011. Anesthesiology 2014; 120: 810–18.Google Scholar
Vinatier, D, Virelizier, S, Depret-Mosser, S, et al. Pregnancy after myocardial infarction. Eur J Obstet Gynecol Reprod Biol 1994; 56: 8993.Google Scholar
Jeejeebhoy, FM, Zelop, CM, Lipman, S, et al. Cardiac arrest in pregnancy: a scientific statement from the American Heart Association. Circulation 2015; 132: 1747–73. https://doi.org/10.1161/CIR.0000000000000300.Google Scholar
Katz, V, Balderston, K, DeFreest, M. Perimortem cesarean delivery: were our assumptions correct? Am J Obstet Gynecol 2005; 192: 1916–21.Google Scholar
Lipman, S, Cohen, S, Einav, S, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the management of cardiac arrest in pregnancy. Anesth Analg 2014; 118: 1003–16.Google Scholar
Fisher, N, Eisen, LA, Bayya, JV, et al. Improved performance of maternal-fetal medicine staff after maternal cardiac arrest simulation-based training. Am J Obstet Gynecol 2011; 205: 239.e1–5.Google Scholar
Maron, BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308–20.Google Scholar
Maki, S, Ikeda, H, Muro, A, et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 774–8.Google Scholar
Deb, SJ, Schaff, HV, Dearani, JA, Nishimura, RA, Ommen, SR. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2004; 78: 2118–22.Google Scholar
Natale, A, Davidson, T, Geiger, MJ, Newby, K. Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation 1997; 96: 2808–12.Google Scholar
Autore, C, Conte, MR, Piccininno, M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40: 1864–9.Google Scholar
Thaman, R, Varnava, A, Hamid, MS, et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003; 89: 752–6.Google Scholar

References

Templeton, A, Kelman, GR. Maternal blood-gases, (PAO2–PaO2), physiological shunt and VD/VT in normal pregnancy. Br J Anaesth 1976; 48: 1001–4.Google Scholar
Hankins, GD, Clark, SL, Harvey, CJ, et al. Third-trimester arterial blood gas and acid base values in normal pregnancy at moderate altitude. Obstet Gynecol 1996; 88: 347–50.Google Scholar
Cugell, DW, Frank, NR, Gaensler, EA, Badger, TL. Pulmonary function in pregnancy. I. Serial observations in normal women. Am Rev Tuberc 1953; 67: 568–97.Google Scholar
Prowse, CM, Gaensler, EA. Respiratory and acid–base changes during pregnancy. Anesthesiology 1965; 26: 381–92.Google Scholar
Bourjeily, G, Powrie, R. Normal respiratory changes in pregnancy. In Rosene-Montella, K, Keely, EJ, Lee, RV, Barbour, LA (eds), Medical Care of the Pregnant Patient, 2nd edn. Philadelphia, PA: ACP Press, 2008.Google Scholar
Greer, IA, Walters, B, Nelson-Piercy, C. Maternal Medicine. Edinburgh: Churchill Livingstone Elsevier, 2007.Google Scholar
Centers for Disease Control and Prevention. Asthma surveillance data. http://www.cdc.gov/asthma/most_recent_data.htm (accessed June 2018).Google Scholar
Kwon, HL, Triche, EW, Belanger, K, Bracken, MB. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006; 26: 2962.Google Scholar
Schatz, M, Hoffman, C. Interrelationships between asthma and pregnancy: clinical and mechanistic considerations. Clin Rev Allergy 1987; 5: 301–15.Google Scholar
Schatz, M, Harden, K, Forsythe, A, et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 1988; 81: 509–17.Google Scholar
Murphy, VE, Namazy, JA, Powell, H, et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG 2011; 118: 1314–23.Google Scholar
Tata, LJ, Lewis, SA, McKeever, TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax 2008; 63: 981–7.Google Scholar
Murphy, VE, Wang, G, Namazy, JA, et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG 2013; 120: 812–22.Google Scholar
Schatz, M. Asthma and pregnancy. Lancet 1999; 353: 1202–4.Google Scholar
Landau, R, Xie, HG, Dishy, V, et al. Beta2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 2002; 187: 1294–8.Google Scholar
Wen, HJ, Chiang, TL, Lin, SJ, Guo, YL. Predicting risk for childhood asthma by pre-pregnancy, perinatal, and postnatal factors. Pediatr Allergy Immunol 2015; 26: 272–9.Google Scholar
Laerum, BN, Svanes, C, Wentzel-Larsen, T, et al. Young maternal age at delivery is associated with asthma in adult offspring. Respir Med 2007; 101: 1431–8.Google Scholar
National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: Summary Report 2007. Bethesda, MD: National Institutes of Health, 2007.Google Scholar
British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: A National Clinical Guideline. Edinburgh: SIGN, 2016. https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016 (accessed June 2018).Google Scholar
Bakhireva, LN, Schatz, M, Chambers, CD. Effect of maternal asthma and gestational asthma therapy on fetal growth. J Asthma 2007; 44: 71–6.Google Scholar
Cydulka, RK, Emerman, CL, Schreiber, D, et al. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999; 160: 887–92.Google Scholar
Carmichael, SL, Shaw, GM, Ma, C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197: 585.e1–7.Google Scholar
Kelly, KN, Domajnko, B. Perioperative stress-dose steroids. Clin Colon Rectal Surg 2013; 26: 163–7.Google Scholar
Ajetunmobi, OM, Whyte, B, Chalmers, J, et al. Breastfeeding is associated with reduced childhood hospitalization: evidence from a Scottish birth cohort (1997–2009). J Pediatr 2015; 166: 620–4.Google Scholar
Cystic Fibrosis Trust. UK Cystic Fibrosis Registry 2014 Annual Data Report. London: Cystic Fibrosis Trust, 2016.Google Scholar
Edenborough, FP. Women with cystic fibrosis and their potential for reproduction. Thorax 2001; 56: 649–55.Google Scholar
Cystic Fibrosis Trust. UK Cystic Fibrosis Registry. https://www.cysticfibrosis.org.uk/the-work-we-do/uk-cf-registry (accessed March 2017).Google Scholar
Thorpe-Beeston, JG, Madge, S, Gyi, K, Hodson, M, Bilton, D. The outcome of pregnancies in women with cystic fibrosis: single centre experience 1998–2011. BJOG 2013; 120: 354–61.Google Scholar
Edenborough, FP, Mackenzie, WE, Stableforth, DE. The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977–1996. BJOG 2000; 107: 254–61.Google Scholar
Ødegaard, I, Stray-Pedersen, B, Hallberg, K, et al. Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis. Acta Obstet Gynecol Scand 2002; 81: 698705.Google Scholar
Jankelson, D, Robinson, M, Parsons, S, Torzillo, P, Peat, B, Bye, P. Cystic fibrosis and pregnancy. Aust N Z J Obstet Gynaecol 1998; 38: 180–4.Google Scholar
Gillet, D, de Braekeleer, M, Bellis, G, Durieu, I; French Cystic Fibrosis Registry. Cystic fibrosis and pregnancy. Report from French data (1980–1999). BJOG 2002; 109: 912–18.Google Scholar
Lau, EM, Barnes, DJ, Moriarty, C, et al. Pregnancy outcomes in the current era of cystic fibrosis care: a 15-year experience. Aust N Z J Obstet Gynaecol 2011; 51: 220–4.Google Scholar
Edenborough, FP, Borgo, G, Knoop, C, et al. Guidelines for the management of pregnancy in women with cystic fibrosis. J Cyst Fibros 2008; 7 (Suppl 1): S2–32.Google Scholar
Burden, C, Ion, R, Chung, Y, et al. Current pregnancy outcomes in women with cystic fibrosis. Eur J Obstet Gynecol Reprod Biol 2012; 164: 142–5.Google Scholar
Lyon, A, Bilton, D. Fertility issues in cystic fibrosis. Paediatr Respir Rev 2002; 3: 236–40.Google Scholar
Hilman, BC, Aitken, ML, Constantinescu, M. Pregnancy in patients with cystic fibrosis. Clin Obstet Gynecol 1996; 39: 7086.Google Scholar
McMullen, AH, Pasta, DJ, Frederick, PD, et al. Impact of pregnancy on women with cystic fibrosis. Chest 2006; 129: 706–11.Google Scholar
Edenborough, FP, Stableforth, DE, Webb, AK, Mackenzie, WE, Smith, DL. Outcome of pregnancy in women with cystic fibrosis. Thorax 1995; 50: 170–4.Google Scholar
Kent, NE, Farquharson, DF. Cystic fibrosis in pregnancy. CMAJ 1993; 149: 809–13.Google Scholar
Frangolias, DD, Nakielna, EM, Wilcox, PG. Pregnancy and cystic fibrosis: a case-controlled study. Chest 1997; 111: 963–9.Google Scholar
Gilljam, M, Antoniou, M, Shin, J, et al. Pregnancy in cystic fibrosis. Fetal and maternal outcome. Chest 2000; 118: 8591.Google Scholar
Briard, ML, Mattei, JF. Cystic fibrosis: preimplantation diagnosis, prenatal diagnosis and medical ethics, a successful combination. Pediatr Pulmonol Suppl 1997; 16: 65.Google Scholar
Tonelli, MR, Aitken, ML. Pregnancy in cystic fibrosis. Curr Opin Pulm Med 2007; 13: 537–40.Google Scholar
Catalano, PM, McIntyre, HD, Cruickshank, JK, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012; 35: 780–6.Google Scholar
Metzger, BE, Lowe, LP, Dyer, AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 19912002.Google Scholar
Suhonen, L, Hiilesmaa, V, Teramo, K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000; 43: 7982.Google Scholar
Mackie, AD, Thornton, SJ, Edenborough, FP. Cystic fibrosis-related diabetes. Diabet Med 2003; 20: 425–36.Google Scholar
Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press, 2009. https://www.ncbi.nlm.nih.gov/books/NBK32813 (accessed March 2017).Google Scholar
Rothman, KJ, Moore, LL, Singer, MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995; 333: 1369–73.Google Scholar
Sawyer, SM, Phelan, PD, Bowes, G. Reproductive health in young women with cystic fibrosis: knowledge, behaviour and attitudes. J Adolesc Health Care 1995; 17: 4650.Google Scholar
Fair, A, Griffiths, K, Osman, LM. Attitudes to fertility issues among adults with cystic fibrosis in Scotland. Thorax 2000; 55: 672–7.Google Scholar
Nixon, GM, Glazner, JA, Martin, JM, Sawyer, SM. Female sexual health care in cystic fibrosis. Arch Dis Child 2003; 88: 265–6.Google Scholar
Oxley, H, Webb, AK. How a clinical psychologist manages the problems of adults with cystic fibrosis. J R Soc Med 2005; 98 (Suppl 45): 3746.Google Scholar
National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. NICE Guideline 3. London: NICE, 2015. https://www.nice.org.uk/guidance/ng3 (accessed March 2017).Google Scholar
Hadid, V, Patenaude, V, Oddy, L, Abenhaim, H. Sarcoidosis and pregnancy: obstetric and neonatal outcomes in a population-based cohort. Obstet Gynecol 2014; 123 (Suppl 1): 148S.Google Scholar
Cremers, JP, Drent, M, Bast, A, et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med 2013; 19: 545–61.Google Scholar
Subramanian, P, Chinthalapalli, H, Krishnan, M, et al. Pregnancy and sarcoidosis: an insight into the pathogenesis of hypercalciuria. Chest 2004; 126: 995–8.Google Scholar
Lapinsky, SE, Tram, C, Mehta, S, Maxwell, CV. Restrictive lung disease in pregnancy. Chest 2014; 145: 394–8.Google Scholar
Ward, S, Chatwin, M, Heather, S, Simonds, AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019–24.Google Scholar
Lal, A, Anderson, G, Cowen, M, Lindow, S, Arnold, AG. Pneumothorax and pregnancy. Chest 2007; 132: 1044–8.Google Scholar
MacDuff, A, Arnold, A, Harvey, J; BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2): ii18–31.Google Scholar
O’Brien, LM, Bullough, AS, Owusu, JT, et al. Snoring during pregnancy and delivery outcomes: a cohort study. Sleep 2013; 36: 1625–32.Google Scholar
Pérez-Chada, D, Videla, AJ, O’Flaherty, ME, et al. Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2007; 86: 788–92.Google Scholar
Yinon, D, Lowenstein, L, Suraya, S, et al. Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J 2006; 27: 328–33.Google Scholar
Louis, J, Auckley, D, Bolden, N. Management of obstructive sleep apnea in pregnant women. Obstet Gynecol 2012; 119: 864–8.Google Scholar
Franklin, KA, Holmgren, PA, Jönsson, F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117: 137–41.Google Scholar
Chen, YH, Kang, JH, Lin, CC, et al. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol 2012; 206: 136.e1–5.Google Scholar
Knight, M, Kenyon, S, Brocklehurst, P, et al. Saving Lives, Improving Mothers’ Care: Lessons Learned to Inform Future Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–2012. Oxford: National Perinatal Epidemiology Unit, 2014.Google Scholar
Yau, W-P, Mitchell, AA, Lin, KJ, Werler, MM, Hernández-Díaz, S. Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol 2013; 178: 198208.Google Scholar
Namazy, JA, Schatz, M. Diagnosing rhinitis during pregnancy. Curr Allergy Asthma Rep 2014; 14: 458.Google Scholar
Finland, M, Dublin, TD. Pneumococcic pneumonias complicating pregnancy and the puerperium. J Am Med Assoc 1939; 112: 1027–32.Google Scholar
Kourtis, AP, Read, JS, Jamieson, DJ. Pregnancy and infection. N Engl J Med 2014; 370: 2211–18.Google Scholar
Lim, WS, Baudouin, SV, George, RC, et al.; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (Suppl 3): iii1–55. doi: 10.1136/thx.2009.121434.Google Scholar
National Institute for Health and Care Excellence. Pneumonia in Adults: Diagnosis and Management. NICE Clinical Guideline 191. London: NICE, 2014. https://www.nice.org.uk/guidance/cg191 (accessed March 2017).Google Scholar
Madinger, NE, Greenspoon, JS, Ellrodt, AG. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol 1989; 161: 657–62.Google Scholar
Intensive Care National Audit & Research Centre. Female Admissions (Aged 16–50 years) to Adult, General Critical Care Units in England, Wales and Northern Ireland Reported as ‘Currently Pregnant’ or ‘Recently Pregnant’: 1 January 2009 to 31 December 2012. London: ICNARC, 2013.Google Scholar
Keller-Stanislawski, B, Englund, JA, Kang, G, et al. Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014; 32: 7057–64.Google Scholar
Andrews, N, McMenamin, J, Durnall, H, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill 2014; 19: 513.Google Scholar
Public Health England. Influenza Immunisation Programme for England. GP Patient Groups. Data Collection Survey, Season 2016 to 2017.Google Scholar
Sheffield, JS, Cunningham, FG. Community-acquired pneumonia in pregnancy. Obstet Gynecol 2009; 114: 915–22.Google Scholar
Yost, NP, Bloom, SL, Richey, SD, Ramin, SM, Cunningham, FG. An appraisal of treatment guidelines for antepartum community-acquired pneumonia. Am J Obstet Gynecol 2000; 183: 131–5.Google Scholar
Jefferson, T, Jones, M A, Doshi, P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014; (4): CD008965.Google Scholar
Siston, AM, Rasmussen, SA, Honein, MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303: 1517–25.Google Scholar
Creanga, AA, Kamimoto, L, Newsome, K, et al. Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol 2011; 204 (6 Suppl 1): S38–45.Google Scholar
Pierce, M, Kurinczuk, JJ, Spark, P, Brocklehurst, P, Knight, M; UKOSS. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011; 342: d3214–4.Google Scholar
Enders, G, Miller, E, Cradock-Watson, J, Bolley, I, Ridehalgh, M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1548–51.Google Scholar
Boyd, K, Walker, E. Use of acyclovir to treat chickenpox in pregnancy. Br Med J 1988; 296: 393–4.Google Scholar
Mandelbrot, L. Fetal varicella: diagnosis, management, and outcome. Prenat Diagn 2012; 32: 511–18.Google Scholar
Salisbury, D, Ramsay, M. Immunisation Against Infectious Disease. London: Public Health England, 2013.Google Scholar
Hamborsky, J, Kroger, A, Wolfe, S; Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th edn. Washington, DC: Public Health Foundation, 2015.Google Scholar
World Health Organization, UNICEF, UNFPA, World Bank. Trends in Maternal Mortality: 1990 to 2015. Geneva: WHO, 2015. http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en (accessed March 2017).Google Scholar
World Health Organization. Global Tuberculosis Report 2015. Geneva: WHO, 2015.Google Scholar
Sugarman, J, Colvin, C, Moran, AC, Oxlade, O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health 2014; 2: e710–16.Google Scholar
Public Health England. Tuberculosis in the UK: 2017 Report. London: Public Health England, 2017.Google Scholar
Selwyn, PA, Hartel, D, Lewis, VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545–50.Google Scholar
Zenner, D, Kruijshaar, ME, Andrews, N, Abubakar, I. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med 2012; 185: 779–84.Google Scholar
Jana, N, Vasishta, K, Jindal, SK, Khunnu, B, Ghosh, K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet 1994; 44: 119–24.Google Scholar
Jana, N, Vasishta, K, Saha, SC, Ghosh, K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med 1999; 341: 645–9.Google Scholar
Asuquo, B, Vellore, AD, Walters, G, et al. A case-control study of the risk of adverse perinatal outcomes due to tuberculosis during pregnancy. J Obstet Gynaecol 2012; 32: 635–8.Google Scholar
Bothamley, G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24: 553–65.Google Scholar
Conway, N, Birt, BD. Streptomycin in pregnancy: effect on the foetal ear. Br Med J 1965; 2 (5456): 260–3.Google Scholar
Cantwell, MF, Shehab, ZM, Costello, AM, et al. Brief report: congenital tuberculosis. N Engl J Med 1994; 330: 1051–4.Google Scholar
World Health Organization. Treatment of Tuberculosis: Guidelines, 4th edn. Geneva: WHO, 2010.Google Scholar
Bothamley, GH. Screening for tuberculosis in pregnancy. Expert Rev Obstet Gynaecol 2012; 7: 387–95.Google Scholar
Getahun, H, Kittikraisak, W, Heilig, CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011; 8(1): e1000391.Google Scholar
Jonnalagadda, S, Lohman, Payne B, Brown, E, et al. Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 2010; 202: 1826–35.Google Scholar
National Institute for Health and Care Excellence. Tuberculosis. NICE Guideline 33. London: NICE, 2016. https://www.nice.org.uk/guidance/ng33 (accessed March 2017).Google Scholar
Nahid, P, Dorman, S, Alipanah, N, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63: 853–67. doi: 10.1093/cid/ciw566.Google Scholar
Snider, DE, Layde, PM, Johnson, MW, Lyle, MA. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980; 122: 6579.Google Scholar
Saukkonen, JJ, Cohn, DL, Jasmer, RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174: 935–52.Google Scholar
Pickering, LK, Baker, CJ, Long, SS, McMillan, JA. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th edn. Elk Grove, IL: American Academy of Pediatrics, 2006.Google Scholar
Mangtani, P, Abubakar, I, Ariti, C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58: 470–80.Google Scholar
Centers for Disease Control and Prevention. Latent Tuberculosis Infection: a Guide for primary health care providers. Atlanta, GA: CDC, 2013.Google Scholar
American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Am J Respir Crit Care Med 2000; 161: S221–47.Google Scholar
Pollock, W, Rose, L, Dennis, CL. Pregnant and postpartum admissions to the intensive care unit: a systematic review. Intensive Care Med 2010; 36: 1465–74.Google Scholar
ARDS Definition Task Force, Ranieri, VM, Rubenfeld, GD, Thompson, BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012; 307: 2526–33.Google Scholar
Spragg, RG, Bernard, GR, Checkley, W, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010; 181: 1121–7.Google Scholar
Phua, J, Badia, JR, Adhikari, NKJ, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009; 179: 220–7.Google Scholar
Perry, KG, Martin, RW, Blake, PG, Roberts, WE, Martin, JN. Maternal mortality associated with adult respiratory distress syndrome. South Med J 1998; 91: 441–4.Google Scholar
Vasquez, DN, Estenssoro, E, Canales, HS, et al. Clinical characteristics and outcomes of obstetric patients requiring ICU admission. Chest 2007; 131: 718–24.Google Scholar
Catanzarite, V, Willms, D, Wong, D, et al. Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes. Obstet Gynecol 2001; 97: 760–4.Google Scholar
Montgomery, AB, Stager, MA, Carrico, CJ, Hudson, LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132: 485–9.Google Scholar
Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301–8.Google Scholar
Gattinoni, L, Taccone, P, Carlesso, E, Marini, JJ. Prone position in acute respiratory distress syndrome: rationale, indications, and limits. Am J Respir Crit Care Med 2013; 188: 1286–93.Google Scholar
Ferguson, ND, Cook, DJ, Guyatt, GH, et al. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368: 795805.Google Scholar
Young, D, Lamb, SE, Shah, S, et al. High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013; 368: 806–13.Google Scholar
Peek, GJ, Mugford, M, Tiruvoipati, R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351–63.Google Scholar

References

World Health Organization. Worldwide Prevalence of Anaemia 1993–2005: WHO Global Database on Anaemia. Geneva: WHO, 2008, pp. 46. http://apps.who.int/iris/bitstream/10665/43894/1/9789241596657_eng.pdf (accessed March 2017).Google Scholar
Centers for Disease Control and Prevention (CDC). Recommendations to prevent and control iron deficiency anemia in the United States. MMWR Recomm Rep 1998; 47 (RR-3): 129.Google Scholar
Hytten, F. Blood volume changes in normal pregnancy. In Letsky, EA (ed.), Hematological Disorders in Pregnancy. London: Saunders, 1985, pp. 601–12.Google Scholar
Letsky, EA. The haematological system. In Broughton Pipkin, F, Chamberlain, GVP (eds), Clinical Physiology in Obstetrics, 3rd edn. Oxford: Blackwell, 1998, pp. 71110.Google Scholar
Khan, KS, Wojdyla, D, Say, L, Gülmezoglu, AM, Van Look, PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 :1066–74.Google Scholar
Milman, N. Prepartum anaemia: prevention and treatment. Ann Hematol 2008; 87: 949–59.Google Scholar
Finch, CA, Cook, JD. Iron deficiency. Am J Clin Nutr 1984; 39: 471–7.Google Scholar
Scholl, TO, Hediger, ML, Fischer, RL, Shearer, JW. Anemia versus iron deficiency: Increased risk of pre-term delivery in a prospective study. Am J Clin Nutr 1992; 55: 985–8.Google Scholar
Cao, C, O’Brien, KO. Pregnancy and iron homeostasis: an update. Nutr Rev 2013; 71: 3551.Google Scholar
Milman, N, Agger, AO, Nielson, OJ. Iron status markers and serum erythropoietin in 120 mothers and newborn infants: Effect of iron supplementation in normal pregnancy. Acta Obstet Gynecol Scand 1994; 73: 200–4.Google Scholar
Colomer, J, Colomer, C, Gutierrez, D, et al. Anaemia during pregnancy as a risk factor for infant deficiency: report from the Valencia Infant Anaemia Cohort (VIAC) Study. Paediatr Perinat Epidemiol 1990; 4: 196204.Google Scholar
Hindmarsh, PC, Geary, MP. Effect of early maternal iron stores on placental weight and structure. Lancet 2000; 356: 719–23.Google Scholar
Barker, DJP, Bull, AR, Osmand, C, Simmonds, SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 1990; 301: 259–62.Google Scholar
Chanarin, I. Folate and cobalamin. Clin Haematol 1985; 14: 629–41.Google Scholar
Thompson, WG. Comparison of tests for diagnosis of iron depletion in pregnancy. Am J Obstet Gynecol 1988; 159: 1132–4.Google Scholar
Carriaga, MT, Skikne, BS, Finley, B, Cutler, B, Cook, JD. Serum transferrin receptor for the detection of iron deficiency in pregnancy. Am J Clin Nutr 1991; 54: 1077–81.Google Scholar
De Leeuw, NK, Lowenstein, L, Hsieh, YS. Iron deficiency and hydremia in normal pregnancy. Medicine (Baltimore) 1966; 45: 291315.Google Scholar
World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention and Control. A Guide for Programme Managers. Geneva: WHO, 2001, pp. 4767.Google Scholar
Campbell, OMR, Graham, WJ. Strategies for reducing maternal mortality: Getting on with what works. Lancet 2006; 368: 1284–99.Google Scholar
Pena Rosas, JP, De-Regil, LM, Dowswell, T, Viteri, FE. Daily iron supplementation during pregnancy. Cochrane Database Syst Rev 2012; (12): CD004736.Google Scholar
Blot, I, Diallo, D, Tchernia, G. Iron deficiency in pregnancy: effects on the newborn. Curr Opin Hematol 1999; 6: 6570.Google Scholar
Allen, LH. Pregnancy and iron deficiency in pregnancy: unresolved issues. Nutr Rev 1997; 55: 91101.Google Scholar
Allen, LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000; 71: 12805–45.Google Scholar
Haram, K, Nilsen, ST, Ulvik, RJ. Iron supplements in pregnancy: evidence and controversies. Acta Obstet Gynecol Scand 2001; 80: 683–8.Google Scholar
Milman, N, Bergholt, T, Byg, KE, Eriksen, L, Graudal, N. Iron status and iron balance during pregnancy: a critical re-appraisal of iron supplementation. Acta Obstet Gynecol Scand 1999; 78: 749–57.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin no 95: Anemia in pregnancy. Obstet Gynecol 2008; 112: 201–7.Google Scholar
National Institute for Health and Care Excellence. Antenatal Care for Uncomplicated Pregnancies. NICE Clinical Guideline CG62. London: NICE, 2008. https://www.nice.org.uk/guidance/cg62 (accessed March 2017).Google Scholar
Pena-Rosas, JP, De-Regil, LM, Dowswell, T, Viteri, FE. Intermittent iron supplementation during pregnancy. Cochrane Database Syst Rev 2012; (7): CD009997.Google Scholar
Bhatt, RV. Poor iron compliance: the way out. J Obstet Gynecol Ind 1997; 47: 185–90.Google Scholar
Schultink, JW, Van der Ree, M, Matulessi, P, Gross, R. Low compliance with an iron supplementation program: a study among pregnant women in Jakarta, Indonesia. Am J Clin Nutr 1993; 57: 135–9.Google Scholar
McKenna, D, Spence, D, Haggan, SE, et al. A randomized trial investigating an iron-rich natural mineral water as prophylaxis against iron deficiency in pregnancy. Clin Lab Hematol 2003; 25: 99103.Google Scholar
Pritchard, JA. Hemoglobin regeneration in severe iron deficiency anemia: response to orally parenterally administered iron preparations. JAMA 1996; 195: 717–20.Google Scholar
Al-Momen, AK, Al-Meshari, A, Al-Nuaim, L, et al. Intravenous iron sucrose complex in the treatment of iron deficiency during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 69: 121–4.Google Scholar
Van Wyck, DB, Martens, MG, Seid, MH, Baker, JB, Mangione, A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia. Obstet Gynecol 2007; 110: 267–78.Google Scholar
Sifakis, S, Angelakis, E, Vardarki, E, et al. Erythropoietin in the treatment of iron deficiency during pregnancy. Gynecol Obstet Invest 2001; 51: 150–6.Google Scholar
Reveiz, L, Gyte, GM, Cuervo, LG Casabuenas, A. Treatments for iron deficiency anemia in pregnancy. Cochrane Database Syst Rev 2011; (10): CD003094.Google Scholar
Dodd, J, Dare, MR, Middleton, P. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database Syst Rev 2012; (8): CD004222Google Scholar
Landon, MJ. Folate metabolism in pregnancy. Clin Obstet Gynaecol 1975; 2: 413.Google Scholar
Lowenstein, L, Brunton, L, Hsieh, YJ. Nutritional anemia and megaloblastosis in pregnancy. Can Med Assoc J 1966; 94: 636–45.Google Scholar
De-Regil, LM, Fernandez-Gaxiola, AC, Dowswell, T, Pena-Rosas, JP. Effects and safety of periconceptual folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; (10): CD007950.Google Scholar
Lassi, ZS, Salam, RA, Haider, BA, Bhutta, ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev 2013; (3): CD006896.Google Scholar
National Institute for Health and Care Excellence. Epilepsies: Diagnosis and Management. NICE Clinical Guideline CG137. London: NICE, 2012. https://www.nice.org.uk/guidance/cg137 (accessed March 2017).Google Scholar
Devalia, V, Hamilton, MS, Molloy, AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol 2014; 2014: 496513.Google Scholar
Cooper, BA. Folate and vitamin B12 in pregnancy. Clin Hematol 1973; 2: 461–6.Google Scholar
Morkbak, AL, Hvas, AM, Milman, N, Nexo, E. Holotranscobalamin remains unchanged during pregnancy. Longditudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 2007; 92: 1711–12.Google Scholar
Grange, DK, Finlay, JL. Nutritional vitamin B12 deficiency in a breastfed infant following maternal gastric bypass. Pediatr Hematol Oncol 1994; 11: 311–18.Google Scholar
World Health Organization. Vitamin and Mineral Requirements in Human Nutrition. Geneva: WHO, 2004, pp. 279–86.Google Scholar
UK National Screening Committee. NHS sickle cell and thalassaemia (SCT) screening programme. https://www.gov.uk/topic/population-screening-programmes/sickle-cell-thalassaemia (accessed March 2017).Google Scholar
Bain, B. The α, β, δ and γ thalassaemias and related conditions; Sickle cell haemoglobin and its interactions with other variant haemoglobins and with thalassaemias. In Haemoglobinopathy Diagnosis, 2nd edn. Oxford: Blackwell, 2005, Chapters 3 and 4.Google Scholar
Tuck, SM, Studd, JWW, White, JM. Pregnancy in women with sickle cell trait. Br J Obstet Gynaecol 1983; 90: 108–11.Google Scholar
Telfer, P, Coen, P, Chakravorty, S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 2007: 92; 905–12.Google Scholar
Wierenga, KJ, Hambleton, IR, Lewis, NA. Survival estimates for patients with homozygous sickle cell disease in Jamaica: a clinic based population study. Lancet 2001; 357: 680–3.Google Scholar
National Heart, Lung and Blood Institute, Division of Blood Diseases and Resources. The Management of Sickle Cell Disease, 4th edn. NIH Publication No. 02–2117. Bethesda, MD: NIH, 2002.Google Scholar
Cantwell, R, Clutton-Brock, T, Cooper, G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eight Report of the Confidential enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl 1): 1203.Google Scholar
Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. London: RCOG, 2015.Google Scholar
Tuck, SM, Studd, JWW, White, JM. Pregnancy in sickle cell disease in the United Kingdom. Br J Obstet Gynaecol 1983; 90: 112–17.Google Scholar
Smith, JA, Espeland, M, Bellevue, R, et al. Pregnancy in sickle cell disease: experience of the co-operative study of sickle cell disease. Obstet Gynecol 1996; 87: 199203.Google Scholar
Ataga, KI, Moore, CG, Jones, S, et al. Pulmonary hypertensions in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006; 134: 109–15.Google Scholar
Sickle Cell Society. Standards for the Clinical Care of Adults with Sickle Cell Disease in the UK. London: Sickle Cell Society, 2008. http://sicklecellsociety.org/wp-content/uploads/2016/02/Standards-for-the-Clinical-Care-of-Adults-with-Sickle-Cell-Disease-in-the-UK.pdf (accessed March 2017).Google Scholar
Davies, EG, Riddington, C, Lottenberg, R, Dower, N. Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev 2004; (1): CD003885.Google Scholar
Diav-Citrin, O, Hunnisett, L, Sher, GD, Koren, G. Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol 1999; 60: 148–50.Google Scholar
Byrd, DC, Pitts, SR, Alexander, CK. Hydroxyurea in two pregnant women with sickle cell anemia. Pharmacotherapy 1999; 19: 1459–62.Google Scholar
Traeger-Synodinos, J. Preimplantation genetic diagnosis: an alternative to conventional diagnosis of the hemoglobinopathies. Int J Lab Hematol 2013; 35: 571–9.Google Scholar
Powars, DR, Sandhu, M, Niland-Weiss, J, et al. Pregnancy in sickle cell disease. Obstet Gynecol 1986; 67: 217–28.Google Scholar
Rahimy, MC, Gangho, A, Adjou, R, et al. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood 2000; 96:1685–9.Google Scholar
National Institute for Health and Care Excellence. Hypertension in Pregnancy: Diagnosis and Management. NICE Clinical Guideline CG107. London: NICE, 2010. https://www.nice.org.uk/guidance/cg107 (accessed March 2017).Google Scholar
Okusanya, BO, Oladapo, OT. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane Database Syst Rev 2013; (12). CD010378.Google Scholar
Tongsong, T, Srisupundit, K, Luewan, S. Outcomes of pregnancies affected by hemoglobin H disease. Int J Gynaecol Obstet 2009; 104: 206–8.Google Scholar
Vichinsky, EP. Alpha thalassemia major: new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program 2009; 2009: 3541.Google Scholar
Ryan, K, Bain, BJ, Worthington, D, et al.; British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 2010; 149: 3549.Google Scholar
Protonotariou, AA, Tolis, GJ. Reproductive health in female patients with β-thalassemia major. Ann N Y Acad Sci 2000; 900: 119–24.Google Scholar
Singer, ST, Vichinsky, EP. Deferoxamine treatment during pregnancy: is it harmful? Am J Hematol 1999; 60: 24–6.Google Scholar
Royal College of Obstetricians and Gynaecologists. Management of Beta Thalassaemia in Pregnancy. Green-top Guideline No. 66. London: RCOG, 2014.Google Scholar
Naik, RP, Lanzkron, S. Baby on board: what you need to know about pregnancy in the hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2012; 2012: 208–14.Google Scholar
United Kingdom Thalassaemia Society. Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK, 3rd edn. London: UKTS, 2016. http://ukts.org/standards (accessed March 2017).Google Scholar
Wood, JCGN, Carson, S, Tyszka, J. Predictors of abnormal myocardial function and T2* in children and young adults with thalassemia major. Poster session 64-I, American Society of Hematology, 2003.Google Scholar
Chaplin, H, Cohen, R, Bloomberg, G, et al. Pregnancy and idiopathic autoimmune hemolytic anemia. Br J Haematol 1973; 24: 219–39.Google Scholar
Benraad, CE, Scheerder, HA, Overbeeke, MA. Autoimmune haemolytic anaemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 55: 209–11.Google Scholar
Lefkou, E, Nelson-Piercy, C, Hunt, BJ. Evans’ syndrome in pregnancy: a systematic literature review and two new cases Eur J Obstet Gynecol Reprod Biol 2010; 149: 1017.Google Scholar
Hoffman, PC. Immune hemolytic anemia: selected topics. Hematology Am Soc Hematol Educ Program 2009; 2009: 80–6.Google Scholar
Baumann, R, Rubin, H. Autoimmune hemolytic anemia during pregnancy with hemolytic disease in the newborn. Blood 1973; 41: 293–7.Google Scholar
Bolton-Maggs, PHB, Langer, JC, Iolascon, A, Tittensor, P, King, MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis: 2011 update. Br J Haematol 2012; 156: 3749.Google Scholar
King, MJ, Behrens, J, Rogers, C, et al. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated hemolytic anemia. Br J Haematol 2000; 111: 924–33.Google Scholar
Zanella, A, Fermo, E, Bianchi, P, Valentini, G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol 2005; 130: 1125.Google Scholar
Amankwah, KS, Dick, BW, Dodge, S. Hemolytic anemia and pyruvate kinase deficiency in pregnancy. Obstet Gynecol 1980; 55: 42S44S.Google Scholar
Luzzatto, L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica 2006; 91: 1303–6.Google Scholar
Kwon, JY, Lee, Y, Shin, JC, et al. Supportive management of pregnancy-associated aplastic anemia. Int J Gynaecol Obstet 2006; 95: 115–20.Google Scholar
Choudry, VP, Gupta, S, Gupta, M, Kashyap, R, Saxena, R. Pregnancy associated aplastic anemia: a series of 10 cases with a review of the literature. Hematology 2002; 7: 233–8.Google Scholar
Young, NS, Calado, RT, Scheinberg, P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; 108: 2509–19.Google Scholar
Marsh, JC, Ball, SE, Cavenagh, J, et al.; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 2009; 147: 4370.Google Scholar
Hillmen, P, Muus, P, Dührsen, U, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007; 110: 4123–8.Google Scholar
Kelly, R, Arnold, L, Richards, S, et al. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab. Br J Haematol 2010; 149: 446–50.Google Scholar
Tichelli, A, Socie, G, Marsh, J, et al.; European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Ann Intern Med 2002; 137: 164–72.Google Scholar
Kahl, C, Leisenring, W, Deeg, HJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long term follow up. Br J Haematol 2005; 130: 747–51.Google Scholar
Haddy, TB, Rana, SR, Castro, O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? Lab Clin Med 1999; 133: 1522.Google Scholar
Royal College of Obstetricians and Gynaecologists. Bacterial Sepsis in Pregnancy. Green-top Guideline No. 64a. London: RCOG, 2012.Google Scholar
Boxer, LA, Bolyard, AA, Marrero, TM, et al. Outcome of pregnancies for women with severe chronic neutropenia with or without GCSF treatment. Haematologica 2014; 99: 1395–402.Google Scholar
Zeidler, C, Grote, UA, Nickel, A, et al. Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry. Haematologica 2014; 99: 1395–402. doi: 10.3324/haematol.2013.099101.Google Scholar

Further Reading: Web Resources

A video produced by the University of Leicester, UK, demonstrating BMB. https://youtu.be/svTQ-zJHY9M.Google Scholar
Patient information regarding hematological cancers and their treatment, produced by the charity Macmillan. www.macmillan.org.uk.Google Scholar
Patient information specific to hematological cancers produced by the charity Bloodcancer UK. bloodcancer.org.uk.Google Scholar
Information for healthcare professionals and patients produced by the American Society of Hematology. www.hematology.org.Google Scholar
Information for professionals produced by the British Society for Haematology. www.b-s-h.org.uk.Google Scholar
Information on a broad range of conditions including hematological disorders produced by the UK National Health Service. www.nhs.uk.Google Scholar
Data on incidence, age at diagnosis, and outcomes for hematological malignancies diagnosed within Yorkshire and Humberside, United Kingdom, from the Haematological Malignancy Research Network (HMRN). www.hmrn.org.Google Scholar

References

Stone, RM, Mandrekar, SJ, Sanford, BL, et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med 2017; 377: 454–64. doi: 10.1056/NEJMoa1614359.Google Scholar
Lancet, JE, Uy, GL, Cortes, JE, et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol 2018; 36: 2684–92. https://doi.org/10.1200/JCO.2017.77.6112.Google Scholar
Döhner, H, Estey, E, Grimwade, D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017; 129: 424–47. https://doi.org/10.1182/blood-2016-08-733196.Google Scholar
Lambert, J, Pautas, C, Terré, C, et al. Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial. Haematologica 2019; 104: 113–19. https://doi.org/10.3324/haematol.2018.188888.Google Scholar
Killick, SB, Carter, C, Culligan, D, et al.; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. Br J Haematol 2014; 164: 503–25. https://doi.org/10.1111/bjh.12694.Google Scholar
Fenaux, P, Giagounidis, A, Selleslag, D, et al.; MDS-004 Lenalidomide del5q Study Group. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with low-/intermediate-1-risk myelodysplastic syndromes with del5q. Blood 2011; 118: 3765–76. https://doi.org/10.1182/blood-2011-01-330126.Google Scholar
Yazji, S, Giles, FJ, Tsimberidou, AM, et al. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes. Leukemia 2003; 17: 2101–6. https://doi.org/10.1038/sj.leu.2403124.Google Scholar
McMullin, MF, Harrison, CN, Ali, S, et al.; BSH Committee. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology guideline. Br J Haematol 2019; 184: 176–91. https://doi.org/10.1111/bjh.15648. Erratum in: Br J Haematol 2019; 185: 198.Google Scholar
Vannucchi, AM, Kiladjian, JJ, Griesshammer, M, et al. Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med 2015; 372: 426–35. https://doi.org/10.1056/NEJMoa1409002.Google Scholar
Marcus, R, Davies, A, Ando, K, et al. Obinutuzumab for the first-line treatment of follicular lymphoma. N Engl J Med 2017; 377: 1331–44. https://doi.org/10.1056/NEJMoa1614598.Google Scholar
Woyach, JA, Ruppert, AS, Heerema, NA, et al. Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL. N Engl J Med 2018; 379: 2517–28. https://doi.org/10.1056/NEJMoa1812836.Google Scholar
Morgan, GJ, Davies, FE, Gregory, WM, et al.; NCRI Haematological Oncology Study Group. Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation. Blood 2011; 118: 1231–8. https://doi.org/10.1182/blood-2011-02-338665.Google Scholar
Hurley, TJ, McKinnell, JV, Irani, MS. Hematologic malignancies in pregnancy. Obstet Gynecol Clini North Am 2005; 32: 595614.Google Scholar
Ali, S, Jones, GL, Culligan, DJ, et al. Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol 2015; 170: 487–95. doi: 10.1111/bjh.13554.Google Scholar
Horowitz, NA, Henig, I, Henig, O, et al. Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis. Leuk Lymphoma 2018; 59: 610–16. doi: 10.1080/10428194.2017.1347651.Google Scholar
Farhadfar, N, Cerquozzi, S, Hessenauer, MR, et al. Acute leukemia in pregnancy: a single institution experience with 23 patients. Leuk Lymphoma 2017; 58: 1052–60. doi: 10.1080/10428194.2016.1222379.Google Scholar
Amant, F, Han, SN, Gziri, MM, Dekrem, J, Van Calsteren, K. Chemotherapy during pregnancy. Curr Opin Oncol 2012; 24: 580–6.Google Scholar
Greenlund, LJ, Letendre, L, Tefferi, A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma 2001; 41: 571–7.Google Scholar
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283–91.Google Scholar
Reynoso, EE, Shepherd, FA, Messner, HA, et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987; 5: 1098–106.Google Scholar
Chelghoum, Y, Vey, N, Raffoux, E, et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005; 104: 110–17.Google Scholar
Shapira, T, Pereg, D, Lishner, M. How I treat acute and chronic leukemia in pregnancy. Blood Rev 2008; 22: 247–59.Google Scholar
Moorman, AV, Harrison, CJ, Buck, GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007; 109: 3189–97.Google Scholar
Lin A, Zhou Q, Devlin S, Adel NG, Douer D. Outcomes of tyrosine kinase inhibitors in combination with various treatments regimens in adult patients with philadelphia chromosome positive acute lymphocytic leukemia. Blood 2013; 122: 2644. https://doi.org/10.1182/blood.V122.21.2644.2644.Google Scholar
Fielding, AK, Rowe, JM, Buck, G, et al. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood 2014; 123: 843–50.Google Scholar
Breccia, M, Mengarelli, A, Mancini, M, et al. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Leuk Res 2005; 29: 749–54.Google Scholar
Ikeda, Y, Masuzaki, H, Nakayama, D, et al. Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome. Leuk Res 2002; 26: 255–60.Google Scholar
Siddiqui, T, Elfenbein, GJ, Noyes, WD, et al. Myelodysplastic syndromes presenting in pregnancy: a report of five cases and the clinical outcome. Cancer 1990; 66: 377–81.Google Scholar
Fadilah, SA, Roswati, MN. Refractory anaemia with excess of blasts in transformation (RAEB-T) during pregnancy with haematological remission following delivery. Br J Haematol 1999; 104: 935–6.Google Scholar
Essien, EM, Sharma, U, Upadhaya, K, Malik, R. Myelodysplastic syndrome and successful pregnancy. Int J Hematol 1998; 68: 449–52.Google Scholar
Yang Z, Mei-Ying L, Shan-Mi W, Xiao-Hui Z. Pregnancy and myelodysplastic syndrome: an analysis of the clinical characteristics, maternal and fetal outcomes. J Matern Fetal Neonatal Med 2015; 28: 2155–9. https://doi.org/10.3109/14767058.2014.980229.Google Scholar
Volpicelli P, Latagliata R, Breccia M, et al. Pregnancy in patients with myelodysplastic syndromes (MDS). Leuk Res 2008; 32: 1605–7. https://doi.org/10.1016/j.leukres.2008.02.006.Google Scholar
Hellström-Lindberg, E. Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br J Haematol 1995; 89: 6771.Google Scholar
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391–405. https://doi.org/10.1182/blood-2016-03-643544.Google Scholar
Robinson, S, Bewley, S, Hunt, BJ, Radia, DH, Harrison, CN. The management and outcome of 18 pregnancies in women with polycythemia vera. Haematologica 2005; 90: 1477–83.Google Scholar
Tulpule, S, Bewley, S, Robinson, SE, et al. The management and outcome of four pregnancies in women with idiopathic myelofibrosis. Br J Haematol 2008; 142: 480–2.Google Scholar
Valera, MC, Parant, O, Vayssiere, C, Arnal, JF, Payrastre, B. Essential thrombocythemia and pregnancy. Eur J Obstet Gynecol Reprod Biol 2011; 158: 141–7.Google Scholar
Barbui, T, Finazzi, G. Myeloproliferative disease in pregnancy and other management issues. Hematology Am Soc Hematol Educ Program 2006: 246–52.Google Scholar
Alimam, S, Bewley, S, Chappell, LC, et al. Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br J Haematol 2016; 175: 31–6.Google Scholar
CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–29.Google Scholar
Gangat, N, Wolanskyj, AP, Schwager, S, Tefferi, A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur J Haematol 2009; 82: 350–3.Google Scholar
Cnossen, JS, Morris, RK, ter Riet, G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008; 178: 701–11.Google Scholar
Llurba, E, Carreras, E, Gratacos, E, et al. Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int 2009; 2009: 275613.Google Scholar
Willoughby, SJ, Fairhead, S, Woodcock, BE, Pearson, TC. Postpartum thrombosis in primary thrombocythaemia. Eur J Haematol 1997; 59: 121–3.Google Scholar
Ware RE, Marahatta A, Ware JL, McElhinney K, Dong M, Vinks AA. Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS). J Pediatr 2020; 222: 236–9. https://doi.org/10.1016/j.jpeds.2020.02.002.Google Scholar
Robinson SE, Harrison CN. How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy. Br J Haematol 2020; 189: 625–34. https://doi.org/10.1111/bjh.16453.Google Scholar
Griesshammer, M, Sadjadian, P, Wille, K. Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy. Expert Rev Hematol 2018; 11: 697706. doi: 10.1080/17474086.2018.1506325.Google Scholar
Kantarjian, H, Sawyers, C, Hochhaus, A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645–52.Google Scholar
Druker, BJ, Guilhot, F, O’Brien, SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408–17.Google Scholar
Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia 2020; 34: 966–84. https://doi.org/10.1038/s41375-020-0776-2.Google Scholar
Pye, SM, Cortes, J, Ault, P, et al. The effects of imatinib on pregnancy outcome. Blood 2008; 111: 5505–8.Google Scholar
Mahon, FX, Rea, D, Guilhot, J, et al.; Intergroupe Français des Leucémies Myéloïdes Chroniques. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010; 11: 1029–35.Google Scholar
Goh, HG, Kim, YJ, Kim, DW, et al. Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy. Leuk Lymphoma 2009; 50: 944–51.Google Scholar
Lasica, M, Willcox, A, Burbury, K, et al. The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia. Leuk Lymphoma 2019; 60: 1796–802. doi: 10.1080/10428194.2018.1551533.Google Scholar
Muller, AM, Ihorst, G, Mertelsmann, R, Engelhardt, M. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 112.Google Scholar
Health Protection Agency, Royal College of Radiologists, College of Radiographers. Protection of Pregnant Patients during Diagnostic Medical Exposures to Ionising Radiation. London: HPA, RCR, CoR, 2009. https://www.rcr.ac.uk/protection-pregnant-patients-during-diagnostic-medical-exposures-ionising-radiation (accessed March 2017).Google Scholar
Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med 2011; 52: 1035–40. https://doi.org/10.2967/jnumed.110.085381.Google Scholar
American College of Obstetricians and Gynecologists. Committee Opinion No. 723. Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017; 130: e210–16. doi: 10.1097/AOG.0000000000002355.Google Scholar
Medicines and Healthcare Products Regulatory Agency. Safety Guidelines for Magnetic Resonance Imaging Equipment in Clinical Use. London: MHRA, 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/476931/MRI_guidance_2015_-_4-02d1.pdf (accessed March 2017).Google Scholar
Webb, JA, Thomsen, HS, Morcos, SK; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005; 15: 1234–40.Google Scholar
Sachs HC; Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics 2013; 132: e796809. https://doi.org/10.1542/peds.2013-1985.Google Scholar
Cheson, BD, Fisher, RI, Barrington, SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68.Google Scholar
Gleissner, B, Kuppers, R, Siebert, R, et al. Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling. Br J Haematol 2008; 142: 166–78.Google Scholar
Hasenclever, D, Diehl, V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 1998; 339: 1506–14.Google Scholar
Mead, GM, Barrans, SL, Qian, W, et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood 2008; 112: 2248–60.Google Scholar
Pinnix, CC, Osborne, EM, Chihara, D, et al. Maternal and fetal outcomes after therapy for hodgkin or non-hodgkin lymphoma diagnosed during pregnancy. JAMA Oncol 2016; 2: 1065–9. doi: 10.1001/jamaoncol.2016.1396.Google Scholar
Evens, AM, Advani, R, Press, OW, et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol 2013; 31: 4132–9.Google Scholar
Stark, D, Lewis, I. Improving outcomes for teenagers and young adults (TYA) with cancer. Klin Padiatr 2013; 225: 331–4.Google Scholar
Reich, EW, Cox, RP, Becker, MH, et al. Recognition in adult patients of malformations induced by folic-acid antagonists. Birth Defects Orig Artic Ser 1978; 14: 139–60.Google Scholar
Sarno, MA, Mancari, R, Azim, HA, Colombo, N, Peccatori, FA. Are monoclonal antibodies a safe treatment for cancer during pregnancy? Immunotherapy 2013; 5: 733–41.Google Scholar
Chakravarty, EF, Murray, ER, Kelman, A, Farmer, P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117: 1499–506.Google Scholar
de Wildt, SN, Taguchi, N, Koren, G. Unintended pregnancy during radiotherapy for cancer. Nat Clin Pract Oncol 2009; 6: 175–8.Google Scholar
Pinnix CC, Osborne EM, Chihara D, et al. Maternal and fetal outcomes after therapy for Hodgkin or non-Hodgkin lymphoma diagnosed during pregnancy. JAMA Oncol 2016; 2: 1065–9. https://doi.org/10.1001/jamaoncol.2016.1396.Google Scholar
Evens AM, Advani R, Losso IS. Lymphoma in pregnancy: excellent fetal outcomes and maternal survival in a large multicenter analysis. Blood 2011; 118: 94. https://doi.org/10.1182/blood.V118.21.94.94.Google Scholar
Barton, S, Hawkes, EA, Wotherspoon, A, Cunningham, D. Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks? Oncologist 2012; 17: 1562–73.Google Scholar
Zhou, Z, Sehn, LH, Rademaker, AW, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 2014; 123: 837–42.Google Scholar
Boyle, J, Beaven, AW, Diehl, LF, Prosnitz, LR, Kelsey, CR. Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy. Oncology (Williston Park) 2014; 28: 1074–81, 1084.Google Scholar
Pregno, P, Chiappella, A, Bello, M, et al. Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood 2012; 119: 2066–73.Google Scholar
Viviani, S, Zinzani, PL, Rambaldi, A, et al.; Gruppo Italiano di Terapie Innovative nei Linfomi, Intergruppo Italiano Linfomi. ABVD versus BEACOPP for Hodgkin’s lymphoma when high-dose salvage is planned. N Engl J Med 2011; 365: 203–12.Google Scholar
Follows, GA, Ardeshna, KM, Barrington, SF, et al.; British Committee for Standards in Haematology. Guidelines for the first line management of classical Hodgkin lymphoma. Br J Haematol 2014; 166: 3449.Google Scholar
Dearden, CE, Johnson, R, Pettengell, R, et al.; British Committee for Standards in Haematology. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). Br J Haematol 2011; 153: 451–85.Google Scholar
Ribera, JM, Garcia, O, Grande, C, et al. Dose-intensive chemotherapy including rituximab in Burkitt’s leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab). Cancer 2013; 119: 1660–8.Google Scholar
Perkins, AS, Friedberg, JW. Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program 2008; 2008: 341–8.Google Scholar
Peterson, C, Lester, DR, Sanger, W. Burkitt’s lymphoma in early pregnancy. J Clin Oncol 2010; 28: e136–8.Google Scholar
Middeke, JM, Bruck, N, Parmentier, S, Bornhauser, M, Schetelig, J. Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome. Ann Hematol 2014; 93: 531–2.Google Scholar
McNamara, C, Davies, J, Dyer, M, et al.; Haemato-oncology Task Force of the British Committee for Standards in Haematology, British Society for Haematology Committee. Guidelines on the investigation and management of follicular lymphoma. Br J Haematol 2012; 156: 446–67.Google Scholar
McKay, P, Leach, M, Jackson, R, Cook, G, Rule, S; British Committee for Standards in Haematology. Guidelines for the investigation and management of mantle cell lymphoma. Br J Haematol 2012; 159: 405–26.Google Scholar
Kluin-Nelemans, HC, Hoster, E, Hermine, O, et al. Treatment of older patients with mantle-cell lymphoma. N Engl J Med 2012; 367: 520–31.Google Scholar
Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538–48. https://doi.org/10.1016/S1470-2045(14)70442-5.Google Scholar
Jurczyszyn A, Olszewska-Szopa M, Vesole AS, et al. Multiple myeloma in pregnancy: a review of the literature and a case series. Clin Lymphoma Myeloma Leuk 2016 Mar; 16(3): e3945. https://doi.org/10.1016/j.clml.2015.11.020.Google Scholar
Green, SB, Pappas, AL. Effects of maternal bisphosphonate use on fetal and neonatal outcomes. Am J Health Syst Pharm 2014; 71: 2029–36.Google Scholar
Hamad, N, Kliman, D, Best, OG, et al. Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management. Br J Haematol 2015; 168: 350–60.Google Scholar
Itala, M, Geisler, CH, Kimby, E, et al. Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study. Eur J Haematol 2002; 69: 129–34.Google Scholar
Einarson, A, Maltepe, C, Navioz, Y, et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004; 111: 940–3.Google Scholar
King, CT, Rogers, PD, Cleary, JD, Chapman, SW. Antifungal therapy during pregnancy. Clin Infect Dis 1998; 27: 1151–60.Google Scholar
Boxer LA, Bolyard AA, Kelley ML, et al. Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia. Obstet Gynecol 2015; 125: 197203. https://doi.org/10.1097/AOG.0000000000000602.Google Scholar
Sanchez-Gonzalez LR, Castro-Melendez SE, Angeles-Torres AC, et al. Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol 2016; 205: 32–6. https://doi.org/10.1016/j.ejogrb.2016.08.004. Epub 2016 Aug 10. PMID: 27566219.Google Scholar
Royal College of Obstetricians and Gynaecologists. Antenatal Corticosteroids to Reduce Neonatal Morbidity. Green-top Guideline No. 7. London: RCOG, 2010. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg7 (accessed March 2017).Google Scholar
Royal College of Obstetricians and Gynaecologists. Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth. Scientific Impact Paper No. 29. London: RCOG, 2011. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/sip29 (accessed March 2017)Google Scholar
Qureshi, H, Massey, E, Kirwan, D, et al.; British Society for Haematology. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med 2014; 24: 820.Google Scholar
US National Library of Medicine. Drugs and Lactation Database (LactMed). https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm (accessed March 2017).Google Scholar

References

Matthews, JH, Benjamin, S, Gill, DS, Smith, NA. Pregnancy-associated thrombocytopenia: definition, incidence and natural history. Acta Haematol 1990; 84:24–9.Google Scholar
Boehlen, F, Hohlfeld, H, Extermann, P, Perneger, T, de Moerloose, P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol 2000; 95: 2933.Google Scholar
Han, L, Liu, X, Li, H, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS One 2014; 9: e114488. doi: 10.1371/journal.pone.0114488.Google Scholar
Karlsson, O, Jeppsson, A, Hellgren, MA. Longitudinal study of factor XIII activity, fibrinogen concentration, platelet count and clot strength during normal pregnancy. Thromb Res 2014; 134: 750–2.Google Scholar
Fay, RA, Hughes, AO, Farron, NT. Platelets in pregnancy: hyperdestruction in pregnancy.Obstet Gynecol 1983; 61: 238–40.Google Scholar
Sainio, S, Kekomaki, R, Riikonen, S, Teramo, K. Maternal thrombo-cytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000; 79: 744–9.Google Scholar
Rodeghiero, F, Stasi, R, Gernsheimer, T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386–93.Google Scholar
American Society of Hematology. Clinical Practice Guide on Thrombocytopenia in Pregnancy. Washington, DC: ASH, 2013. http://www.hematology.org/Clinicians/Guidelines-Quality/Quick-Ref/530.aspx (accessed March 2017).Google Scholar
Myers, B. Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol 2012; 158: 315. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2012.09135.x/pdf (accessed March 2017).Google Scholar
Gernsheimer, T, James, AH, Stasi, R. How I treat thrombocytopenia in pregnancy. Blood 2013; 121: 3847. http://www.bloodjournal.org/content/121/1/38 (accessed March 2017).Google Scholar
National Institute for Health and Care Excellence. Intrapartum care for women with existing medical conditions or obstetric complications and their babies. NICE Guideline NG121. London: NICE, 2019. www.nice.org.uk/guidance/ng121 (accessed September 2019).Google Scholar
Burrows, RF, Kelton, JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731–4.Google Scholar
Burrows, RF, Kelton, JG. Platelets and pregnancy. In Lee, RV (ed.), Current Obstetric Medicine. St. Louis, MO: Mosby-Year Book, 1993, Vol. 2, p. 83.Google Scholar
Win, N, Rowley, M, Pollard, C, et al. Severe gestational (incidental) thrombocytopenia: to treat or not to treat. Haematology, 2005; 10: 6972.Google Scholar
Kwon, JY, Shin, JC, Lee, JW, Kim, SP, Rha, JG. Predictors of idiopathic thrombocytopenic purpura in pregnant women presenting with thrombocytopenia. Int J Gynaecol Obstet 2007; 96: 85–8.Google Scholar
Horn, EH. Platelets in normal and hypertensive pregnancy. Platelets 1991; 2: 183–95.Google Scholar
Douglas, JT, Shah, M, Lowe, GD, et al. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 1982; 47: 54–5.Google Scholar
Letsky, EA, Greaves, M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Br J Haematol 1996; 95: 21–6.Google Scholar
Burrows, RF, Kelton, JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988; 319: 142–5.Google Scholar
British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574–96.Google Scholar
McCrae, KR. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program 2010; 2010: 397402. doi: 10.1182/asheducation-2010.1.397.Google Scholar
Shalev, O, Anteby, E. Epidural anesthesia can be safely performed in gestational thrombocytopenia of >50,000/uL [abstract]. Blood 1996; 88: 62a.Google Scholar
Provan, A, Stasi, R, Newland, AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168–86. http://www.bloodjournal.org/content/115/2/168 (accessed March 2017).Google Scholar
van Veen, JJ, Nokes, TJ, Makris, M. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol 2010; 148: 1525.Google Scholar
Neunert, C, Lim, W, Crowther, M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190–207. http://www.bloodjournal.org/content/117/16/4190 (accessed March 2017).Google Scholar
Nugent, D, McMillan, R, Nichol, JL, Slichter, SJ. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 2009; 146: 585–96.Google Scholar
Abrahamson, KK, Hall, SA, Feudjo-Tepie, M, Mitrani-Gold, FS, Logie, J. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol 2009; 83: 83–9.Google Scholar
Gill, KK, Kelton, JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000; 37: 275–89.Google Scholar
Segal, JB, Powe, NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006; 4: 2377–83.Google Scholar
Webert, KE, Mittal, R, Sigouin, C, Heddle, NM, Kelton, JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003; 102: 4306–11.Google Scholar
Johnsen, J. Pathogenesis in immune thrombocytopenia: new insights. Hematology Am Soc Hematol Educ Program 2012; 2012: 306–12. http://asheducationbook.hematologylibrary.org/content/2012/1/306.full (accessed March 2017).Google Scholar
Calderwood, C. Thromboembolism and thrombophilia in pregnancy. Curr Obstet Gynaecol 2006; 16: 321–6.Google Scholar
Veneri, D, Franchini, M, Raffaelli, R, et al. Idiopathic thrombocytopenic purpura in pregnancy: analysis of 43 consecutive cases followed at a single Italian institution. Ann Hematol 2006; 85: 552–55.Google Scholar
Won, YW, Moon, W, Yun, YS, et al. Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP). Korean J Intern Med 2005; 20: 129–34.Google Scholar
Fujimura, K, Harada, Y, Fujimoto, T, et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 2002; 75: 426–33.Google Scholar
Loustau, V, Debouverie, O, Canoui-Poitrine, F, et al. Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol 2014; 166: 929–35.Google Scholar
Schiavotto, C, Ruggeri, M, Rodeghiero, F. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica (1993); 78 (6 suppl 2): 3540.Google Scholar
Cayco, AV, Perazella, MA, Hayslett, JP. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J Am Soc Nephrol 1997; 8: 1788–94.Google Scholar
Ozkan, H, Cetinkaya, M, Koksal, N, et al. Neonatal outcomes of pregnancy complicated by idiopathic thrombocytopenic purpura. J Perinatol 2010; 30: 3844.Google Scholar
Gasim, T. Immune thrombocytopenia in pregnancy: a reappraisal of obstetric management and outcome.J Reprod Med 2011; 56: 163–8.Google Scholar
Jensen, JF, Wiedmeier, SE, Henry, E, Silver, RM, Christensen, RD. Linking maternal platelet counts with neonatal platelet counts and outcomes using the data repositories of a multihospital health care system. Am J Perinatol 2011; 28: 597604.Google Scholar
Burrows, RF, Kelton, JG. Fetal thrombocytopenia and its relationship to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463–6.Google Scholar
Kawaguchi, K, Matsubara, K, Takafuta, T, et al. Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia. Int J Hematol 2014; 99: 570–6.Google Scholar
Koyama, S, Tomimatsu, T, Kanagawa, T, et al. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol 2012; 87: 1521.Google Scholar
Samuels, P, Bussel, JB, Braitman, LE, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990; 323: 229–35.Google Scholar
Payne, SD, Resnik, R, Moore, TR, Hedriana, HL, Kelly, TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 1997; 177: 149–55.Google Scholar
Scioscia, AL, Grannum, PA, Copel, JA, Hobbins, JC. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol 1988; 159: 1066–8.Google Scholar
Cines, DB, Bussel, JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244–51.Google Scholar
Care, A, Pavord, S, Knight, M, Alfirevic, Z. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. BJOG 2018; 125: 604–12. doi: 10.1111/1471-0528.14697Google Scholar
Schwartz, J, Leber, MD, Gillis, SM, et al. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 2003; 72: 94–8.Google Scholar
Kojouri, K, Vesely, SK, Terrell, DR, George, JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623–34.Google Scholar
Shanafelt, TD, Madueme, HL, Wolf, RC, Tefferi, A. Rituximab for immune cytopenia in adults:idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc 2003; 78: 1340–6.Google Scholar
Patel, V, Mihatov, N, Cooper, N, et al. Long term follow-up of patients with immune thrombocytopenic purpura (ITP) whose initial response to rituximab lasted a minimum of 1 year [abstract]. Blood 2006; 108: Abstract 479.Google Scholar
Kuter, DJ, Bussel, JB, Lyons, RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008; 371: 395403.Google Scholar
Gernsheimer, TB, George, JN, Aledort, LM, et al. Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP). J Thromb Haemost 2010; 8: 1372–82.Google Scholar
Cheng, G, Saleh, MN, Marcher, C, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet 2011; 377: 393402.Google Scholar
Laskin, CA, Bombardier, C, Hannah, ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148–53.Google Scholar
Christiaens, GC, Nieuwenhuis, HK, von dem Borne, AE, et al. Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990; 97: 893–8.Google Scholar
Park-Wyllie, L, Mazzotta, P, Pastuszak, A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.Google Scholar
Bussel, JB, Pham, LC, Aledort, L, Nachman, R. Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72: 121.Google Scholar
Ancona, KG, Parker, RI, Atlas, MP, Prakash, D. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2002; 24: 540–4.Google Scholar
Griffiths, J, Sia, W, Shapiro, AM, Tataryn, I, Turner, AR. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can 2005; 27: 771–4.Google Scholar
Alstead, ME, Ritchie, JK, Lennard-Jones, JE, Farthing, MJ, Clark, ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990; 99: 443–6.Google Scholar
Davison, JM, Lindheimer, MD. Pregnancy in renal transplant recipients. J Reprod Med 1982; 27: 613–21.Google Scholar
Cleary, BJ, Källén, B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res A Clin Mol Teratol 2009; 85: 647–54.Google Scholar
Gisbert, JP. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflamm Bowel Dis 2010; 16: 881–95.Google Scholar
Gall, B, Yee, A, Berry, B, et al. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura. J Obstet Gynaecol Can 2010; 32: 1167–71.Google Scholar
Schmid, J, Piroth, D, Buhrlen, M, et al. Successful rituximab treatment of refractory immune thrombocytopenia during pregnancy. Onkologie 2011; 34 (Suppl 6): 240, 0378–584X.Google Scholar
Patil, AS, Dotters-Katz, SK, Metjian, AD, James, AH, Swamy, GK. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy. Obstet Gynecol 2013; 122: 483–5.Google Scholar
Giermasz, A, Knoche, J, Fogarty, PF. Tolerability and efficacy of romiplostim as management of severe refractory immune thrombocytopenia (ITP) during pregnancy. J Thromb Haemost 2013; 11 (Suppl): 75–6.Google Scholar
Decroocq, J, Marcellin, L, LeRay, C, Willems, L. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. Obstet Gynecol 2014; 124: 481–3.Google Scholar
Kong, Z, Qin, P, Xiao, S, et al. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy. Blood 2017; 130: 1097–103. doi: 10.1182/blood-2017-01-761262.Google Scholar
Moise, KJ, Patton, DE, Cano, LE. Misdiagnosis of a normal fetal platelet count after coagulation of intrapartum scalp samples in autoimmune thrombocytopenic purpura. Am J Perinatol 1991; 8: 295–6.Google Scholar
Cook, RL, Miller, RC, Katz, VL. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 1991; 78: 578–83.Google Scholar
Keeling, D, Mackie, I, Moore, GW, Greer, IA, Greaves, M; British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012; 157: 4758. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2012.09037.x/epdf (accessed March 2017).Google Scholar
Pengo, V, Tripodi, A, Reber, G, et al.; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7: 1737–40. http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2009.03555.x/epdf (accessed March 2017).Google Scholar
Giannakopoulos, B, Krilis, SA. How I treat the antiphospholipid syndrome. Blood 2009; 114: 2020–30. http://www.bloodjournal.org/content/114/10/2020 (accessed March 2017).Google Scholar
Miyakis, S, Lockshin, MD, Atsumi, T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295306.Google Scholar
Cervera, R, Piette, JC, Font, J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019–27.Google Scholar
Asherson, RA, Khamashta, MA, Ordi-Ros, J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 68: 366–74.Google Scholar
Ruggeri, M, Tosetto, A, Palandri, F, et al. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. J Thromb Haemost 2014; 12: 1266–73.Google Scholar
Comellas-Kirkerup, L, Hernández-Molina, G, Cabral, AR. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study. Blood 2010; 116: 3058–63.Google Scholar
Out, HJ, Bruinse, HW, Christiaens, GC, et al. Prevalence of aPL in patients with fetal loss. Ann Rheum Dis 1991; 50, 553–7.Google Scholar
Oku, K, Atsumi, T, Bohgaki, M, et al. Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 2009; 68: 1030–5.Google Scholar
Di Simone, N, Castellini, R, Caliandro, D, Caruso, A. Antiphospholipid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertil Steril 2002; 77: 805–11.Google Scholar
Bates, SM, Greer, I, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e691Se736S.Google Scholar
Mak, A, Cheung, MW, Cheak, AA, Ho, RC. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 2009; 49: 281–8.Google Scholar
Newman, K, Owlia, MB, El-Hemaidi, I, Akhtari, M. Management of immune cytopenias in patients with systemic lupus erythematosus: old and new. Autoimmun Rev 2013; 12: 784–91.Google Scholar
Fernandez, M, Alarcon, GS, Apte, M, et al. Systemic lupus erythematosis in a multi-ethnic US cohort: The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum 2007; 56: 614–21.Google Scholar
de Ruiter, A, Taylor, GP, Clayden, P, et al. British HIV Association guidelines for the management of HIV infection in pregnant women 2012(2014 interim review). HIV Med 2014; 15 (Suppl 4): 177. http://www.bhiva.org/documents/Guidelines/Pregnancy/2012/BHIVA-Pregnancy-guidelines-update-2014.pdf (accessed March 2017).Google Scholar
Sullivan, AK, Raben, D, Reekie, J, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One 2013; 8: e52845.Google Scholar
Morris, L, Distenfeld, A, Amorosi, E, Karpatkin, S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 1982; 96: 714–17.Google Scholar
Cines, DB, Liebman, H, Stasi, R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 2009; 46 (1 Suppl 2): S2–14.Google Scholar
Ucar, A, Fernandez, HF, Byrnes, JJ, Lian, EC, Harrington, WJ. Thrombotic microangiopathy and retroviral infections: A 13 year experience. Br J Haematol 1994; 45: 304–9.Google Scholar
Thompson, GR, Lawrence, VA, Crawford, GE. HIV infection increases the risk of heparin-induced thrombocytopenia. Clin Infect Dis 2007; 45: 1393–6.Google Scholar
Scaradavou, A, Cunningham-Rundles, S, Ho, JL, et al. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison. Am J Hematol 2007; 82: 335–41.Google Scholar
Scaradavou, A, Woo, B, Woloski, BM, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997; 89: 2689–700.Google Scholar
Fultz, SL, McGinnis, KA, Skanderson, M, Ragni, MV, Justice, AC. Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med 2004; 116: 420–3.Google Scholar
Chiao, EY, Engels, EA, Kramer, JR, et al. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med 2009; 169: 357–63.Google Scholar
Ranjan, SK, Espina, BM, Liebman, HA. Hepatitis C virus related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol 2005; 129: 818–24.Google Scholar
Watson, H, Davidson, S, Keeling, D; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin induced thrombocytopenia: second edition. Br J Haematol 2012; 159: 528–40. http://onlinelibrary.wiley.com/doi/10.1111/bjh.12059/epdf (accessed March 2017).Google Scholar
Royal College of Obstetricians and Gynaecologists. The Acute Management of Thrombosis and Embolism During Pregnancy and the Puerperium. Green-top Guideline No. 37b. London: RCOG, 2010. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37b (accessed March 2017).Google Scholar
Warkentin, TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535–55.Google Scholar
Martel, N, Lee, J, Wells, PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood, 2005; 106: 2710–15.Google Scholar
Greer, IA, Nelson-Piercy, C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401–7.Google Scholar
Fausset, MB, Vogtlander, M, Lee, RM, et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001; 185: 148–52.Google Scholar
Lindhoff-Last, E, Kreutzenbeck, HJ, Magnani, HN. Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost 2005; 93, 63–9.Google Scholar
Ekbatani, A, Asaro, LR, Malinow, AM. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia. Int J Obstet Anesth 2010; 19: 82–7.Google Scholar
Tanimura, K, Ebina, Y, Sonoyama, A, et al. Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency. J Obstet Gynaecol Res 2012; 38: 749–52.Google Scholar
National Institute for Health and Care Excellence. Hypertension in Pregnancy: the Management of Hypertensive Disorders During Pregnancy. Clinical Guideline CG107. London: NICE, 2010. https://www.nice.org.uk/guidance/cg107 (accessed March 2017).Google Scholar
American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122–31. http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy (accessed March 2017).Google Scholar
Weinstein, L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1978; 142: 159–67.Google Scholar
Buimer, M, Keijser, R, Jebbink, JM, et al. Seven placental transcripts characterize HELLP-syndrome. Placenta 2008; 29: 444–53.Google Scholar
Irgens, HU, Reisaeter, L, Irgens, LM, Lie, RT. Long term mortality of mothers and fathers after pre eclampsia: population based cohort study. BMJ 2001; 323: 1213–17.Google Scholar
Kirkpatrick, CA. The HELLP syndrome. Acta Clinica 2010; 65: 91–7.Google Scholar
Scully, M, Hunt, BJ, Benjamin, S, et al.; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012; 158: 323–35. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2012.09167.x/epdf (accessed March 2017).Google Scholar
Galbusera, M, Noris, M, Remuzzi, G. Thrombotic thrombocytopenic purpura–then and now. Semin Thromb Hemost 2006; 32: 81–9.Google Scholar
Ridolfi, RL, Bell, WR. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 1981; 60: 413–28.Google Scholar
Vesely, SK, Li, X, McMinn, JR, Terrell, DR, George, JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2004; 44: 1149–58.Google Scholar
Scully, M, Yarranton, H, Liesner, R, et al. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 2008; 142: 819–26.Google Scholar
Mokrzycki, MH, Rickles, FR, Kaplan, AA, Kohn, OF. Thrombotic thrombocytopenic purpura in pregnancy: successful treatment with plasma exchange. Case report and review of the literature. Blood Purif 1995; 13: 271–82.Google Scholar
Scully, M, Starke, R, Lee, R, et al. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagul Fibrinolysis 2006; 17: 459–63.Google Scholar
Ducloy-Bouthors, AS, Caron, C, Subtil, D, et al. Thrombotic thrombocytopenic purpura: medical and biological monitoring of six pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 111: 146–52.Google Scholar
Gordon, LI, Kwaan, HC, Rossi, EC. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Semin Hematol 1987; 24: 194201.Google Scholar
Nester, CM, Thomas, CP. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program 2012; 2012: 617–25. http://asheducationbook.hematologylibrary.org/content/2012/1/617.full (accessed March 2017).Google Scholar
Taylor, CM, Machin, S, Wigmore, S, Goodship, TH; Renal Association, British Committee for Standards in Haematology, British Transplantation Society. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 2010; 148: 3747. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2009.07916.x/epdf (accessed March 2017).Google Scholar
Kavanagh, D, Goodship, TH, Richards, A. Atypical haemolytic uraemic syndrome. Br Med Bull 2006; 77–78: 522.Google Scholar
Fang, CJ, Richards, A, Liszewski, MK, et al. Advances in understanding a pathogenesis of AHUS and HELLP. Br J Haematol 2008; 143: 336–48.Google Scholar
Fakhouri, F, Roumenina, L, Provot, F, et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010; 21: 859–67.Google Scholar
Cañigral, C1, Moscardó, F, Castro, C, et al. Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome. Ann Hematol 2014; 93: 1421–2.Google Scholar
Loguidice, C. Does eculizumab play a role in treating pregnancy-associated atypical hemolytic–uremic syndrome? Rare Disease Report 2014. http://www.raredr.com/news/Eculizumab-Pregnancy-AssociatedaHUS (accessed March 2017).Google Scholar
Knight, M, Nelson-Piercy, C, Kurinczuk, JJ, Spark, P, Brocklehurst, P; UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008; 57: 951–6.Google Scholar
Royal College of Obstetricians and Gynaecologists. Management of Inherited Bleeding Disorders in Pregnancy. Green-top Guideline No. 71. London: RCOG, 2017. www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg71 (accessed September 2019)Google Scholar
Laffan, MA, Lester, W, O’Donnell, JS, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014; 167: 453–65. http://onlinelibrary.wiley.com/doi/10.1111/bjh.13064/epdf (accessed March 2017).Google Scholar
Rodeghiero, F, Castaman, G, Dini, E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69: 454–9.Google Scholar
Bloom, AL. von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc 1991; 66: 743–51.Google Scholar
Lillicrap, D, James, P. von Willebrand Disease: an Introduction for the Primary Care Physician. Treatment of Haemophilia No. 47. Montreal: World Federation of Hemophilia, 2009. http://www1.wfh.org/publication/files/pdf-1204.pdf (accessed March 2017).Google Scholar
Tosetto, A, Rodeghiero, F, Castaman, G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766–73.Google Scholar
Rodeghiero, F, Castaman, G, Tosetto, A. How I treat von Willebrand disease. Blood 2009; 114: 1158–65.Google Scholar
Ranger, A, Manning, RA, Lyall, H, Laffan, MA, Millar, CM. Pregnancy in type 2B VWD: a case series. Haemophilia 2012; 18: 406–12.Google Scholar
Giles, AR, Hoogendoorn, H, Benford, K. Type IIB von Willebrand’s disease presenting as thrombocytopenia during pregnancy. Br J Haematol 1987; 67: 349–53.Google Scholar
Rick, ME, Williams, SB, Sacher, RA, et al. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand’s disease. Blood 1987; 69: 786–9.Google Scholar
James, AH, Jamison, MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 5: 1165–9.Google Scholar
Lutomski, J, Byrne, B, Devane, D, Greene, R. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG 2012; 119: 306–14.Google Scholar
Carroli, G, Cuesta, C, Abalos, E, Gulmezoglu, AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22: 9991012.Google Scholar
Kujovich, JL. von Willebrand disease and pregnancy. J Thromb Haemost 2005; 3: 246–53.Google Scholar
Conti, M, Mari, D, Conti, E, et al. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68: 282–5.Google Scholar
Kirtava, A, Drews, C, Lally, C, Dilley, A, Evatt, B. Medical reproductive and psychosocial experiences of women diagnosed with vWD receiving care in haemophilia treatment centres: a case–control study. Haemophilia 2003; 9: 292–7.Google Scholar
James, AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005; 11: 295307.Google Scholar
Lak, M, Peyvandi, F, Mannucci, PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000; 111: 1236–9.Google Scholar
Lee, CA, Chi, C, Pavord, SR, et al. The obstetric and gynaecological management of woman with inherited bleeding disorders. Haemophilia 2006; 12: 301–36.Google Scholar
Kadir, RA, Lee, CA, Sabin, CA, et al. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314–21.Google Scholar
Kouides, PA. Obstetric and gynaecological aspects of vWD. Ballieres Best Pract Clin Haematol 2001; 14: 381–99.Google Scholar
Federici, AB, Mannucci, PM. Diagnosis and management of von Willebrand disease. Haemophilia 1999; 5 (Suppl 2): 2837.Google Scholar
Mannucci, PM. How I treat patients with von Willebrand’s disease. Blood 2001; 97: 1915–19.Google Scholar
Ray, JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998; 53: 450–5.Google Scholar
Mannucci, PM. Use of desmopressin (DDAVP) during early pregnancy in factor VIII deficient women. Blood 2005; 105: 3382.Google Scholar
Sanchez-Luceros, A, Meschengieser, SS, Turdo, KL, et al. Evaluation of the clinical safety of desmopression during pregnancy in woman with a low plasmatic von Willebrand factor level and bleeding history. Thromb Res 2007; 120: 387–90.Google Scholar
Goudemard, J, Negrier, C, Ounnoughene, O, Sultan, Y. Clinical management of patients with vWD with a VHP VWF concentrate: the French experience. Haemophilia 1998; 4: 4852.Google Scholar
Varughese, J, Cohen, AJ. Experience with epidural anaesthesia in pregnant women with von Willebrand disease. Haemophilia 2007; 13: 730–3.Google Scholar
TSE Working Group of the HPA. TSE Agents: Safe Working and Prevention of Infection. Part 4: Infection Control of CJD and Related Disorders in the Healthcare Setting. London: Health Protection Agency, 2007.Google Scholar
TSE Working Group of the Health Protection Agency. Distribution of the TSE Infectivity in Human Tissues and Body Fluids, Annex A1 of Safe Working and Prevention of Infection. London: Health Protection Agency, 2008.Google Scholar
Andrew, M, Paes, B, Milner, R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165–72.Google Scholar
Smith, TJ, Gill, JC, Ambruso, DR, Hathaway, WE. Hyponatremia and seizures in young children given DDAVP. Am J Hematol 1989; 31: 199202.Google Scholar
Keeling, D, Tait, C, Makris, M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2008; 14: 671–84. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2008.01695.x/epdf (accessed March 2017).Google Scholar
Bolton-Maggs, PH, Pasi, JK. Haemophilias A and B. Lancet 2003: 361; 1801–9.Google Scholar
Lyon, MF. X-Chromosome Inactivation. In Encyclopedia of Molecular Medicine, 2002.Google Scholar
Giannelli, F, Green, PM. The molecular basis of haemophilia A and B. Baillieres Clin Haematol 1996; 9: 211–28.Google Scholar
Plug, I, Mauser-Bunschoten, EP, Bröcker-Vriends, AH, et al. Bleeding in carriers of hemophilia. Blood 2006; 108: 52–6.Google Scholar
Chi, C, Lee, CA, Shiltagh, N, Khan, A, Pollard, D, Kadir, RA. Pregnancy in carriers of haemophilia. Haemophilia 2008; 14: 5664.Google Scholar
Ljung, RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008; 140: 378–84.Google Scholar
Ludlam, CA, Pasi, KJ, Bolton-Maggs, P, et al.; UKHCDO Genetics Working Party. Clinical genetics services for haemophilia. Haemophilia 2005; 11: 145–63.Google Scholar
Mitchell, M, Keeney, S, Goodeve, A. The molecular analysis of haemophilia B: a guideline from the UK Haemophilia Centre Doctors Organisation, Haemophilia Genetics Laboratory Network. Haemophilia 2005; 11: 398404.Google Scholar
Naylor, J, Brinke, A, Hassock, S, et al. Characteristic mRNA abnormality found in half of the patients with severe haemophilia A is due to large DNA inversions. Hum Mol Genet 1993; 11: 1773–8.Google Scholar
Manucci, PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90: 2515–21.Google Scholar
Miller, R. Counselling about diagnosis and inheritance of genetic bleeding disorders: haemophilia A and B. Haemophilia 1999; 5: 7783.Google Scholar
Giangrande, PLF. Management of pregnancy in carriers of haemophilia. Haemophilia 1998; 4: 779–84.Google Scholar
Efrat, Z, Perri, T, Ramati, E, Tugendreich, D, Meizner, I. Fetal gender assignment by first-trimester ultrasound. Ultrasound Obstet Gynecol 2006; 27: 619–21.Google Scholar
Chi, C, Hyett, JA, Finning, KM, et al. Noninvasive first trimester determination of foetal gender: a new approach for pre-natal diagnosis of haemophilia. BJOG 2006; 113: 239–42.Google Scholar
Ren, CC, Miao, XH, Cheng, H, et al. Detection of fetal sex in the peripheral blood of pregnant women. Fetal Diagn Ther 2007; 22: 377–82.Google Scholar
Santacroce, R, Vecchione, G, Tomaiyolo, M, et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006; 12: 417–22.Google Scholar
Mujezinovic, F, Alfirevic, Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110: 687–94.Google Scholar
Picone, O, Senat, MV, Rosenblatt, J, et al. Fear of pregnancy loss in fetal karyotyping: A place for third trimester amniocentesis? Fetal Diagn Ther 2008; 23: 30–5.Google Scholar
Tsui, NB, Kadir, RA, Chan, KC, et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011; 117: 3684–91.Google Scholar
Buscaglia, M, Ghisoni, L, Bellotti, M, et al. Percutaneous umbilical blood sampling: indication changes and procedure loss rate in a nine years’ experience. Fetal Diagn Ther 1996; 11: 106–13.Google Scholar
Econamides, DL, Kadir, RA, Braithwaite, JM, et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997; 104: 803–10.Google Scholar
Ljung, R, Lindgren, AC, Petrini, P, et al. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994; 83: 609–11.Google Scholar
Kulkarni, R, Lusher, J. Perinatal management of newborns with haemophilia. Br J Haematol 2001; 112: 264–74.Google Scholar
Lorenzo, JI, Lopez, A, Altisent, C, Asnar, JA. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age. Br J Haematol 2001; 113: 600–3.Google Scholar
Levi, M, Toh, CH, Thachil, J, Watson, HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009; 145: 2433. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2009.07600.x/epdf (accessed March 2017).Google Scholar
Giles, AR. Disseminated intravascular coagulation. In Bloom, AL, Forbes, CD, Thomas, DP, Taddenham, EGD (eds), Haemostasis and Thrombosis, 3rd edn, vol. 2. Edinburgh: Churchill Livingstone, 1994.Google Scholar
Levi, M, TenCate, H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586–92.Google Scholar
Toh, CH, Hoots, WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a five year overview. J Thromb Haemost 2007; 5: 604–6.Google Scholar
Johansson, PI, Stissing, T, Bochsen, L, Ostrowski, SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45.Google Scholar
Girdauskas, E, Kempfert, J, Kuntze, T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010; 140: 1117–24.Google Scholar
National Institute for Health and Care Excellence. Detecting, Managing and Monitoring Haemostasis: Viscoelastometric Point-of-Care Testing (ROTEM, TEG and Sonoclot systems). Diagnostics Guidance DG13. London: NICE, 2014. https://www.nice.org.uk/guidance/dg13 (accessed March 2017).Google Scholar
Charbit, B, Mandelbrot, L, Samain, E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266–73. doi:10.1111/j.1538–7836.2007.02297.x.Google Scholar
Thachil, J, Toh, CH, Levi, M, Watson, HG. The withdrawal of activated protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]. Br J Haematol 2012; 157: 493–4. doi: 10.1111/j.1365–2141.2011.09019.Google Scholar
Stainsby, D, MacClennan, S, Thomas, D, et al. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135: 634–41.Google Scholar
Ferrer, P, Roberts, I, Sydenham, E, Blackhall, K, Shakur, H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009; 9: 29.Google Scholar
O’Connell, NM, Perry, DJ, Hodgson, AJ, et al. Recombinant factor VIIa in the management of uncontrolled haemorrhage. Transfusion 2003; 43: 1649–51Google Scholar
Moscardo, F, Perez, F, de la Rubia, J, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 114: 174–6.Google Scholar
Kadir, RA, Davies, J. Hemostatic disorders in women. J Thromb Haemost 2013; 11 (Suppl. 1): 170–9.Google Scholar
Tripodi, A, Mannucci, PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365: 147–56.Google Scholar
Kalina, U, Bickhard, H, Schulte, S. Biochemical comparison of seven commercially available prothrombin complex concentrates. Int J Clin Pract 2008; 62: 1614–22.Google Scholar
Lorenz, R, Kienasi, J, Otto, U, et al. Efficacy and safety of a prothrombin complex concentrate with two virus inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol 2003; 15: 1520.Google Scholar
Collins, PW, Chalmers, E, Hart, DP, et al. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol 2013; 160: 153–70. http://onlinelibrary.wiley.com/doi/10.1111/bjh.12091/epdf (accessed March 2017).Google Scholar
Giangrande, P. Acquired Haemophilia, revised edn. Treatment of Haemophilia No. 38. Montreal: World Federation of Hemophilia, 2012. http://www1.wfh.org/publication/files/pdf-1186.pdf (accessed March 2017).Google Scholar
Hauser, I, Schneider, B, Lechner, K. Post-partum factor VIII inhibitors: a review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995; 73: 15.Google Scholar
Coller, BS, Hultin, MB, Hoyer, LW, et al. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood 1981; 58: 619–24.Google Scholar
Franchini, M, Zaffanello, M, Lippi, G. Acquired hemophilia in pediatrics: a systematic review. Pediatr Blood Cancer 2010; 55606611. doi: 10.1002/pbc.2265.Google Scholar

References

Leung, AN, Bull, TM, Jaeschke, R, et al. An official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline: Evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med 2011; 184: 1200–8.Google Scholar
Watson, H, Davidson, S, Keeling, D. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol 2012; 159: 528–40.Google Scholar
Linkins, LA, Dans, AL, Moores, LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e495S–530S.Google Scholar
Bates, SM, Greer, IA, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e691S–736S.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy. Obstet Gynecol 2018; 132: e1834. https://doi.org/10.1097/AOG.0000000000002703.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 2012; 120: 1514–21. [Reaffirmed 2017.]Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstet Gynecol 2018; 132: e117. https://doi.org/10.1097/AOG.0000000000002706.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 723. Guidelines for diagnostic imaging in pregnancy and lactation. Obstet Gynecol 2017; 130: e210–16. doi: 10.1097/AOG.0000000000002355.Google Scholar
Miyakis, S, Lockshin, MD, Atsumi, T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006: 4295306.Google Scholar
Leffert L, Butwick A, Carvalho B, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg 2018; 126: 928–44. https://doi.org/10.1213/ANE.0000000000002530.Google Scholar
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv 2018; 2: 3317–59. https://doi.org/10.1182/bloodadvances.2018024802.Google Scholar
Royal College of Obstetricians and Gynaecologists. Thrombosis and Embolism during Pregnancy and the Puerperium: Reducing the Risk. Green-top Guideline 37a. London: RCOG, 2015. www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a (accessed September 2020).Google Scholar
Oshiro, BT, Silver, RM, Scott, JR, Yu, H, Branch, DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87: 489–93.Google Scholar
Lima, F, Khamashta, MA, Buchanan, NM, et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131–6.Google Scholar
Branch, DW, Silver, RM, Blackwell, JL, Reading, JC, Scott, JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614–20.Google Scholar
Andreoli, L, Chighizola, CB, Banzato, A, et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res 2013; 65: 1869–73.Google Scholar
Lockshin, MD, Kim, M, Laskin, CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012: 642311–18.Google Scholar
Arnaud, L, Mathian, A, Ruffatti, A, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 2014; 13: 281–91.Google Scholar
Ruffatti, A, Salvan, E, Del Ross, T, et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicenter retrospective study. Thromb Haemost 2014; 112: 727–35.Google Scholar
Borowitz, MJ, Craig, FE, Digiuseppe, JA, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom 2010; 78: 211–30.Google Scholar
Pu, JJ, Brodsky, RA. Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin Transl Sci 2011; 4: 219–24.Google Scholar
Danilov, AV, Brodsky, RA, Craigo, S, Smith, H, Miller, KB. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Leuk Res 2010; 34: 566–71.Google Scholar
Burwick, RM, Feinberg, BB. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta 2013; 34: 201–3.Google Scholar
Wright, CA, Tefferi, A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001; 66: 152–9.Google Scholar
Harrison, C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol 2005; 129: 293306.Google Scholar
Jorquera, JI, Montoro, JM, Fernandez, MA, Aznar, JA, Aznar, J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162–3.Google Scholar
Poort, SR, Rosendaal, FR, Reitsma, PH, Bertina, RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–703.Google Scholar
Reverdiau-Moalic, P, Delahousse, B, Body, G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88: 900–6.Google Scholar
Howley, HE, Walker, M, Rodger, MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694708.Google Scholar
Carraro, P. Guidelines for the laboratory investigation of inherited thrombophilias. Recommendations for the first level clinical laboratories. Clin Chem Lab Med 2003; 41: 382–91.Google Scholar
Dizon-Townson, D, Miller, C, Sibai, B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for the mother and fetus. National Institute of Child Health and Human Development Maternal-Fetal Units Network. Obstet Gynceol 2005; 106: 517–24.Google Scholar
Silver, RM, Zhao, Y, Spong, CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 2010; 115: 1420.Google Scholar
Horlocker, TT, Wendel, DJ, Rowlingson, JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines. Reg Anesth Pain Med 2010; 35: 64101.Google Scholar
Warkentin, TE, Sheppard, JI, Moore, JC, Sigouin, CS, Kelton, JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme immunoassays. J Thromb Haemost 2008: 6: 1304–12.Google Scholar
Centers for Disease Control and Prevention (CDC). Pregnancy Mortality Surveillance System. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html (accessed March 2017).Google Scholar
Horlander, KT, Manninno, DM, Leeper, KV. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003; 163: 1711–17.Google Scholar
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e419S–94S.Google Scholar
Browse, NL, Thomas, ML. Source of non-lethal pulmonary emboli. Lancet 1974; 1: 258–9.Google Scholar
Tamariz, LJ, Eng, J, Segal, JB, et al. Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: a systematic review. Am J Med 2004; 117: 676–84.Google Scholar
van der Pol, LM, Tromeur, C, Bistervels, IM, et al. Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism. N Engl J Med 2019; 380: 1139–49. https://doi.org/10.1056/NEJMoa1813865.Google Scholar
Polak, JF, Wilkinson, DL. Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy. Am J Obstet Gynecol 1991; 155: 625–9.Google Scholar
Turrentine, MA, Braems, G, Ramirez, MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 1995; 50: 534–41.Google Scholar
Bates, SM, Middeldorp, S, Rodger, M, James, AH, Greer, I. Guidance for the treatment and prevention for obstetric-associated venous thromboembolism. J Thromb Thrombolysis 2016; 41: 92128.Google Scholar
McCall, CA, Grimes, DA, Lyerly, AD. “Therapeutic” bed rest in pregnancy: unethical and unsupported by data. Obstet Gynecol 2013; 121: 1305–8.Google Scholar
Biggio, JR. Bed rest in pregnancy: time to put the issue to rest. Obstet Gynecol 2013; 121: 1158–60.Google Scholar
Liu, S, Rouleau, J, Joseph, KS, et al. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can 2009; 31: 611–20.Google Scholar
Carr, MH, Towers, CV, Eastenson, AR, et al. Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis. J Matern Fetal Med 1997; 6: 264–7Google Scholar
Tsai, HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003; 14: 1072–81.Google Scholar
von Baeyer, H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 2002; 6: 320–8.Google Scholar
Matsuo, K, Conturie, CL, Lee, RH. Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol 2014; 181: 341–2.Google Scholar
Scully, M, Thomas, M, Underwood, M, et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 2014; 124: 211–19.Google Scholar
McCrae, KR, Cines, DB. Thrombotic microangiopathy during pregnancy. Semin Hematol 1997; 34: 148–58.Google Scholar
Natelson, EA, White, D. Recurrent thrombotic thrombocytopenic purpura in early pregnancy: effect of uterine evacuation. Obstet Gynecol 1985; 66: 54S56S.Google Scholar
Kremer Hovinga, JA, Vesely, SK, Terrell, DR, Lämmle, B, George, JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010; 115: 1500–11.Google Scholar
Sethi, S, Fervenza, FC. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome. Semin Thromb Hemost 2014; 40: 416–21.Google Scholar
Rodriguez de Cordoba, S, Hidalgo, MS, Pinto, S, Tortajada, A. Genetics of aHUS. Semin Thromb Hemost 2014; 40: 422–30.Google Scholar
Wong, EK, Kavanagh, D. Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Transl Res 2015; 165: 306–20.Google Scholar

References

Beeson, PB. Age and sex associations of 40 autoimmune diseases. Am J Me 1994; 96: 457–62.Google Scholar
Ansar Ahmed, S, Dauphinee, MJ, Talal, N. Effects of short-term administration of sex hormones on normal and autoimmune mice. J Immunol 1985; 134: 204–10.Google Scholar
Jungers, P, Dougados, M, Pelissier, C, et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 618–23.Google Scholar
Mackworth-Young, CG, Parke, AL, Morley, KD, Fotherby, K, Hughes, GR. Sex hormones in male patients with systemic lupus erythematosus: a comparison with other disease groups. Eur J Rheumatol Inflamm 1983; 6: 228–32.Google Scholar
Lockshin, MD, Qamar, T, Druzin, ML. Hazards of lupus pregnancy. J Rheumatol 1987; 14 (Suppl 13): 214–17.Google Scholar
Rahman, P, Gladman, DD, Urowitz, MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998; 25: 1526–30.Google Scholar
Guller, S, Kong, L, Wozniak, R, Lockwood, CJ. Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab 1995; 80: 2244–50.Google Scholar
Lockwood, CJ, Radunovic, N, Nastic, D, et al. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 1996; 24: 243–51.Google Scholar
Buchanan, NM, Toubi, E, Khamashta, MA, et al. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 1996; 55: 486–8.Google Scholar
Khamashta, MA, Buchanan, NM, Hughes, GR. The use of hydroxychloroquine in lupus pregnancy: the British experience. Lupus 1996 ;5 (Suppl 1): S65–6.Google Scholar
Motta, M, Tincani, A, Faden, D, Zinzini, E, Chirico, G. Antimalarial agents in pregnancy. Lancet 2002; 359: 524–5.Google Scholar
Costedoat-Chalumeau, N, Amoura, Z, Duhaut, P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003; 48: 3207–11.Google Scholar
Hart, CW, Naunton, RF. The ototoxicity of chloroquine phosphate. Arch Otolaryngol 1964; 80: 407–12.Google Scholar
Nylander, U. Ocular damage in chloroquine therapy. Acta Ophthalmol (Copenh) 1967; (Suppl 92): 91–71.Google Scholar
Levy, RA, Vilela, VS, Cataldo, MJ, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001; 10: 401–4.Google Scholar
Daniel, S, Matok, I, Gorodischer, R, et al. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J Rheumatol 2012; 39: 2163–9.Google Scholar
Schisterman, EF, Silver, RM, Lesher, LL, et al. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet 2014; 384: 2936.Google Scholar
Askie, LM, Duley, L, Henderson-Smart, DJ, Stewart, LA, Group, PC. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791–8.Google Scholar
Hammers, AL, Sanchez-Ramos, L, Kaunitz, AM. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. Am J Obstet Gynecol 2015; 212: 505.e501–13.Google Scholar
Koren, G, Florescu, A, Costei, AM, Boskovic, R, Moretti, ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006; 40: 824–9.Google Scholar
Macones, GA, Robinson, CA. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol 1997; 177: 819–24.Google Scholar
Macones, GA, Marder, SJ, Clothier, B, Stamilio, DM. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol 2001; 184: 264–72.Google Scholar
Ostensen, M, Khamashta, M, Lockshin, M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8: 209.Google Scholar
Ostensen, M, Villiger, PM. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus. Lupus 2001;10:135–139. Lupus 2001; 10: 135–9.Google Scholar
Viktil, KK, Engeland, A, Furu, K. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41: 196201.Google Scholar
Moskovitz, DN, Bodian, C, Chapman, ML, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 2004; 99: 656–61.Google Scholar
Francella, A, Dyan, A, Bodian, C, Rubin, P, Chapman, M, Present, DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003; 124: 917.Google Scholar
Armenti, VT, Coscia, LA, McGrory, CH, Moritz, MJ. National Transplantation Pregnancy Registry. Update on pregnancy and renal transplantation. Nephrol News Issues 1998; 12: 1923.Google Scholar
Armenti, VT, Moritz, MJ, Davison, JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998; 19: 219–32.Google Scholar
Norgard, B, Pedersen, L, Christensen, LA, Sorensen, HT. Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007; 102: 1406–13.Google Scholar
Bar Oz, B, Hackman, R, Einarson, T, Koren, G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71: 1051–5.Google Scholar
Ujhazy, E, Balonova, T, Durisova, M, et al. Teratogenicity of cyclophosphamide in New Zealand white rabbits. Neoplasma 1993; 40: 45–9.Google Scholar
Kirshon, B, Wasserstrum, N, Willis, R, Herman, GE, McCabe, ER. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 1988; 72: 462–4.Google Scholar
Enns, GM, Roeder, E, Chan, RT, et al. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 1999; 86: 237–41.Google Scholar
Berry, DL, Theriault, RL, Holmes, FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855–61.Google Scholar
Ring, AE, Smith, IE, Jones, A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005; 23: 4192–7.Google Scholar
Ehrenstein, MR, Evans, JG, Singh, A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200: 277–85.Google Scholar
Rychly, DJ, DiPiro, JT. Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 2005; 25: 1181–92.Google Scholar
Baker, DE. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody. Rev Gastroenterol Disord 2004; 4: 196210.Google Scholar
Mahadevan, U. Pregnancy and inflammatory bowel disease. Gastroenterol Clin North Am 2009; 38: 629–49.Google Scholar
Carter, JD, Ladhani, A, Ricca, LR, Valeriano, J, Vasey, FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36: 635–41.Google Scholar
Crijns, HJ, Jentink, J, Garne, E, et al. The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population. J Rheumatol 2011; 38: 1871–4.Google Scholar
Gisbert, JP, Chaparro, M. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. Am J Gastroenterol 2013; 108: 1426–38.Google Scholar
Clowse, M, Wolf, D, Forger, F, et al. Retrospective Analysis Of Certolizumab Pegol Use During Pregnancy: Update Of Impact On Birth Outcomes. Arthritis Rheum 2013; 65: S187–8.Google Scholar
Kavanaugh, A, Cush, JJ, Ahmed, MS, et al. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res 2015; 67: 313–25.Google Scholar
Herold, M, Schnohr, S, Bittrich, H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 2001; 19: 3439.Google Scholar
Friedrichs, B, Tiemann, M, Salwender, H, et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006; 91: 1426–7.Google Scholar
Buckley, LM, Bullaboy, CA, Leichtman, L, Marquez, M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997; 40: 971–3.Google Scholar
Hyoun, SC, Obican, SG, Scialli, AR. Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol 2012; 94: 187207.Google Scholar
Sifontis, NM, Coscia, LA, Constantinescu, S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006; 82: 1698–702.Google Scholar
Perez-Aytes, A, Ledo, A, Boso, V, et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet A 2008; 146A: 17.Google Scholar
Cassina, M, Johnson, DL, Robinson, LK, et al. Pregnancy outcome in women exposed to leflunomide before or during pregnancy. Arthritis Rheum 2012; 64: 2085–94.Google Scholar
Food and Drug Administration (FDA). Drug approval package: Actemra (tocilizumab) injection, 1/8/2010. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/125276s000TOC.cfm (accessed March 2017).Google Scholar
Kotzin, BL. Systemic lupus erythematosus. Cell 1996; 85: 303–6.Google Scholar
Buckman, KJ, Moore, SK, Ebbin, AJ, Cox, MB, Dubois, EL. Familial systemic lupus erythematosus. Arch Intern Med 1978; 138: 1674–6.Google Scholar
Isenberg, D. Autoantibodies. In Wallace, DJ, Hahn, BH (eds), Dubois’ Lupus Erythematosus and Related Syndromes, 8th edn. Philadelphia, PA: Elsevier Saunders, 2013, p. 282.Google Scholar
Tomer, Y, Viegas, OA, Swissa, M, Koh, SC, Shoenfeld, Y. Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome. Clin Exp Rheumatol. 1996; 14: 275–80.Google Scholar
Benito-Garcia, E, Schur, PH, Lahita, R. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. Arthritis Rheum 2004; 51: 1030–44.Google Scholar
Bertoli, AM, Vila, LM, Reveille, JD, Alarcon, GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol 2008; 35: 2355–8.Google Scholar
Lee, SS, Singh, S, Link, K, Petri, M. High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum 2008; 38: 4154.Google Scholar
Barnes, EV, Narain, S, Naranjo, A, et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 2005; 14: 576–82.Google Scholar
Vila, LM, Alarcon, GS, McGwin, G, et al. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 2005; 32: 2150–5.Google Scholar
Lattanzi, B, Consolaro, A, Solari, N, et al. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician’s Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI). Arthritis Care Res 2011; 63 (Suppl 11): S112–17.Google Scholar
Ruperto, N, Hanrahan, LM, Alarcon, GS, et al. International consensus for a definition of disease flare in lupus. Lupus 2011; 20: 453–62.Google Scholar
Hochberg, MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.Google Scholar
Petri, M, Orbai, AM, Alarcon, GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–86.Google Scholar
Lech, M, Anders, HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol 2013; 24: 1357–66.Google Scholar
Ortega, LM, Schultz, DR, Lenz, O, Pardo, V, Contreras, GN. Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 2010; 19: 557–74.Google Scholar
O’Flynn, J, Flierman, R, van der Pol, P, et al. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. Mol Immunol 2011; 49: 7583.Google Scholar
Waldman, M, Madaio, MP. Pathogenic autoantibodies in lupus nephritis. Lupus 2005; 14: 1924.Google Scholar
Weening, JJ, D’Agati, VD, Schwartz, MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241–50.Google Scholar
Wong, KL, Woo, EK, Yu, YL, Wong, RW. Neurological manifestations of systemic lupus erythematosus: a prospective study. Q J Med 1991; 81: 857–70.Google Scholar
Futrell, N, Schultz, LR, Millikan, C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992; 42: 1649–57.Google Scholar
Sibley, JT, Olszynski, WP, Decoteau, WE, Sundaram, MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992; 19: 4752.Google Scholar
Mikdashi, J, Krumholz, A, Handwerger, B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 2005; 64: 2102–7.Google Scholar
Joseph, FG, Lammie, GA, Scolding, NJ. CNS lupus: a study of 41 patients. Neurology 2007; 69: 644–54.Google Scholar
Hanly, JG, Su, L, Farewell, V, McCurdy, G, Fougere, L, Thompson, K. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009; 36: 1449–59.Google Scholar
Hanly, JG, McCurdy, G, Fougere, L, Douglas, JA, Thompson, K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004; 31: 2156–62.Google Scholar
Garenstein, M PV, Kark, RM. Systemic lupus erythematosus and pregnancy. N Engl J Med 1962 ;267: 165–9.Google Scholar
Estes, D LD. Systemic lupus erythematosus and pregnancy. Clin Obstet Gynecol 1965; 8: 307–21.Google Scholar
Lockshin, MD, Reinitz, E, Druzin, ML, Murrman, M, Estes, D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984; 77: 893–8.Google Scholar
Meehan, RT, Dorsey, JK. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 1987; 14: 252–8.Google Scholar
Mintz, G, Niz, J, Gutierrez, G, Garcia-Alonso, A, Karchmer, S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13: 732–9.Google Scholar
Petri, M, Howard, D, Repke, J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538–45.Google Scholar
Urowitz, MB, Gladman, DD, Farewell, VT, Stewart, J, McDonald, J. Lupus and pregnancy studies. Arthritis Rheum 1993; 36: 1392–7.Google Scholar
Ruiz-Irastorza, G, Lima, F, Alves, J, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996; 35: 133–8.Google Scholar
Georgiou, PE, Politi, EN, Katsimbri, P, Sakka, V, Drosos, AA. Outcome of lupus pregnancy: a controlled study. Rheumatology 2000; 39: 1014–19.Google Scholar
Kleinman, D, Katz, VL, Kuller, JA. Perinatal outcomes in women with systemic lupus erythematosus. J Perinatol 1998; 18: 178–82.Google Scholar
Johns, KR, Morand, EF, Littlejohn, GO. Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases. Aust N Z J Med 1998; 28: 1822.Google Scholar
Derksen, RH, Bruinse, HW, de Groot, PG, Kater, L. Pregnancy in systemic lupus erythematosus: a prospective study. Lupus 1994; 3: 149–55.Google Scholar
Aggarwal, N, Sawhney, H, Vasishta, K, Chopra, S, Bambery, P. Pregnancy in patients with systemic lupus erythematosus. Aust N Z J Obstet Gynaecol 1999; 39: 2830.Google Scholar
Le Huong, D, Wechsler, B, Vauthier-Brouzes, D, et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997; 36: 772–7.Google Scholar
Lockshin, MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989; 32: 665–70.Google Scholar
Hayslett, JP. Maternal and fetal complications in pregnant women with systemic lupus erythematosus. Am J Kidney Dis 1991; 17: 123–6.Google Scholar
Bobrie, G, Liote, F, Houillier, P, Grunfeld, JP, Jungers, P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987; 9: 339–43.Google Scholar
Huong, DL, Wechsler, B, Vauthier-Brouzes, D, et al. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 2001; 60: 599604.Google Scholar
Ruiz-Irastorza, G, Khamashta, MA. Lupus and pregnancy: ten questions and some answers. Lupus 2008; 17: 416–20.Google Scholar
Cortes-Hernandez, J, Ordi-Ros, J, Paredes, F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 2002; 41: 643–50.Google Scholar
Clowse, ME, Magder, L, Witter, F, Petri, M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006; 54: 3640–7.Google Scholar
Julkunen, H, Kaaja, R, Palosuo, T, Gronhagen-Riska, C, Teramo, K. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand 1993; 72: 258–63.Google Scholar
Tandon, A, Ibanez, D, Gladman, DD, Urowitz, MB. The effect of pregnancy on lupus nephritis. Arthritis Rheum 2004; 50: 3941–6.Google Scholar
Wong, KL, Chan, FY, Lee, CP. Outcome of pregnancy in patients with systemic lupus erythematosus: a prospective study. Arch Intern Med 1991; 151: 269–73.Google Scholar
Petri, M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 1997; 23: 113.Google Scholar
Nossent, HC, Swaak, TJ. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 1990; 17: 771–6.Google Scholar
Tincani, A, Faden, D, Tarantini, M, et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992; 10: 439–46.Google Scholar
Hayslett, JP, Lynn, RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980; 18: 207–20.Google Scholar
Jungers, P, Dougados, M, Pelissier, C, et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982; 142: 771–6.Google Scholar
Bear, R. Pregnancy and lupus nephritis. A detailed report of six cases with a review of the literature. Obstet Gynecol 1976; 47: 715–18.Google Scholar
Julkunen, H. Pregnancy and lupus nephritis. Scan J Urol Nephrol 2001; 35: 319–27.Google Scholar
Oviasu, E, Hicks, J, Cameron, JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991; 1: 1925.Google Scholar
Packham, DK, Lam, SS, Nicholls, K, Fairley, KF, Kincaid-Smith, PS. Lupus nephritis and pregnancy. Q J Med 1992; 83: 315–24.Google Scholar
Moroni, G, Ponticelli, C. Pregnancy after lupus nephritis. Lupus 2005; 14: 8994.Google Scholar
Moroni, G, Ponticelli, C. The risk of pregnancy in patients with lupus nephritis. J Nephrol 2003; 16: 161–7.Google Scholar
Ruiz-Irastorza, G, Khamas hta, MA. Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 2004; 13: 679–82.Google Scholar
Clowse, ME. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007; 33: 237–52, v.Google Scholar
Bootsma, H, Spronk, P, Derksen, R, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345: 1595–9.Google Scholar
ter Borg, EJ, Horst, G, Hummel, EJ, Limburg, PC, Kallenberg, CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990; 33: 634–43.Google Scholar
Devoe, LD, Loy, GL. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus. Obstet Gynecol 1984; 63: 796800.Google Scholar
Devoe, LD, Taylor, RL. Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 1979; 135: 473–9.Google Scholar
Buyon, JP, Cronstein, BN, Morris, M, Tanner, M, Weissmann, G. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med 1986; 81: 194200.Google Scholar
Girardi, G, Salmon, JB. The role of complement in pregnancy and fetal loss. Autoimmunity 2003; 36: 1926.Google Scholar
Shibata, S, Sasaki, T, Hirabayashi, Y, et al. Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis. Ann Rheum Dis 1992; 51: 619–23.Google Scholar
Lockshin, MD, Qamar, T, Redecha, P, Harpel, PC. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus. Arthritis Rheum 1986; 29: 1467–72.Google Scholar
Adelsberg, BR. The complement system in pregnancy. Am J Reprod Immunol. 1983; 4: 3844.Google Scholar
Weiner, CP, Brandt, J. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia. Am J Obstet Gynecol 1982; 142: 275–81.Google Scholar
Weiner, CP, Kwaan, HC, Xu, C, Paul, M, Burmeister, L, Hauck, W. Antithrombin III activity in women with hypertension during pregnancy. Obstet Gynecol 1985; 65: 301–6.Google Scholar
Julkunen, H, Jouhikainen, T, Kaaja, R, et al. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 1993; 2: 125–31.Google Scholar
Nicklin, JL. Systemic lupus erythematosus and pregnancy at the Royal Women’s Hospital, Brisbane 1979–1989. Aus N Z J Obstet Gynaecol 1991; 31: 128–33.Google Scholar
Yasmeen, S, Wilkins, EE, Field, NT, Sheikh, RA, Gilbert, WM. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 2001; 10: 91–6.Google Scholar
Ramsey-Goldman, R, Kutzer, JE, Kuller, LH, et al. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Edpidemiol 1993; 138: 1057–69.Google Scholar
Hayslett, JP. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol 1992; 28: 199204.Google Scholar
Petri, M, Allbritton, J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 1993; 20: 650–6.Google Scholar
McHugh, NJ, Reilly, PA, McHugh, LA. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol 1989; 16: 42–6.Google Scholar
Pierce, DA, Stern, R, Jaffe, R, Zulman, J, Talal, N. Immunoblastic sarcoma with features of Sjogren’s syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy. Arthritis Rheum 1979; 22: 911–16.Google Scholar
Gimovsky, ML, Montoro, M, Paul, RH. Pregnancy outcome in women with systemic lupus erythematosus. Obstet Gynecol 1984; 63: 686–92.Google Scholar
Clark, CA, Spitzer, KA, Laskin, CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005; 32: 1709–12.Google Scholar
Andrade, R, Sanchez, ML, Alarcon, GS, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]. Clin Exp Rheumatol 2008; 26: 268–74.Google Scholar
Imbasciati, E, Surian, M, Bottino, S, et al. Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron 1984; 36: 4651.Google Scholar
Lima, F, Khamashta, MA, Buchanan, NM, et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131–6.Google Scholar
Englert, HJ, Derue, GM, Loizou, S, et al. Pregnancy and lupus: prognostic indicators and response to treatment. Q J Med 1988; 66: 125–36.Google Scholar
Siamopoulou-Mavridou, A, Manoussakis, MN, Mavridis, AK, Moutsopoulos, HM. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis 1988; 47: 982–7.Google Scholar
Varner, MW, Meehan, RT, Syrop, CH, Strottmann, MP, Goplerud, CP. Pregnancy in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1983; 145: 1025–40.Google Scholar
Houser, MT, Fish, AJ, Tagatz, GE, Williams, PP, Michael, AF. Pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol 1980; 138: 409–13.Google Scholar
Johnson, MJ, Petri, M, Witter, FR, Repke, JT. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 1995; 86: 396–9.Google Scholar
Buyon, JP. Neonatal lupus syndromes. Curr Opin Rheumatol 1994; 6: 523–9.Google Scholar
Lockshin, MD, Bonfa, E, Elkon, K, Druzin, ML. Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum 1988; 31: 697701.Google Scholar
Buyon, JP, Hiebert, R, Copel, J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658–66.Google Scholar
Neiman, AR, Lee, LA, Weston, WL, Buyon, JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000; 137: 674–80.Google Scholar
Brucato, A, Doria, A, Frassi, M, et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002; 11: 716–21.Google Scholar
Llanos, C, Izmirly, PM, Katholi, M, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009; 60: 3091–7.Google Scholar
Meisgen, S, Ostberg, T, Salomonsson, S, et al. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence. J Intern Med 2014; 275: 640–51.Google Scholar
Buyon, JP, Clancy, RM, Friedman, DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol 2009; 5: 139–48.Google Scholar
Friedman, DM, Zervoudakis, I, Buyon, JP. Perinatal monitoring of fetal well-being in the presence of congenital heart block. Am J Perinatol 1998; 15: 669–73.Google Scholar
Jaeggi, ET, Hamilton, RM, Silverman, ED, Zamora, SA, Hornberger, LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J AM Coll Cardiol 2002; 39: 130–7.Google Scholar
Izmirly, PM, Saxena, A, Kim, MY, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011; 124: 1927–35.Google Scholar
Waldman, M, Appel, GB. Update on the treatment of lupus nephritis. Kidney Int 2006; 70: 1403–12.Google Scholar
Rovin, BH, Parikh, SV. Lupus nephritis: the evolving role of novel therapeutics. Am J Kidney Dis 2014; 63: 677–90.Google Scholar
Rovin, BH, Parikh, SV, Alvarado, A. The kidney biopsy in lupus nephritis: is it still relevant? Rheum Dis Clin North Am 2014; 40: 537–52, ix.Google Scholar
Melander, C, Sallee, M, Trolliet, P, et al. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome. Clin J Am Soc Nephrol 2009; 4: 579–87.Google Scholar
Druzin, ML, Lockshin, M, Edersheim, TG, Hutson, JM, Krauss, AL, Kogut, E. Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am J Obstet Gynecol 1987; 157: 1503–10.Google Scholar
Austin, HA, Balow, JE. Treatment of lupus nephritis. Semin Nephrol 2000; 20: 265–76.Google Scholar
Rauova, L, Lukac, J, Levy, Y, Rovensky, J, Shoenfeld, Y. High-dose intravenous immunoglobulins for lupus nephritis: a salvage immunomodulation. Lupus6 2001; 10: 209–13.Google Scholar
Sesso, R, Monteiro, M, Sato, E, et al. A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis. Lupus 1994; 3: 107–12.Google Scholar
Pisoni, CN, Brucato, A, Ruffatti, A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum 2010; 62: 1147–52.Google Scholar
Friedman, DM, Llanos, C, Izmirly, PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 2010; 62: 1138–46.Google Scholar
Izmirly, PM, Kim, MY, Llanos, C, et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 2010; 69: 1827–30.Google Scholar
Izmirly, PM, Costedoat-Chalumeau, N, Pisoni, CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012; 126: 7682.Google Scholar
Phoon, CK, Kim, MY, Buyon, JP, Friedman, DM. Finding the “PR-fect” solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease? Congenit Heart Dis 2012; 7: 349–60.Google Scholar
Friedman, DM, Kim, MY, Copel, JA, et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 2008; 117: 485–93.Google Scholar
Friedman, DM, Kim, MY, Copel, JA, et al. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 2009; 103: 1102–6.Google Scholar
Rein, AJ, Mevorach, D, Perles, Z, et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Circulation 2009; 119: 1867–72.Google Scholar
Saleeb, S, Copel, J, Friedman, D, Buyon, JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 2335–45.Google Scholar
Eliasson, H, Sonesson, SE, Sharland, G, et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 2011; 124: 1919–26.Google Scholar
Ruiz-Irastorza, G, Khamashta, MA, Castellino, G, Hughes, GR. Systemic lupus erythematosus. Lancet 2001; 357: 1027–32.Google Scholar
Miyakis, S, Lockshin, MD, Atsumi, T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006: 4295306.Google Scholar
Blank, M, Cohen, J, Toder, V, Shoenfeld, Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991; 88: 3069–73.Google Scholar
Pierangeli, SS, Harris, EN. In vivo models of thrombosis for the antiphospholipid syndrome. Lupus 1996; 5: 451–5.Google Scholar
Erlendsson, K, Steinsson, K, Johannsson, JH, Geirsson, RT. Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus. J Rheumatol 1993; 20: 1779–85.Google Scholar
Rand, JH, Wu, XX, Andree, HA, et al. Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism. N Engl J Med 997; 337: 154–60.Google Scholar
Di Simone, N, Meroni, PL, de Papa, N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000; 43: 140–50.Google Scholar
Meroni, PL, Raschi, E, Camera, M, et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 2000; 15: 237–40.Google Scholar
Vaarala, O, Alfthan, G, Jauhiainen, M, et al. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341: 923–5.Google Scholar
Horkko, S, Miller, E, Dudl, E, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. The J Clin Invest 1996; 98: 815–25.Google Scholar
Shi, WT, Forsberg, F, Vaidyanathan, P, Tornes, A, Ostensen, J, Goldberg, BB. The influence of acoustic transmit parameters on the destruction of contrast microbubbles in vitro. Phys Med Biol 2006; 51: 4031–45.Google Scholar
Price, BE, Rauch, J, Shia, MA, et al. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J Immunol 1996; 157: 2201–8.Google Scholar
Holers, VM, Girardi, G, Mo, L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195: 211–20.Google Scholar
Berman, J, Girardi, G, Salmon, JE. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 2005; 174: 485–90.Google Scholar
Lockwood, CJ, Romero, R, Feinberg, RF, Clyne, LP, Coster, B, Hobbins, JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369–73.Google Scholar
Harris, EN, Spinnato, JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991; 165: 1272–7.Google Scholar
Ruiz-Irastorza, G, Crowther, M, Branch, W, Khamashta, MA. Antiphospholipid syndrome. Lancet 2010; 376: 1498–509.Google Scholar
Galli, M, Luciani, D, Bertolini, G, Barbui, T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827–32.Google Scholar
Lockshin, MD, Kim, M, Laskin, CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012; 64: 2311–18.Google Scholar
Pengo, V, Biasiolo, A. The risk of overdiagnosis of antiphospholipid antibody syndrome. Thromb Haemost 2001; 86: 933.Google Scholar
Cervera, R, Piette, JC, Font, J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019–27.Google Scholar
Andreoli, L, Chighizola, CB, Banzato, A, Pons-Estel, GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res 2013; 65: 1869–73.Google Scholar
Bushnell, CD, Goldstein, LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000; 31: 3067–78.Google Scholar
Branch, DW. Antiphospholipid antibodies and pregnancy: maternal implications. Semin Perinatol 1990; 14: 139–46.Google Scholar
Branch, DW, Silver, RM, Blackwell, JL, Reading, JC, Scott, JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614–20.Google Scholar
Levine, JS, Branch, DW, Rauch, J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752–63.Google Scholar
Moodley, J, Bhoola, V, Duursma, J, et al. The association of antiphospholipid antibodies with severe early-onset pre-eclampsia. S Afr Med J 1995; 85: 105–7.Google Scholar
Bouvier, S, Cochery-Nouvellon, E, Lavigne-Lissalde, G, et al. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 2014; 123: 404–13.Google Scholar
Pauzner, R, Dulitzki, M, Langevitz, P, Livneh, A, Kenett, R, Many, A. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001; 86: 1379–84.Google Scholar
Branch, DW, Porter, TF, Rittenhouse, L, et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001; 184: 825–32.Google Scholar
Branch, DW, Andres, R, Digre, KB, Rote, NS, Scott, JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73: 541–5.Google Scholar
Kupferminc, MJ, Fait, G, Many, A, et al. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45–9.Google Scholar
Lee, RM, Brown, MA, Branch, DW, Ward, K, Silver, RM. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 2003; 102: 294300.Google Scholar
Mello, G, Parretti, E, Marozio, L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005; 46: 1270–4.Google Scholar
Polzin, WJ, Kopelman, JN, Robinson, RD, Read, JA, Brady, K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991; 78: 1108–11.Google Scholar
Huong, DL, Wechsler, B, Bletry, O, et al. A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001; 28: 2025–30.Google Scholar
de Jesus, GR, Agmon-Levin, N, Andrade, CA, et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014; 13: 795813.Google Scholar
Branch, DW, Gibson, M, Silver, RM. Clinical practice. Recurrent miscarriage. N Engl J Med 2010; 363: 1740–7.Google Scholar
Opatrny, L, David, M, Kahn, SR, Shrier, I, Rey, E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 2006; 33: 2214–21.Google Scholar
Clark, CA, Laskin, CA, Spitzer, KA. Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence. Hum Reprod Update 2012; 18: 474–84.Google Scholar
Silver, RM, Parker, CB, Reddy, UM, et al. Antiphospholipid antibodies in stillbirth. Obstet Gynecol 2013; 122: 641–57.Google Scholar
Hanouna, G, Morel, N, Le Thi Huong, D, et al. Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases. Rheumatology 2013; 52: 1635–41.Google Scholar
Asherson, RA, Cervera, R. Catastrophic antiphospholipid syndrome. Curr Rheumatol Rep 2003; 5: 395400.Google Scholar
Asherson, RA, Cervera, R, de Groot, PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530–4.Google Scholar
Camera, A, Rocco, S, De Lucia, D, et al. Reversible adult respiratory distress in primary antiphospholipid syndrome. Haematologica 2000; 85: 208–10.Google Scholar
Cervera, R, Bucciarelli, S, Espinosa, G, et al. Catastrophic antiphospholipid syndrome: lessons from the “CAPS Registry”– a tribute to the late Josep Font. Ann N Y Acad Sci 2007; 1108: 448–56.Google Scholar
Gomez-Puerta, JA, Cervera, R, Espinosa, G, et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis 2007; 66: 740–6.Google Scholar
Berman, H, Rodriguez-Pinto, I, Cervera, R, et al. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev 2013; 12: 1085–90.Google Scholar
Lonze, BE, Singer, AL, Montgomery, RA. Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med 2010; 362: 1744–5.Google Scholar
Bramham, K, Hunt, BJ, Germain, S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010; 19: 5864.Google Scholar
Farquharson, RG, Quenby, S, Greaves, M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100: 408–13.Google Scholar
Kutteh, WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584–9.Google Scholar
Laskin, CA, Spitzer, KA, Clark, CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009; 36: 279–87.Google Scholar
Rai, R, Cohen, H, Dave, M, Regan, L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253–7.Google Scholar
Noble, LS, Kutteh, WH, Lashey, N, Franklin, RD, Herrada, J. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005; 83: 684–90.Google Scholar
Stephenson, MD, Ballem, PJ, Tsang, P, et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004; 26: 729–34.Google Scholar
Pattison, NS, Chamley, LW, Birdsall, M, Zanderigo, AM, Liddell, HS, McDougall, J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000; 183: 1008–12.Google Scholar
Silver, RK, MacGregor, SN, Sholl, JS, et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411–17.Google Scholar
Empson, M, Lassere, M, Craig, J, Scott, J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005 (2): CD002859.Google Scholar
Bates, SM, Greer, IA, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e691S–736S.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 2012; 120: 1514–21.Google Scholar
Lefevre, G, Lambert, M, Bacri, JL, et al. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients. Lupus 2011; 20: 861–5.Google Scholar
Ruiz-Irastorza, G, Khamashta, MA, Hughes, GR. Heparin and osteoporosis during pregnancy: 2002 update. Lupus 2002; 11: 680–2.Google Scholar
Rodger, MA, Kahn, SR, Cranney, A, et al. Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost 2007; 5: 1600–6.Google Scholar
Fausett, MB, Vogtlander, M, Lee, RM, et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001; 185: 148–52.Google Scholar
Arnaud, L, Mathian, A, Ruffatti, A, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 2014; 13: 281–91.Google Scholar
Triolo, G, Ferrante, A, Ciccia, F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 2003; 48: 728–31.Google Scholar
Branch, DW, Peaceman, AM, Druzin, M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000; 182: 122–7.Google Scholar
Erkan, D, Willis, R, Murthy, VL, et al. A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients. Ann Rheum Dis 2014; 73: 1176–80.Google Scholar
Costantine, MM, Cleary, K, Eunice Kennedy Shriver National Institute of Child H, Human Development Obstetric–Fetal Pharmacology Research Units N. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol 2013; 121: 349–53.Google Scholar
Horlocker, TT, Wedel, DJ, Rowlingson, JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010; 35: 64101.Google Scholar
Dugowson, CE, Koepsell, TD, Voigt, LF, et al. Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987–1989. Arthritis Rheum 1991; 34: 1502–7.Google Scholar
MacGregor, AJ, Snieder, H, Rigby, AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30–7.Google Scholar
Jawaheer, D, Seldin, MF, Amos, CI, et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003; 48: 906–16.Google Scholar
Fisher, SA, Lanchbury, JS, Lewis, CM. Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16. Arthritis Rheum 2003; 48: 1200–6.Google Scholar
Lee, DM, Weinblatt, ME. Rheumatoid arthritis. Lancet 2001; 358: 903–11.Google Scholar
Aletaha, D, Neogi, T, Silman, AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569–81.Google Scholar
Whiting, PF, Smidt, N, Sterne, JA, et al. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 2010; 152: 456–.Google Scholar
Nelson, JL, Ostensen, M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997; 23: 195212.Google Scholar
Persellin, RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976; 27: 922–7.Google Scholar
de Man, YA, Dolhain, RJ, van de Geijn, FE, Willemsen, SP, Hazes, JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008; 59: 1241–8.Google Scholar
Oka, M. Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheum Dis 1953; 12: 227–9.Google Scholar
Betson, JR, Dorn, RV. Forty cases of arthritis and pregnancy. J Int Coll Surg 1964; 42: 521–6.Google Scholar
Ostensen, M, Husby, G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 1983; 26: 1155–9.Google Scholar
de Man, YA, Hazes, JM, van der Heide, H, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60: 3196–206.Google Scholar
Morris, WI. Pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Aus N Z J Obstet Gynaecol 1969; 9: 136–44.Google Scholar
Ostensen, M, Villiger, PM, Forger, F. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 2012; 11: A437–46.Google Scholar
Brun, JG, Nilssen, S, Kvale, G. Breast feeding, other reproductive factors and rheumatoid arthritis: a prospective study. Br J Rheumatol 1995; 34: 542–6.Google Scholar
Neely, NT, Persellin, RH. Activity of rheumatoid arthritis during pregnancy. Tex Med 1977; 73: 5963.Google Scholar
Viktil, KK, Engeland, A, Furu, K. Use of antirheumatic drugs in mothers and fathers before and during pregnancy: a population-based cohort study. Pharmacoepidemiol Drug Saf 2009; 18: 737–42.Google Scholar
Chifflot, H, Fautrel, B, Sordet, C, Chatelus, E, Sibilia, J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Seminars in Arthritis Rheum 2008; 37: 223–35.Google Scholar
Steen, VD. Scleroderma and pregnancy. Rheum Dis Clin North Am 1997; 23: 133–47.Google Scholar
LeRoy, EC, Black, C, Fleischmajer, R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5.Google Scholar
Reveille, JD, Solomon, DH. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003; 49: 399412.Google Scholar
Boin, F, Franchini, S, Colantuoni, E, et al. Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients. Arthritis Rheum 2009; 60: 2480–9.Google Scholar
Steen, VD. Pregnancy in women with systemic sclerosis. Obstet Gynecol 1999; 94: 1520.Google Scholar
Steen, VD, Conte, C, Day, N, Ramsey-Goldman, R, Medsger, TA. Pregnancy in women with systemic sclerosis. Arthritis Rheum 1989; 32: 151–7.Google Scholar
Knupp, MZ, O’Leary, JA. Pregnancy and scleroderma. Systemic sclerosis. J Fla Med Assoc 1971; 58: 2830.Google Scholar
Ballou, SP, Morley, JJ, Kushner, I. Pregnancy and systemic sclerosis. Arthritis Rheum 1984; 27: 295–8.Google Scholar
Taraborelli, M, Ramoni, V, Brucato, A, et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum 2012; 64: 1970–7.Google Scholar
Englert, H, Brennan, P, McNeil, D, Black, C, Silman, AJ. Reproductive function prior to disease onset in women with scleroderma. J Rheumatol 1992; 19: 1575–9.Google Scholar
Black, CM. Systemic sclerosis and pregnancy. Baillieres Clin Rheumatol 1990; 4: 105–24.Google Scholar
Silman, AJ, Black, C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis 1988; 47: 441–4.Google Scholar
Chakravarty, EF, Khanna, D, Chung, L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol 2008; 111: 927–34.Google Scholar
Giordano, M, Valentini, G, Lupoli, S, Giordano, A. Pregnancy and systemic sclerosis. Arthritis Rheum 1985; 28: 237–8.Google Scholar
Kreuter, A, Breuckmann, F, Uhle, A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 2004; 50: 740–7.Google Scholar
Braunstein, I, Werth, V. Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy. Dermatol Ther 2013; 26: 354–63.Google Scholar
Steen, VD. Pregnancy in scleroderma. Rheum Dis Clin North Am 2007; 33: 345–58, vii.Google Scholar
Batocchi, AP, Majolini, L, Evoli, A, et al. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999; 52: 447–52.Google Scholar
Lindstrom, J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977; 7: 3643.Google Scholar
Vincent, A, Newsom-Davis, J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985; 48: 1246–52.Google Scholar
Donaldson, JO, Penn, AS, Lisak, RP, et al. Antiacetylcholine receptor antibody in neonatal myasthenia gravis. Am J Dis Child 1981; 135: 222–6.Google Scholar
Plauche, WC. Myasthenia gravis in pregnancy: an update. Am J Obstet Gynecol 1979; 135: 691–7.Google Scholar
Drachman, DB. Myasthenia gravis. N Engl J Med 1994; 330: 1797–810.Google Scholar
Vincent, A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002; 2: 797804.Google Scholar
Shiraishi, H, Motomura, M, Yoshimura, T, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005; 57: 289–93.Google Scholar
Cole, RN, Reddel, SW, Gervasio, OL, Phillips, WD. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann Neurol 2008; 63: 782–9.Google Scholar
Meraouna, A, Cizeron-Clairac, G, Panse RL, , et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006; 108: 432–40.Google Scholar
Luckman, SP, Skeie, GO, Helgeland, G, Gilhus, NE. Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle Nerve 2006; 33: 93103.Google Scholar
Richman, DP, Agius, MA. Treatment of autoimmune myasthenia gravis. Neurology 2003; 61: 1652–61.Google Scholar
Zinman, L, Ng, E, Bril, V. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial. Neurology 2007; 68: 837–41.Google Scholar
Buckley, GA, Roberts, DV, Roberts, JB, Thomas, BH, Wilson, A. Drug-induced neonatal myasthenia. Br J Pharmacol 1968; 34: 203P204P.Google Scholar
Skeie, GO, Apostolski, S, Evoli, A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010; 17: 893902.Google Scholar
Norwood, F, Dhanjal, M, Hill, M, et al. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry 2014; 85: 538–43.Google Scholar
Djelmis, J, Sostarko, M, Mayer, D, Ivanisevic, M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 2002; 104: 21–5.Google Scholar
Plauche, WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991; 34: 8299.Google Scholar
McNall, PG, Jafarnia, MR. Management of myasthenia gravis in the obstetrical patient. Am J Obstet Gynecol 1965; 92: 518–25.Google Scholar
Chambers, DC, Hall, JE, Boyce, J. Myasthenia gravis and pregnancy. Obstet Gynecol 1967; 29: 597603.Google Scholar
Hoff, JM, Daltveit, AK, Gilhus, NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 2003; 61: 1362–6.Google Scholar
Lefvert, AK, Osterman, PO. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 1983; 33: 133–8.Google Scholar
Bartoccioni, E, Evoli, A, Casali, C, et al. Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants. J Neuroimmunol 1986; 12: 155–61.Google Scholar
Brenner, T, Beyth, Y, Abramsky, O. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor. Proc Natl Acad Sci U S A 1980; 77: 3635–9.Google Scholar
Polizzi, A, Huson, SM, Vincent, A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology 2000; 62: 332–41.Google Scholar
Levine, SE, Keesey, JC. Successful plasmapheresis for fulminant myasthenia gravis during pregnancy. Arch Neurol 1986; 43: 197–8.Google Scholar
Bader, A. Neurologic and neuromuscular disease. In Chestnut, DH, Wong, CA, Tsen, LC, et al. (eds), Chestnuts’ Obstetric Anesthesia: Principles and Practices, 5th edn. Philadelphia, PA: Elsevier, 2014, p. 1113.Google Scholar
Mao, ZF, Yang, LX, Mo, XA, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci 2011; 121: 121–9.Google Scholar

References

Mitchell, S, Shaw, D. The worldwide epidemic of female obesity. Best Pract Res Clin Obstet Gynaecol 2015; 29: 289–99.Google Scholar
Misra, A, Ramchandran, A, Jayawardena, R, Shrivastava, U, Snehalatha, C. Diabetes in South Asians. Diabet Med 2014; 31: 1153–62.Google Scholar
Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990; 7: 360.Google Scholar
Bell, R, Bailey, K, Cresswell, T, et al. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008; 115: 445–52.Google Scholar
American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27 (Suppl 1): S88–90.Google Scholar
International Association of Diabetes Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676–82.Google Scholar
Reece, EA, Homko, CJ. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 2000; 43: 3245.Google Scholar
Towner, D, Kjos, SL, Leung, B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995; 18: 1446–51.Google Scholar
Sharpe, PB, Chan, A, Haan, EA, Hiller, JE. Maternal diabetes and congenital anomalies in South Australia 1986–2000: a population-based cohort study. Birth Defects Res A Clin Mol Teratol 2005; 73: 605–11.Google Scholar
Farrell, T, Neale, L, Cundy, T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002; 19: 322–6.Google Scholar
Garner, P. Type I diabetes mellitus and pregnancy. Lancet 1995; 346: 157–61.Google Scholar
Berk, MA, Mimouni, F, Miodovnik, M, Hertzberg, V, Valuck, J. Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics 1989; 83: 1029–34.Google Scholar
Macfarlane, CM, Tsakalakos, N. The extended Pedersen hypothesis. Clin Physiol Biochem 1988; 6: 6873.Google Scholar
Nesbitt, TS, Gilbert, WM, Herrchen, B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol 1998; 179: 476–80.Google Scholar
Sandmire, HF, O’Halloin, TJ. Shoulder dystocia: its incidence and associated risk factors. Int J Gynaecol Obstet 1988; 26: 6573.Google Scholar
Mollberg, M, Hagberg, H, Bager, B, Lilja, H, Ladfors, L. High birthweight and shoulder dystocia: the strongest risk factors for obstetrical brachial plexus palsy in a Swedish population-based study. Acta Obstet Gynecol Scand 2005; 84: 654–9.Google Scholar
HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 19912002.Google Scholar
Lindsay, RS. Many HAPO returns: maternal glycemia and neonatal adiposity: new insights from the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study. Diabetes 2009; 58: 302-3.Google Scholar
Sacks, DA. Fetal macrosomia and gestational diabetes: what’s the problem? Obstet Gynecol 1993; 81: 775–81.Google Scholar
Persson, B, Hanson, U. Fetal size at birth in relation to quality of blood glucose control in pregnancies complicated by pregestational diabetes mellitus. Br J Obstet Gynaecol 1996; 103: 427–33.Google Scholar
Combs, CA, Gunderson, E, Kitzmiller, JL, Gavin, LA, Main, EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992; 15: 1251–7.Google Scholar
Peck, RW, Price, DE, Lang, GD, MacVicar, J, Hearnshaw, JR. Birthweight of babies born to mothers with type 1 diabetes: is it related to blood glucose control in the first trimester? Diabet Med 1991; 8: 258–62.Google Scholar
Lock, M, McGillick, EV, Orgeig, S, McMillen, IC, Morrison, JL. Regulation of fetal lung development in response to maternal overnutrition. Clin Exp Pharmacol Physiol 2013; 40: 803–16.Google Scholar
De Luca, R, Boulvain, M, Irion, O, Berner, M, Pfister, RE. Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery. Pediatrics 2009; 123: e1064–71.Google Scholar
Mitanchez, D. Fetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab 2010; 36: 617–27.Google Scholar
Moore, TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 2002; 186: 641–50.Google Scholar
Esakoff, TF, Cheng, YW, Sparks, TN, Caughey, AB. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol 2009; 200: 672.e1–4.Google Scholar
Crowther, CA, Hiller, JE, Moss, JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477–86.Google Scholar
Horvath, K, Koch, K, Jeitler, K, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 2010; 340: c1395.Google Scholar
Cundy, T, Gamble, G, Townend, K, et al. Perinatal mortality in type 2 diabetes mellitus. Diabet Med 2000; 17: 33–9.Google Scholar
HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453–9.Google Scholar
Mitanchez, D. Management of infants born to mothers with gestational diabetes. Paediatric environment. Diabetes Metab 2010; 36: 587–94.Google Scholar
Tsang, RC, Ballard, J, Braun, C. The infant of the diabetic mother: today and tomorrow. Clin Obstet Gynecol 1981; 24: 125–47.Google Scholar
Katz, L, Tsang, RC. Hypocalcemia in infants of diabetic mothers. J Pediatr 1972; 81: 633–4.Google Scholar
Landon, MB. Is there a benefit to the treatment of mild gestational diabetes mellitus? Am J Obstet Gynecol 2010; 202: 649–53.Google Scholar
Catov, JM, Ness, RB, Kip, KE, Olsen, J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007; 36: 412–19.Google Scholar
Schneider, S, Freerksen, N, Rohrig, S, Hoeft, B, Maul, H. Gestational diabetes and preeclampsia: similar risk factor profiles? Early Hum Dev 2012; 88: 179–84.Google Scholar
Ostlund, I, Haglund, B, Hanson, U. Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004; 113: 1216.Google Scholar
Yogev, Y, Xenakis, EM, Langer, O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004; 191: 1655–60.Google Scholar
Hartling, L, Dryden, DM, Guthrie, A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013; 159: 123–9.Google Scholar
Confidential Enquiry into Maternal and Child Health (CEMACH). Pregnancy in Women with Type 2 and Type 2 Diabetes in 2002–03, England, Wales and Northern Ireland. London: CEMACH 2005.Google Scholar
Wahabi, HA, Alzeidan, RA, Bawazeer, GA, Alansari, LA, Esmaeil, SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2010; 10: 63.Google Scholar
Wahabi, HA, Alzeidan, RA, Esmaeil, SA. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health 2012; 12: 792.Google Scholar
Ray, JG, O’Brien, TE, Chan, WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 2001; 94: 435–44.Google Scholar
Lipscombe, LL, McLaughlin, HM, Wu, W, Feig, DS. Pregnancy planning in women with pregestational diabetes. J Matern Fetal Neonatal Med 2011; 24: 1095–101.Google Scholar
National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period. Clinical Guideline 63. London: NICE, 2008. https://www.nice.org.uk/guidance/cg63 (accessed March 2017).Google Scholar
Guerin, A, Nisenbaum, R, Ray, JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007; 30: 1920–5.Google Scholar
American Diabetes Association. 12. Management of diabetes in pregnancy. Diabetes Care 2015; 38 (Suppl): S77–9.Google Scholar
National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. NICE Guideline 3. London: NICE, 2015. https://www.nice.org.uk/guidance/ng3 (accessed March 2017).Google Scholar
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.Google Scholar
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Diabetes and pregnancy. Can J Diabetes 2013; 37 (Suppl 1): S168–83.Google Scholar
Wilson, RD, Johnson, JA, Wyatt, P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007; 29: 1003–26.Google Scholar
Ray, JG, Vermeulen, MJ, Shapiro, JL, Kenshole, AB. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Diabetes Endocrine Pregnancy Outcome Study in Toronto. QJM 2001; 94: 347–56.Google Scholar
Kovo, M, Haroutiunian, S, Feldman, N, Hoffman, A, Glezerman, M. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol 2008; 136: 2933.Google Scholar
Nanovskaya, TN, Nekhayeva, IA, Patrikeeva, SL, Hankins, GD, Ahmed, MS. Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 2006; 195: 1081–5.Google Scholar
Falavigna, M, Schmidt, MI, Trujillo, J, et al. Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment. Diabetes Res Clin Pract 2012; 98: 396405.Google Scholar
Coetzee, EJ, Jackson, WP. Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half year study at Groote Schuur Hospital. S Afr Med J 1980; 58: 795802.Google Scholar
Coetzee, EJ, Jackson, WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984; 65: 635–7.Google Scholar
Hellmuth, E, Damm, P, Molsted-Pedersen, L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000; 17: 507–11.Google Scholar
Jakubowicz, DJ, Iuorno, MJ, Jakubowicz, S, Roberts, KA, Nestler, JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 524–9.Google Scholar
Glueck, CJ, Wang, P, Goldenberg, N, Sieve-Smith, L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; 17: 2858–64.Google Scholar
Glueck, CJ, Wang, P, Kobayashi, S, Phillips, H, Sieve-Smith, L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520-5.Google Scholar
Kovo, M, Weissman, A, Gur, D, et al. Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy. J Matern Fetal Neonatal Med 2006; 19: 415–19.Google Scholar
Bolton, S, Cleary, B, Walsh, J, Dempsey, E, Turner, MJ. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. Eur J Pediatr 2009; 168: 203–6.Google Scholar
Gilbert, C, Valois, M, Koren, G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006; 86: 658–63.Google Scholar
Elliott, BD, Schenker, S, Langer, O, Johnson, R, Prihoda, T. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994; 171: 653–60.Google Scholar
Hebert, MF, Ma, X, Naraharisetti, SB, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009; 85: 607–14.Google Scholar
Gutzin, SJ, Kozer, E, Magee, LA, Feig, DS, Koren, G. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. Can J Clin Pharmacol 2003; 10: 179–83.Google Scholar
Blumer, I, Hadar, E, Hadden, DR, et al. Diabetes and pregnancy: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4227–49.Google Scholar
Pollex, E, Moretti, ME, Koren, G, Feig, DS. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother 2011; 45: 9-16.Google Scholar
Cooper, WO, Hernandez-Diaz, S, Arbogast, PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443–51.Google Scholar
Quan, A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006; 82: 23–8.Google Scholar
Velazquez-Armenta, EY, Han, JY, Choi, JS, Yang, KM, Nava-Ocampo, AA. Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature. Hypertens Pregnancy 2007; 26: 5166.Google Scholar
Kazmin, A, Garcia-Bournissen, F, Koren, G. Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can 2007; 29: 906-8.Google Scholar
Edison, RJ, Muenke, M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004; 350: 1579–82.Google Scholar
Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000; 23: 1084–91.Google Scholar
Chew, EY, Mills, JL, Metzger, BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 1995; 18: 631–7.Google Scholar
Vestgaard, M, Ringholm, L, Laugesen, CS, et al. Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes. Diabet Med 2010; 27: 431–5.Google Scholar
Rosenn, B, Miodovnik, M, Kranias, G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166: 1214–18.Google Scholar
Ekbom, P, Damm, P, Feldt-Rasmussen, B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001; 24: 1739–44.Google Scholar
Dunne, FP, Chowdhury, TA, Hartland, A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM 1999; 92: 451–4.Google Scholar
Sibai, BM, Caritis, S, Hauth, J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 364–9.Google Scholar
Biesenbach, G, Grafinger, P, Stoger, H, Zazgornik, J. How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance. J Nephrol 1999; 12: 41–6.Google Scholar
Gordon, M, Landon, MB, Samuels, P, Hissrich, S, Gabbe, SG. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996; 87: 401–9.Google Scholar
Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract 2014; 103: 341–63.Google Scholar
American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care 2015; 38 (Suppl): S8–16.Google Scholar
Committee on Practice Bulletins – Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013; 122: 406–16.Google Scholar
Australasian Diabetes in Pregnancy Society. ADIPS Consensus Guidelines for the Testing and Diagnosis of Hyperglycaemia in Pregnancy in Australia and New Zealand, 2014. http://adips.org/downloads/ADIPSConsensusGuidelinesGDM-03.05.13VersionACCEPTEDFINAL.pdf (accessed March 2017).Google Scholar
McCarthy, AD, Curciarello, R, Castiglione, N, et al. Universal versus selective screening for the detection, control and prognosis of gestational diabetes mellitus in Argentina. Acta Diabetol 2010; 47: 97103.Google Scholar
Teh, WT, Teede, HJ, Paul, E, et al. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol 2011; 51: 2630.Google Scholar
American Diabetes Association. Standards of medical care in diabetes: 2009. Diabetes Care 2009; 32 (Suppl 1): S13–61.Google Scholar
American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care 2014; 37 (Suppl 1): S14–80.Google Scholar
Tan, YY, Yeo, GS. Impaired glucose tolerance in pregnancy: is it of consequence? Aust N Z J Obstet Gynaecol 1996; 36: 248–55.Google Scholar
Morikawa, M, Yamada, T, Yamada, T, et al. Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women. Diabetes Res Clin Pract 2010; 90: 339–42.Google Scholar
Agarwal, MM, Dhatt, GS, Shah, SM. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 2010; 33: 2018–20.Google Scholar
O’Sullivan, EP, Avalos, G, O’Reilly, M, et al. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011; 54: 1670–5.Google Scholar
Bodmer-Roy, S, Morin, L, Cousineau, J, Rey, E. Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes and Pregnancy Study Groups criteria. Obstet Gynecol 2012; 120: 746–52.Google Scholar
Ekeroma, AJ, Chandran, GS, McCowan, L, et al. Impact of using the International Association of Diabetes and Pregnancy Study Groups criteria in South Auckland: prevalence, interventions and outcomes. Aust N Z J Obstet Gynaecol 2015; 55: 3441.Google Scholar
Mission, JF, Ohno, MS, Cheng, YW, Caughey, AB. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 2012; 207: 326.e1–9.Google Scholar
Werner, EF, Pettker, CM, Zuckerwise, L, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 2012; 35: 529–35.Google Scholar
Landon, MB, Spong, CY, Thom, E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361: 1339–48.Google Scholar
de Veciana, M, Major, CA, Morgan, MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333: 1237–41.Google Scholar
Weisz, B, Shrim, A, Homko, CJ, et al. One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. J Perinatol 2005; 25: 241–4.Google Scholar
Ben-Haroush, A, Yogev, Y, Chen, R, Rosenn, B, Hod, M, Langer, O. The postprandial glucose profile in the diabetic pregnancy. Am J Obstet Gynecol 2004; 191: 576–81.Google Scholar
Kitzmiller, JL, Block, JM, Brown, FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 2008; 31: 1060–79.Google Scholar
Hernandez, TL, Friedman, JE, Van Pelt, RE, Barbour, LA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care 2011; 34: 1660–8.Google Scholar
Metzger, BE, Buchanan, TA, Coustan, DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30 (Suppl 2): S251–60.Google Scholar
Lurie, S. Changes in age distribution of erythrocytes during pregnancy: a longitudinal study. Gynecol Obstet Invest 1993; 36: 141–4.Google Scholar
Mosca, A, Paleari, R, Dalfra, MG, et al. Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 2006; 52: 1138–43.Google Scholar
Radder, JK, van Roosmalen, J. HbA1c in healthy, pregnant women. Neth J Med 2005; 63: 256–9.Google Scholar
Gandhi, RA, Brown, J, Simm, A, Page, RC, Idris, I. HbA1c during pregnancy: its relationship to meal related glycaemia and neonatal birth weight in patients with diabetes. Eur J Obstet Gynecol Reprod Biol 2008; 138: 45–8.Google Scholar
Voormolen, DN, DeVries, JH, Evers, IM, Mol, BW, Franx, A. The efficacy and effectiveness of continuous glucose monitoring during pregnancy: a systematic review. Obstet Gynecol Surv 2013; 68: 753-63.Google Scholar
Yu, F, Lv, L, Liang, Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab 2014; 99: 4674–82.Google Scholar
Feig, DS, Donovan, LE, Corcoy, R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017; 390: 2347–59. https://doi.org/10.1016/S0140-6736(17)32400-5.Google Scholar
Jones, LV, Ray, A, Moy, FM, Buckley, BS. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes. Cochrane Database Syst Rev 2019; 5: CD009613. https://doi.org/10.1002/14651858.CD009613.pub4.Google Scholar
American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31 (Suppl 1): S61–78.Google Scholar
Major, CA, Henry, MJ, De Veciana, M, Morgan, MA. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet Gynecol 1998; 91: 600–4.Google Scholar
Viana, LV, Gross, JL, Azevedo, MJ. Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care 2014; 37: 3345–55.Google Scholar
Mikines, KJ, Sonne, B, Farrell, PA, Tronier, B, Galbo, H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol 1988; 254: E248–59.Google Scholar
Artal, R, Catanzaro, RB, Gavard, JA, Mostello, DJ, Friganza, JC. A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Appl Physiol Nutr Metab 2007; 32: 596601.Google Scholar
Bung, P, Artal, R, Khodiguian, N, Kjos, S. Exercise in gestational diabetes: an optional therapeutic approach? Diabetes 1991; 40 (Suppl 2): 182–5.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period. Obstet Gynecol 2002; 99: 171–3.Google Scholar
Rowan, JA, Hague, WM, Gao, W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358: 2003–15.Google Scholar
Rowan, JA, Rush, EC, Obolonkin, V, Battin, M, Wouldes, T, Hague, WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011; 34: 2279–84.Google Scholar
Lautatzis, ME, Goulis, DG, Vrontakis, M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism 2013; 62: 1522–34.Google Scholar
Su, DF, Wang, XY. Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014.Google Scholar
Langer, O, Conway, DL, Berkus, MD, Xenakis, EM, Gonzales, O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343: 1134–8.Google Scholar
Langer, O, Yogev, Y, Xenakis, EM, Rosenn, B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 2005; 192: 134–9.Google Scholar
Moretti, ME, Rezvani, M, Koren, G. Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother 2008; 42: 483–90.Google Scholar
Nicholson, W, Bolen, S, Witkop, CT, Neale, D, Wilson, L, Bass, E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009; 113: 193205.Google Scholar
Holt, RI, Lambert, KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med 2014; 31: 282–91.Google Scholar
Ogunyemi, D, Jesse, M, Davidson, M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007; 13: 427–8.Google Scholar
Mathiesen, ER, Hod, M, Ivanisevic, M, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012; 35: 2012–7.Google Scholar
Mecacci, F, Carignani, L, Cioni, R, et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. Eur J Obstet Gynecol Reprod Biol 2003; 111: 1924.Google Scholar
Pettitt, DJ, Ospina, P, Howard, C, Zisser, H, Jovanovic, L. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med 2007; 24: 1129–35.Google Scholar
Torlone, E, Di Cianni, G, Mannino, D, Lapolla, A. Insulin analogs and pregnancy: an update. Acta Diabetol 2009; 46: 163–72.Google Scholar
Gallen, IW, Jaap, A, Roland, JM, Chirayath, HH. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabet Med 2008; 25: 165–9.Google Scholar
Poyhonen-Alho, M, Ronnemaa, T, Saltevo, J, Ekblad, U, Kaaja, RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007; 86: 1171–4.Google Scholar
Price, N, Bartlett, C, Gillmer, M. Use of insulin glargine during pregnancy: a case-control pilot study. BJOG 2007; 114: 453–7.Google Scholar
Fang, YM, MacKeen, D, Egan, JF, Zelop, CM. Insulin glargine compared with neutral protamine hagedorn insulin in the treatment of pregnant diabetics. J Matern Fetal Neonatal Med 2009; 22: 249–53.Google Scholar
Smith, JG, Manuck, TA, White, J, Merrill, DC. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy. Am J Perinatol 2009; 26: 5762.Google Scholar
Egerman, RS, Ramsey, RD, Kao, LW, et al. Perinatal outcomes in pregnancies managed with antenatal insulin glargine. Am J Perinatol 2009; 26: 591-5.Google Scholar
Imbergamo, MP, Amato, MC, Sciortino, G, et al. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther 2008; 30: 1476–84.Google Scholar
Pollex, EK, Feig, DS, Lubetsky, A, Yip, PM, Koren, G. Insulin glargine safety in pregnancy: a transplacental transfer study. Diabetes Care 2010; 33: 2933.Google Scholar
Hofmann, T, Horstmann, G, Stammberger, I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol 2002; 21: 181–9.Google Scholar
Lepercq, J, Jacqueminet, S, Hieronimus, S, Timsit, J, Grimaldi, A. Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes. Diabetes Metab 2010; 36: 209-12.Google Scholar
Negrato, CA, Rafacho, A, Negrato, G, et al. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study. Diabetes Res Clin Pract 2010; 89: 4651.Google Scholar
Nachum, Z, Ben-Shlomo, I, Weiner, E, Shalev, E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 1999; 319: 1223–7.Google Scholar
Evers, IM, ter Braak, EW, de Valk, HW, et al. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002; 25: 554–9.Google Scholar
Nielsen, LR, Pedersen-Bjergaard, U, Thorsteinsson, B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008; 31: 914.Google Scholar
Kimmerle, R, Heinemann, L, Delecki, A, Berger, M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 1992; 15: 1034–7.Google Scholar
Ringholm, L, Pedersen-Bjergaard, U, Thorsteinsson, B, Damm, P, Mathiesen, ER. Hypoglycaemia during pregnancy in women with type 1 diabetes. Diabet Med 2012; 29: 558–66.Google Scholar
Leinonen, PJ, Hiilesmaa, VK, Kaaja, RJ, Teramo, KA. Maternal mortality in type 1 diabetes. Diabetes Care 2001; 24: 1501–2.Google Scholar
Sibai, BM, Viteri, OA. Diabetic ketoacidosis in pregnancy. Obstet Gynecol 2014; 123: 167–78.Google Scholar
Beischer, NA, Wein, P, Sheedy, MT, Steffen, B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol 1996; 36: 239–47.Google Scholar
Cullen, MT, Reece, EA, Homko, CJ, Sivan, E. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Perinatol 1996; 13: 449–51.Google Scholar
Bochner, CJ, Medearis, AL, Williams, J, et al. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 1987; 157: 703–8.Google Scholar
Balsells, M, Garcia-Patterson, A, Gich, I, Corcoy, R. Ultrasound-guided compared to conventional treatment in gestational diabetes leads to improved birthweight but more insulin treatment: systematic review and meta-analysis. Acta Obstet Gynecol Scand 2014; 93: 144–51.Google Scholar
Hedderson, MM, Ferrara, A, Sacks, DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 2003; 102: 850–6.Google Scholar
Nelson, L, Wharton, B, Grobman, WA. Prediction of large for gestational age birth weights in diabetic mothers based on early third-trimester sonography. J Ultrasound Med 2011; 30: 1625–8.Google Scholar
Yogev, Y, Langer, O. Spontaneous preterm delivery and gestational diabetes: the impact of glycemic control. Arch Gynecol Obstet 2007; 276: 361–5.Google Scholar
Ostlund, I, Hanson, U, Bjorklund, A, et al. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 2003; 26: 2107–11.Google Scholar
Mathiesen, ER, Christensen, AB, Hellmuth, E, et al. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm. Acta Obstet Gynecol Scand 2002; 81: 835–9.Google Scholar
Thiebaugeorges, O, Guyard-Boileau, B. Obstetrical care in gestational diabetes and management of preterm labour. Diabetes Metab 2010; 36: 672–81.Google Scholar
Gabbe, SG, Carpenter, LB, Garrison, EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol 2007; 50: 1014–24.Google Scholar
Garabedian, C, Deruelle, P. Delivery (timing, route, peripartum glycemic control) in women with gestational diabetes mellitus. Diabetes Metab 2010; 36: 515–21.Google Scholar
Rosenstein, MG, Cheng, YW, Snowden, JM, et al. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol 2012; 206: 309.e1–7.Google Scholar
Montgomery (Appellant) v Lanarkshire Health Board (Respondent) (Scotland) [2015] UKSC 11. 2015.Google Scholar
Donnelly, V, Foran, A, Murphy, J, et al. Neonatal brachial plexus palsy: an unpredictable injury. Am J Obstet Gynecol 2002; 187: 1209–12.Google Scholar
Royal College of Obstetricians and Gynaecologists. Shoulder Dystocia, 2nd edn. Green-top Guideline No. 42. London: RCOG, 2012.Google Scholar
Obenshain, SS, Adam, PA, King, KC, et al. Human fetal insulin response to sustained maternal hyperglycemia. N Engl J Med 1970; 283: 566–70.Google Scholar
Taylor, R, Lee, C, Kyne-Grzebalski, D, Marshall, SM, Davison, JM. Clinical outcomes of pregnancy in women with type 1 diabetes(1). Obstet Gynecol 2002; 99: 537–41.Google Scholar
Barrett, HL, Morris, J, McElduff, A. Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Aust N Z J Obstet Gynaecol 2009; 49: 162–7.Google Scholar
Kitzmiller, JL, Gavin, L. Preexisting diabetes and pregnancy. In Lavin, N (ed.), Manual of Endocrinology and Metabolism, 3rd edn. Baltimore, MD: Lippincott Williams & Wilkins, 2002.Google Scholar
Rosenberg, VA, Eglinton, GS, Rauch, ER, Skupski, DW. Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am J Obstet Gynecol 2006; 195: 1095–9.Google Scholar
Mollberg, M, Hagberg, H, Bager, B, Lilja, H, Ladfors, L. Risk factors for obstetric brachial plexus palsy among neonates delivered by vacuum extraction. Obstet Gynecol 2005; 106: 913–18.Google Scholar
Robertshaw, HJ, McAnulty, GR, Hall, GH. Strategies for managing the diabetic patient. Best Pract Res Clin Anaesthesiol 2004; 18: 631–43.Google Scholar
Grylack, LJ, Chu, SS, Scanlon, JW. Use of intravenous fluids before cesarean section: effects on perinatal glucose, insulin, and sodium homeostasis. Obstet Gynecol 1984; 63: 654–8.Google Scholar
Kenepp, NB, Kumar, S, Shelley, WC, et al. Fetal and neonatal hazards of maternal hydration with 5% dextrose before caesarean section. Lancet 1982; 1: 1150–2.Google Scholar
Kim, C, Newton, KM, Knopp, RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862–8.Google Scholar
Glueck, CJ, Wang, P. Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opin Drug Saf 2007; 6: 191–8.Google Scholar
Glueck, CJ, Salehi, M, Sieve, L, Wang, P. Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome. J Pediatr 2006; 148: 628–32.Google Scholar
Feig, DS, Briggs, GG, Kraemer, JM, et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005; 28: 1851–5.Google Scholar
Cordero, L, Treuer, SH, Landon, MB, Gabbe, SG. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 1998; 152: 249–54.Google Scholar
Sobngwi, E, Boudou, P, Mauvais-Jarvis, F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003; 361: 1861–5.Google Scholar
Vaarasmaki, M, Pouta, A, Elliot, P, et al. Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort. Am J Epidemiol 2009; 169: 1209–15.Google Scholar
Clausen, TD, Mathiesen, ER, Hansen, T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab 2009; 94: 2464–70.Google Scholar

References

Glinoer, D. Pregnancy and iodine. Thyroid 2001; 11: 471–81.Google Scholar
Zimmermann, MB. Symposium on “Geographical and geological influences on nutrition”: iodine deficiency in industrialised countries. Proc Nutr Soc 2010; 69: 133–43.Google Scholar
Vanderpump, MP, Lazarus, JH, Smyth, PP, et al. Iodine status of UK schoolgirls: a cross–sectional survey. Lancet 2011; 377: 2007–12.Google Scholar
Lazarus, JH, Smyth, PP. Iodine deficiency in the UK and Ireland. Lancet 2008; 372: 888.Google Scholar
Bath, S, Walter, A, Taylor, A, et al. Iodine status of UK women of childbearing age. J Hum Nutr Diet 2008; 21: 379–80.Google Scholar
WHO, UNICEF, ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring their Elimination, 3rd edn. Geneva: World Health Organization, 2007.Google Scholar
Lazarus, J, Brown, RS, Daumerie, C, et al. European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014; 3: 7694.Google Scholar
Alexander, EK, Pearce, EN, Brent, GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017; 27: 315–89. doi: 10.1089/thy.2016.0457.Google Scholar
De Groot, L, Abalovich, M, Alexander, EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 2543–65.Google Scholar
Shi, X, Han, C, Li, C, et al. Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: a cross-sectional study of 7190 pregnant women in China. J Clin Endocrinol Metab 2015; 100: 1630–8.Google Scholar
Zimmermann, MB. Iodine deficiency. Endocr Rev 2009; 30: 376408.Google Scholar
Taylor, PN, Okosieme, OE, Dayan, CM, Lazarus, JH. Therapy of endocrine disease: impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis. Eur J Endocrinol 2013; 170: R1R15. doi: 10.1530/EJE-13-0651.Google Scholar
Hibbeln, JR, Davis, JM, Steer, C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007; 369: 578–85.Google Scholar
Hynes, KL, Otahal, P, Hay, I, et al. Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the Gestational Iodine Cohort. J Clin Endocrinol Metab 2013; 98: 1954–62.Google Scholar
Bath, SC, Steer, CD, Golding, J, et al. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet 2013; 382: 331–7.Google Scholar
Bray, GA. Increased sensitivity of the thyroid in iodine depleted rats to the goitrogenic effects of thyrotropin. J Clin Invest 1968; 47: 1640–7.Google Scholar
Pisarev, M, Gärtner, R. Autoregulatory actions of iodine. In Braverman, LE, Utiger, RD (eds), The Thyroid. Philadelphia, PA: Lippincott Williams & Wilkins, 2000, pp. 8590.Google Scholar
Studer, H, Derwahl, M. Mechanisms of nonneoplastic endocrine hyperplasia: a changing concept. A review focused on the thyroid gland. Endocr Rev 1995; 16: 411–26.Google Scholar
De Geyter, C, Steimann, S, Muller, B, et al. Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. Thyroid 2009; 19: 53–9.Google Scholar
Alexander, EK, Marqusee, E, Lawrence, J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351: 241–9.Google Scholar
Haddow, JE, Knight, GJ, Palomaki, GE, et al. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen 2004; 11: 170–4.Google Scholar
Larsson, A, Palm, M, Hansson, LO, Axelsson, O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008; 115: 874–81.Google Scholar
Derakhshan, A, Shu, H, Broeren, MAC, et al. Reference ranges and determinants of thyroid function during early pregnancy: the SELMA study. J Clin Endocrinol Metab 2018 Jul 2. doi: 10.1210/jc.2018-00890.Google Scholar
Cotzias, C, Wong, SJ, Taylor, E, et al. A study to establish gestation-specific reference intervals for thyroid function tests in normal singleton pregnancy. Eur J Obstet Gynecol Reprod Biol 2008; 137:61–6.Google Scholar
Khalid, AS, Marchocki, Z, Hayes, K et al. Establishing trimester-specific maternal thyroid function reference intervals. Ann Clin Biochem 2014; 51: 277–83.Google Scholar
Pop, V, Broeren, M, Wijnen, H, et al. Longitudinal trajectories of gestational thyroid function: a new approach to better understand changes in thyroid function. J Clin Endocrinol Metab 2018; 103: 2889–900. doi: 10.1210/jc.2017-02556.Google Scholar
Li, C, Shan, Z, Mao, J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab 2014; 99: 73–9.Google Scholar
Marwaha, RK, Chopra, S, Gopalakrishnan, S et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. Br J Obstet Gynaecol 2008; 115: 602–6.Google Scholar
Moon, HW, Chung, HJ, Park, CM, Hur, M, Yun, YM. Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann Lab Med 2015; 35: 198204. doi: 10.3343/alm.2015.35.2.198.Google Scholar
Casey, BM, Thom, EA, Peaceman, AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med 2017; 376: 815–25. doi: 10.1056/NEJMoa1606205.Google Scholar
Springer, D, Bartos, V, Zima, T. Reference intervals for thyroid markers in early pregnancy determined by 7 different analytical systems. Scand J Clin Lab Inv 2014; 74: 95101.Google Scholar
Lambert-Messerlian, G, McClain, M, Haddow, JE, et al. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol 2008; 199: 62.e1–6.Google Scholar
Teng, W, Shan, Z, Patil-Sisodia, K, et al. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol 2013; 1: 228–3.Google Scholar
Brabant, G, Peeters, R, Chan, S, et al. Management of subclinical hypothyroidism in pregnancy. Are we too simplistic? Eur J Endocrinol 2015; 173: P1–11.Google Scholar
Thorpe-Beeston, JG, Nicolaides, KH, Felton, CV, Butler, J, McGregor, AM. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991; 324: 532–6.Google Scholar
Garber, JR, Cobin, RH, Gharib, H, et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Endocr Pract 2012; 18: 9881028.Google Scholar
Hall, R, Richards, CJ, Lazarus, JH. The thyroid and pregnancy. Br J Obstet Gynaecol 1993; 100: 512–15.Google Scholar
Medici, M, Korevaar, TI, Schalekamp-Timmermans, S, et al. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the Generation R study. J Clin Endocrinol Metab 2014; 99: E2591–8.Google Scholar
Leung, AS, Millar, LK, Koonings, PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81: 349–53.Google Scholar
Haddow, JE, Palomaki, GE, Allan, WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549–55.Google Scholar
Pop, VJ, Brouwers, EP, Vader, HL, et al. Maternal hypothyroxinemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003; 59: 282–8.Google Scholar
Liu, H, Momotani, N, Noh, JY, et al. Maternal hypothyroidism during early-pregnancy and intellectual development of the progeny. Arch Intern Med 1994; 154: 785–7.Google Scholar
Momotani, N, Iwama, S, Momotani, K. Neurodevelopment in children born to hypothyroid mothers restored to normal thyroxine (T4) concentration by late pregnancy in Japan: no apparent influence of maternal T4 deficiency. J Clin Endocrinol Metab 2012; 97: 1104–8.Google Scholar
Lazarus, JH, Bestwick, JP, Channon, S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366: 493501.Google Scholar
Hales, C, Taylor, PN, Channon, S, et al. Controlled Antenatal Thyroid Screening II: effect of treating maternal suboptimal thyroid function on child cognition. J Clin Endocrinol Metab 2018; 103: 1583–91. doi: 10.1210/jc.2017-02378.Google Scholar
Korevaar, TI, Muetzel, R, Medici, M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol 2016; 4: 3543. doi: 10.1016/S2213-8587(15)00327-7.Google Scholar
Levie, D, Korevaar, TIM, Bath, SC, et al. Thyroid function in early pregnancy, child IQ, and autistic traits: a meta-analysis of individual participant data. J Clin Endocrinol Metab 2018; 103: 2967–79. https://doi.org/10.1210/jc.2018-00224.Google Scholar
Nelson, SM, Haig, C, McConnachie, A, et al. Maternal thyroid function and child educational attainment: prospective cohort study. BMJ 2018; 360: k452. https://doi.org/10.1136/bmj.k452.Google Scholar
Krassas, GE, Pontikides, N, Kaltsas, T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol 1999; 50: 655–9.Google Scholar
National Collaborating Centre for Women’s and Children’s Health, National Institute for Health and Care Excellence. Heavy Menstrual Bleeding: Assessment and Management. Clinical Guideline 44. London: NICE, 2007.Google Scholar
Verga, U, Bergamaschi, S, Cortelazzi, D, et al. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism. Clin Endocrinol 2009; 70: 798802.Google Scholar
Abalovich, M, Gutierrez, S, Alcaraz, G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12: 63–8.Google Scholar
Yassa, L, Marqusee, E, Fawcett, R, et al. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab 2010; 95: 3234–41.Google Scholar
Girling, J. Thyroid disease in pregnancy. Obstet Gynecol Reprod Med 2008; 18: 259–64.Google Scholar
Chopra, IJ, Baber, K. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy? Metabolism 2003; 52: 122–8.Google Scholar
Taylor, PN, Minassian, C, Rehman, A, et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J Clin Endocrinol Metab 2014; 99: 3895–902.Google Scholar
Busnelli, A, Vannucchi, G, Paffoni, A, et al. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF. Eur J Endocrinol 2015; 173: 417–24. doi: 10.1530/EJE-15-0151.Google Scholar
Burch, HB, Burman, KD, Cooper, DS, et al. A 2013 survey of clinical practice patterns in the management of primary hypothyroidism. J Clin Endocrinol Metab 2014; 99: 2077–85.Google Scholar
Managing subclinical hypothyroidism. Drug Ther Bull 1998; 36: 13.Google Scholar
Shields, BM, Knight, BA, Hill, AV, Hattersley, AT, Vaidya, B. Five-year follow-up for women with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab 2013; 98: E1941–5.Google Scholar
van den Boogaard, E, Vissenberg, R, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011; 17: 605–19.Google Scholar
Dashe, JS, Casey, BM, Wells, CE,et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 2005; 106: 753–7.Google Scholar
Moreno-Reyes, R, Glinoer, D, Van Oyen, H et al. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab 2013; 98: 3694–70.Google Scholar
Blatt, AJ, Nakamoto, JM, Kaufman, HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 2012; 97: 777–84.Google Scholar
Korevaar, TI, Medici, M, de Rijke, YB, et al. Ethnic differences in maternal thyroid parameters during pregnancy: the generation R study. J Clin Endocrinol Metab 2013; 98: 3678–86.Google Scholar
Abalovich, M, Amino, N, Barbour, LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 2007; 92: S1–7.Google Scholar
Karakosta, P, Alegakis, D, Georgiou, V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab 2012; 97: 4464–72.Google Scholar
Lazarus, JH. Screening for thyroid dysfunction in pregnancy: is it worthwhile? J Thyroid Res 2011; 2011: 397012.Google Scholar
Toulis, KA, Goulis, DG, Venetis, CA et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol 2010; 162: 643–52.Google Scholar
Negro, R, Schwartz, A, Gismondi, R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95: E44–8.Google Scholar
Benhadi, N, Wiersinga, WM, Reitsma, JB, et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009; 160: 985–91.Google Scholar
Cleary-Goldman, J, Malone, FD, Lambert-Messerlian, G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112: 8592.Google Scholar
Maraka, S, Mwangi, R, McCoy, RG, et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ 2017; 356: i6865. https://doi.org/10.1136/bmj.i6865.Google Scholar
Liu, H, Shan, Z, Li, C, et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid 2014; 24: 1642–9. doi: 10.1089/thy.2014.0029.Google Scholar
Zhang, Y, Wang, H, Pan, X, Teng, W, Shan, Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: a systematic review and meta-analysis. PLoS One 2017; 12: e0175708. doi: 10.1371/journal.pone.0175708.Google Scholar
Allan, WC, Haddow, JE, Palomaki, GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7: 127–30.Google Scholar
Casey, BM, Dashe, JS, Wells, CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 105: 239–45.Google Scholar
Stagnaro-Green, A, Chen, X, Bogden, JD, et al. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 2005; 15: 351–7.Google Scholar
Chen, LM, Du, WJ, Dai, J, et al. Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PLoS One 2014; 9: e109364.Google Scholar
Andersen, SL, Knøsgaard, L, Olsen, J, Vestergaard, P, Andersen, S. Maternal thyroid function, use of antithyroid drugs in early pregnancy, and birth defects. J Clin Endocrinol Metab 2019; 104: 6040–8. https://doi.org/10.1210/jc.2019-01343.Google Scholar
Yoshihara, A, Noh, J, Yamaguchi, T, et al. Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012; 97: 2396–403. https://doi.org/10.1210/jc.2011-2860.Google Scholar
Grattan, MJ, Thomas, DS, Hornberger, LK, et al. Maternal hypothyroidism may be associated with CHD in offspring. Cardiol Young 2015; 25: 1247–53. https://doi.org/10.1017/S1047951114001887.Google Scholar
Turunen, S, Vääräsmäki, M, Männistö, T, et al. Pregnancy and perinatal outcome among hypothyroid mothers: a population-based cohort study. Thyroid 2019; 29: 135–41. https://doi.org/10.1089/thy.2018.0311.Google Scholar
Li, Y, Shan, Z, Teng, W, et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25–30 months. Clin Endocrinol 2010; 72: 825–9.Google Scholar
Williams, F, Watson, J, Ogston, S, et al.; Scottish Preterm Thyroid Group. Mild maternal thyroid dysfunction at delivery of infants born ≤34 weeks and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab 2012; 97: 1977–85.Google Scholar
Behrooz, HG, Tohidi, M, Mehrabi, Y, et al. Subclinical hypothyroidism in pregnancy: intellectual development of offspring. Thyroid 2011; 21: 1143–7.Google Scholar
Hales, C, Taylor, PN, Channon, S, et al. Controlled antenatal thyroid screening II: effect of treating maternal suboptimal thyroid function on child behavior. J Clin Endocrinol Metab 2020; 105(3): dgz098. https://doi.org/10.1210/clinem/dgz098.Google Scholar
Wang, S, Teng, WP, Li, JX, et al. Effects maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy. J Endocrinol Invest 2012; 35: 322–5.Google Scholar
Velkeniers, B, Van Meerhaeghe, A, Poppe, K, et al. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update 2013; 19: 251–8.Google Scholar
Reid, SM, Middleton, P, Cossich, MC, et al. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. Cochrane Database Syst Rev 2013; (5): CD007752.Google Scholar
Glinoer, D, Riahi, M, Grun, JP, Kinthaert, J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994; 79: 197204.Google Scholar
Poppe, K, Glinoer, D, Tournaye, H, et al. Assisted reproduction and thyroid autoimmunity: An unfortunate combination? J Clin Endocrinol Metab 2003; 88: 4149–52.Google Scholar
Stagnaro-Green, A, Roman, SH, Cobin, RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264: 1422–5.Google Scholar
Poppe, K, Glinoer, D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update 2003; 9: 149–61.Google Scholar
Muller, AF, Verhoeff, A, Mantel, MJ, Berghout, A. Thyroid autoimmunity and abortion: A prospective study in women undergoing in vitro fertilization. Fertil Steril 1999; 71: 30–4.Google Scholar
Wilson, R, Ling, H, MacLean, MA, et al. Thyroid antibody titer and avidity in patients with recurrent miscarriage. Fertil Steril 1999; 71: 558–61.Google Scholar
Negro, R, Formoso, G, Mangieri, T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587–91.Google Scholar
Seror, J, Amand, G, Guibourdenche, J, et al. Anti-TPO antibodies diffusion through the placental barrier during pregnancy. PLoS One 2014; 9: e84647.Google Scholar
Mao, J, Pop, VJ, Bath, SC, et al. Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 2016; 55: 5561.Google Scholar
Wang, X, Zhang, Y, Tan, H, et al. Effect of levothyroxine on pregnancy outcomes in women with thyroid autoimmunity: a systematic review with meta-analysis of randomized controlled trials. Fertil Steril 2020: S0015-0282(20)30605-1. https://doi.org/10.1016/j.fertnstert.2020.06.034.Google Scholar
Dhillon-Smith, RK, Middleton, LJ, Sunner, KK, et al. Levothyroxine to increase live births in euthyroid women with thyroid antibodies trying to conceive: the TABLET RCT. Efficacy Mech Eval 2019; 6(11). https://doi.org/10.3310/eme06110.Google Scholar
Vissenberg, R, van Dijk, MM, Fliers, E, et al. Effect of levothyroxine on live birth rate in euthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFE study). Contemporary Clin Trials 2015; 44: 134–8.Google Scholar
Burrow, GN. Thyroid function and hyperfunction during gestation. Endocr Rev 1993; 14: 194202.Google Scholar
Smith, C, Thomsett, M, Choong, C, et al. Congenital thyrotoxicosis in premature infants. a. Clin Endocrinol 2001; 54: 371–6.Google Scholar
Cooper, DS, Lauberg, P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 2013; 1: 238–49.Google Scholar
Goodwin, TM, Montoro, M, Mestman, JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992; 167: 648–52.Google Scholar
Glinoer, D, Soto, MF, Bourdoux, P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991; 73: 421–7.Google Scholar
Momotani, N, Ito, K, Hamada, N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 1984; 20: 695700.Google Scholar
Anderson, SL, Olsen, , Wu, CS, et al. Spontaneous abortion, stillbirth and hyperthyroidism: a Danish population-based study.Eur Thyroid J 2014; 3: 164–72.Google Scholar
Millar, LK, Wing, DA, Leung, AS, et al. Low-birth-weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994; 84: 946–9.Google Scholar
León, G, Murcia, M, Rebagliato, M, et al. Maternal thyroid dysfunction during gestation, preterm delivery, and birthweight. The Infancia y Medio Ambiente Cohort, Spain. Paediatr Perinat Epidemiol 2015; 29: 113–22.Google Scholar
Milham, S, Elledge, W. Maternal methimazole and congenital defects in children. Teratology 1972; 5: 125. doi: 10.1002/tera.1420050117.Google Scholar
Andersen, SL, Olsen, J, Wu, CS, Laurberg, P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab 2013; 98: 4373–81. doi: 10.1210/jc.2013-2831.Google Scholar
Andersen, SL, Laurberg, P. Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole/carbimazole embryopathy. Eur J Endocrinol 2014; 171: C13.Google Scholar
Andersen, SL, Olsen, J, Wu, CS, Laurberg, P. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid 2014; 24: 1533–40.Google Scholar
Seo, GH, Kim, TH, Chung, JH. Antithyroid drugs and congenital malformations: a nationwide Korean cohort study. Ann Intern Med 2018; 168: 405–13. https://doi.org/10.7326/M17-1398.Google Scholar
Glinoer, D, Cooper, DS. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes 2012; 19: 402–7.Google Scholar
Yoshihara, A, Noh, JY, Watanabe, N, et al. Substituting potassium iodide for methimazole as the treatment for Graves’ disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid 2015; 25: 1155–61. https://doi.org/10.1089/thy.2014.0581.Google Scholar
Yoshihara, A, Noh, JY, Watanabe, N, et al. Characteristics of1patients with Graves' disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy. Thyroid 2020; 30: 451–6. https://doi.org/10.1089/thy.2019.0392.Google Scholar
Donnelly, MA, Wood, C, Casey, B, Hobbins, J, Barbour, LA. Early severe fetal Graves disease in a mother after thyroid ablation and thyroidectomy. Obstet Gynecol 2015; 125: 1059–62. doi: 10.1097/AOG.0000000000000582.Google Scholar
Abeillon-du Payrat, J, Chikh, K, Bossard, N, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol 2014; 171: 451–60. doi: 10.1530/EJE-14-0254.Google Scholar
O’Doherty, MJ, McElhatton, PR, Thomas, SH. Treating thyrotoxicosis in pregnant or potentially pregnant women: the risk to the fetus is very low. BMJ 1999; 318: 56.Google Scholar
Cooper, DS, Rivkees, SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009; 94: 1881–2.Google Scholar
Momotani, N, Noh, J, Oyanagi, H, Ishikawa, N, Ito, K. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986; 315: 24–8.Google Scholar
Rotondi, M, Cappelli, C, Pirali, B, et al. The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008; 93: 3985–8.Google Scholar
Perros, P, Colley, S, Boelaert, K. British Thyroid Association guidelines for the management of thyroid cancer, third edition. Clin Endocrinol 2014; 81 (Suppl 1): 1122. http://onlinelibrary.wiley.com/doi/10.1111/cen.12515/pdf (accessed March 2017).Google Scholar
Zhu, J, Zhu, X, Tu, C, et al. Parity and thyroid cancer risk: a meta-analysis of epidemiological studies. Cancer Med 2016; 5: 739–52.Google Scholar
Kim, H, Kim, KY, Baek, JH, Jung, J. Are pregnancy, parity, menstruation and breastfeeding risk factors for thyroid cancer? Results from the Korea National Health and Nutrition Examination Survey, 2010–2015. Clin Endocrinol (Oxf) 2018; 89: 233–9. doi: 10.1111/cen.13750.Google Scholar
Shindo, H, Amino, N, Ito, Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 2014; 24: 840–4.Google Scholar
Chen, AC, Livhits, MJ, Du, L, et al. Recent pregnancy is not associated with high-risk pathological features of well-differentiated thyroid cancer. Thyroid 2018; 28: 6871. doi: 10.1089/thy.2017.0496.Google Scholar
Stuckey, BG, Kent, GN, Allen, JR: The biochemical and clinical course of postpartum thyroid dysfunction: the treatment decision. Clin Endocrinol 2001; 54: 377–83.Google Scholar

References

Gonzalez, JG, Elizondo, G, Saldivar, D, et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85: 217–20.Google Scholar
Tyson, JE, Hwang, P, Guyda, H, Friesen, HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972; 113: 1420.Google Scholar
Karaca, Z, Tanriverdi, F, Unluhizarci, K, Kelestimur, F. Pregnancy and pituitary disorders. Eur J Endocrinol 2010; 162: 453–75.Google Scholar
Eriksson, L, Frankenne, F, Eden, S, Hennen, G, Von Schoultz, B. Growth hormone 24-h serum profiles during pregnancy: lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989; 96: 949–53.Google Scholar
Samaan, NA, Goplerud, CP, Bradbury, JT. Effect of arginine infusion on plasma levels of growth hormone, insulin, and glucose during pregnancy and the puerperium. Am J Obstet Gynecol 1970; 107: 1002–7.Google Scholar
Carr, BR, Parker, CR Jr., Madden, JD, MacDonald, PC, Porter, JC. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 1981; 139: 416–22.Google Scholar
Davison, JM, Sheills, EA, Barron, WM, Robinson, AG, Lindheimer, MD. Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy. J Clin Invest 1989; 83: 1313–18.Google Scholar
Gemzell, C, Wang, CF. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363–72.Google Scholar
Huang, W, Molitch, ME. Pituitary tumors in pregnancy. Endocrinol Metab Clin N Am 2019; 48: 569–81.Google Scholar
Magyar, DM, Marshall, JR. Pituitary tumors and pregnancy. Am J Obstet Gynecol 1978; 132: 739–51.Google Scholar
Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273–88.Google Scholar
Wang, AT, Mullan, RJ, Lane, MA, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev 2012; 1: 33.Google Scholar
Molitch, ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab 2011; 25: 885–96.Google Scholar
Divers, WA, Yen, SS. Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 1983; 62: 425–9.Google Scholar
van Roon, E, van der Vijver, JC, Gerretsen, G, Hekster, RE, Wattendorff, RA. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy. Fertil Steril 1981; 36: 173–7.Google Scholar
Tan, SL, Jacobs, HS. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy. Int J Gynaecol Obstet 1986; 24: 209–15.Google Scholar
Auriemma, RS, Perone, Y, Di Sarno, A, Grasso, LF, Guerra, E, Gasperi, M, et al. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 2013; 98: 372–9.Google Scholar
Domingue, ME, Devuyst, F, Alexopoulou, O, Corvilain, B, Maiter, D. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin Endocrinol 2014; 80: 642–8.Google Scholar
Katznelson, L, Laws, ER, Melmed, S, et al. Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 3933–51.Google Scholar
Caron, P, Broussaud, S, Bertherat, J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 2010; 95: 4680–7.Google Scholar
Kasuki, L, Neto, LV, Takiya, CM, Gadelha, MR. Growth of an aggressive tumor during pregnancy in an acromegalic patient. Endocr J 2012; 59: 313–19.Google Scholar
Cozzi, R, Attanasio, R, Barausse, M. Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 2006; 155: 279–84.Google Scholar
Abucham, J, Bronstein, MD, Dias, ML. Management of endocrine disease. Acromegaly and pregnancy: a contemporary review. Eur J Endocrinol 2017; 177(1): R112. doi: 10.1530/EJE-16-1059.Google Scholar
Caufriez, A, Frankenne, F, Hennen, G, Copinschi, G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993; 265: E572–7.Google Scholar
Fassnacht, M, Capeller, B, Arlt, W, Steck, T, Allolio, B. Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol 2001; 55: 411–15.Google Scholar
Cheng, S, Grasso, L, Martinez-Orozco, JA, et al. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol 2012; 76: 264–71.Google Scholar
Vialon, M, Grunenwald, S, Mouly, C, et al. First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegaly. Endocrine 2020; 70: 396–403. https://doi.org/10.1007/s12020-020-02430-1.Google Scholar
Brian, SR, Bidlingmaier, M, Wajnrajch, MP, Weinzimer, SA, Inzucchi, SE. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 2007; 92: 3374–7.Google Scholar
Iwasaki, Y, Oiso, Y, Kondo, K, et al. Aggravation of subclinical diabetes insipidus during pregnancy. N Eng J Med 1991; 324: 522–6.Google Scholar
Jin-no, Y, Kamiya, Y, Okada, M, et al. Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin. Endocr J 1998; 45: 693–6.Google Scholar
Hime, MC, Richardson, JA. Diabetes insipidus and pregnancy. Case report, incidence and review of literature. Obstet Gynecol Surv 1978; 33: 375–9.Google Scholar
Durr, JA, Hoggard, JG, Hunt, JM, Schrier, RW. Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. N Eng J Med 1987; 316: 1070–4.Google Scholar
Kalelioglu, I, Kubat, Uzum A, Yildirim, A, et al. Transient gestational diabetes insipidus diagnosed in successive pregnancies: review of pathophysiology, diagnosis, treatment, and management of delivery. Pituitary 2007; 10: 8793.Google Scholar
Cammu, H, Velkeniers, B, Charels, K, Vincken, W, Amy, JJ. Idiopathic acute fatty liver of pregnancy associated with transient diabetes insipidus. Case report. Br J Obstet Gynaecol 1987; 94: 173–8.Google Scholar
Kennedy, S, Hall, PM, Seymour, AE, Hague, WM. Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol 1994; 101: 387–91.Google Scholar
Brewster, UC, Hayslett, JP. Diabetes insipidus in the third trimester of pregnancy. Obstet Gynecol 2005; 105: 1173–6.Google Scholar
Ananthakrishnan, S. Gestational diabetes insipidus: diagnosis and management. Best Pract Res Clin Endocrinol Metab 2020; 34(5): 101384. https://doi.org/10.1016/j.beem.2020.101384.Google Scholar
Garofeanu, CG, Weir, M, Rosas-Arellano, MP, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 2005; 45: 626–37.Google Scholar
Burrow, GN, Wassenaar, W, Robertson, GL, Sehl, H. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period. Acta Endocrinol 1981; 97: 23–5.Google Scholar
Shangold, MM, Freeman, R, Kumaresan, P, Feder, AS, Vasicka, A. Plasma oxytocin concentrations in a pregnant woman with total vasopressin deficiency. Obstet Gynecol 1983; 61: 662–7.Google Scholar
Sheehan, HL. Postpartum necrosis of the anterior pituitary. J Pathol Bacteriol 1937; 45: 189214.Google Scholar
Kelestimur, F. Sheehan’s syndrome. Pituitary. 2003; 6(4):181–8.Google Scholar
Sert, M, Tetiker, T, Kirim, S, Kocak, M. Clinical report of 28 patients with Sheehan’s syndrome. Endocr J 2003; 50: 297301.Google Scholar
Grimes, HG, Brooks, MH. Pregnancy in Sheehan’s syndrome: report of a case and review. Obstet Gynecol Surv 1980; 35: 481–8.Google Scholar
Caturegli, P, Newschaffer, C, Olivi, A, et al. Autoimmune hypophysitis. Endocr Rev 2005; 26: 599614.Google Scholar
Khare, S, Jagtap, VS, Budyal, SR, et al. Primary (autoimmune) hypophysitis: a single center experience. Pituitary 2015; 18: 1622. doi: 10.1007/s11102-013-0550-9.Google Scholar
Chiloiro, S, Tartaglione, T, Angelini, F, et al. An overview of diagnosis of primary autoimmune hypophysitis in a prospective single-center experience. Neuroendocrinology 2017; 104: 280–90. doi: 10.1159/000446544.Google Scholar
Portocarrero, CJ, Robinson, AG, Taylor, AL, Klein, I. Lymphoid hypophysitis. An unusual cause of hyperprolactinemia and enlarged sella turcica. JAMA 1981; 246: 1811–12.Google Scholar
Dorfman, SG, Dillaplain, RP, Gambrell, RD. Antepartum pituitary infarction. Obstet Gynecol 1979; 53: 21S24S.Google Scholar
Piantanida, E, Gallo, D, Lombardi, V, et al. Pituitary apoplexy during pregnancy: a rare, but dangerous headache. J Endocrinol Invest 2014; 37: 789–97.Google Scholar
Motivala, S, Gologorsky, Y, Kostandinov, J, Post, KD. Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 2011; 40: 827–36.Google Scholar
Fleseriu, M, Hashim, IA, Karavitaki, N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 3888–921. doi: 10.1210/jc.2016-2118.Google Scholar
Vila, G, Akerblad, A, Mattsson, A, et al. Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril 2015; 104: 1210–17.e1. doi: 10.1016/j.fertnstert.2015.07.1132.Google Scholar
Grossman, R, Mukherjee, D, Chaichana, KL, et al. Complications and death among elderly patients undergoing pituitary tumour surgery. Clin Endocrinol 2010; 73: 361–8.Google Scholar
Jung, C, Ho, JT, Torpy, DJ, Rogers, A, Doogue, M, Lewis, JG, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 2011; 96: 1533–40.Google Scholar
Robinson, BG, Emanuel, RL, Frim, DM, Majzoub, JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 1988; 85: 5244–8.Google Scholar
Dorr, HG, Heller, A, Versmold, HT, et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 1989; 68: 863–8.Google Scholar
Lindsay, JR, Nieman, LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005; 26: 775–99.Google Scholar
Aron, DC, Schnall, AM, Sheeler, LR. Cushing’s syndrome and pregnancy. Am J Obstet Gynecol 1990; 162: 244–52.Google Scholar
Buescher, MA, McClamrock, HD, Adashi, EY. Cushing syndrome in pregnancy. Obstet Gynecol 1992; 79: 130–7.Google Scholar
Achong, N, D’Emden, M, Fagermo, N, Mortimer, R. Pregnancy-induced Cushing’s syndrome in recurrent pregnancies: case report and literature review. Aust N Z J Obstet Gynaecol 2012; 52: 96100.Google Scholar
Hana, V, Dokoupilova, M, Marek, J, Plavka, R. Recurrent ACTH-independent Cushing’s syndrome in multiple pregnancies and its treatment with metyrapone. Clin Endocrinol 2001; 54: 277–81.Google Scholar
Xu, JJ, Wang, YJ, Shan, LZ, Gu, W, Zeng, WH. Recurrent ACTH-independent Cushing’s syndrome in multiple pregnancies. Gynecol Endocrinol 2013; 29: 309–10.Google Scholar
Lindsay, JR, Jonklaas, J, Oldfield, EH, Nieman, LK. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 2005; 90: 3077–83.Google Scholar
Koerten, JM, Morales, WJ, Washington, SR, Castaldo, TW. Cushing’s syndrome in pregnancy: a case report and literature review. Am J Obstet Gynecol 1986; 154: 626–8.Google Scholar
Nieman, LK, Biller, BM, Findling, JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 1526–40.Google Scholar
Manetti, L, Rossi, G, Grasso, L, et al. Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol. Eur J Endocrinol 2013; 168: 315–21.Google Scholar
Lopes, LM, Francisco, RP, Galletta, MA, Bronstein, MD. Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing–s disease. Pituitary 2016; 19: 30–8. doi: 10.1007/s11102-015-0680-3.Google Scholar
Odagiri, E, Demura, R, Demura, H, et al. The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing’s disease. Endocrinol Jpn 1988; 35: 795802.Google Scholar
Terhune, KP, Jagasia, S, Blevins, LS, Phay, JE. Diagnostic and therapeutic dilemmas of hypercortisolemia during pregnancy: a case report. Am Surg 2009; 75: 232–4.Google Scholar
Lim, WH, Torpy, DJ, Jeffries, WS. The medical management of Cushing’s syndrome during pregnancy. Eur J Obstet Gynecol Reprod Biol 2013; 168: 16.Google Scholar
Riester, A, Reincke, M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol 2015; 172: R23–30.Google Scholar
Wyckoff, JA, Seely, EW, Hurwitz, S, et al. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000; 35: 668–72.Google Scholar
Ronconi, V, Turchi, F, Zennaro, MC, Boscaro, M, Giacchetti, G. Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism. Clin Endocrinol 2011; 74: 278–9.Google Scholar
Funder, JW, Carey, RM, Fardella, C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266–81.Google Scholar
Lu, W, Zheng, F, Li, H, Ruan, L. Primary aldosteronism and pregnancy: a case report. Aust N Z J Obstet Gynaecol 2009; 49: 558.Google Scholar
Okawa, T, Asano, K, Hashimoto, T, et al. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol 2002; 19: 31–6.Google Scholar
Kamoun, M, Mnif, MF, Charfi, N, et al. Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. Am J Med Sci 2014; 347: 6473.Google Scholar
Lotgering, FK, Derkx, FM, Wallenburg, HC. Primary hyperaldosteronism in pregnancy. Am J Obstet Gynecol 1986; 155: 986–8.Google Scholar
Bothou, C, Anand, G, Li, D, et al. Current management and outcome of pregnancies in women with adrenal insuffiency: experience from a multicenter survey. J Clin Endorinol Metab 2020; 105: e2853–63. https://doi.org/10.1210/clinem/dgaa266.Google Scholar
Cabassi, A, Rocco, R, Berretta, R, Regolisti, G, Bacchi-Modena, A. Eplerenone use in primary aldosteronism during pregnancy. Hypertension 2012; 59: e18–19.Google Scholar
Björnsdottir, S, Cnattingius, S, Brandt, L, et al. Addison’s disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Metab 2010; 95: 5249–57. https://doi.org/10.1210/jc.2010-0108.Google Scholar
Schneiderman, M, Czuzoj-Shulman, N, Spence, AR, Abenhaim HA. Maternal and neonatal outcomes of pregnancies in women with Addison’s disease: a population-based cohort study on 7.7 million births. BJOG 2017; 124: 1772–9. https://doi.org/10.1111/1471-0528.14448.Google Scholar
McKenna, DS, Wittber, GM, Nagaraja, HN, Samuels, P. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function. Am J Obstet Gynecol 2000; 183: 669–73.Google Scholar
Yuen, KC, Chong, LE, Koch, CA. Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management. Endocrine 2013; 44: 283–92.Google Scholar
Lebbe, M, Arlt, W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol 2013; 78: 497502. doi: 10.1111/cen.12097.Google Scholar
Bornstein, SR, Allolio, B, Arlt, W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 364–89. doi: 10.1210/jc.2015-1710.Google Scholar
Bancos, I, Hahner, S, Tomlinson, J, Arlt, W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216–26. doi: 10.1016/S2213-8587(14)70142-1.Google Scholar
Bornstein, SR, Allolio, B, Arlt, W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 264–89. doi: 10.1210/jc.2015-1710.Google Scholar
Lenders, JW. Pheochromocytoma and pregnancy: a deceptive connection. Eur J Endocrinol 2012; 166: 143–50.Google Scholar
Biggar, MA, Lennard, TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg 2013; 100: 182–90.Google Scholar
Lenders, JW, Duh, QY, Eisenhofer, G, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 1915–42.Google Scholar
Lenders, JWM, Langton, K, Langenhuijsen, JF, Eisenhofer, G. Pheochromocytoma and pregnancy. Endocrinol Metab Clin North Am 2019; 48: 605–17. https://doi.org/10.1016/j.ecl.2019.05.006.Google Scholar
Schenker, JG, Chowers, I. Pheochromocytoma and pregnancy: review of 89 cases. Obstet Gynecol Surv 1971; 26: 739–47.Google Scholar
Finkenstedt, G, Gasser, RW, Hofle, G, et al. Pheochromocytoma and sub-clinical Cushing’s syndrome during pregnancy: diagnosis, medical pre-treatment and cure by laparoscopic unilateral adrenalectomy. J Endocrinol Invest 1999; 22: 551–7.Google Scholar
Song, Y, Liu, J, Li, H, et al. Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy. Intern Med J 2013; 43: 588–91.Google Scholar

References

Keller, J, Frederking, D, Layer, P. The spectrum and treatment of gastrointestinal disorders during pregnancy. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 430–43.Google Scholar
Baron, TH, Ramirez, B, Richter, JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med 1993; 118: 366–75.Google Scholar
Goodwin, TM. Nausea and vomiting of pregnancy: an obstetric syndrome. Am J Obstet Gynecol 2002; 186 (5 Suppl): S184–9.Google Scholar
Jarvis, S, Nelson-Piercy, C. Management of nausea and vomiting in pregnancy. BMJ 2011; 342: d3606.Google Scholar
Knudsen, A, Lebech, M, Hansen, M. Upper gastrointestinal symptoms in the third trimester of the normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1995; 60: 2933.Google Scholar
Koch, KL. Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002; 186 (5 Suppl Understanding): S198–203.Google Scholar
Boregowda, G, Shehata, HA. Gastrointestinal and liver disease in pregnancy. Best Pract Res Clin Obstet Gynaecol 2013; 27: 835–53.Google Scholar
Jueckstock, JK, Kaestner, R, Mylonas, I. Managing hyperemesis gravidarum: a multimodal challenge. BMC Med 2010; 8: 46.Google Scholar
Trogstad, LI, Stoltenberg, C, Magnus, P, Skjaerven, R, Irgens, LM. Recurrence risk in hyperemesis gravidarum. BJOG 2005; 112: 1641–5.Google Scholar
Dodds, L, Fell, DB, Joseph, KS, Allen, VM, Butler, B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol 2006; 107: 285–92.Google Scholar
Tersigni, C, Castellani, R, de Waure, C, et al. Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. Hum Reprod Update 2014; 20: 582–93.CrossRefGoogle ScholarPubMed
Fiaschi, L, Nelson-Piercy, C, Gibson, J, Szatkowski, L, Tata, LJ. Adverse maternal and birth outcomes in women admitted to hospital for hyperemesis gravidarum: a population-based cohort study. Paediatr Perinat Epidemiol 2018; 32: 4051. doi: 10.1111/ppe.12416.CrossRefGoogle ScholarPubMed
Fossum, S, Naess, Ø, Halvorsen, S, Tell, GS, Vikanes, ÅV. Long-term cardiovascular morbidity following hyperemesis gravidarum: a Norwegian nationwide cohort study. PLoS One 2019; 14 (6): e0218041. doi: 10.1371/journal.pone.0218051.Google Scholar
Kallen, B, Lundberg, G, Aberg, A. Relationship between vitamin use, smoking, and nausea and vomiting of pregnancy. Acta Obstet Gynecol Scand 2003; 82: 916–20.Google Scholar
Mahadevan, U, Kane, S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 283311.Google Scholar
Mahadevan, U, Kane, S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 278–82.Google Scholar
American College of Obstetrics and Gynecology (ACOG). Practice bulletin: nausea and vomiting of pregnancy. Obstet Gynecol 2004; 103: 803–14.Google Scholar
Arsenault, MY, Lane, CA, MacKinnon, CJ, et al. The management of nausea and vomiting of pregnancy. J Obstet Gynaecol Can 2002; 24: 817–31.Google Scholar
Association of Professors of Gynecology and Obstetrics. Nausea and Vomiting of Pregnancy. APGO Educational Series on Women’s Health Issues. Crofton, MD: APGO, 2011.Google Scholar
Brent, R. Bendectin and birth defects: hopefully, the final chapter. Birth Defects Res A Clin Mol Teratol 2003; 67: 7987.Google Scholar
Lamm, SH. The epidemiological assessment of the safety and efficacy of bendectin. In Koren, G, Bishai, R (eds), Nausea and Vomiting of Pregnancy: State of the Art 2000. Toronto: Motherisk, 2000.Google Scholar
Choi, JS, Han, JY, Ahn, K, et al. Fetal outcome after exposure to domperidone during early pregnancy. Birth Defects Res A Clin Mol Teratol. Conference: Teratology Society 49th Annual Meeting Rio Grande Puerto Rico. Conference Publication 2009; 85 (5): 496.Google Scholar
Bottomley, C, Bourne, T. Management strategies for hyperemesis. Pract Res Clin Obstet Gynaecol 2009; 23: 549–64.Google Scholar
Fell, DB, Dodds, L, Joseph, KS, Allen, VM, Butler, B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol 2006; 107: 277–84.Google Scholar
Gill, SK, Einarson, A. The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf 2007; 6: 685–94.CrossRefGoogle ScholarPubMed
Matok, I, Gorodischer, R, Koren, G, et al. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009; 360: 2528–35.CrossRefGoogle ScholarPubMed
Mazzotta, P, Magee, LA. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs 2000; 59: 781800.Google Scholar
Einarson, A, Maltepe, C, Navioz, Y, et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004; 111: 940–3.CrossRefGoogle ScholarPubMed
Pasternak, B, Svanstrom, H, Hviid, A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med 2013; 368: 814–23.Google Scholar
Gill, SK, Maltepe, C, Mastali, K, Koren, G. The effect of acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy. Obstet Gynecol Int 2009; 2009: 585269.Google Scholar
Yost, NP, McIntire, DD, Wians, FH, et al. A randomized, placebo-controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol 2003; 102: 1250–4.Google Scholar
Bailit, JL. Hyperemesis gravidarium: epidemiologic findings from a large cohort. Am J Obstet Gynecol 2005; 193: 811–14.Google Scholar
Viljoen, E, Visser, J, Koen, N, Musekiwa, A. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J 2014; 13: 20.Google Scholar
DeVault, KR, Castell, DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999; 94: 1434–42.Google Scholar
Bassey, OO. Pregnancy heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach. Br J Obstet Gynaecol 1977; 84: 439–43.Google Scholar
Rey, E, Rodriguez-Artalejo, F, Herraiz, MA, et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007; 102: 2395–400.Google Scholar
Richter, JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 2003; 32: 235–61.Google Scholar
Richter, JE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther 2005; 22: 749–57.Google Scholar
Al-Amri, SM. Twenty-four hour pH monitoring during pregnancy and at postpartum: a preliminary study. Eur J Obstet Gynecol Reprod Biol 2002; 102: 127–30.Google Scholar
Ching, CK, Lam, SK. Antacids: indications and limitations. Drugs 1994; 47: 305–17.Google Scholar
Lindow, SW, Regnell, P, Sykes, J, Little, S. An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy. Int J Clin Pract 2003; 57: 175–9.Google Scholar
Bredenoord, AJ, Pandolfino, JE, Smout, AJ. Gastro-oesophageal reflux disease. Lancet 2013; 381: 1933–42.CrossRefGoogle ScholarPubMed
Matok, I, Gorodischer, R, Koren, G, et al. The safety of H(2)-blockers use during pregnancy. J Clin Pharmacol 2010; 50: 81–7.Google Scholar
Ruigómez, A, García, Rodríguez LA, Cattaruzzi, C, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999; 150: 476–81.Google Scholar
Garbis, H, Elefant, E, Diav-Citrin, O, et al. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol 2005; 19: 453–8.Google Scholar
Cappell, MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 2003; 32: 123–79.Google Scholar
Diav-Citrin, O, Arnon, J, Shechtman, S, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005; 21: 269–75.Google Scholar
Kallen, BA. Use of omeprazole during pregnancy: no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 2001; 96: 63–8.CrossRefGoogle ScholarPubMed
Lalkin, A, Loebstein, R, Addis, A, et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998; 179: 727–30.Google Scholar
Pasternak, B, Hviid, A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med 2010; 363: 2114–23.Google Scholar
Astra Zeneca. Prilosec [package insert]. 2012.Google Scholar
Brent, RL. Radiation teratogenesis. Teratology 1980; 21: 281–98.Google Scholar
Cappell, MS, Colon, VJ, Sidhom, OA. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison control groups. Am J Gastroenterol 1996; 91: 348–54.Google Scholar
Moayyedi, P, Bardhan, C, Young, L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001; 121: 1120–6.Google Scholar
Di Mario, F, Ingegnoli, A, Dal Bo, N, et al. Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis? Helicobacter 2004; 9: 92–4.Google Scholar
Qian, B, Ma, S, Shang, L, Qian, J, Zhang, G. Effects of Helicobacter pylori eradication on gastroesophageal reflux disease. Helicobacter 2011; 16: 255–65.Google Scholar
Malfertheiner, P, Megraud, F, O’Morain, CA, et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646–64.Google Scholar
Bradley, CS, Kennedy, CM, Turcea, AM, Rao, SS, Nygaard, IE. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol 2007; 110: 1351–7.Google Scholar
Drossman, DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016; 150: 1262–79.e2.Google Scholar
Vazquez, JC. Constipation, haemorrhoids, and heartburn in pregnancy. BMJ Clin Evid 2008; 2008: 1411.Google Scholar
Trottier, M, Erebara, A, Bozzo, P. Treating constipation during pregnancy. Can Fam Physician 2012; 58: 836–8.Google Scholar
Poskus, T, Buzinskiene, D, Drasutiene, G, et al. Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study. BJOG 2014; 121: 1666–71.CrossRefGoogle ScholarPubMed
Ebrahimi, N, Vohra, S, Gedeon, C, et al. The fetal safety of hydrocortisone–pramoxine (Proctofoam-HC) for the treatment of hemorrhoids in late pregnancy. J Obstet Gynaecol Can 2011; 33: 153–8.Google Scholar
Wald, A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. Gastroenterol Clin North Am 2003; 32: 309–22, vii.Google Scholar
Girling, JC, Dow, E, Smith, JH. Liver function tests in preeclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997; 104: 246–50.Google Scholar
David, AL, Kotecha, M, Girling, JC. Factors influencing postnatal liver function tests. BJOG 2000; 107: 1421–6.Google Scholar
Hay, JE. Liver disease in pregnancy. Hepatology 2008; 47: 1067–76.Google Scholar
Gabzdyl, EM, Schlaeger, JM. Intrahepatic cholestasis of pregnancy: a critical clinical review. J Perinat Neonatal Nurs 2015; 29: 4150.Google Scholar
Gonzalez, MC, Reyes, H, Arrese, M, et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol 1989; 9: 8490.Google Scholar
Pan, SG, Li, XW, Jiang, P, et al. Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones. Mol Med Rep 2015; 11: 434–46.Google Scholar
Bacq, Y, Gendrot, C, Perrotin, F, et al. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J Med Genet 2009; 46: 711–15.Google Scholar
Sookoian, S, Castano, G, Burgueno, A, Gianotti, TF, Pirola, CJ. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol 2008; 48: 125–32.Google Scholar
Williamson, C, Geenes, V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014; 124: 120–33.Google Scholar
Reyes, H, Baez, ME, Gonzalez, MC, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000; 32: 542–9.Google Scholar
Kauppila, A, Korpela, H, Makila, UM, Yrjanheikki, E. Low serum selenium concentration and glutathione-peroxidase activity in intrahepatic cholestasis of pregnancy. Br Med J 1987; 294: 150–2.Google Scholar
Royal College of Obstetricians and Gynaecologists. Obstetric Cholestasis, 2nd edn. Green-top Guideline No. 43. London: RCOG, 2011. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_43.pdf (accessed March 2017).Google Scholar
Glantz, A, Marschall, HW, Mattsson, LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40: 467–74.Google Scholar
Campos, GA, Guerra, FA, Israel, EJ. Effects of cholic acid infusion in fetal lambs. Acta Obstet Gynecol Scand 1986; 65: 23–6.Google Scholar
Reid, R, Ivey, KJ, Rencoret, RH, Storey, B. Fetal complications of obstetric cholestasis. Br Med J 1976; 1: 870–2.Google Scholar
Hämäläinen, ST, Turenen, K, Mattila, KJ, Kosunen, E, Sumanen, M. Long-term survival after intrahepatic cholestasis of pregnancy: a follow-up of 571 mothers. Eur J Obstet Gynecol Reprod Biol 2019; 240: 109112. doi: 10.1016/j.ejogrb.2019.06.008.Google Scholar
Ovadia, C, Seed, PT, Sklavounos, A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analysis. Lancet 2019; 393: 899909. doi: 10.1016/S0140-6736(18)31877-4.Google Scholar
Savander, M, Ropponen, A, Avela, K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52: 1025–9.Google Scholar
Molsa, A, Turunen, K, Mattila, KJ, Sumanen, M. Unnecessary confusion about family planning after intrahepatic cholestasis of pregnancy. Contraception 2012; 86: 639–44.Google Scholar
Food and Drug Administration. [Ursodiol prescribing information.] http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020675s017lbl.pdf (accessed March 2017).Google Scholar
Chappell, LC, Gurung, V, Seed, PT, et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012; 344: e3799.Google Scholar
Bacq, Y, Sentilhes, L, Reyes, HB, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012; 143: 1492–501.Google Scholar
Grand’Maison, S, Durand, M, Mahone, M. The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies. J Obstet Gynaecol Can 2014; 36: 632–41.Google Scholar
Jiang, ZH, Qiu, ZD, Liu, WW, et al. Intrahepatic cholestasis of pregnancy and its complications: analysis of 100 cases in Chongqing area. Chin Med J (Engl) 1986; 99: 957–60.Google Scholar
Bergasa, NV. The pruritus of cholestasis. Semin Dermatol 1995; 14: 302–12.Google Scholar
Ropponen, A, Sund, R, Riikonen, S, Ylikorkala, O, Aittomaki, K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006; 43: 723–8.Google Scholar
Barton, JR, Sibai, BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004; 31: 807–33, vii.Google Scholar
Weinstein, L. Syndrome of hemolysis, elevated liver-enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159–67.Google Scholar
Sibai, BM, Taslimi, MM, Elnazer, A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver-enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501–9.Google Scholar
Sibai, BM. The HELLP syndrome (hemolysis, elevated liver-enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990; 162: 311–16.Google Scholar
Lambert, G, Brichant, JF, Hartstein, G, Bonhomme, V, Dewandre, PY. Preeclampsia: an update. Acta Anaesthesiol Belg 2014; 65: 137–49.Google Scholar
Roberts, JM, August, PA, Bakris, G, et al. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122–31.Google Scholar
Magann, EF, Bass, D, Chauhan, SP, et al. Antepartum corticosteroids: disease, stabilization in patients with the syndrome of hemolysis, elevated liver-enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994; 171: 1148–53.Google Scholar
O’Brien, JM, Milligan, DA, Barton, JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183: 921–4.CrossRefGoogle ScholarPubMed
Minakami, H, Morikawa, M, Yamada, T, et al. Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts. J Obstet Gynaecol Res 2014; 40: 641–9.Google Scholar
Junquera, CG, Balmaseda, E, Gil, E, et al. Acute fatty liver of pregnancy and neonatal long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency. Eur J Pediatr 2009; 168: 103–6.Google Scholar
Reyes, H. Acute fatty liver of pregnancy. Clin Liver Dis 1999; 3: 6981.Google Scholar
Browning, MF, Levy, HL, Wilkins-Haug, LE, Larson, C, Shih, VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006; 107: 115–20.Google Scholar
Homer, L, Hebert, T, Nousbaum, JB, Bacq, Y, Collet, M. How to confirm acute fatty liver of pregnancy in case of emergency? Gynecol Obstet Fertil 2009; 37: 246–51.Google Scholar
Wu, Z, Huang, P, Gong, Y, Wan, J, Zou, W. Treating acute fatty liver of pregnancy with artificial liver support therapy. Medicine (Baltimore) 2018; 97: e12473. doi: 10.1097/MD.0000000000012473.Google Scholar
Tein, I. Metabolic disease in the fetus predisposes to maternal hepatic complications of pregnancy. Pediatr Res 2000; 47: 68.Google Scholar
Fair, J, Klein, AS, Feng, T, Merritt, WT, Burdick, JF. Intrapartum orthotopic liver transplantation with successful outcome of pregnancy. Transplantation 1990; 50: 534–5.Google Scholar
Hamilton, MI, Alcock, R, Magos, L, et al. Liver transplantation during pregnancy. Transplant Proc 1993; 25: 2967–8.Google Scholar
Westbrook, RH, Yeoman, AD, Joshi, D, et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant 2010; 10: 2520–6.Google Scholar
Khashan, AS, Quigley, EM, McNamee, R, et al. Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol 2012; 10: 902–9.Google Scholar
Brandt, LJ, Chey, WD, Foxx-Orenstein, AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 (Suppl 1): S1–35.Google Scholar
Hasler, WL. The irritable bowel syndrome during pregnancy. Gastroenterol Clin North Am 2003; 32: 385406, viii.Google Scholar
Wen, SW, Walker, M. Risk of fetal exposure to tricyclic antidepressants. J Obstet Gynaecol Can 2004; 26: 887–92.Google Scholar
van der Woude, CJ, Metselaar, HJ, Danese, S. Management of gastrointestinal and liver diseases during pregnancy. Gut 2014; 63: 1014–23.Google Scholar
Myles, N, Newall, H, Ward, H, Large, M. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations. Aust N Z J Psychiatry 2013; 47: 1002–12.Google Scholar
Stephansson, O, Kieler, H, Haglund, B, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013; 309: 4854.Google Scholar
Goa, SY, Wu, QJ, Zhang, TN, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med 2018; 16: 205. doi: 10.1186/s12916-018-1193-5.Google Scholar
Brown, HK, Hussain-Shamsy, N, Lunsky, Y, Dennis, CE, Vigod, SN. The association between antenatal exposure to selective serotonin reuptake inhibitors and autism: a systematic review and meta-analysis. J Clin Psychiatry 2017; 78 (1): e4858. doi: 10.4088/JCP.15r10194.Google Scholar
Einarson, A, Mastroiacovo, P, Arnon, J, et al. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 2000; 14: 185–7.Google Scholar
Kallen, B, Nilsson, E, Otterblad, Olausson P. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr 2008; 97: 541–5.Google Scholar
Schwethelm, B, Margolis, LH, Miller, C, Smith, S. Risk status and pregnancy outcome among medicaid recipients. Am J Prev Med 1989; 5: 157–63.Google Scholar
Nardulli, G, Limongi, F, Sue, G, Zapata, L, Bompart, I. [Use of polyethylene glycol in the treatment of puerperal constipation]. G E N 1995; 49: 224–6.Google Scholar
Cornish, J, Tan, E, Teare, J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007; 56: 830–7.Google Scholar
Dominitz, JA, Young, JC, Boyko, EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97: 641–8.Google Scholar
Fonager, K, Sorensen, HT, Olsen, J, Dahlerup, JF, Rasmussen, SN. Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93: 2426–30.Google Scholar
Kornfeld, D, Cnattingius, S, Ekbom, A. Pregnancy outcomes in women with inflammatory bowel disease: a population-based cohort study. Am J Obstet Gynecol 1997; 177: 942–6.Google Scholar
Pedersen, N, Bortoli, A, Duricova, D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther 2013; 38: 501–12.Google Scholar
Nielsen, OH, Andreasson, B, Bondesen, S, Jacobsen, O, Jarnum, S. Pregnancy in Crohn’s disease. Scand J Gastroenterol 1984; 19: 724–32.Google Scholar
Norgard, B, Hundborg, HH, Jacobsen, BA, Nielsen, GL, Fonager, K. Disease activity in pregnant women with Crohn’s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007; 102: 1947–54.Google Scholar
Reddy, D, Murphy, SJ, Kane, SV, Present, DH, Kornbluth, AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008; 103: 1203–9.Google Scholar
Broms, G, Granath, F, Linder, M, et al. Complications from inflammatory bowel disease during pregnancy and delivery. Clinical Gastroenterol Hepatol 2012; 10: 1246–52.Google Scholar
Hanan, IM. Inflammatory bowel disease in the pregnant woman. Compr Ther 1998; 24: 409–14.Google Scholar
Nielsen, OH, Andreasson, B, Bondesen, S, Jarnum, S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735–42.Google Scholar
van der Woude, CJ, Kolacek, S, Dotan, I, et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010; 4: 493510.Google Scholar
De Lima, A, Zelinkova, Z, Mulders, AGMGJ, van der Woude, CJ. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol 2016; 14: 1285–92.e1. doi: 10.1016/j.cgh.2016.03.018.Google Scholar
Hernandez-Diaz, S, Su, YC, Mitchell, AA, et al. Medications as a potential source of exposure to phthalates among women of childbearing age. Reprod Toxicol 2013; 37: 15.Google Scholar
Jurewicz, J, Hanke, W. Exposure to phthalates: reproductive outcome and children health. Int J Occup Med Environ Health 2011; 24: 115–41.Google Scholar
Norgard, B, Czeizel, AE, Rockenbauer, M, Olsen, J, Sorensen, HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001; 15: 483–6.Google Scholar
Rahimi, R, Nikfar, S, Rezaie, A, Abdollahi, M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 2008; 25: 271–5.Google Scholar
Park-Wyllie, L, Mazzotta, P, Pastuszak, A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.Google Scholar
Hviid, A, Molgaard-Nielsen, D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 2011; 183: 796804.Google Scholar
Homar, V, Grosek, S, Battelino, T. High-dose methylprednisolone in a pregnant woman with Crohn’s disease and adrenal suppression in her newborn. Neonatology 2008; 94: 306–9.Google Scholar
van Runnard Heimel, PJ, Franx, A, Schobben, AF, et al. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv 2005; 60: 5770.Google Scholar
van Runnard, Heimel PJ, Schobben, AF, Huisjes, AJ, Franx, A, Bruinse, HW. The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. Placenta 2005; 26: 842–5.Google Scholar
Beaulieu, DB, Ananthakrishnan, AN, Issa, M, et al. Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis 2009; 15: 25–8.CrossRefGoogle ScholarPubMed
Jharap, B, de Boer, NK, Stokkers, P, et al. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 2014; 63: 451–7.Google Scholar
de Boer, NK, Van Elburg, RM, Wilhelm, AJ, et al. 6-Thioguanine for Crohn’s disease during pregnancy: thiopurine metabolite measurements in both mother and child. Scand J Gastroenterol 2005; 40: 1374–7.Google Scholar
Angelberger, S, Reinisch, W, Messerschmidt, A, et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011; 5: 95100.Google Scholar
Casanova, MJ, Chaparro, M, Domenech, E, et al. Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol 2013; 108: 433–40.Google Scholar
Coelho, J, Beaugerie, L, Colombel, JF, et al. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 2011; 60: 198203.Google Scholar
Hutson, JR, Matlow, JN, Moretti, ME, Koren, G. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol 2013; 33: 18.Google Scholar
Shim, L, Eslick, GD, Simring, AA, Murray, H, Weltman, MD. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohns Colitis 2011; 5: 234–8.Google Scholar
Akbari, M, Shah, S, Velayos, FS, Mahadevan, U, Cheifetz, AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1522.Google Scholar
Kanis, SL, de Lima-Karagiannis, A, de Boer, NK, van der Woude, CJ. Use of thiopurines during conception and pregnancy not associated with adverse pregnancy outcomes or health of infants at 1 year in a prospective study. Clin Gastroenterol Hepatol 2017; S1542-3565(17): 30319–1.Google Scholar
Kozlowski, RD, Steinbrunner, JV, MacKenzie, AH, et al. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990; 88: 589–92.Google Scholar
Smithells, RW, Newman, CG. Recognition of thalidomide defects. J Med Genet 1992; 29: 716–23.Google Scholar
Bar Oz, B, Hackman, R, Einarson, T, Koren, G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71: 1051–5.Google Scholar
Branche, J, Cortot, A, Bourreille, A, et al. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis 2009; 15: 1044–8.Google Scholar
Mahadevan, U, Wolf, DC, Dubinsky, M, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013; 11: 286–92.Google Scholar
Zelinkova, Z, van der Ent, C, Bruin, KF, et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol 2013; 11: 318–21.Google Scholar
Marchioni, RM, Lichtenstein, GR. Tumor necrosis factor-alpha inhibitor therapy and fetal risk: a systematic literature review. World J Gastroenterol 2013; 19: 2591–602.Google Scholar
Schnitzler, F, Fidder, H, Ferrante, M, et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011; 17: 1846–54.Google Scholar
Mahadevan, U, Martin, CF, Sandler, RS, et al. PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterology 2012; 142(5 Suppl 1): S-149.Google Scholar
Nielsen, OH, Loftus, EV, Jess, T. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review. BMC Med 2013; 11: 174.Google Scholar
Kanis, SL, de Lima-Karagiannis, A, van der Ent, C, Rizopoulos, D, van der Woude, CJ. Anti-TNF levels in cord blood at birth are associated with anti-TNF type. J Crohns Colitis 2018; 12: 939–47. doi: 10.1093/ecco-jcc/jjy058.Google Scholar
de Lima, A, Zelinkova, Z, van der Ent, C, Steegers, EA, van der Woude, CJ. Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety. Gut 2016; 65: 1261–8.Google Scholar
Moens, A, van Hoeve, K, Humblet, E, et al. Outcome of pregnancies in female patients with inflammatory bowel diseases treated with vedolizumab. J Crohns Colitis 2019; 13: 1218. doi: 10.1093/ecco-jcc/jjy142.Google Scholar
Bar-Gil Shitrit, A, Ben Ya’acov, A, Livovsky, DM. Exposure to vedolizumab in IBD pregnant women appears of low risk for mother and neonate: a first prospective comparison study. Am J Gastroenterol 2019; 114: 1172–5. doi: 10.14309/ajg.0000000000000186.Google Scholar
Moens, A, van der Woude, CJ, Julsgaard, M, et al. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment Pharmacol Ther 2020; 51: 129–38. https://doi.org/10.1111/apt.15539.Google Scholar
Klenske, E, Osaba, L, Nagore, D, et al. Drug levels in the maternal serum, cord blood and breast milk of a ustekinumab-treated patient with Crohn's disease. J Crohns Colitis 2019; 13: 267–9. doi: 10.1093/ecco-jcc/jjy153.Google Scholar
Rowan, CR, Cullen, G, Mulcahy, HE, et al. Ustekinumab drug levels in maternal and cord blood in a woman with Crohn–s disease treated until 33 weeks of gestation. J Crohns Colitis 2018; 12: 376–8. doi: 10.1093/ecco-jcc/jjx141.Google Scholar
Venturin, C, Nancey, S, Danoin, P, et al. Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature. BMC Gastroenterol 2017; 17: 80. doi: 10.1186/s12876-017-0633-6.Google Scholar
Cortes, X, Borras-Blasco, J, Antequera, B, et al. Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature. J Clin Pharm Ther 2017; 42: 234–6. doi: 10.1111/jcpt.12492.Google Scholar
Tofacitinib: prescribing information [Internet]. www.accessdata.fda.gov/drugsatfda_docs/label/2018/203214s018lbl.pdf (accessed September 2019).Google Scholar
Mahadevan, U, Dubinsky, MC, Chinyu, S, et al. Outcomes of pregnancies with maternal/paternal exposure in the tofacitinib safety databases for ulcerative colitis. Inflamm Bowel Dis 2018; 24: 2494–500. doi: 10.1093/ibd/izy160.Google Scholar
Koss, CA, Baras, DC, Lane, SD, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother 2012; 56: 4800–5.Google Scholar
Berkovitch, M, Pastuszak, A, Gazarian, M, Lewis, M, Koren, G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 535–8.Google Scholar
Linseman, DA, Hampton, LA, Branstetter, DG. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995; 28: 5964.Google Scholar
Hill, J, Treasure, T, Guideline Development Group. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart 2010; 96: 879–82.Google Scholar
Van Assche, G, Dignass, A, Reinisch, W, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis 2010; 4: 63101.Google Scholar
Chen, YH, Lin, HC, Lou, HY. Increased risk of low birthweight, infants small for gestational age, and preterm delivery for women with peptic ulcer. Am J Obstet Gynecol 2010; 202: 164 e1–8.Google Scholar
Cappell, MS, Sidhom, O. A multicenter, multiyear study of the safety and clinical utility of esophagogastroduodenoscopy in 20 consecutive pregnant females with follow-up of fetal outcome. Am J Gastroenterol 1993; 88: 1900–5.Google Scholar
Cappell, MS. Risks versus benefits of gastrointestinal endoscopy during pregnancy. Nat Rev Gastroenterol Hepatol 2011; 8: 610–34.Google Scholar
Institute of Medicine Committee on Nutritional Status During Pregnancy and Lactation. Nutrition During Pregnancy. Washington, DC: National Academies Press, 1990.Google Scholar
Atherton, JC. H. pylori virulence factors. Br Med Bull 1998; 54: 105–20.Google Scholar
Chey, WD, Wong, BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808–25.Google Scholar
James, LF, Lazar, VA, Binns, W. Effects of sublethal doses of certain minerals on pregnant ewes and fetal development. Am J Vet Res 1966; 27: 132–5.Google Scholar
Lione, A. Nonprescription drugs as a source of aluminum, bismuth, and iodine during pregnancy. Reprod Toxicol 1987; 1: 243–52.Google Scholar
Whalley, PJ, Adams, RH, Combes, B. Tetracycline toxicity in pregnancy. liver and pancreatic dysfunction. JAMA 1964; 189: 357–62.Google Scholar
West, J. Coeliac disease: studies of its frequency and consequence. PhD thesis, University of Nottingham, 2005.Google Scholar
Rashtak, S, Murray, JA. Review article: coeliac disease, new approaches to therapy. Aliment Pharm Ther 2012; 35: 768–81.Google Scholar
Green, PH, Jabri, B. Coeliac disease. Lancet 2003; 362: 383–91.Google Scholar
Sultan, AA, Tata, LJ, Fleming, KM, et al. Pregnancy complications and adverse birth outcomes among women with celiac disease: a population-based study from England. Am J Gastroenterol 2014; 109: 1653–61.Google Scholar
Greco, L, Veneziano, A, Di Donato, L et al. Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 2004; 53: 149–51.Google Scholar
Ludvigsson, JF, Montgomery, SM, Ekbom, A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005; 129: 454–63.Google Scholar
Meloni, GF, Dessole, S, Vargiu, N, Tomasi, PA, Musumeci, S. The prevalence of coeliac disease in infertility. Hum Reprod 1999; 14: 2759–61.Google Scholar
Kolho, KL, Tiitinen, A, Tulppala, M, Unkila-Kallio, L, Savilahti, E. Screening for coeliac disease in women with a history of recurrent miscarriage or infertility. Br J Obstet Gynaecol 1999; 106: 171–3.Google Scholar
Tata, LJ, Card, TR, Logan, RF, et al. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology 2005; 128: 849–55.Google Scholar
Sungler, P, Heinerman, PM, Steiner, H, et al.. Laparoscopic cholecystectomy and interventional endoscopy for gallstone complications during pregnancy. Surg Endosc 2000; 14: 267–71.Google Scholar
Ko, CW, Beresford, SA, Schulte, SJ, Matsumoto, AM, Lee, SP. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 2005; 41: 359–65.Google Scholar
Al-Hashem, H, Muralidharan, V, Cohen, H, Jamidar, PA. Biliary disease in pregnancy with an emphasis on the role of ERCP. J Clin Gastroenterol 2009; 43: 5862.Google Scholar
Van Bodegraven, AA, Bohmer, CJ, Manoliu, RA, et al. Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol 1998; 33: 993–7.Google Scholar
Ramin, KD, Ramsey, PS. Disease of the gallbladder and pancreas in pregnancy. Obstet Gynecol Clin North Am 2001; 28: 571–80.Google Scholar
McKellar, DP, Anderson, CT, Boynton, CJ, Peoples, JB. Cholecystectomy during pregnancy without fetal loss. Surg Gynecol Obstet 1992; 174: 465–8.Google Scholar
Axelrad, AM, Fleischer, DE, Strack, LL, Benjamin, SB, al-Kawas, FH. Performance of ERCP for symptomatic choledocholithiasis during pregnancy: techniques to increase safety and improve patient management. Am J Gastroenterol 1994; 89: 109–12.Google Scholar
Shelton, J, Linder, JD, Rivera-Alsina, ME, Tarnasky, PR. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc 2008; 67: 364–8.Google Scholar
Tang, SJ, Mayo, MJ, Rodriguez-Frias, E, et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc 2009; 69: 453–61.Google Scholar
Manns, MP, Czaja, AJ, Gorham, JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193–213.Google Scholar
Schramm, C, Herkel, J, Beuers, U, et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006; 101: 556–60.Google Scholar
Heneghan, MA, Norris, SM, O’Grady, JG, Harrison, PM, McFarlane, IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001; 48: 97102.Google Scholar
Gronbaek, L, Vilstrup, H, Jepsen, P. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Aliment Pharmacol Ther 2018; 48: 655–63. doi: 10.1111/apt.14925.Google Scholar
Anderka, MT, Lin, AE, Abuelo, DN, Mitchell, AA, Rasmussen, SA. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 2009; 149A: 1241–8.Google Scholar
Talwalkar, JA, Lindor, KD. Primary biliary cirrhosis. Lancet 2003; 362: 5361.Google Scholar
Boonstra, K, Bokelaar, R, Stadhouders, PH, et al. Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years. Hepatol Int 2014; 8: 266–74.Google Scholar
Ahrens, EH, Payne, MA, Kunkel, HG, Eisenmenger, WJ, Blondheim, SH. Primary biliary cirrhosis. Medicine (Baltimore) 1950; 29: 299364.Google Scholar
Whelton, MJ, Sherlock, S. Pregnancy in patients with hepatic cirrhosis management and outcome. Lancet 1968; 2: 995–9.Google Scholar
Mack, HC, Segar, LF, Robinson, AR, Wiseman, ME, Moyer, EZ Electrophoretic patterns of plasma proteins in pregnancy II. Pregnancy complicated by liver disease. Obstet Gynecol 1953; 204: 204–11.Google Scholar
Nir, A, Sorokin, Y, Abramovici, H, Theodor, E. Pregnancy and primary biliary-cirrhosis. Int J Gynaecol Obstet 1989; 28: 279–82.Google Scholar
Wong, KK, Goh, KL. Pregnancy in primary biliary cirrhosis. Eur J Obstet Gynecol Reprod Biol 1992; 45: 149–51.Google Scholar
Olsson, R, Loof, L, Wallerstedt, S. Pregnancy in patients with primary biliary cirrhosis: a case for dissuasion? Liver 1993; 13: 316–18.Google Scholar
Ji, HX, Haring, P, Kirkinen, P, Saarikoski, S. Glucocorticoid treatment of primary biliary cirrhosis in a pregnant woman. Acta Obstet Gynecol Scand 1995; 74: 654–6.Google Scholar
Rabinovitz, M, Appasamy, R, Finkelstein, S. Primary biliary cirrhosis diagnosed during pregnancy: does it have a different outcome? Digest Dis Sci 1995; 40: 571–4.Google Scholar
Rudi, J, Schonig, T, Stremmel, W. Treatment with ursodeoxycholic acid in primary biliary cirrhosis during pregnancy. Z Gastroenterol 1996; 34: 188–91.Google Scholar
Goh, SK, Gull, SE, Alexander, GJ. Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature. BJOG 2001; 108: 760–2.Google Scholar
Allen, AM, Hay, JE. Review article: the management of cirrhosis in women. Aliment Pharm Ther 2014; 40: 1146–54.Google Scholar
Ducarme, G, Bernuau, J, Luton, D. [Primary biliary cirrhosis and pregnancy]. J Gynecol Obstet Biol Reprod (Paris) 2014; 43: 335–41.Google Scholar
Ali, AH, Carey, EJ, Lindor, KD. Diagnosis and management of primary biliary cirrhosis. Expert Rev Clin Immunol 2014; 10: 1667–78.Google Scholar
Heidelbaugh, JJ, Bruderly, M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 2006; 74: 756–62.Google Scholar
Russell, MA, Craigo, SD. Cirrhosis and portal hypertension in pregnancy. Seminars in perinatology 1998; 22: 156–65.Google Scholar
Benjaminov, FS, Heathcote, J. Liver disease in pregnancy. Am J Gastroenterol 2004; 99: 2479–88.Google Scholar
Hagstrom, H, Hoijer, J, Marschall, HU, et al. Outcomes of pregnancy in mothers with cirrhosis: a national population-based cohort study of 1.3 million pregnancies. Hepatol Commun 2018; 2: 1299–305. doi: 10.1002/hep4.1255.Google Scholar
Tan, J, Surti, B, Saab, S. Pregnancy and cirrhosis. Liver Transpl 2008; 14: 1081–91.Google Scholar
Sumana, G, Dadhwal, V, Deka, D, Mittal, S. Non-cirrhotic portal hypertension and pregnancy outcome. J Obstet Gynaecol Res 2008; 34: 801–4.Google Scholar
Cappell, MS. Hepatic disorders mildly to moderately affected by pregnancy: medical and obstetric management. Med Clin North Am 2008; 92: 717–37, vii.Google Scholar
Blachier, M, Leleu, H, Peck-Radosavljevic, M, Valla, DC, Roudot-Thoraval, F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58: 593608.Google Scholar
Deshpande, NA, James, NT, Kucirka, LM, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012; 18: 621–9.Google Scholar
Walcott, WO, Derick, DE, Jolley, JJ, Snyder, DL, Schmid, R. Successful pregnancy in a liver transplant patient. Am J Obstet Gynecol 1978; 132: 340–1.Google Scholar
Ramirez, CB, Doria, C. Pregnancy after liver transplantation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1137–45.Google Scholar
Cyganek, A, Pietrzak, B, Kociszewska-Najman, B, et al. Intrauterine growth restriction in pregnant renal and liver transplant recipients: risk factors assessment. Transplant Proc 2014; 46: 2794–7.Google Scholar
Prodromidou, A, kostakis, ID, Machairas, N, et al. Pregnancy outcomes after liver transplantation. Transplant Proc 2019, 51, 446–9. doi: 10.1016/j.transproceed.2019.01.014.Google Scholar
Deshpande, NA, James, NT, Kucirka, LM, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012; 18: 621–9. doi: 10.1002/lt.23416.Google Scholar
Blume, C, Pischke, S, von Versen-Hoynck, F, Gunter, HH, Gross, MM. Pregnancies in liver and kidney transplant recipients: a review of the current literature and recommendation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1123–36.Google Scholar
Kamarajah, SK, Arntdz, K, Bundred, J, et al. Outcomes of pregnancy in recipients of liver transplants. Clin Gastroenterol Hepatol 2019; 17: 1398–1404.e1. doi: 10.1016/j.cgh.2018.11.055.Google Scholar
Zaffar, N, Soete, E, Gandhi, S, et al. Pregnancy outcomes following single and repeat liver transplantation: an international two-centre cohort. Liver Transpl 2018; 24: 769–78. doi: 10.1002/lt.25071.Google Scholar
Christopher, V, Al-Chalabi, T, Richardson, PD, et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl 2006; 12: 1138–43.Google Scholar
Sifontis, NM, Coscia, LA, Nguyen, TD, et al. Pregnancy outcomes with exposure to mycophenolic acid products. Am J Transplant 2010; 10 (S4): 169–70.Google Scholar
Joshi, D, James, A, Quaglia, A, Westbrook, RH, Heneghan, MA. Liver disease in pregnancy. Lancet 2010; 375: 594605.Google Scholar

Further Reading

Briggs, GG, Freeman, R, Yaffe, SJ (eds). Drugs in Pregnancy and Lactation. Philadelphia, PA: Lippincott Williams & Williams, 2008.Google Scholar
Coutinho, JM, Majoie, CB, Coert, BA, Stam, J. Decompressive hemicraniectomy in cerebral sinus thrombosis: Consecutive case series and review of the literature. Stroke 2009; 40: 2233–5.Google Scholar
Davis, SM, Donnan, GA. 4.5 hours: the new time window for tissue plasminogen activator in stroke. Stroke 2009; 40: 2266–7.Google Scholar
Helms, AK, Drogan, O, Kittner, SJ. First trimester stroke prophylaxis in pregnant women with a history of stroke. Stroke 2009; 40: 1158–61.Google Scholar
Murugappan, A, Coplin, WM, Al-Sadat, AN, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 2006; 66: 768–70.Google Scholar
Pennell, PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003; 61: S35–42.Google Scholar
Piotin, M, de Souza Filho, CB, Kothimbakam, R, Moret, J. Endovascular treatment of acutely ruptured intracranial aneurysms in pregnancy. Am J Obstet Gynecol 2001; 185: 1261–2.Google Scholar
Sances, G, Granella, F, Nappi, RE, et al. Course of migraine during pregnancy and postpartum: A prospective study. Cephalalgia 2003; 23: 197205.Google Scholar
Sloan, MA, Stern, BJ. Cerebrovascular disease in pregnancy. Curr Treat Options Neurol 2003; 5: 391407.Google Scholar
Wong, CA, Scavone, BM, Dugan, S, et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003; 101: 279–88.Google Scholar

References

Briggs, GG, Freeman, R, Yaffe, SJ (eds). Drugs in Pregnancy and Lactation. Philadelphia, PA: Lippincott Williams & Williams, 2008.Google Scholar
Barton, JR, Sibai, BM. Cerebral pathology in eclampsia. Clin Perinatol 1991; 18: 891910.Google Scholar
Sheehan, HL, Lynch, JB (eds). Pathology of Toxemia of Pregnancy. Baltimore, MD: Williams & Wilkins, 1973.Google Scholar
Colosimo, C, Fineli, A, Moschini, M, Guerrini, P. CT findings in eclampsia. Neuroradiology 1985; 27: 313–17.Google Scholar
Crawford, S, Varner, MW, Digre, KB, Servais, G, Corbett, JJ. Cranial magnetic resonance imaging in eclampsia. Obstet Gynecol 1987; 70: 474–7.Google Scholar
Lewis, LK, Hinshaw, DB, Will, AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988; 30: 5964.Google Scholar
Raroque, JG, Orrison, WW, Rosenberg, GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology 1990; 40: 167–9.Google Scholar
Schwaighofer, BW, Jesselink, JR, Jealy, ME. MR demonstration of reversible brain abnormalities in eclampsia. J Comput Assist Tomogr 1989; 13: 310–12.Google Scholar
Cunningham, FG, Fernandez, CO, Hernandez, C. Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol 1995; 172: 1291–8.Google Scholar
Richards, A, Graham, D, Bullock, R. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatry 1988; 51: 416–21.Google Scholar
Douglas, KA, Redman, CWG. Eclampsia in the United Kingdom. BMJ 1994; 309: 1395–400.Google Scholar
Hallum, AV. Eye changes in hypertensive toxemia of pregnancy. JAMA 1936; 106: 1649–51.Google Scholar
Carpenter, F, Kava, HL, Plotkin, D. The development of total blindness as a complication of pregnancy. Am J Obstet Gynecol 1953; 66: 641–7.Google Scholar
Will, AD, Lewis, KL, Hinshaw, DB, et al. Cerebral vasoconstriction in toxemia. Neurology 1987; 37: 1555–7.Google Scholar
Schaefer, PW, Buonanno, FS, Gonzalez, RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28: 1082–5.Google Scholar
Beck, DW, Menezes, AH. Intracerebral hemorrhage in a patient with eclampsia. JAMA 1981; 246: 1492.Google Scholar
Lewis, G. Saving Mother’s Lives: Reviewing Maternal Deaths to Make Motherhood Safer: 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007.Google Scholar
Mattar, F, Sibai, BM. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000; 182: 307–12.Google Scholar
Duley, L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547–53.Google Scholar
Sibai, BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049–55.Google Scholar
Berhan, Y, Berhan, A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports. J Obstet Gynaecol Res 2015; 41: 831–42.Google Scholar
Miles, JF, Martin, JN, Blake, PG, et al. Postpartum eclampsia: A recurring perinatal dilemma. Obstet Gynecol 1990; 76: 328–31.Google Scholar
Lubarsky, SL, Barton, JR, Friedman, SA, et al. Late postpartum eclampsia revisited. Obstet Gynecol 1994; 83: 502–5.Google Scholar
Sibai, BM. Magnesium sulfate prophylaxis in preeclampsia. Am J Obstet Gynecol 2004/190: 1520–6.Google Scholar
Coan, EJ, Collinridge, GL. Magnesium ions block an N-methyl-d-aspartate receptor–mediated component of synaptic transmission on rat hippocampus. Neurosci Lett 1985; 53: 21–6.Google Scholar
Stasheff, SF, Anderson, WW, Clark, S, et al. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 1989; 245: 648–51.Google Scholar
Standley, CA, Irtenkauf, SM, Stewart, L, et al. Magnesium sulfate versus phenytoin for seizure prevention in amygdala kindled rats. Am J Obstet Gynecol 1994; 171: 948–51.Google Scholar
Mason, BA, Standley, CA, Irtenkauf, SM, et al. Magnesium is more efficacious than phenytoin in reducing N-methyl-d-aspartate seizures in rats. Am J Obstet Gynecol 1994; 171: 9991002.Google Scholar
Duley, L, Gülmezoglu, AM, Henderson-Smart, DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003; (3): CD000025.Google Scholar
Lucas, MJ, Leveno, KJ, Cunningham, FG. A comparision of mangesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201–5.Google Scholar
Henderson, JT, Whitlock, EP, O’Connor, E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 160: 695703.Google Scholar
Magee, LA, Ornstein, MP, von Dadelszen, P. Management of hypertension in pregnancy. BMJ 1999; 318: 1332–6.Google Scholar
Harden, CL, Hopp, J, Ting, TY, et al. Practice parameter update: management issues for women with epilepsy: focus on pregnancy (an evidence-based review): obstetric complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73: 126–32.Google Scholar
Cook, SD, Troiano, R, Bansil, S, et al. Multiple sclerosis and pregnancy. In Devinski, O, Hainline, B (eds), Neurologic Complications of Pregnancy. New York, NY: Raven, 1993, pp. 8395.Google Scholar
Yerby, MS, Devinsky, O. Epilepsy and pregnancy. Adv Neurol 1994; 64: 4564.Google Scholar
Schmidt, D, Conyen, R, Avanzini, GM, et al. Change of seizure frequency in pregnancy epileptic women. J Neurol Neurosurg Psychiatry 1983; 46: 751–5.Google Scholar
Delgado-Escueta, AV, Jantz, D. Consensus guidelines: preconception counseling, management, and care of the pregnant women with epilepsy. Neurology 1992; 42: 149–60.Google Scholar
Yerby, M, Freil, PN, McCormick, KB, et al. Pharmacokinetics of anticonvulsants in pregnancy: alteration in plasma protein binding. Epilepsy Res 1990; 5: 223–8.Google Scholar
Perruca, E, Crema, A. Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet 1982; 7: 336–52.Google Scholar
Nelson, KB, Ellenberg, JH. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children. Neurology 1982; 32: 1247–54.Google Scholar
Samren, EB, van Duijn, CM, Koch, S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38: 981–90.Google Scholar
Lindhout, D, Rene, JE, Hoppener, A, et al. Teratogenicity of antiephileptic drug combinations with special emphasis on epoxidation of carbamazepine. Epilepsia 1984; 25: 7783.Google Scholar
Hanson, JW, Smith, DW. The fetal hydantoin syndrome. J Pediatr 1975; 87: 285–90.Google Scholar
Rudd, NL, Freedom, RM. A possible primidone embryopathy. J Pediat 1979; 94: 835–7.Google Scholar
Jones, KL, Lacro, RV, Johnson, KA, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320: 1661–6.Google Scholar
Buehler, BA, Delimont, D, van Waes, M, et al. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990; 322: 1567–72.Google Scholar
Gaily, E, Granstorm, ML, Hiilesmaa, V, et al. Minor anomalies in offspring of eplileptic mothers. J Pediat 1988; 112: 520–9.Google Scholar
Lindhout, D, Omzigt, JGC, Cornel, MC. Spectrum of neural tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992; 42 (Suppl 5): 111–18.Google Scholar
Meador, KJ, Baker, GA, Browning, N, et al. Congitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360: 1597–605.Google Scholar
Vert, P, Deblay, MF. Hemorrhagic disorders in infants of epileptic mothers. In Janz, D, Richens, A, et al. (eds), Epilepsy, Pregnancy and the Child. New York: Raven, 1982.Google Scholar
Chong, DJ, Bazil, CW. Update on anticonvulsant drugs. Curr Neurol Neurosci Rep 2010; 10: 308–18.Google Scholar
Longo, B, Forinash, AB, Murphy, JA. Levetiracetam use in pregnancy. Ann Pharmacother 2009; 43: 1692–5.Google Scholar
Chen, P, Lin, JJ, Lu, CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011; 364: 1126–33.Google Scholar
Leckband, SG, Kelsoe, JR, Dunnenberg, HM, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. Clin Pharmacol Ther 2013; 94: 324–8.Google Scholar
Crawford, P, Appleton, R, Betts, T, et al. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure 2000; 8: 201–17.Google Scholar
Hixson, JD. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol 2010; 12: 434–42.Google Scholar
Borthen, I, Eide, MG, Velby, G, Daltveit, AK, Gilhus, NE. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG 2009; 116: 1736–42.Google Scholar
Pennell, PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003; 61: S35–42.Google Scholar
Verrotti, A, D’Egidio, C, Agostinelli, S, Verrotti, C, Pavone, P. Diagnosis and management of catamenial seizures: a review. Int J Womens Health 2012; 4: 535–41.Google Scholar
Donaldson, JO. Neurologic emergencies in pregnancy. Obstet Gynecol Clin North Am 1991; 18: 199211.Google Scholar
Grear, KE, Bushnell, CD. Stroke and pregnancy: clinical presentation, evaluation, treatment, and epidemiology. Clin Obstet Gynecol 2013; 56: 350–9.Google Scholar
James, AH, Bushnell, CD, Jamison, MG, Myers, ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509–16.Google Scholar
Ji, R, Schwamm, LH, Pervez, MA, Singhal, AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013: 70: 51–7.Google Scholar
Wiebers, D, Mokri, B. Internal carotid artery dissection after childbirth. Stroke 1985; 16: 956–9.Google Scholar
Hauenstein, E, Frank, H, Bauer, JS, Schneider, KT, Fischer, T. Takayasu’s arteritis in pregnancy: review of literature and discussion. J Perinat Med 2010; 38: 5562.Google Scholar
Tate, J, Bushnell, C. Pregnancy and stroke risk in women. Womens Health (Lond Engl) 2011; 7: 363–74.Google Scholar
Del Zotto, E, Giossi, A, Volonghi, I, Costa, P, Padovani, A, Pezzini, A. Ischemic stroke during pregnancy and puerperium. Stroke Res Treat 2011; 2011: 606780. doi: 10.4061/2011/606780.Google Scholar
Ezra, Y, Kidron, D, Beyth, Y. Fibromuscular dysplasia of the carotid arteries complicating pregnancy. Obstet Gynecol 1989; 73: 840–3.Google Scholar
Fletcher, A, Alkjaersig, N, Burstein, R. The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function. Am J Obstet Gynecol 1979; 134: 743–51.Google Scholar
Donaldson, JO. Thrombophilic coagulapathies and pregnancy-associated cerebrovascular disease. Curr Obstet Gynaecol 1991; 1: 186–90.Google Scholar
Lockwood, CJ. Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 2006; 49: 836–43.Google Scholar
Boketwa, MI, Bremme, K, Blomback, M. Arg 506-gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996; 92: 473–8.Google Scholar
Suppiej, A, Franzoi, M, Gentilomo, C, et al. High prevalence of inherited thrombophilia in “presumed peri-neonatal” ischemic stroke. Eur J Haematol 2008; 80: 71–5.Google Scholar
Egerman, RS, Sibai, BM. Imitators of preeclampsia and eclampsia. Clin Obstet Gynecol 1999; 42: 551–62.Google Scholar
Levine, SR, Brust, JCM, Futrel, N, et al. Cerebrovascular complication of the use of the “crack” forms of alkaloidal cocaine. N Engl J Med 1990; 323: 699704.Google Scholar
King, TA, Perlman, JM, Laptook, AR, et al. Neurologic manifestations of in utero cocaine exposure in near-term and term infants. Pediatrics 1995; 96: 259–64.Google Scholar
Galli, M, Barbui, T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol J 2003; 4: 180–6.Google Scholar
Levine, SR, Welch, KM. Antiphospholipid antibodies. Ann Neurol 1989; 26: 386–9.Google Scholar
Branch, DW. Antiphospholipid antibodies and pregnancy: maternal implications. Semin Perinatol 1990; 14: 139–46.Google Scholar
Triplett, DA. Antiphospholipid protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 131.Google Scholar
Fischer-Betz, R, Specker, C, Brinks, R, Schneider, M. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. Lupus 2012; 21: 1183–9.Google Scholar
Shapiro, SS. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 1995; 47: 533–53.Google Scholar
Levine, SR, Brey, RL, Sawaya, KL, et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995; 38: 119–24.Google Scholar
Levine, SR, Salowich-Palm, L, Sawaya, KL, et al. IgG anticardiolipin antibody titer > 40 gpl and the risk of subsequent thrombo-occlusive events and death: a prospective cohort study. Stroke 1997; 28: 1660–4.Google Scholar
Grotta, J, Manner, C, Pettigrew, L, et al. Red blood cell disorders and stroke. Stroke 1986; 17: 811–17.Google Scholar
Hodgman, MT, Pessin, MS, Homans, DC, et al. Cerebral embolism as the initial manifestation of peripartum cardiomyopathy. Neurology 1982; 32: 668–71.Google Scholar
Connor, RCR, Adams, JH. Importance of cardiomyopathy and cerebral ischemia in the diagnosis of fatal coma in pregnancy. J Clin Pathol 1996; 19: 244–9.Google Scholar
Barnett, HJM, Boughner, DR, Taylor, DW. Further evidence relating mitral valve prolapse to cerebral ischemic events. N Engl J Med 1980; 302: 139–44.Google Scholar
Levy, D, Savage, D. Prevalance and clinical features of mitral valve prolapse. Am Heart J 1987; 113: 12811290.Google Scholar
Bartz, PJ, Cetta, F, Cabalka, AK, et al. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc 2006; 81: 615–18.Google Scholar
Roberts, N, Ross, D, Flint, SK, Arya, R, Blott, M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. BJOG 2001; 108: 327–9.Google Scholar
Vink, R, Van Den Brink, RB, Levi, M. Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillation. Hematology 2004; 9: 19.Google Scholar
Kebed, KY, Bishu, K, Al Adham, RI, et al. Pregnancy and postpartum infective endocarditis: a systematic review. Mayo Clin Proc 2014; 89: 1143–52.Google Scholar
Kang, AH, Graves, CR. Libman-Sacks endocarditis in a pregnant women with acute respiratory distress syndrome. Obstet Gynecol 1999; 93: 819–21.Google Scholar
Helms, AK, Drogan, O, Kittner, SJ. First trimester stroke prophylaxis in pregnant women with a history of stroke. Stroke 2009; 40: 1158–61.Google Scholar
Bates, SM, Greer, IA, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e691S–736S. doi: 10.1378/chest.11-2300.Google Scholar
Fuller, KP, Turner, G, Polavarapu, S, Prabulos, AM. Guidelines for use of anticoagulation in pregnancy. Clin Lab Med 2013; 33: 343–56.Google Scholar
Stein, PD, Hull, RD, Matta, F, Yaekoub, AY, Liang, J. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med 2009; 122: 919–30.Google Scholar
Alban, S. Adverse effects of heparin. Handb Exp Pharmacol 2012; (207): 211–63.Google Scholar
Kher, A, Bauersachs, R, Nielsen, JD. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Thromb Haemost 2007; 97: 505–13.Google Scholar
Santoro, R, Iannaccaro, P, Prejano, S, Muleo, G. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy. Blood Coagul Fibrinolysis 2009; 20: 240–3.Google Scholar
Witlin, AG, Mabie, WC, Sibai, BM. Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 1997; 176: 182–8.Google Scholar
Davis, SM, Donnan, GA. 4.5 hours: the new time window for tissue plasminogen activator in stroke. Stroke 2009; 40: 2266–7.Google Scholar
Li, Y, Margraf, J, Kluck, B, Jenny, D, Castaldo, J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review. Neurologist 2012; 18: 44–8.Google Scholar
Murugappan, A, Coplin, WM, Al-Sadat, AN, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 2006; 66: 768–70.Google Scholar
Jeng, JS, Tang, SC, Yip, PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis 2004; 18: 290–5.Google Scholar
Srinivasan, K. Cerebral venous and arterial thrombosis in pregnancy and puerperium: a study of 135 patients. Angiology 1983; 34: 731–74.Google Scholar
Razmara, A, Bakhadirov, k, Batra, A, Feske, SK. Cerebrovascular complications of pregnancy and the postpartum period. Curr Cardiol Rep 2014; 16: 532. doi: 10.1007/211886-014-0532-1.Google Scholar
Khan, M, Wasay, M, Menon, B, et al. Pregnancy and puerperium-related strokes in Asian women. J Stroke Cerebrovasc Dis 2013; 22: 1292–8.Google Scholar
Ferro, JM, Canhao, P, Stam, J, Bousser, MG, Barinagarrementeria, F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 34: 664–70.Google Scholar
Klai, S, Fekih-Mrissa, N, Mrissa, R, Rachdi, R, Gritli, N. Maternal cerebral venous thrombosis, uncommon but serious disorder, pathologic predictors and contribution of prothrombotic abnormalities. Blood Coagul Fibrinolysis 2013; 24: 269–72.Google Scholar
Deschiens, MA, Conard, J, Horellou, MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27: 1724–30.Google Scholar
Zuber, M, Toulon, P, Marnet, L, et al. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 1996; 27: 1721–3.Google Scholar
Carhuapoma, JR, Mitsias, P, Levine, SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997; 28: 2363–9.Google Scholar
Provenzale, JM, Loganbill, HA. Dual sinus thrombosis and venous infarction associated with antiphospholipid antibodies: MR findings. J Comput Assist Tomogr 1994; 18: 719–23.Google Scholar
Coutinho, J, de Bruijn, SF, Deveber, G, Stam, J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011; (8): CD002005.Google Scholar
Khan, M, Kamal, AK, Wasay, M. Controversies of treatment modalities for cerebral venous thrombosis. Stroke Res Treat 2010; 2010: 956302.Google Scholar
Coutinho, JM, Majoie, CB, Coert, BA, Stam, J. Decompressive hemicraniectomy in cerebral sinus thrombosis: Consecutive case series and review of the literature. Stroke 2009; 40: 2233–5.Google Scholar
Dias, M, Sekhar, L. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and puerperium. Neurology 1990; 27: 855–66.Google Scholar
Enomoto, H, Goto, H. Moyamoya disease presenting as intracerebral hemorrhage during pregnancy: case report and review of the literature. Neurosurgery 1987; 20: 33–5.Google Scholar
Isla, A, Alvarez, F, Gonzalez, A, et al. Brain tumor and pregnancy. Obstet Gynecol 1997; 89: 19.Google Scholar
Henderson, CE, Torbey, M. Rupture of intracranial aneurysm associated with cocaine use during pregnancy. Am J Perinatol 1988; 5: 142.Google Scholar
Iriye, BK, Asrat, T, Adashek, JA, et al. Intraventricular haemorrhage and maternal brain death associated with antepartum cocaine abuse. Br J Obstet Gynaecol 1995; 102: 68–9.Google Scholar
Maher, LM, Peterson, PL, Dela-Cruz, C. Postpartum intracranical hemorrhage and phenylpropanolamine use. Neurology 1987; 37: 1686.Google Scholar
Barrow, DL, Reisner, A. Natural history of intracranial aneurysms and vascular malformations. Clin Neurosurg 1993; 40: 3.Google Scholar
Wilterdink, JL, Feldman, E. Cerebral hemorrhage. In Devinsky, O, Feldman, E, Hairlire, B (eds), Neurological Complications of Pregnancy. New York, NY: Raven, 1994, pp. 1223.Google Scholar
Forster, DMC, Kunkler, IH, Hartland, P. Risk of cerebral bleeding from arteriovenous malformations in pregnancy: the Sheffield experience. Stereot Funct Neurosurg 1993; 61 (Suppl 1): 20–2.Google Scholar
Bateman, BT, Schumacher, HC, Bushnell, CD, et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 2006; 67: 424–9.Google Scholar
Horton, JC, Chambers, WA, Lynos, SL, et al. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1990; 27: 867–71.Google Scholar
Piotin, M, de Souza Filho, CB, Kothimbakam, R, Moret, J. Endovascular treatment of acutely ruptured intracranial aneurysms in pregnancy. Am J Obstet Gynecol 2001; 185: 1261–2.Google Scholar
Willoughby, JS. Sodium nitroprusside, pregnancy and multiple intracranial aneurysms. Anaesth Intensive Care 1984; 12: 358–60.Google Scholar
Newman, B, Lam, AM. Induced hypotension for clipping of a cerebral aneurysm during pregnancy: a case report and brief review. Anesth Analg 1986; 65: 675–8.Google Scholar
Kassel, NF, Peerless, SJ, Durward, QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11: 337–43.Google Scholar
Kassel, NF, Sasaki, T, Colohan, AR, Nazar, G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562–72.Google Scholar
Guida, M, Altieri, R, Palatucci, V, et al. Aneurysmal subarachnoid haemorrhage in pregnancy: a case series. Transl Med UniSa 2012; 2: 5963.Google Scholar
Stånge, K, Halldin, M. Hypothermia in pregnancy. Anesthesiology 1983; 58: 460–1.Google Scholar
Belfort, MA, Saade, GR, Moise, KJ, et al. Nimodipine in the management of preeclampsia: maternal and fetal effects. Am J Obstet Gynecol 1994; 171: 417–24.Google Scholar
Duscay, CA, Thompson, JS, Wu, AT, Novy, MJ. The effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: Fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 1987; 157: 1482–6.Google Scholar
Van Rossum, J, Wintzen, AR, Endtz, LJ, et al. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double blind control trial. Ann Neurol 1977; 2: 238–42.Google Scholar
Robinson, JL, Hall, CS, Sedzimir, CB. AV malformations, aneurysms and pregnancy. J Neurosurg 1974; 41: 6370.Google Scholar
Mosiewicz, A, Jakiel, G, Janusz, W, Markiewicz, P. Treatment of intracranial aneurysms during pregnancy. Ginekol Pol 2001; 72: 8692.Google Scholar
Parkinson, D, Bachers, G. Arteriovenous malformations: summary of 100 consecutive supratentorial cases. J Neurosurg 1980; 53: 285–99.Google Scholar
Young, DC, Leveno, KJ, Whalley, PS. Induced delivery prior to surgery for ruptured cerebral aneurysm. Obstet Gynecol 1983; 61: 749–52.Google Scholar
Broderick, JP, Brott, T, Tomsick, T, Miller, R, Huster, G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993; 78: 188–91.Google Scholar
Qureshi, AI, Tuhrim, S, Broderick, JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344: 1450–60.Google Scholar
Hemphill, JC, Greenberg, SM, Anderson, CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46: 2032–60.Google Scholar
Zhu, XL, Chan, MS, Poon, WS. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 1997; 28: 1406–9.Google Scholar
Flibotte, JJ, Hagan, N, O’Donnell, J, Greenberg, SM, Rosand, J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63: 1059–64.Google Scholar
Lee, SB, Manno, EM, Layton, KF, Wijdicks, EF. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 2006; 67: 1272–4.Google Scholar
Diringer, MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 1993; 21: 1591–603.Google Scholar
Bhardwaj, A, Ulatowski, JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004; 10: 126–31.Google Scholar
Misra, UK, Kalita, J, Ranjan, P, Mandal, SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci 2005; 234: 41–5.Google Scholar
Dereeper, E, Berre, J, Vandesteene, A, Lefranc, F, Vincent, JL. Barbiturate coma for intracranial hypertension: clinical observations. J Crit Care 2002; 17: 5862.Google Scholar
Kang, TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002; 36: 1453–6.Google Scholar
Steiner, T, Ringleb, P, Hacke, W. Treatment options for large hemispheric stroke. Neurology 2001; 57 (5, Suppl 2): S61–8.Google Scholar
Poungvarin, N, Bhoopat, W, Viriyavejakul, A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987; 316: 1229–33.Google Scholar
Aegidius, K, Zwart, JA, Hagen, K, Stovner, L. The effect of pregnancy and parity on headache prevalence: the Head-HUNT study. Headache 2009; 49: 851–9.Google Scholar
Fox, MW, Harms, RW, Davis, DH. Selected neurologic complications of pregnancy. Mayo Clin Proc 1990; 65: 1595–618.Google Scholar
Sances, G, Granella, F, Nappi, RE, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23: 197205.Google Scholar
Kvisvik, EV, Stovner, LJ, Helde, G, Bovim, G, Linde, M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 2011; 12: 443–51.Google Scholar
Digre, KB. Headaches during pregnancy. Clin Obstet Gynecol 2013; 56: 317–29.Google Scholar
Contag, SA, Bushnell, C. Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol 2010; 22: 437–45.Google Scholar
Macgregor, EA. Headache in pregnancy. Continuum (Minneap Minn) 2014; 20 (1 Neurology of Pregnancy): 128–47.Google Scholar
Bellissima, V, Ververs, TF, Visser, GH, Gazzolo, D. Selective serotonin reuptake inhibitors in pregnancy. Curr Med Chem 2012; 19: 4554–61.Google Scholar
Seebacher, J, Ribeiro, V, LeGillou, JL, et al. Epidural blood patch in the treatment of post dural puncture headache: a double blind study. Headache 1989; 29: 630–2.Google Scholar
Biousse, V, Bruce, BB, Newman, NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2012; 83: 488–94.Google Scholar
Kesler, A, Kupferminc, M. Idiopathic intracranial hypertension and pregnancy. Clin Obstet Gynecol 2013; 56: 389–96.Google Scholar
Bradley, NK, Liakos, AM, McAllister, JP, et al. Maternal shunt dependency: implications for obstetric care, neurosurgical management, and pregnancy outcomes and a review of selected literature. Neurosurgery 1998; 43: 448–60.Google Scholar
Wisoff, JH, Kartzert, KJ, Handwerker, SM. Pregnancy in patients with cerebrospinal fluid shunts: report of a series and review of the literature. Neurosurgery 1991; 29: 827–31.Google Scholar
Cusimano, MD, Meffe, FM, Gentili, F, Semer, M. Ventriculoperitoneal shunt malfunction during pregnancy. Neurosurgery 1990; 27: 969–71.Google Scholar
Houston, CS, Clein, LJ. Ventriculoperitoneal shunt malfunction in a pregnant patient with meningomyelocele. Can Med Assoc J 1989; 141: 701–2.Google Scholar
Li, G, Dutta, S. Perioperative management of ventriculoperitoneal shunts during abdominal surgery. Surg Neurol 2008; 70: 492–5.Google Scholar
Baker, ER, Cardenas, DD, Benedetti, TJ. Risks associated with pregnancy in spinal cord injured women. Obstet Gynecol 1992; 80: 425–8.Google Scholar
American College of Obstetricians and Gynecologists. Obstetric Management of Patients with Spinal Cord Injuries. ACOG Committee Opinion 275. Washington, DC: ACOG, 2002.Google Scholar
Vrabec, JT, Isaacson, B, Van Hook, JW. Bell’s palsy and pregnancy. Otolaryngol Head Neck Surg 2007; 137: 858–61.Google Scholar
Voitk, AJ, Mueller, JC, Farlinger, DE, Johnston, RU. Carpal tunnel syndrome in pregnancy. Can Med Assoc J 1983; 128: 277–81.Google Scholar
Wand, JS. Carpal tunnel syndrome in pregnancy and lactation. J Hand Surg Br 1990; 15: 93–4.Google Scholar
Snell, NJ, Coysh, HL, Snell, BJ. Carpal tunnel syndrome presenting in the puerperium. Practitioner 1980; 224: 191–3.Google Scholar
Van Diver, T, Camann, W. Meralgia paresthetica in the parturient. Int J Obstet Anesth 1995; 4: 109–12.Google Scholar
Fast, A, Shapiro, D, Ducommun, EJ, et al. Low-back pain in pregnancy. Spine 1987; 12: 368–71.Google Scholar
LaBan, MM, Perrin, JCS, Latimer, FR. Pregnancy and the herniated lumbar disc. Arch Phys Med Rehabil 1983; 64: 319–21.Google Scholar
Wong, CA, Scavone, BM, Dugan, S, et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003; 101: 279–88.Google Scholar
Weinreb, JC, Wolbarsht, LB, Cohen, JM, Brown, CE, Maravilla, KR. Prevalence of lumbosacral intervertebral disc abnormalities on MR images in pregnant and asymptomatic women. Radiology 1989; 170: 125–8.Google Scholar
Roy, S, Levine, AB, Herbison, GJ, Jacobs, SR. Intraoperative positioning during cesarean as a cause of sciatic neuropathy. Obstet Gynecol 2002; 99: 652–3.Google Scholar
Rodin, A, Ferner, R, Russell, R. Guillain–Barré syndrome in pregnancy and puerperium. J Obstet Gynecol 1988; 9: 3942.Google Scholar
Chan, LY, Tsui, MH, Leung, TN. Guillain–Barré syndrome in pregnancy. Acta Obstet Gynecol Scand 2004; 83: 319–25.Google Scholar
Yamada, H, Noro, N, Kato, EH, et al. Massive intravenous immunoglobulin treatment in pregnancy complicated by Guillain–Barré syndrome. Eur J Obstet Gynecol Reprod Biol 2001; 97: 101104.Google Scholar
Watson, WJ, Katz, VL, Bowes, WA. Plasmapheresis during pregnancy. Obstet Gynecol 1990; 76: 451–7.Google Scholar
van der Merché, FGA, Schmitz, PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain–Barré syndrome. Dutch Guillain–Barré Study Group. N Engl J Med 1992; 326: 1123–9.Google Scholar
Dyck, PJ, Prneas, J, Pollard, J. Chronic inflammatory demyelinating polyradiculaneuropathy. In Dyck, PJ, Griffin, JW, et al. (eds), Peripheral Neuropathy. Philadelphia, PA: Saunders, 1993, pp. 1498–517.Google Scholar
Gold, R, Stangel, M, Dalakas, MC. Drug insight: the use of intravenous immunoglobulin in neurology – therapeutic considerations and practical issues. Nat Clin Pract Neurol 2007; 3: 3644.Google Scholar
Rudnik-Schoneborn, S, Zerres, K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004; 114: 4453.Google Scholar
Jaffe, R, Mock, M, Abramowitz, J, et al. Myotonic dystrophy and pregnancy: a review. Obstet Gynecol Surv 1986; 41: 272–8.Google Scholar
Hughes, RG, Lyall, EGH, Liston, WA. Obstetric and neonatal complications of myotonic dystrophy. J Obstet Gynaecol 1991; 11: 191–3.Google Scholar
Fall, LH, Young, WW, Power, JA, et al. Severe congestive heart failure and cardiomyopathy as a complication of myotonic dystrophy in pregnancy. Obstet Gynecol 1990; 76: 481–5.Google Scholar
Moorman, J, Coleman, R, Packer, D, et al. Cardiac involvement in myotonic dystrophy. Medicine (Baltimore) 1985; 64: 371–87.Google Scholar
Jaffe, R, Mock, M, Abramowitz, J, et al. Myotonic dystrophy and pregnancy: a review. Obstet Gynecol Surv 1986; 41: 272–8.Google Scholar
Grrella, P, Santarossa, C, Pennazzato, S, et al. Pregnancy, labour and delivery in myotonic dystrophy. Basic Appl Myol 1997; 7: 351–5.Google Scholar
Rutherford, MA, Heckmatt, JZ, Dubowitz, V. Congenital myotonic dystrophy: respiratory function at birth determines survival. Arch Dis Child 1989; 64: 191–5.Google Scholar
Reardon, W, Newcombe, R, Fenton, I, Sibert, J, Harper, PS. The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child 1993; 68: 177–81.Google Scholar
Harper, PS. Congenital myotonic dystrophy in Britain: genetic basis. Arch Dis Child 1975; 50: 514–21.Google Scholar
Bowater, RP, Wells, RD. The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders. Prog Nucleic Acid Res Mol Biol 2001; 66: 159202.Google Scholar
Blumgart, CH, Hughes, DG, Redfern, N. Obstetric anaesthesia in dystrophia myotonica. Anaesthesia 1990; 45: 26–9.Google Scholar
Polman, CH, Reingold, SC, Banwell, B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 2011; 69: 292302.Google Scholar
Finkelsztejn, A, Brooks, JB, Paschoal, FM, Fragoso, YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011; 118: 790–7.Google Scholar
Runmarker, B, Anderson, O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118: 253–61.Google Scholar
Vukusic, S, Hutchinson, M, Hours, M, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127: 1353–60.Google Scholar
Langer-Gould, A, Beaber, BE. Effects of pregnancy and breast feeding on the multiple sclerosis disease course. Clin Immunol 2013; 149: 244–50.Google Scholar
Worthington, J, Jones, R, Crawford, M, et al. Pregnancy and multiple sclerosis: a 3 year prospective study. J Neurol 1994; 241: 228–33.Google Scholar
Houtchens, MK. Pregnancy and multiple sclerosis. Semin Neurol 2007; 27: 434–41.Google Scholar
Hellwig, K, Correale, J. Artificial reproductive techniques in multiple sclerosis. Clin Immunol 2013; 149; 219–24.Google Scholar
Sadovnick, AD. Empiric recurrence risks for use in the genetic counselling of multiple sclerosis patients. Am J Med Genet 1984; 17: 713–14.Google Scholar
Lu, E, Wang, BW, Guimond, C, et al. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology 2012; 79: 1130–5.Google Scholar
Lu, E, Wang, BW, Alwan, S, et al. A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis. CNS Drugs 2014; 28: 8994.Google Scholar
Ferrero, S, Pretta, S, Ragni, N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 15: 3-9.Google Scholar
Carroll, RS, Zhang, J, Black, PM. Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol 1999; 42: 109–16.Google Scholar
Kasper, EM, Hess, PE, Silasi, M, et al. A pregnant female with a large intracranial mass: reviewing the evidence to obtain management guidelines for intracranial meningiomas during pregnancy. Surg Neurol Int 2010; 1: 95 doi: 10.4103/2152-7806.74242.Google Scholar
Verheecke, M, Halaska, MJ, Lok, CA, et al. Primary brain tumours, meningiomas and grain metastases in pregnancy: report on 27 cases and review of literature. Eur J Cancer 2014; 50: 1462–71.Google Scholar
Dildy, GA, Moise, KJ, Carpenter, RJ, Klima, T. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv 1989; 44: 535–40.Google Scholar
Weed, JC, Hunter, VJ. Diagnosis and management of brain metastasis from gestational trophoblastic disease. Oncology 1991; 5: 4850.Google Scholar
Weed, JC, Wood, KT, Hammond, CB. Choriocarcinoma metastatic to the brain: therapy and prognosis. Semin Oncol 1982; 9: 208–12.Google Scholar
Nakagawa, Y, Tashiro, K, Isu, T, Tsuru, M. Occlusion of cerebral artery due to metastasis of chorioepithelioma. J Neurosurg 1979; 51: 247–50.Google Scholar
Huang, CY, Chen, CA, Hsieh, CY, Cheng, WF. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review. Int J Gynecol Cancer 2007; 17: 1166–71.Google Scholar
Gonzalez, JG, Elizonda, G, Saldivar, D, et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85: 217–20.Google Scholar
Molitch, ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab 2011; 25: 885–96.Google Scholar
Kulkarni, MV, Lee, KF, McArdle, CB, Yeakley, JW, Haar, FL. 1.5-T NR imaging of pituitary microadenomas: technical consideration and CT correlation. AJNR Am J Neuroradiol 1988; 9: 511.Google Scholar
Klibanski, A. Prolactinomas. N Engl J Med 2010; 362: 1219–26.Google Scholar
Auriemma, RS, Perone, Y, Di Sarno, A, et al. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 2013; 98: 372–9.Google Scholar
Kranick, SM, Mowry, EM, Colcher, A, Horn, S, Golbe, LI. Movement disorders and pregnancy: a review of the literature. Mov Disord 2010; 25: 665–71.Google Scholar
Bordelon, YM, Smith, M. Movement disorders in pregnancy. Semin Neurol 2007; 27: 467–75.Google Scholar
Golbe, LI. Pregnancy and movement disorders. Neurol Clin 1994; 12: 497508.Google Scholar
Cardoso, F. Chorea gravidarum. Arch Neurol 2002; 59: 868–70.Google Scholar
Caviness, JN, Muenter, M. An unusual cause of recurrent chorea. Mov Disord 1991; 6: 355–7.Google Scholar
Lorincz, MT. Neurologic Wilson’s disease. Ann NY Acad Sci 2010; 1184: 173–87.Google Scholar
Dreifuss, FE, McKinney, WM. Wilson’s disease (hepatolenticular degeneration) and pregnancy. JAMA 1966; 195: 960–2.Google Scholar
Scheinberg, IH, Sternlieb, I. Pregnancy in penicillamine treated patients with Wilson’s disease. N Engl J Med 1975; 293: 1300–2.Google Scholar
Mjolneod, OK, Dommerud, SA, Rasmussen, K, Gjeruldsen, ST. Congeinital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet 1971; 1: 673–5.Google Scholar
Malik, A, Khawaja, A, Sheikh, L. Wilson’s disease in pregnancy: case series and review of literature. BMC Res Notes 2013; 6: 421. doi: 10.1186/1756-0500-6-421.Google Scholar
Brewer, GJ, Johnson, VD, Dick, RD, Fink, JK, Kluin, KJ. Treatment of Wilson’s disease with zinc, SVII: treatment during pregnancy. Hepatology 2000; 31: 364–70.Google Scholar
Yeh, P, Walters, AS, Tsuang, JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2012: 16: 9871007.Google Scholar
Picchietti, DL, Hensley, JG, Bainbridge, JL, et al.; International Restless Legs Syndrome Study Group (IRLSSG). Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev 2015; 22: 6477. http://dx.doi.org/10.1016/j.smrrv.2014.10.009 (accessed March 2017).Google Scholar
Srivanitchapoom, P, Pandey, S, Hallett, M. Restless legs syndrome and pregnancy: a review. Parkinsonism Relat Disord 2014; 20: 716–22.Google Scholar
Caine, SM, Kumar, A. Young onset Parkinson’s disease: practical management of medical issues. Parkinsonism Relat Disord 2008; 14: 132–42.Google Scholar
Shulman, LM, Minagar, A, Weiner, WJ. The effect of pregnancy in Parkinson’s disease. Mov Disord 2000; 15: 132–5.Google Scholar
Was, JR, Pinette, MG, Blackstone, J, Cartin, A. Brain abscess complicating pregnancy. Obstet Gynecol Surv 2004; 59: 207–13.Google Scholar

References

Renal Association. Acute kidney injury: guidelines. http://www.renal.org/guidelines/modules/acute-kidney-injury (accessed March 2017).Google Scholar
Gurrieri, C, Garovic, VD, Gullo, A, et al. Kidney injury during pregnancy: associated comorbid conditions and outcomes. Arch Gynecol Obstet 2012; 286: 567–73.Google Scholar
Bentata, Y, Housni, B, Mimouni, A, Azzouzi, A, Abouqal, R. Acute kidney injury related to pregnancy in developing countries: etiology and risk factors in an intensive care unit. J Nephrol 2012; 25: 764–75.Google Scholar
Acharya, A, Santos, J, Linde, B, Anis, K. Acute kidney injury in pregnancy-current status. Adv Chronic Kidney Dis 2013; 20: 215–22.Google Scholar
Williams, D, Davison, J. Chronic kidney disease in pregnancy. BMJ 2008; 336: 211–15.Google Scholar
Okundaye, I, Abrinko, P, Hou, S. Registry of pregnancy in dialysis patients. Am J Kidney Dis 1998; 31: 766–73.Google Scholar
Brown, JH, Maxwell, AP, McGeown, MG. Outcome of pregnancy following renal transplantation. Ir J Med Sci 1991; 160: 255–6.Google Scholar
Hussein, W, Lafayette, RA. Renal function in normal and disordered pregnancy. Curr Opin Nephrol Hypertens 2014; 23: 4653.Google Scholar
Odutayo, A, Hladunewich, M. Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol 2012; 7: 2073–80.Google Scholar
Higby, K, Suiter, CR, Phelps, JY. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol 1994; 171: 984–9.Google Scholar
Erman, A, van Dyk, DJ, Rabinov, M, Boner, G, Rosenfeld, JB. Urinary albumin excretion in the healthy population. Isr J Med Sci 1990; 26: 389–92.Google Scholar
Hytten, FE, Thomson, AM, Taggart, N. Total body water in normal pregnancy. J Obstet Gynaecol Br Commonw 1966; 73: 553–61.Google Scholar
Davison, JM, Lindheimer, MD. Volume homeostasis and osmoregulation in human pregnancy. Baillieres Clin Endocrinol Metab 1989; 3: 451–72.Google Scholar
Machado, S, Figueiredo, N, Borges, A, et al. Acute kidney injury in pregnancy: a clinical challenge. J Nephrol 2012; 25: 1930.Google Scholar
Ganesan, C, Maynard, SE. Acute kidney injury in pregnancy: the thrombotic microangiopathies. J Nephrol 2011; 24: 554–63.Google Scholar
Silva, GB, Monteiro, FA, Mota, RM, et al. Acute kidney injury requiring dialysis in obstetric patients: a series of 55 cases in Brazil. Arch Gynecol Obstet 2009; 279: 131–7.Google Scholar
Sibai, BM, Ramadan, MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682–7.Google Scholar
Khwaja, A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120: c179–84.Google Scholar
Drakeley, AJ, Le Roux, PA, Anthony, J, Penny, J. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 2002; 186: 253–6.Google Scholar
Smaill, F, Vazquez, JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2015; (8): CD000490.Google Scholar
Widmer, M, Gulmezoglu, AM, Mignini, L, Roganti, A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev 2015; (11): CD000491.Google Scholar
Vazquez, JC, Abalos, E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev 2011; (1): CD002256.Google Scholar
Wing, DA, Fassett, MJ, Getahun, D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014; 210: 219.e1–6.Google Scholar
Hill, JB, Sheffield, JS, McIntire, DD, Wendel, GD. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005; 105: 1823.Google Scholar
Foley, ME, Farquharson, R, Stronge, JM. Is screening for bacteriuria in pregnancy worthwhile? Br Med J 1987; 295: 270.Google Scholar
Jolley, JA, Kim, S, Wing, DA. Acute pyelonephritis and associated complications during pregnancy in 2006 in US hospitals. J Matern Fetal Neonatal Med 2012; 25: 2494–8.Google Scholar
Schneeberger, C, Geerlings, SE, Middleton, P, Crowther, CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev 2015; (7): CD009279.Google Scholar
Lumbiganon, P, Laopaiboon, M, Thinkhamrop, J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol 2010; 22: 95–9.Google Scholar
D’Souza, Z, D’Souza, D. Urinary tract infection during pregnancy: dipstick urinalysis vs. culture and sensitivity. J Obstet Gynaecol 2004; 24: 22–4.Google Scholar
Jolley, JA, Wing, DA. Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs 2010; 70: 1643–55.Google Scholar
Rouse, DJ, Andrews, WW, Goldenberg, RL, Owen, J. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis. Obstet Gynecol 1995; 86: 119–23.Google Scholar
Wing, DA, Rumney, PJ, Preslicka, CW, Chung, JH. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol 2008; 180: 1367–72.Google Scholar
Lenke, RR, VanDorsten, JP, Schifrin, BS. Pyelonephritis in pregnancy: a prospective randomized trial to prevent recurrent disease evaluating suppressive therapy with nitrofurantoin and close surveillance. Am J Obstet Gynecol 1983; 146: 953–7.Google Scholar
Meher, S, Gibbons, N, DasGupta, R. Renal stones in pregnancy. Obstet Med 2014; 7: 103–10.Google Scholar
Semins, MJ, Matlaga, BR. Kidney stones and pregnancy. Adv Chronic Kidney Dis 2013; 20: 260–4.Google Scholar
Ross, AE, Handa, S, Lingeman, JE, Matlaga, BR. Kidney stones during pregnancy: an investigation into stone composition. Urol Res 2008; 36: 99102.Google Scholar
Swartz, MA, Lydon-Rochelle, MT, Simon, D, Wright, JL, Porter, MP. Admission for nephrolithiasis in pregnancy and risk of adverse birth outcomes. Obstet Gynecol 2007; 109: 1099–104.Google Scholar
Rosenberg, E, Sergienko, R, Abu-Ghanem, S, et al. Nephrolithiasis during pregnancy: characteristics, complications, and pregnancy outcome. World J Urol 2011; 29: 743–7.Google Scholar
Tangren JS, Powe CE, Ecker J, et al. Metabolic and hypertensive complications of pregnancy in women with nephrolithiasis. Clin J Am Soc Nephrol 2018; 13: 612–19. doi: 10.2215/CJN.12171017.Google Scholar
Banhidy, F, Acs, N, Puho, EH, Czeizel, AE. Maternal kidney stones during pregnancy and adverse birth outcomes, particularly congenital abnormalities in the offspring. Arch Gynecol Obstet 2007; 275: 481–7.Google Scholar
Butler, EL, Cox, SM, Eberts, EG, Cunningham, FG. Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol 2000; 96: 753–6.Google Scholar
Health Protection Agency, Royal College of Radiologists, College of Radiographers. Protection of Pregnant Patients during Diagnostic Medical Exposures to Ionising Radiation. Didcot: HPA, 2009. http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/meetings/prevalence_survey/imaging_regnant_hpa.pdf (accessed March 2017).Google Scholar
Smith-Bindman, R, Aubin, C, Bailitz, J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med 2014; 371: 1100–10.Google Scholar
Shokeir, AA, Mahran, MR, Adbulmaaboud, M. Renal colic in pregnant women: role of resistive index. Urology 2000; 55: 344–7.Google Scholar
White, WM, Johnson, EB, Zite, NB, et al. Predictive value of current imaging modalities for the detection of urolithiasis during pregnancy: a multicenter, longitudinal study. J Urol 2013; 189: 931–4.Google Scholar
Semins, MJ, Trock, BJ, Matlaga, BR. The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol 2009; 181: 139–43.Google Scholar
Mackay, EV. Pregnancy and renal disease: a ten year survey. Aust N Z J Obstet Gynecol 1963; 3: 21.Google Scholar
Youssouf, S, Hall, M, Lightstone, L, Brunskill, NJ, Carr, S. Pregnancy in a prospective cohort of women with CKD 3-5: maternal outcomes. J Am Soc Nephrol 2011; 22: 16A.Google Scholar
Imbasciati, E, Gregorini, G, Cabiddu, G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 2007; 49: 753–62.Google Scholar
Piccoli, GB, Cabiddu, G, Attini, R, et al. Pregnancy in CKD: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol 2015; 29: 625–42.Google Scholar
Jungers, P, Chauveau, D, Choukroun, G, et al. Pregnancy in women with impaired renal function. Clin Nephrol 1997; 47: 281–8.Google Scholar
Basgul, A, Kavak, ZN, Sezen, D, et al. A rare case of early onset nephrotic syndrome in pregnancy. Clin Exp Obstet Gynecol 2006; 33: 127–8.Google Scholar
Fisher, KA, Ahuja, S, Luger, A, Spargo, BH, Lindheimer, MD. Nephrotic proteinuria with pre-eclampsia. Am J Obstet Gynecol 1977; 129: 643–6.Google Scholar
First, MR, Ooi, BS, Jao, W, Pollak, VE. Pre-eclampsia with the nephrotic syndrome. Kidney Int 1978; 13: 166–77.Google Scholar
Imbasciati, E, Ponticelli, C. Pregnancy and renal disease: predictors for fetal and maternal outcome. Am J Nephrol 1991; 11: 353–62.Google Scholar
Hall, M, Brunskill, NJ. Glomerulonephritis and the nephrotic syndrome in pregnancy. Fetal Matern Med Rev 2010; 21: 163–84.Google Scholar
Pregnancy and renal disease. Lancet 1975; 2: 801–2.Google Scholar
Nevis, IF, Reitsma, A, Dominic, A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 2011; 6: 2587–98.Google Scholar
Franceschini, N, Savitz, DA, Kaufman, JS, Thorp, JM. Maternal urine albumin excretion and pregnancy outcome. Am J Kidney Dis 2005; 45: 1010–18.Google Scholar
Yao, T, Yao, H, Wang, H. Diagnosis and treatment of nephrotic syndrome during pregnancy. Chin Med J (Engl) 1996; 109: 471–3.Google Scholar
Brown, RA, Kemp, GJ, Walkinshaw, SA, Howse, M. Pregnancies complicated by preeclampsia and non-preeclampsia-related nephrotic range proteinuria. Obstet Med 2013; 6: 159–64.Google Scholar
De Castro I, Easterling TR, Bansal N, Jefferson JA. Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications. Kidney Int 2017; 91: 1464–72. doi: 10.1016/j.kint.2016.12.019.Google Scholar
Jones, DC, Hayslett, JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996; 335: 226–32.Google Scholar
Bramham, K, Lightstone, L. Pre-pregnancy counseling for women with chronic kidney disease. J Nephrol 2012; 25: 450–9.Google Scholar
Li, DK, Yang, C, Andrade, S, Tavares, V, Ferber, JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 2011; 343: d5931.Google Scholar
Tabacova, S, Little, R, Tsong, Y, Vega, A, Kimmel, CA. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003; 12: 633–46.Google Scholar
Murawski, IJ, Gupta, IR. Vesicoureteric reflux and renal malformations: a developmental problem. Clin Genet 2006; 69: 105–17.Google Scholar
Mallik, M, Watson, AR. Antenatally detected urinary tract abnormalities: more detection but less action. Pediatr Nephrol 2008; 23: 897904.Google Scholar
Day, C, Hewins, P, Hildebrand, S, et al. The role of renal biopsy in women with kidney disease identified in pregnancy. Nephrol Dial Transplant 2008; 23: 201–6.Google Scholar
Fink, JC, Schwartz, SM, Benedetti, TJ, Stehman-Breen, CO. Increased risk of adverse maternal and infant outcomes among women with renal disease. Paediatr Perinat Epidemiol 1998; 12: 277–87.Google Scholar
Royal College of Obstetricians and Gynaecologists. The Investigation and Management of the Small-for-Gestational-Age Fetus, 2nd edn. Green-top Guideline No. 31. London: RCOG, 2013. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_31.pdf (accessed March 2017).Google Scholar
Valentin, M, Muller, F, Beaujard, MP, et al. First-trimester combined screening for trisomy 21 in women with renal disease. Prenat Diagn 2015; 35: 244–8.Google Scholar
Visintin, C, Mugglestone, MA, Almerie, MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010; 341: c2207.Google Scholar
Mahmoodi, BK, ten Kate, MK, Waanders, F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117: 224–30.Google Scholar
KDIGO. Blood pressure in CKD. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. http://kdigo.org/home/guidelines/blood-pressure-in-ckd (accessed March 2017).Google Scholar
Magee, LA, von Dadelszen, P, Rey, E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015; 372: 407–17.Google Scholar
Piccoli, GB, Attini, R, Vasario, E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 2010; 5: 844–55.Google Scholar
Kamel, H, Navi, BB, Sriram, N, et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014; 370: 1307–15.Google Scholar
Moon, SJ, Park, HS, Kwok, SK, et al. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis. Clin Exp Rheumatol 2013; 31: 31–9.Google Scholar
Park, EJ, Jung, H, Hwang, J, et al. Pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective review of 62 pregnancies at a single tertiary center in South Korea. Int J Rheum Dis 2014; 17: 887–97.Google Scholar
Zhao, C, Zhao, J, Huang, Y, et al. New-onset systemic lupus erythematosus during pregnancy. Clin Rheumatol 2013; 32: 815–22.Google Scholar
Moroni, G, Quaglini, S, Banfi, G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002; 40: 713–20.Google Scholar
Chen, TK, Gelber, AC, Witter, FR, Petri, M, Fine, DM. Renal biopsy in the management of lupus nephritis during pregnancy. Lupus 2015; 24: 147–54.Google Scholar
Borella, E, Lojacono, A, Gatto, M, et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res 2014; 60: 170–6.Google Scholar
Jara, LJ, Medina, G, Cruz-Dominguez, P, et al. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res 2014; 60: 184–92.Google Scholar
Moroni, G, Ponticelli, C. Pregnancy after lupus nephritis. Lupus 2005; 14: 8994.Google Scholar
Kirshon, B, Wasserstrum, N, Willis, R, Herman, GE, McCabe, ER. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 1988; 72: 462–4.Google Scholar
Webster, P, Wardle, A, Bramham, K, et al. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus 2014; 23: 1192–6.Google Scholar
Enns, GM, Roeder, E, Chan, RT, et al. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 1999; 86: 237–41.Google Scholar
Sangle, SR, Lutalo, PM, Davies, RJ, Khamashta, MA, D’Cruz, DP. B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun 2013; 43: 55–9.Google Scholar
Bertsias, GK, Tektonidou, M, Amoura, Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771–82.Google Scholar
Bramham, K, Soh, MC, Nelson-Piercy, C. Pregnancy and renal outcomes in lupus nephritis: an update and guide to management. Lupus 2012; 21: 1271–83.Google Scholar
Damm, JA, Asbjornsdottir, B, Callesen, NF, et al. Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care 2013; 36: 3489–94.Google Scholar
Sato, T, Sugiyama, T, Kurakata, M, et al. Pregnancy outcomes in women with type 1 and type 2 diabetes mellitus in a retrospective multi-institutional study in Japan. Endocr J 2014; 61: 759–64.Google Scholar
Ekbom, P, Damm, P, Feldt-Rasmussen, B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001; 24: 1739–44.Google Scholar
Piccoli, GB, Clari, R, Ghiotto, S, et al. Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. Rev Diabet Stud 2013; 10: 626.Google Scholar
Nielsen, LR, Damm, P, Mathiesen, ER. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009; 32: 3844.Google Scholar
Mathiesen, ER, Ringholm, L, Feldt-Rasmussen, B, Clausen, P, Damm, P. Obstetric nephrology: pregnancy in women with diabetic nephropathy–the role of antihypertensive treatment. Clin J Am Soc Nephrol 2012; 7: 2081–8.Google Scholar
Wu, M, Wang, D, Zand, L, et al. Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study. J Matern Fetal Neonatal Med 2016; 29: 807–12.Google Scholar
Harris, PC, Rossetti, S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2010; 6: 197206.Google Scholar
Vidaeff, AC, Yeomans, ER, Ramin, SM. Pregnancy in women with renal disease. Part I: general principles. Am J Perinatol 2008; 25: 385–97.Google Scholar
Pietrzak, B, Cyganek, A, Jabiry-Zieniewicz, Z, et al. Function of the ovaries in female kidney transplant recipients. Transplant Proc 2006; 38: 180–3.Google Scholar
EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17 (Suppl 4): 50–5.Google Scholar
Armenti, VT, Radomski, JS, Moritz, MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2005: 69–83.Google Scholar
Deshpande, NA, James, NT, Kucirka, LM, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant 2011; 11: 2388–404.Google Scholar
Moon, JI, Park, SG, Cheon, KO, et al. Pregnancy in renal transplant patients. Transplant Proc 2000; 32: 1869–70.Google Scholar
Piccoli GB, Cabiddu G, Attini R, et al. Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis. Transplantation 2017; 101: 2536–44. doi: 10.1097/TP.0000000000001645.Google Scholar
Mohammadi FA, Borg M, Gulyani A, McDonald SP, Jesudason S. Pregnancy outcomes and impact of pregnancy on graft function in women after kidney transplantation. Clin Transplant 2017; 31(10). doi: 10.1111/ctr.13089.Google Scholar
Sibanda, N, Briggs, JD, Davison, JM, Johnson, RJ, Rudge, CJ. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation 2007; 83: 1301–7.Google Scholar
Hebert, MF, Zheng, S, Hays, K, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation 2013; 95: 908–15.Google Scholar
Zheng, S, Easterling, TR, Umans, JG, et al. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit 2012; 34: 660–70.Google Scholar
Camargo, LF, Esteves, AB, Ulisses, LR, Rivelli, GG, Mazzali, M. Urinary tract infection in renal transplant recipients: incidence, risk factors, and impact on graft function. Transplant Proc 2014; 46: 1757–9.Google Scholar
Briggs, JD, Jager, K. The first year of the new ERA-EDTA Registry. Nephrol Dial Transplant 2001; 16: 1130–1.Google Scholar
Shrestha, BM, Throssell, D, McKane, W, Raftery, AT. Injury to a transplanted kidney during caesarean section: a case report. Exp Clin Transplant 2007; 5: 618–20.Google Scholar
Hoeltzenbein, M, Elefant, E, Vial, T, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 2012; 158A: 588–96.Google Scholar
Sifontis, NM, Coscia, LA, Constantinescu, S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006; 82: 1698–702.Google Scholar
Saarikoski, S, Seppala, M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973; 115: 1100–6.Google Scholar
Armenti, VT, Ahlswede, KM, Ahlswede, BA, et al. National Transplantation Pregnancy Registry: outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994; 57: 502–6.Google Scholar
McKay, DB, Josephson, MA. Pregnancy in recipients of solid organs–effects on mother and child. N Engl J Med 2006; 354: 1281–93.Google Scholar
Bar Oz, B, Hackman, R, Einarson, T, Koren, G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71: 1051–5.Google Scholar
Hou, S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999; 33: 235–52.Google Scholar
Park-Wyllie, L, Mazzotta, P, Pastuszak, A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.Google Scholar
Jain, AB, Shapiro, R, Scantlebury, VP, et al. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center’s experience. Transplantation 2004; 77: 897902.Google Scholar
Bramham, K, Chusney, G, Lee, J, Lightstone, L, Nelson-Piercy, C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol 2013; 8: 563–7.Google Scholar
Constantinescu, S, Pai, A, Coscia, LA, et al. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1163–73.Google Scholar
Steenkamp, R, Castledine, C, Feest, T, Fogarty, D. UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses. Nephron Clin Pract 2011; 119 (Suppl 2): c27–52.Google Scholar
Nadeau-Fredette, AC, Hladunewich, M, Hui, D, Keunen, J, Chan, CT. End-stage renal disease and pregnancy. Adv Chronic Kidney Dis 2013; 20: 246–52.Google Scholar
Filocamo, MT, Zanazzi, M, Li Marzi, V, et al. Sexual dysfunction in women during dialysis and after renal transplantation. J Sex Med 2009; 6: 3125–31.Google Scholar
Schwarz, A, Post, KG, Keller, F, Molzahn, M. Value of human chorionic gonadotropin measurements in blood as a pregnancy test in women on maintenance hemodialysis. Nephron 1985; 39: 341–3.Google Scholar
Shahir, AK, Briggs, N, Katsoulis, J, Levidiotis, V. An observational outcomes study from 1966–2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry. Nephrology (Carlton) 2013; 18: 276–84.Google Scholar
Chan, WS, Okun, N, Kjellstrand, CM. Pregnancy in chronic dialysis: a review and analysis of the literature. Int J Artif Organs 1998; 21: 259–68.Google Scholar
Shan, HY, Rana, S, Epstein, FH, et al. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Am J Kidney Dis 2008; 51: 1029–32.Google Scholar
Davison, JM, Nelson-Piercy, C, Kehoe, S, Baker, P. Renal Disease in Pregnancy. London: Royal College of Obstetricians and Gynaecologists, 2008.Google Scholar
Jefferys, A, Wyburn, K, Chow, J, Cleland, B, Hennessy, A. Peritoneal dialysis in pregnancy: a case series. Nephrology (Carlton) 2008; 13: 380–3.Google Scholar
Okundaye, I, Hou, S. Management of pregnancy in women undergoing continuous ambulatory peritoneal dialysis. Adv Perit Dial 1996; 12: 151–5.Google Scholar
Hladunewich, M, Hercz, AE, Keunen, J, Chan, C, Pierratos, A. Pregnancy in end stage renal disease. Semin Dial 2011; 24: 634–9.Google Scholar
Hladunewich, MA, Hou, S, Odutayo, A, et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol 2014; 25: 1103–9.Google Scholar
Registration Committee of the European Dialysis and Transplant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol 1980; 87: 839–45.Google Scholar
Romao, JE, Luders, C, Kahhale, S, et al. Pregnancy in women on chronic dialysis. A single-center experience with 17 cases. Nephron 1998; 78: 416–22.Google Scholar
Jesudason, S, Grace, BS, McDonald, SP. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol 2014; 9: 143–9.Google Scholar
Barua, M, Hladunewich, M, Keunen, J, Pierratos, A, McFarlane, P, Sood, M, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008; 3: 392–6.Google Scholar
FHN Trial Group; Chertow, GM, Levin, NW, Beck, GJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363: 2287–300.Google Scholar
Chou, CY, Ting, IW, Hsieh, FJ, Lee, CN. Haemoperitoneum in a pregnant woman with peritoneal dialysis. Nephrol Dial Transplant 2006; 21: 1454–5.Google Scholar
Lew, SQ. Persistent hemoperitoneum in a pregnant patient receiving peritoneal dialysis. Perit Dial Int 2006; 26: 108–10.Google Scholar

Further Reading

Betz, RR, Bunnell, WP, Lombrecht-Mulier, E, et al. Scoliosis and pregnancy. J Bone Joint Surg Am 1987; 69: 90–6.Google Scholar
Borg-Stein, J, Dugan, SA, Gruber, J. Musculoskeletal aspects of pregnancy. Am J Phys Med Rehabil 2005; 84: 180–92.Google Scholar
Danielsson, AJ, Nachemson, AL. Childbearing, curve progression, and sexual function in women 22 years after treatment for adolescent idiopathic scoliosis: a case–control study. Spine 2001; 26: 1449–56.Google Scholar
Goldsmith, LT, Weiss, G, Steinetz, BG. Relaxin and its role in pregnancy. Endocrinol Metab Clin North Am 1995; 24: 171–86.Google Scholar
Grahame, R, Bird, HA, Child, A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 2000; 27: 1777–9.Google Scholar
Mens, JM, Pool-Goudzwaard, A, Stam, HJ. Mobility of the pelvic joints in pregnancy-related lumbopelvic pain: a systematic review. Obstet Gynecol Surv 2009; 64: 200–8.Google Scholar
Sierra, RJ, Trousdale, RT, Cabanela, ME. Pregnancy and childbirth after total hip arthroplasty. J Bone Joint Surg Br 2005; 87: 21–4.Google Scholar
Smith, MW, Marcus, PS, Wurtz, LD. Orthopedic issues in pregnancy. Obstet Gynecol Surv 2008; 63: 103–11.Google Scholar
Wu, WH, Meijer, OG, Uegaki, K, et al. Pregnancy-related pelvic girdle pain (PPP), I: Terminology, clinical presentation, and prevalence. Eur Spine J 2004; 13: 575–89.Google Scholar
Wurdinger, S, Humbsch, K, Reichenbach, JR, et al. MRI of the pelvic ring joints postpartum: normal and pathologic findings. J Magn Reson Imaging 2002; 15: 324–9.Google Scholar

References

Stapleton, DB, MacLennan, AH, Kristiansson, P. The prevalence of recalled low back pain during and after pregnancy: a South Australian population survey. Aust N Z J Obstet Gynaecol 2002; 42: 482–5.Google Scholar
Pennick, VE, Young, G. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database Syst Rev 2007; (2): CD001139.Google Scholar
Wu, WH, Meijer, OG, Uegaki, K, et al. Pregnancy-related pelvic girdle pain (PPP), I: Terminology, clinical presentation, and prevalence. Eur Spine J 2004; 13: 575–89.Google Scholar
Walde, J. Obstetrical and gynecological back and pelvic pains, especially those contracted during pregnancy. Acta Obstet Gynecol Scand Suppl 1962; 41 (Suppl 2): 1153.Google Scholar
Brynnildsen, J, Hansson, A, Persson, A, Hammar, M. Follow-up of patients with low back pain during pregnancy. Obstet Gynecol 1998; 91: 182–6.Google Scholar
Berg, G, Hammar, M, Möller-Nielsen, J, Lindén, U, Thorblad, J. Low back pain during pregnancy. Obstet Gynecol 1988; 71: 71–5.Google Scholar
Fast, A, Weiss, L, Parikh, S, Hertz, G. Night backache in pregnancy: hypothetical pathophysiological mechanisms. Am J Phys Med Rehabil 1989; 68: 227–9.Google Scholar
Albert, HB, Godskesen, M, Westergaard, JG. Incidence of four syndromes of pregnancy-related pelvic joint pain. Spine 2002; 27: 2831–4.Google Scholar
Bhardwaj, A, Nagandla, K. Musculoskeletal symptoms and orthopaedic complications in pregnancy: pathophysiology, diagnostic approaches and modern management. Postgrad Med J 2014; 90: 450–60.Google Scholar
Goldsmith, LT, Weiss, G, Steinetz, BG. Relaxin and its role in pregnancy. Endocrinol Metab Clin North Am 1995; 24: 171–86.Google Scholar
Kristiansson, P, Svardsudd, K, von Schoultz, B. Serum relaxin, symphyseal pain, and back pain during pregnancy. Am J Obstet Gynecol 1996; 175: 1342–7.Google Scholar
Mens, JM, Pool-Goudzwaard, A, Stam, HJ. Mobility of the pelvic joints in pregnancy-related lumbopelvic pain: a systematic review. Obstet Gynecol Surv 2009; 64: 200–8.Google Scholar
Björklund, K, Bergström, S, Nordström, ML, Ulmsten, U. Symphyseal distention in relation to serum relaxin levels and pelvic pain in pregnancy. Acta Obstet Gynecol Scand 2000; 79: 269–75.Google Scholar
Wong, CA, Scavone, BM, Dugan, S, et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003; 101: 279–88.Google Scholar
Bushnell, LF. Postural backache of the gynecic patient. Clin Orthop 1955; 5: 164–8.Google Scholar
Ostgaard, HC, Anderson, GBJ, Schultz, AB, et al. Influence of some biomechanical factors on low-back pain in pregnancy. Spine 1993; 18: 61–5.Google Scholar
Bullock, JE, Jull, GA, Bullock, M. The relationship of low back pain to postural changes during pregnancy. Aust J Physiother 1987; 33: 1017.Google Scholar
Rodacki, CL, Fowler, NE, Rodacki, AL, et al. Stature loss and recovery in pregnant women with and without low back pain. Arch Phys Med Rehabil 2003; 84: 507–12.Google Scholar
Grahame, R, Bird, HA, Child, A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 2000; 27: 1777–9.Google Scholar
Sanderson, PL, Fraser, RD. The influence of pregnancy on the development of degenerative spondylolisthesis. J Bone Joint Surg Br 1996; 78: 951–4.Google Scholar
Brown, MD, Levi, AD. Surgery for lumbar disc herniation during pregnancy. Spine 2001; 26: 440–3.Google Scholar
De Wilde, JP, Rivers, AW, Price, DL. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol 2005; 87: 335–53.Google Scholar
Smith, MW, Marcus, PS, Wurtz, LD. Orthopedic issues in pregnancy. Obstet Gynecol Surv 2008; 63: 103–11.Google Scholar
Kathirgamanathan, A, Jardine, AD, Levy, DM, Grevitt, MP. Lumbar disc surgery in the third trimester: with the fetus in utero. Int J Obstet Anesth 2006; 15: 181–2.Google Scholar
Desai, P, Suk, M. Orthopedic trauma in pregnancy. Am J Orthop 2007; 36: E160–6.Google Scholar
Wells, J. Osteitis condensans ilii. Am J Roentgenol Radium Ther Nucl Med 1956; 76: 1141–3.Google Scholar
Shipp, FL, Haggart, GE. Further experience in the management of osteitis condensans ilii. J Bone Joint Surg Am 1950; 32: 841–7.Google Scholar
Borg-Stein, J, Dugan, SA, Gruber, J. Musculoskeletal aspects of pregnancy: Am J Phys Med Rehabil 2005; 84: 180–92.Google Scholar
Stuge, B, Laerum, E, Kirkesola, G, et al. The efficacy of a treatment program focusing on specific stabilizing exercises for pelvic girdle pain after pregnancy. Spine 2004; 29: 351–9.Google Scholar
Institute of Obstetricians & Gynaecologists, Royal College of Physicians of Ireland. Clinical Practice Guideline: Management of Pelvic Girdle Pain in Pregnancy and Post-Partum. Version 1.0, Guideline 16. Dublin: RCPI, 2014.Google Scholar
Naumburg, E, Bellocco, R, Cnattingius, S, et al. Intrauterine exposure to diagnostic x-rays and risk of childhood leukemia subtypes. Radiat Res 2001; 156: 718–23.Google Scholar
Stuge, B, Garratt, A, Krogstad Jenssen, H, Grotle, M. The Pelvic Girdle Questionnaire: a condition-specific instrument for assessing activity limitations and symptoms in people with pelvic girdle pain. Phys Ther 2011; 91: 1096–108.Google Scholar
Casagrande, D, Gugala, Z, Clark, SM, Lindsey, RW. Low back pain and pelvic girdle pain in pregnancy. J Am Acad Orthop Surg 2015; 23: 539–49. doi: 10.5435/JAAOS-D-14-00248.Google Scholar
Jain, S, Eedarapalli, P, Jamjute, P, Sawdy, P. Symphysis pubus dysfunction: a practical approach to management. Obstetrician Gynaecologist 2006; 8: 153–8.Google Scholar
Nilsson-Wikmar, L, Holm, K, Oijerstedt, R, et al. Effect of three different physical therapy treatments on pain and activity in pregnant women with pelvic girdle pain: a randomized clinical trial with 3-, 6-, and 12-month follow-up postpartum. Spine 2005; 30: 850–6.Google Scholar
Noren, L, Ostgaard, S, Nielsen, TF, et al. Reduction of sick leave for lumbar back and posterior pelvic pain in pregnancy. Spine 1997; 22: 2157–60.Google Scholar
Richardson, CA, Snijders, CJ, Hides, JA, et al. The relationship between the transversus abdominis muscles, sacroiliac joint mechanics, and low back pain. Spine 2002; 27: 399405.Google Scholar
Damen, L, Buyruk, HM, Guler-Uysal, F, et al. Pelvic pain during pregnancy is associated with asymmetrical laxity of the sacroiliac joints. Acta Obstet Gynecol Scand 2001; 80: 1019–24.Google Scholar
Garshasbi, A, Zadeh, SF. The effect of exercise on the intensity of low back pain in pregnant women. Int J Gynaecol Obstet 2005; 88: 271–5.Google Scholar
Waller, B, Lambeck, J, Daly, D. Therapeutic aquatic exercise in the treatment of low back pain: a systematic review. Clin Rehabil 2009; 23: 314.Google Scholar
Almousa, S, Lamprianidou, E, Kitsoulis, G. The effectiveness of stabilising exercises in pelvic girdle pain during pregnancy and after delivery: a systematic review. Physiother Res Int 2018; 23 (1). doi: 10.1002/pri.1699.Google Scholar
Stuber, KJ, Smith, DL. Chiropractic treatment of pregnancy-related low back pain: a systematic review of the evidence. J Manipulative Physiol Ther 2008; 31: 447–54.Google Scholar
Kushtagi, P, Bhanu, BT. Effectiveness of subcutaneous injection of sterile water to the lower back for pain relief in labor. Acta Obstet Gynecol Scand 2009; 88: 231–3.Google Scholar
Fogarty, V. Intradermal sterile water injections for the relief of low back pain in labour: a systematic review of the literature. Women Birth 2008; 21: 157–63.Google Scholar
Mårtensson, L, Wallin, G. Sterile water injections as treatment for low-back pain during labour: a review. Aust N Z J Obstet Gynaecol 2008; 48: 369–74.Google Scholar
Pennick, V, Liddle, SD. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database Syst Rev 2013 (8): CD001139.Google Scholar
Röst, CC, Jacqueline, J, Kaiser, A, Verhagen, AP, Koes, BW. Prognosis of women with pelvic pain during pregnancy: a long-term follow-up study. Acta Obstet Gynecol Scand 2006; 85: 771–7.Google Scholar
Robinson, HS, Mengshoel, AM, Bjelland, EK, Vøllestad, NK. Pelvic girdle pain, clinical tests and disability in late pregnancy. Man Ther 2010; 15: 280–5.Google Scholar
Albert, H, Godskesen, M, Westergaard, J. Prognosis in four syndromes of pregnancy-related pelvic pain. Acta Obstet Gynecol Scand 2001; 80: 505–10.Google Scholar
Weinstein, SL. Adolescent idiopathic scoliosis: Prevalence and natural history. In Weinstein, SL (ed), The Pediatric Spine: Principles and Practice. New York, NY: Raven, 1994, pp. 463–78.Google Scholar
Betz, RR, Bunnell, WP, Lombrecht-Mulier, E, et al. Scoliosis and pregnancy. J Bone Joint Surg Am 1987; 69: 90–6.Google Scholar
Danielsson, AJ, Nachemson, AL. Childbearing, curve progression, and sexual function in women 22 years after treatment for adolescent idiopathic scoliosis: a case-control study. Spine 2001; 26: 1449–56.Google Scholar
To, WW, Wong, MW. Kyphoscoliosis complicating pregnancy. Int J Gynaecol Obstet 1996; 55: 123–8.Google Scholar
Reddy, R, Evans, E, Khoo, O, Allen, MB. Pregnancy in kyphoscoliosis: benefit of non-invasive ventilatory support. J Obstet Gynaecol 2005; 25: 267–8.Google Scholar
Costello, JF, Balki, M. Cesarean delivery under ultrasound-guided spinal anesthesia in a parturient with poliomyelitis and Harrington instrumentation. Can J Anaesth 2008; 55: 606–11.Google Scholar
Lebel, DE Levy, A, Holcberg, G, Sheiner, E. Symphysiolysis as an independent risk factor for cesarean delivery. J Matern Fetal Neonatal Med 2010; 23: 417–20.Google Scholar
Damen, L, Buyruk, HM, Guler-Uysal, F, et al. The prognostic value of asymmetrical laxity of the sacroiliac joints in pregnancy-related pelvic pain. Spine 2002; 27: 2820–4.Google Scholar
Van Dongen, PW, De Boer, M, Lemmens, WA, et al. Hypermobility and peripartum pelvic pain syndrome in pregnant South African women. Eur J Obstet Gynecol Reprod Biol 1999; 84: 7782.Google Scholar
Scriven, MW, Jones, DA, McKnight, L. The importance of pubic pain following childbirth: a clinical and ultrasonographic study of diastasis of the pubic symphysis. J R Soc Med 1995; 88: 2830.Google Scholar
Bjorklund, K, Nordstrom, ML, Bergstrom, S. Sonographic assessment of symphyseal joint distention during pregnancy and post partum with special reference to pelvic pain. Acta Obstet Gynecol Scand 1999; 78: 125–30.Google Scholar
Wurdinger, S, Humbsch, K, Reichenbach, JR, et al. MRI of the pelvic ring joints postpartum: normal and pathologic findings. J Magn Reson Imaging 2002; 15: 324–9.Google Scholar
Kurzel, RB, Au, AH, Rooholamini, SA, et al. Magnetic resonance imaging of peripartum rupture of the symphysis pubis. Obstet Gynecol 1996; 87: 826–9.Google Scholar
Depledge, J, McNair, PJ, Keal-Smith, C, Williams, M. Management of symphysis pubis dysfunction during pregnancy using exercise and pelvic support belts. Phys Ther 2005; 85: 1290–300.Google Scholar
Rommens, PM. Internal fixation in postpartum symphysis rupture: report of three cases. J Orthop Trauma 1997; 11: 273–6.Google Scholar
Dunbar, RP, Ries, AM. Puerperal diastasis of the pubic symphysis: a case report. J Reprod Med 2002; 47: 581–3.Google Scholar
Heath, T, Gherman, RB. Symphyseal separation, sacroiliac joint dislocation and transient lateral femoral cutaneous neuropathy associated with McRobert’s manoeuvre: a case report. J Reprod Med 1999; 44: 902–4.Google Scholar
Kharrazi, FD, Rodgers, WB, Kennedy, JG, Lhowe, DW. Parturition-induced pelvic dislocation: a report of four cases. J Orthop Trauma 1997; 11: 277–81.Google Scholar
Jain, N, Sternberg, LB. Symphyseal separation. Obstet Gynecol 2005; 105: 1229–32.Google Scholar
Lindsey, RW, Leggon, RE, Wright, DG, et al. Separation of the symphysis pubis in association with childbearing: a case report. J Bone Joint Surg Am 1988; 70: 289–92.Google Scholar
Dhar, S, Anderton, J. Rupture of the symphysis pubis during labor. Clin Orthop Relat Res 1992; 283: 252–7.Google Scholar
Luger, EJ, Arbel, R, Dekel, S. Traumatic separation of the symphysis pubis during pregnancy: a case report. J Trauma 1995; 38: 255–6.Google Scholar
Giannoudis, PV, Chalidis, BE, Roberts, CS. Internal fixation of traumatic diastasis of pubic symphysis: is plate removal essential? Arch Orthop Trauma Surg 2008; 128: 325–31.Google Scholar
Kowalk, DL, Perdue, PS, Bourgeois, FJ, et al. Disruption of the symphysis pubis during vaginal delivery: a case report. J Bone Joint Surg Am 1996; 78: 1746–8.Google Scholar
Culligan, P, Hill, S, Heit, M. Rupture of the symphysis pubis during vaginal delivery followed by two subsequent uneventful pregnancies. Obstet Gynecol 2002; 100: 1114–17.Google Scholar
Gonik, B, Stringer, A. Postpartum osteitis pubis. South Med J 1985; 78: 213–14.Google Scholar
Borg-Stein, J, Dugan, S., Musculoskeletal disorders of pregnancy, delivery and postpartum. Phys Med Rehabil Clin N Am 2007; 18: 459–76.Google Scholar
Maksymowych, WP, Aaron, SL, Rusel, AS. Treatment of refractory symphysitis pubis with intravenous pamidronate. J Rheumatol 2001; 28: 2754–7.Google Scholar
Magnusdottir, R, Franklin, J, Gestsson, J. Septic symphysial disruption presenting as severe symphysiolysis in pregnancy. Acta Obstet Gynecol Scand 1996; 75: 681–2.Google Scholar
Lovisetti, G, Sala, F, Battaini, A, Lovisetti, L, Guicciardi, E. Osteomyelitis of the pubic symphysis, abscess and late disjunction after delivery: a case report. Chir Organi Mov 2000; 85: 85–8.Google Scholar
Moran, JJ. Stress fractures in pregnancy. Am J Obstet Gynecol 1988; 158: 1274–7.Google Scholar
Mikawa, Y, Watanabe, R, Yamano, Y, et al. Stress fracture of the body of pubis in a pregnant woman. Arch Orthop Trauma Surg 1988; 107: 193–4.Google Scholar
Almog, G, Liebergall, M, Tsafrir, A, Barzilay, Y, Mosheiff, R. Management of pelvic fractures during pregnancy. Am J Orthop 2007; 36: E153–9.Google Scholar
Leggon, RE, Wood, GC, Indeck, MC. Pelvic fractures in pregnancy: factors influencing maternal and fetal outcomes. J Trauma 2002; 53: 796804.Google Scholar
Porter, SE, Russell, GV, Qin, Z, Graves, ML. Operative fixation of acetabular fractures in the pregnant patient. J Orthop Trauma 2008; 22: 508–16.Google Scholar
Madsen, LV, Jensen, J, Christensen, ST. Parturition and pelvic fracture. follow-up of 34 obstetric patients with a history of pelvic fracture. Acta Obstet Gynecol Scand 1983; 62: 617–20.Google Scholar
Funk, JL, Shoback, DM, Genant, HK. Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density. Clin Endocrinol 1995; 43: 373–82.Google Scholar
Lequesne, M. Transient osteoporosis of the hip: a nontraumatic variety of Sudecks atrophy. Ann Rheum Dis 1968; 27: 463–71.Google Scholar
Bruinsma, BJ, LaBan, MM. The ghost joint: transient osteoporosis of the hip. Arch Phys Med Rehabil 1990; 71: 295–8.Google Scholar
Guerra, JJ, Steinberg, ME. Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg Am 1995; 77: 616–24.Google Scholar
Shifrin, LZ, Reis, ND, Zinman, H, Besser, MI. Idiopathic transient osteoporosis of the hip. J Bone Joint Surg Br 1987; 69: 769–73.Google Scholar
Curtiss, PH, Kincaid, WE. Transitory demineralization of the hip in pregnancy: A report of three cases. J Bone Joint Surg Am 1959; 41: 1327–33.Google Scholar
Montella, BJ, Nunley, JA, Urbaniak, JR. Osteonecrosis of the femoral head associated with pregnancy: a preliminary report. J Bone Joint Surg Am 1999; 81: 790–8.Google Scholar
Sierra, RJ, Trousdale, RT, Cabanela, ME. Pregnancy and childbirth after total hip arthroplasty. J Bone Joint Surg Br 2005; 87: 21–4.Google Scholar
McDowell, CM, Lachiewicz, PF. Pregnancy after total hip replacement. J Bone Joint Surg Am 2001; 83: 1490–4.Google Scholar
Meldrum, R, Feinberg, JR, Capello, WN, et al. Clinical outcome and incidence of pregnancy after bipolar and total hip arthroplasty in young women. J Arthroplasty 2003; 18: 879–85.Google Scholar
Loder, RT. The long-term effect of pelvic osteotomy on birth canal size. Arch Orthop Trauma Surg 2002; 122: 2934.Google Scholar
Masui, T. Hasegawa, T, Yamaguchi, J, et al. Childbirth and sexual activity after eccentric rotational acetabular osteotomy. Clin Orthop Relat Res 2007; 459: 195–9.Google Scholar
Zyluk, A. Carpal tunnel syndrome in pregnancy: a review. Pol Orthop Traumatol 2013; 78: 223–7.Google Scholar
Balik, G, Sabri Balik, M, Ustüner, I, et al. Hand and wrist complaints in pregnancy. Arch Gynecol Obstet 2014; 290: 479–83.Google Scholar
Moghtaderi, AR, Moghtaderi, N, Loghmani, A. Evaluating the effectiveness of local desamethasone injection in pregnant women with carpal tunnel syndrome. J Res Med Sci 2011; 16: 687–90.Google Scholar
Mondelli, M, Rossi, S, Monti, E, et al. Long term follow-up of carpal tunnel syndrome during pregnancy: a cohort study and review of the literature. Electromyogr Clin Neurophysiol 2007; 47: 259–71.Google Scholar
van Slobbe, AM, Bohnyen, AM, Byernsen, RM, et al. Incidence rates and determinants in meralgia paresthetica in general practice. J. Neurol 2004; 251: 294–7.Google Scholar
Klein, A. Peripheral nerve disease in pregnancy. Clin Obstet Gynecol 2013; 56: 382–8.Google Scholar
American Academy of Orthopaedic Surgeons. De Quervain’s tenosynovitis. http://orthoinfo.aaos.org/topic.cfm?topic=a00007 (accessed March 2017).Google Scholar

References

Kroumpouzos, G, Cohen, LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001; 45: 119.Google Scholar
Kroumpouzos, G, Avgerinou, G. Acanthosis nigricans without diabetes during pregnancy. Br J Dermatol 2002; 146: 925–8.Google Scholar
Rubin, AI, Laborde, SV, Stiller, MJ. Aquired dermal melanocytosis: appearance during pregnancy. J Am Acad Dermatol 2001; 45: 609–13.Google Scholar
Garcia, RL. Verrucose areolar hyperpigmentation of pregnancy. Arch Dermatol 1973; 107: 774.Google Scholar
Schiller, M, Kütting, B, Luger, T, Metze, D. [Localized reticulate hyperpigmentation]. Hautarzt 1999; 50: 580–5.Google Scholar
Galasso, F, Sbano, E, Altamura, V, Della Corte, G. [Acanthosis nigricans in pregnancy]. G Ital Dermatol Venereol 1989; 124: 511–15.Google Scholar
Kroumpouzos, G. Introduction to physiologic skin changes and skin disease in pregnancy. In Kroumpouzos, G (ed.), Text Atlas of Obstetric Dermatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 69.Google Scholar
Winton, GB, Lewis, CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6: 977–98.Google Scholar
McKenzie, AW. Skin disorders in pregnancy. Practitioner 1971; 206: 773–80.Google Scholar
Sanchez, NP, Pathak, MA, Sato, S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698710.Google Scholar
Snell, RS, Bischitz, PG. The effects of large doses of estrogen and progesterone on melanin pigmentation. J Invest Dermatol 1960; 35: 7382.Google Scholar
Higgins, W, Jenkins, J, Horn, T, Kroumpouzos, G. Pregnancy-associated hyperkeratosis of the nipple: a report of 25 patients. JAMA Dermatol 2013; 149: 722–6.Google Scholar
Kligman, AM, Willis, I. A new formula for depigmenting human skin. Arch Dermatol 1975; 111: 40–8.Google Scholar
Shankar, K, Godse, K, Aurangabadkar, S, et al. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther (Heidelb) 2014; 4: 165–86.Google Scholar
Winton, GB. Skin diseases aggravated by pregnancy. J Am Acad Dermatol 1989; 20: 113.Google Scholar
Vaughan Jones, SA, Hern, S, Nelson-Piercy, C, et al. A prospective study of 200 women with dermatoses of pregnancy correlating the clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999; 141: 7181.Google Scholar
Schafer, T, Dirschedl, P, Kunz, B. Maternal smoking during pregnancy and lactation increases the risk for atopic eczema in the offspring. J Am Acad Dermatol 1997; 36: 550–6.Google Scholar
Ambros-Rundolph, CM, Mullegger, RR, Vaughan-Jones, SA, et al. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 2006; 54: 395404.Google Scholar
Kroumpouzos, G, Cohen, LM. Prurigo, pruritic foliculitis, and atopic eruption of pregnancy. In Kroumpouzos, G (ed.), Text Atlas of Obstetric Dermatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 205216.Google Scholar
Koutroulis, I, Papoutsis, J, Kroumpouzos, G. Atopic dermatitis in pregnancy: current status and challenges. Obstet Gynecol Surv 2011; 66: 654–63.Google Scholar
Hale, EK, Pomeranz, MK. Dermatologic agents during pregnancy and lactation: an update and clinical review. Int J Dermatol 2002; 41: 197203.Google Scholar
Boyd, AS, Morris, LF, Phillips, CM, Menter, MA. Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol 1996; 35: 169–72.Google Scholar
McHugh, NJ, Laurent, MR. The effect of pregnancy on the onset of psoriatic arthritis. Br J Rheumatol 1989; 28: 50–2.Google Scholar
Tauscher, AE, Fleischer, AB, Phelps, KC, Feldman, SR. Psoriasis and pregnancy. J Cutan Med Surg 2002; 6: 561–70.Google Scholar
Bajaj, AK, Swarup, V, Gupta, OP, Gupta, SC. Impetigo herpetiformis. Dermatologica 1977; 155: 292–5.Google Scholar
Ott, F, Krakowski, A, Tur, E, et al. Impetigo herpetiformis with lowered serum level of vitamin D and its diminished intestinal absorption. Dermatologica 1982; 164: 360–5.Google Scholar
Oumeish, OY, Farraj, SE, Bataineh, AS. Some aspects of impetigo herpetiformis. Arch Dermatol 1982; 118: 103–5.Google Scholar
Kuijpers, ALA, Schalkwijk, J, Rulo, HFC, et al. Extremely low levels of epidermal skin derived antileucoproteinase/elafin in a patient with impetigo herpetiformis. Br J Dermatol 1997; 137: 123–9.Google Scholar
Beveridge, GW, Harkness, RA, Livingston, JRB. Impetigo herpetiformis in two successive pregnancies. Br J Dermatol 1966; 78: 106–12.Google Scholar
Finch, TM, Tan, CY. Pustular psoriasis exacerbated by pregnancy and controlled by cyclosporin A. Br J Dermatol 2000; 142: 582–4.Google Scholar
Gimenez-Garcia, R, Gimenez Garcia, MC, Llorente de la Fuente, A. Impetigo herpetiformis: Response to steroids and etretinate. Int J Dermatol 1989; 28: 551–2.Google Scholar
Breier-Maly, J, Ortel, B, Breier, F, et al. Generalized pustular psoriasis of pregnancy (impetigo herpetiformis). Dermatology 1999; 198: 61–4.Google Scholar
Spence, MR. Genital infections in pregnancy. Med Clin North Am 1977; 61: 139–51.Google Scholar
Hopsu-Havu, VK, Grönroos, M, Punnonen, R. Vaginal yeasts in parturients and infestation of the newborns. Acta Obstet Gynecol Scand 1980; 59: 73–7.Google Scholar
Sobel, JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152: 924–35.Google Scholar
Gravett, MG, Hummel, D, Eschenbach, DA, Holmes, KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986; 67: 229–37.Google Scholar
Lockwood, DN, Sinha, HH. Pregnancy and leprosy: a comprehensive literature review. Int J Lep Mycobact Dis 1999; 67: 612.Google Scholar
Duncan, ME, Pearson, JMH. Neuritis in pregnancy and lactation. Int J Lepr Mycobact Dis 1982; 50: 31–8.Google Scholar
Cotch, MF, Pastorek, JG II, Nugent, RP, et al. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstet Gynecol 1991; 78: 1087–92.Google Scholar
Cotch, MF, Pastorek, JG, Nugent, RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24: 353–60.Google Scholar
Heymann, WR, Wolf, DJ. Malassezia (pityrosporum) folliculitis occurring during pregnancy. Int J Dermatol 1986; 25: 4951.Google Scholar
Lockshin, MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989; 32: 665–70.Google Scholar
Ruiz-Irastorza, G, Lima, F, Alves, J, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996; 35: 133–8.Google Scholar
Khamashta, MA, Ruiz-Irastorza, G, Hughes, GRV. Systemic lupus flares during pregnancy. Rheum Dis Clin North Am 1997; 23: 1530.Google Scholar
Frances, C, Piette, JC. Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus. Lupus 1997; 6: 139–44.Google Scholar
Tseng, C-E, Buyon, JP. Neonatal lupus syndromes. Rheum Dis Clin North Am 1997; 23: 3154.Google Scholar
Gutierrez, G, Dagnino, R, Mintz, G. Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum 1984; 27: 291–4.Google Scholar
Steen, VD. Scleroderma and pregnancy. Rheum Dis Clin North Am 1997; 23: 133–47.Google Scholar
Kardos, M, Levine, D, Gurcan, HM, et al. Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes. Obstet Gynecol Surv 2009; 64: 739–49.Google Scholar
Collier, PM, Kelly, SE, Wojnarowska, FW. Linear IgA disease and pregnancy. J Am Acad Dermatol 1994; 30: 407–11.Google Scholar
Wan, J, Imadojemu, S, Werth, VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum. Clin Dermatol 2016; 34: 344–52. doi: 10.1016/j.clindermatol.2016.02.006.Google Scholar
Loret de Mola, JR, Muise, KL, Duchon, MA. Porphyria cutanea tarda and pregnancy. Obstet Gynecol Surv 1996; 15: 493–7.Google Scholar
Bronson, DM, Barsky, R, Barsky, S. Acrodermatitis enteropathica: recognition at long last during a recurrence in pregnancy. J Am Acad Dermatol 1983; 9: 140–4.Google Scholar
Rudd, NL, Nimrod, C, Holbrook, KA, et al. Pregnancy complications in type IV Ehlers–Danlos syndrome. Lancet 1983; I: 50–3.Google Scholar
Berde, C, Willis, DC, Sandberg, EC. Pregnancy in women with pseudoxanthoma elasticum. Obstet Gynecol Surv 1983; 38: 339–44.Google Scholar
Bercovitch, L, Leroux, T, Terry, S, et al. Pregnancy and obstetric outcomes in pseudoxanthoma elasticum. Br J Dermatol 2004; 151: 1011–18.Google Scholar
Swapp, GH. Neurofibromatosis in pregnancy. Br J Dermatol 1973; 80: 431–5.Google Scholar
Tierney, E, Kroumpouzos, G, Rogers, G. Skin tumors. In Kroumpouzos, G (ed.), Text Atlas of Obstetric Dermatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 141–51.Google Scholar
Travers, RL, Sober, AJ, Berwick, M, et al. Increased thickness of pregnancy-associated melanoma. Br J Dermatol 1995; 132: 876–83.Google Scholar
Johansson, AL, Andersson, TM, Plym, A, et al. Mortality in women with pregnancy-associated malignant melanoma. J Am Acad Dermatol 2014; 71: 1093–101.Google Scholar
Walker, JL, Wang, AR, Kroumpouzos, G, Weinstock, MA. Cutaneous tumors in pregnancy. Clin Dermatol 2016; 34: 359–67. doi: 10.1016/j.clindermatol.2016.02.008.Google Scholar
Byrom, L, Olsen, C, Knight, L, Khosrotehrani, K, Green, AC. Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2015; 29: 1457–66. doi: 10.1111/jdv.12972.Google Scholar
Alexander, A, Samlowski, WE, Grossman, D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 2003; 21: 2179–86.Google Scholar
Schwartz, JL, Mozurkewich, EL, Johnson, TM. Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant. Cancer 2003; 97: 2130–3.Google Scholar
Leachman, SA, Jackson, R, Eliason, MJ, et al. Management of melanoma during pregnancy. Dermatol Nurs 2007; 19: 145–52.Google Scholar
Mackie, RM. Pregnancy and exogenous female sex hormones in melanoma patients. In Balch, CM, Houghton, AN, Sober, AJ, Soong, SJ (eds), Cutaneous Melanoma, 3rd edn. St Louis, MO: QMP Publishing, 1998, pp. 187193.Google Scholar
Nading, MA, Nanney, LB, Boyd, AS, et al. Estrogen receptor beta expression in nevi during pregnancy. Exp Dermatol 2008; 17: 489–97.Google Scholar
Rubegni, P, Sbano, P, Burroni, M, et al. Melanocytic skin lesions and pregnancy: digital dermoscopy analysis. Skin Res Technol 2007; 13: 143–7.Google Scholar
Jenkins, J, Robinson-Bostom, L, Girolomoni, G, Kroumpouzos, G. Autoimmune progesterone dermatitis. In Kroumpouzos, G (ed.), Text Atlas of Obstetric Dermatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 5765.Google Scholar
Kroumpouzos, G. Intrahepatic cholestasis of pregnancy: what’s new. J Eur Acad Dermatol Venereol 2002; 16: 316–18.Google Scholar
Abedin, P, Weaver, JB, Egginton, E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 1999; 4: 35–7.Google Scholar
Kroumpouzos, G, Cohen, LM. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol 2003; 188: 1083–92.Google Scholar
Dann, AT, Kenyon, AP, Wierzbicki, AS, et al. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol 2006; 107: 106–14.Google Scholar
Geenes, V, Williamcon, C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049–66.Google Scholar
Kondrackiene, J, Beuers, U, Zalinkevicius, R et al. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 2007; 14: 6226–30.Google Scholar
Campo, GA, Guerra, FA, Israel, EJ. Effects of cholic acid infusion in fetal lambs. Acta Obstet Gynecol Scand 1986; 65: 23–6.Google Scholar
Kenyon, AP, Nelson Piercy, C, Girling, J et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 2002; 109: 282–8.Google Scholar
Roncaglia, N, Arreghini, A, Locatelli, A, et al. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002; 100: 167–70.Google Scholar
Heinonen, S, Kirkinen, P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999; 94: 189–93.Google Scholar
Rioseco, AJ, Ivankovic, MB, Manzur, A, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890–5.Google Scholar
Zapata, R, Sandoval, L, Palma, J, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. Liver Int 2005; 25: 548–54.Google Scholar
Davies, MH, da Silva, RCMA, Jones, SR, et al. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995; 37: 580–4.Google Scholar
Geenes, V, Williamson, C. Pruritus and obstetric cholestasis. In Kroumpouzos, G (ed.), Text Atlas of Obstetric Dermatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 164–75.Google Scholar
Roncaglia, N, Locatelli, A, Arreghini, A, et al. A randomized controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of gestational cholestasis. BJOG 2004; 111: 1721.Google Scholar
Binder, T, Salaj, P, Zima, T, et al. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006; 34: 383–91.Google Scholar
Glantz, A, Marschall, HU, Lammert, F, et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399–405.Google Scholar
Laatikainen, T. Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy Am J Obstet Gynecol 1978; 132: 501–6.Google Scholar
Sadler, LC, Lane, M, North, R. Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1995; 102: 169–70.Google Scholar
Kondrackiene, J, Beuers, U, Kupcinskas, L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005; 129: 894901.Google Scholar
Holmes, RC, Black, MM. The specific dermatoses of pregnancy. J Am Acad Dermatol 1983; 8: 405–12.Google Scholar
Cohen, LM, Kroumpouzos, G. Pruritic dermatoses of pregnancy: to lump or to split? J Am Acad Dermatol 2007; 56: 708–9.Google Scholar
Kroumpouzos, G. Specific dermatoses of pregnancy: advances and controversies. Expert Rev Dermatol 2010; 5: 633.Google Scholar
Roger, D, Vaillant, L, Fignon, A, et al. Specific pruritic dermatoses of pregnancy: a prospective study of 3192 women. Arch Dermatol 1994; 130: 734–9.Google Scholar
Chander, R, Garg, T, Kakkar, S, Arpita, J. Specific dermatoses in 1430 females from northern India. J Dermatol Case Reports. 2011; 4: 6973.Google Scholar
Engineer, L, Bhol, K, Ahmed, AR. Pemphigoid gestationis: a review. Am J Obstet Gynecol 2000; 183: 483–91.Google Scholar
Jenkins, RE, Hern, S, Black, MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 1999; 24: 255–9.Google Scholar
Holmes, RC, Black, MM, Jurecka, W, et al. Clues to the etiology and pathogenesis of herpes gestationis. Br J Dermatol 1983; 109: 131–9.Google Scholar
Sadik, CD, Lima, AL, Zillikens, D. Pemphigoid gestationis: Toward a better understanding of the etiopathogenesis. Clin Dermatol 2016; 34: 378–82. doi: 10.1016/j.clindermatol.2016.02.010.Google Scholar
Kroumpouzos, G, Zillikens, D. Pemphigoid gestationis. In Kroumpouzos, G (ed.), Text Atlas of Obstetric Dermatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 180–93.Google Scholar
Morrison, LH, Labib, RS, Zone, JJ, et al. Herpes gestationis autoantibodies recognize a 180-kd human epidermal antigen. J Clin Invest 1988; 81: 2023–6.Google Scholar
Lin, MS, Gharia, M, Fu, CL, et al. Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. Clin Immunol 1999; 92: 285–92.Google Scholar
Kelly, SE, Black, MM. Pemphigoid gestationis: placental interactions. Semin Dermatol 1989; 8: 1217.Google Scholar
Huilaja, L, Hurskainen, T, Autio-Harmainen, H, et al. Pemphigoid gestationis autoantigen, transmembrane collagen XVII, promotes the migration of cytotrophoblastic cells of placenta and is a structural component of fetal membranes. Matrix Biol 2008; 27: 190200.Google Scholar
Kwon, EJ, Ntiamoah, P, Shulman, KJ. The utility of C4d immunohistochemistry on formalin-fixed paraffin-embedded tissue in the distinction of polymorphic eruption of pregnancy from pemphigoid gestationis. Am J Dermatopathol 2013; 35: 787–91.Google Scholar
Karna, P, Broecker, AH. Neonatal herpes gestationis. J Pediatr 1991; 119: 299301.Google Scholar
Shornick, JK, Black, MM. Fetal risks in herpes gestationis. J Am Acad Dermatol 1992; 26: 63–8.Google Scholar
Huilaja, L, Mäkikallio, T, Sormunen, R, et al. Pemphigoid gestationis: placental morphology and function. Acta Derm Venereol 2013; 93: 33–8.Google Scholar
Chi, CC, Wang, SH, Charles-Holmes, R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol 2009; 160: 12221228.Google Scholar
Hern, S, Harman, K, Bhogal, BS, Black, MM. A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporine. Clin Exp Dermatol 1998; 23: 185–8.Google Scholar
Loo, WJ, Dean, D, Wojnarowska, F. A severe case of recurrent pemphigoid gestation is successfully treated with minocycline and nicotinamide. Clin Exp Dermatol 2001; 26: 726–7.Google Scholar
Lawley, TJ, Hertz, KC, Wade, TR, et al. Pruritic urticarial papules and plaques of pregnancy. JAMA 1979; 241: 1696–9.Google Scholar
Aronson, IK, Bond, S, Fiedler, VC, et al. Pruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patients. J Am Acad Dermatol 1998; 39: 933–9.Google Scholar
Regnier, S, Fermand, V, Levy, P, et al. A case–control study of polymorphic eruption of pregnancy. J Am Acad Dermatol. 2008; 59: 722–3.Google Scholar
Cohen, LM, Capeless, EL, Krusinski, PA, Maloney, ME. Pruritic urticarial papules and plaques of pregnancy and its relationship to maternal-fetal weight gain and twin pregnancy. Arch Dermatol 1989; 125: 1534–6.Google Scholar
Elling, SV, McKenna, P, Powell, FC. Pruritic urticarial papules and plaques of pregnancy in twin and triplet pregnancies. J Eur Acad Dermatol Venereol 2000; 14: 378–81.Google Scholar
Ohel, I, Levy, A, Silberstein, T, et al. Pregnancy outcome of patients with pruritic urticarial papules and plaques of pregnancy. J Matern Fetal Neonat Med 2006; 19: 305–8.Google Scholar
Im, S, Lee, E-S, Kim, W, et al. Expression of progesterone receptor in human keratinocytes. J Korean Med Sci 2000; 15: 647–54.Google Scholar
Carli, P, Tarocchi, S, Mello, G, Fabbri, P. Skin immune system activation in pruritic urticarial papules and plaques of pregnancy. Int J Dermatol 1994; 33: 884–5.Google Scholar
Aractingi, S, Bertheau, P, Le Goue, C, et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 1998; 352: 1898–901.Google Scholar
Rudolph, CM, Al-Fares, S, Vaughan-Jones, SA, et al. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol 2006; 154: 5460.Google Scholar
Taylor, D, Pappo, E, Aronson, IK. Polymorphic eruption of pregnancy. Clin Dermatol 2016; 34: 383–91. doi: 10.1016/j.clindermatol.2016.02.011.Google Scholar
Jeon, IK, On, HR, Oh, SH, Hann, SK. Three cases of pruritic urticarial papules and plaques of pregnancy (PUPPP) treated with intramuscular injection of autologous whole blood. J Eur Acad Dermatol Venereol 2015; 29: 797800. doi: 10.1111/jdv.12414.Google Scholar
Spangler, AS, Reddy, W, Bardawil, WA, et al. Papular dermatitis of pregnancy: a new clinical entity? JAMA 1962; 181: 577–81.Google Scholar
Zoberman, E, Farmer, ER. Pruritic folliculitis of pregnancy. Arch Dermatol 1981; 117: 20–2.Google Scholar
Kroumpouzos, G, Cohen, LM. Pruritic folliculitis of pregnancy. J Am Acad Dermatol 2000; 43: 132–4.Google Scholar
Kroumpouzos, G. Pityrosporum folliculitis during pregnancy is not pruritic folliculitis of pregnancy. J Am Acad Dermatol 2005; 53: 1098–9.Google Scholar

Further Reading

Amant, F, Deckers, S, Van Calsteren, K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2010; 46: 3158–68.Google Scholar
Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394403.Google Scholar
Azim, HA, Pavlidis, N, Peccatori, FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev 2010; 36: 110–21.Google Scholar
Azim, HA, Peccatori, FA, Pavlidis, N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 2010; 36: 101–9.Google Scholar
Brenner, B, Avivi, I, Lishner, M. Haematological cancers in pregnancy. Lancet. 2012; 379: 580–7.Google Scholar
Cardonick, E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health 2014; 6: 935–43.Google Scholar
Peccatori, FA, Azim, HA, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi160–70.Google Scholar
Salani, R, Billingsley, CC, Crafton, SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol 2014; 211: 714.Google Scholar
Selig, BP, Furr, JR, Huey, RW, et al. Cancer chemotherapeutic agents as human teratogens. Birth Defects Res A Clin Mol Teratol 2012; 94: 626–50.Google Scholar

References

Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2017. CA Cancer J Clin 2017; 67: 730.Google Scholar
Peccatori, FA, Azim, HA, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi160–70.Google Scholar
Miniño, AM. Death in the United States, 2011. NCHS Data Brief 2013; (115): 1–8.Google Scholar
Cardonick, E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health 2014; 6: 935–43.Google Scholar
Salani, R, Billingsley, CC, Crafton, SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol 2014; 211: 714.Google Scholar
Stensheim, H, Moller, B, van Dijk, T, Fossa, SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27: 4551.Google Scholar
Ahn, BY, Kim, HH, Moon, WK, et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J Ultrasound Med 2003; 22: 491–7.Google Scholar
Brenner, B, Avivi, I, Lishner, M. Haematological cancers in pregnancy. Lancet. 2012; 379: 580–7.Google Scholar
Han, SN, Verheecke, M, Vandenbroucke, T, et al. Management of gynecological cancers during pregnancy. Curr Oncol Rep 2014; 16: 415.Google Scholar
Leiserowitz, GS, Xing, G, Cress, R, et al. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol 2006; 101: 315–21.Google Scholar
Morice, P, Uzan, C, Gouy, S, Verschraegen, C, Haie-Meder, C. Gynaecological cancers in pregnancy. Lancet 2012; 379: 558–69.Google Scholar
Smith, LH, Danielsen, B, Allen, ME, Cress, R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128–35.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004; 104: 647–51.Google Scholar
Wang, PI, Chong, ST, Kielar, AZ, et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol 2012; 198: 778–84.Google Scholar
Donnelly, EH, Smith, JM, Farfan, EB, Ozcan, I. Prenatal radiation exposure: background material for counseling pregnant patients following exposure to radiation. Disaster Med Public Health Prep 2011; 5: 62–8.Google Scholar
Amant, F, Deckers, S, Van Calsteren, K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2010; 46: 3158–68.Google Scholar
Shellock, FG, Kanal, E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999; 10: 477–84.Google Scholar
Vashi, R, Hooley, R, Butler, R, Geisel, J, Philpotts, L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. AJR Am J Roentgenol 2013; 200: 321–8.Google Scholar
Morice, P, Narducci, F, Mathevet, P, et al. French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer 2009; 19: 1638–41.Google Scholar
Zanotti-Fregonara, P. Pregnancy should not rule out 18FDG PET/CT for women with cancer. Lancet 2012; 379: 1948.Google Scholar
Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394403.Google Scholar
Selig, BP, Furr, JR, Huey, RW, et al. Cancer chemotherapeutic agents as human teratogens. Birth Defects Res A Clin Mol Teratol 2012; 94: 626–50.Google Scholar
Dale, DC, Cottle, TE, Fier, CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 8293.Google Scholar
Azim, HA, Pavlidis, N, Peccatori, FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev 2010; 36: 110–21.Google Scholar
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283–91.Google Scholar
Pagani, O, Partridge, A, Korde, L, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 2011; 129: 309–17.Google Scholar
Azim, HA, Peccatori, FA, Pavlidis, N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 2010; 36: 101–9.Google Scholar
Falk, AT, Barriere, J, Francois, E, Follana, P. Bevacizumab: a dose review. Crit Rev Oncol Hematol 2015; 94: 311–22.Google Scholar
Toesca, A, Gentilini, O, Peccatori, F, Azim, HA, Amant, F. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg 2014; 11: 279–84.Google Scholar
DeSantis, CE, Lin, CC, Mariotto, AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64: 252–71.Google Scholar
Pereg, D, Koren, G, Lishner, M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 2008; 34: 302–12.Google Scholar
Nettleton, J, Long, J, Kuban, D, et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol 1996; 87: 414–18.Google Scholar
Petrek, JA. Breast cancer and pregnancy. J Natl Cancer Inst Monogr 1994; (16): 113–21.Google Scholar
Clark, RM, Chua, T. Breast cancer and pregnancy: the ultimate challenge. Clin Oncol (R Coll Radiol) 1989; 1: 1118.Google Scholar
Rodriguez, AO, Chew, H, Cress, R, et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008; 112: 71–8.Google Scholar
Amant, F, von Minckwitz, G, Han, SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013; 31: 2532–9.Google Scholar
Azim, HA, Santoro, L, Russell-Edu, W, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 2012; 38: 834–42.Google Scholar
Loibl, S, von Minckwitz, G, Gwyn, K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006; 106: 237–46.Google Scholar
Berry, DL, Theriault, RL, Holmes, FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855–61.Google Scholar
Rosenkranz, KM, Lucci, A. Surgical treatment of pregnancy associated breast cancer. Breast Dis 2005; 23: 8793.Google Scholar
Gropper, AB, Calvillo, KZ, Dominici, L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol 2014; 21: 2506–11.Google Scholar
Khera, SY, Kiluk, JV, Hasson, DM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008; 14: 250–4.Google Scholar
Upponi, SS, Ahmad, F, Whitaker, IS, Purushotham, AD. Pregnancy after breast cancer. Eur J Cancer 2003; 39: 736–41.Google Scholar
Velentgas, P, Daling, JR, Malone, KE, et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 1999; 85: 2424–32.Google Scholar
Eedarapalli, P, Biswas, N, Coleman, M. Epirubicin for breast cancer during pregnancy: a case report. J Reprod Med 2007; 52: 730–2.Google Scholar
Gadducci, A, Cosio, S, Fanucchi, A, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 2003; 23: 5225–9.Google Scholar
Mendez, LE, Mueller, A, Salom, E, Gonzalez-Quintero, VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 2003; 102: 1200–2.Google Scholar
Sood, AK, Shahin, MS, Sorosky, JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001; 83: 599600.Google Scholar
Dawrant, MJ, Giles, S, Bannigan, J, Puri, P. Adriamycin produces a reproducible teratogenic model of vertebral, anal, cardiovascular, tracheal, esophageal, renal, and limb anomalies in the mouse. J Pediatr Surg 2007; 42: 1652–8.Google Scholar
Dawrant, MJ, Giles, S, Bannigan, J, Puri, P. Adriamycin produces a reproducible teratogenic model of gastrointestinal atresia in the mouse. Pediatr Surg Int 2008; 24: 731–5.Google Scholar
Kim, JH, Kim, HS, Sung, CW, et al. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung Cancer 2008; 59: 270–3.Google Scholar
Mir, O, Berveiller, P, Ropert, S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008; 19: 607–13.Google Scholar
Gonzalez-Angulo, AM, Broglio, K, Kau, SW, et al. Women age ≤ 35 years with primary breast carcinoma: disease features at presentation. Cancer 2005; 103: 2466–72.Google Scholar
Witzel, ID, Muller, V, Harps, E, Janicke, F, Dewit, M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008; 19: 191–2.Google Scholar
Zagouri, F, Sergentanis, TN, Chrysikos, D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat 2013; 137: 349–57.Google Scholar
Kelly, H, Graham, M, Humes, E, et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 2006; 7: 339–41.Google Scholar
Gerardin, DC, Pereira, OC. Reproductive changes in male rats treated perinatally with an aromatase inhibitor. Pharmacol Biochem Behav 2002; 71: 301–5.Google Scholar
Kragie, L. Aromatase in primate pregnancy: a review. Endocr Res 2002; 28: 121–8.Google Scholar
Sankila, R, Heinavaara, S, Hakulinen, T. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 1994; 170: 818–23.Google Scholar
Ives, A, Saunders, C, Bulsara, M, Semmens, J. Pregnancy after breast cancer: population based study. BMJ 2007; 334: 194.Google Scholar
Sood, AK, Sorosky, JI. Invasive cervical cancer complicating pregnancy. How to manage the dilemma. Obstet Gynecol Clin North Am 1998; 25: 343–52.Google Scholar
Zagouri, F, Sergentanis, TN, Chrysikos, D, Bartsch, R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol 2013; 121: 337–43.Google Scholar
McIntyre-Seltman, K, Lesnock, JL. Cervical cancer screening in pregnancy. Obstet Gynecol Clin North Am 2008; 35: 645–58; x.Google Scholar
Michael, CW, Esfahani, FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997; 17: 99107.Google Scholar
Morimura, Y, Fujimori, K, Soeda, S, et al. Cervical cytology during pregnancy: comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 2737.Google Scholar
Pisharodi, LR, Jovanoska, S. Spectrum of cytologic changes in pregnancy. A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol 1995; 39: 905–8.Google Scholar
Rhatigan, RM. Endocervical gland atypia secondary to Arias-Stella change. Arch Pathol Lab Med 1992; 116: 943–6.Google Scholar
Schneider, V. Arias-Stella reaction of the endocervix: frequency and location. Acta Cytol 1981; 25: 224–8.Google Scholar
Jones, WB, Shingleton, HM, Russell, A, et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 1996; 77: 1479–88.Google Scholar
Baloglu, A, Uysal, D, Aslan, N, Yigit, S. Advanced stage of cervical carcinoma undiagnosed during antenatal period in term pregnancy and concomitant metastasis on episiotomy scar during delivery: a case report and review of the literature. Int J Gynecol Cancer 2007; 17: 1155–9.Google Scholar
Van Calsteren, K, Vergote, I, Amant, F. Cervical neoplasia during pregnancy: diagnosis, management and prognosis. Best Pract Res Clin Obstet Gynaecol 2005; 19: 611–30.Google Scholar
Yang, KY. Abnormal pap smear and cervical cancer in pregnancy. Clin Obstet Gynecol 2012; 55: 838–48.Google Scholar
American College of Obstetricians and Gynecologists. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol 2013; 122: 1338–67.Google Scholar
Karam, A, Feldman, N, Holschneider, CH. Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol 2007; 4: 375–80.Google Scholar
Lee, JM, Lee, KB, Kim, YT, et al. Cervical cancer associated with pregnancy: results of a multicenter retrospective Korean study (KGOG-1006). Am J Obstet Gynecol 2008; 198: 92.e1–6.Google Scholar
Monk, BJ, Montz, FJ. Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomy. Obstet Gynecol 1992; 80: 199203.Google Scholar
Sood, AK, Sorosky, JI, Krogman, S, et al. Surgical management of cervical cancer complicating pregnancy: a case–control study. Gynecol Oncol 1996; 63: 294–8.Google Scholar
van der Vange, N, Weverling, GJ, Ketting, BW, et al. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet Gynecol 1995; 85: 1022–6.Google Scholar
Sood, AK, Sorosky, JI, Mayr, N, et al. Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol 2000; 95: 832–8.Google Scholar
Cliby, WA, Dodson, MK, Podratz, KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet Gynecol 1994; 84: 179–82.Google Scholar
Copeland, LJ, Saul, PB, Sneige, N. Cervical adenocarcinoma: tumor implantation in the episiotomy sites of two patients. Gynecol Oncol 1987; 28: 230–5.Google Scholar
Gordon, AN, Jensen, R, Jones, HW. Squamous carcinoma of the cervix complicating pregnancy: recurrence in episiotomy after vaginal delivery. Obstet Gynecol 1989; 73: 850–2.Google Scholar
Schmeler, KM, Mayo-Smith, WW, Peipert, JF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol 2005; 105: 1098–103.Google Scholar
Whitecar, MP, Turner, S, Higby, MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 1999; 181: 1924.Google Scholar
Moore, RD, Smith, WG. Laparoscopic management of adnexal masses in pregnant women. J Reprod Med 1999; 44: 97100.Google Scholar
Bernhard, LM, Klebba, PK, Gray, DL, Mutch, DG. Predictors of persistence of adnexal masses in pregnancy. Obstet Gynecol 1999; 93: 585–9.Google Scholar
Zanetta, G, Mariani, E, Lissoni, A, et al. A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy. BJOG. 2003; 110: 578–83.Google Scholar
Katz, VL, Watson, WJ, Hansen, WF, Washington, JL. Massive ovarian tumor complicating pregnancy: a case report. J Reprod Med 1993; 38: 907–10.Google Scholar
King, LA, Nevin, PC, Williams, PP, Carson, LF. Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy. Gynecol Oncol 1991; 41: 7880.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Management of adnexal masses. Obstet Gynecol 2007; 110: 201–14.Google Scholar
Giuntoli, RL, Vang, RS, Bristow, RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol 2006; 49: 492505.Google Scholar
Eichelberger, KY, Cantrell, LA, Balthazar, U, et al. Robotic resection of adnexal masses during pregnancy. Am J Perinatol 2013; 30: 371–5.Google Scholar
Christman, JE, Teng, NN, Lebovic, GS, Sikic, BI. Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecol Oncol 1990; 37: 292–5.Google Scholar
Han, JY, Nava-Ocampo, AA, Kim, TJ, Shim, JU, Park, CT. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol 2005; 19: 557–61.Google Scholar
Malone, JM, Gershenson, DM, Creasy, RK, et al. Endodermal sinus tumor of the ovary associated with pregnancy. Obstet Gynecol 1986; 68 (3 Suppl): 86S89S.Google Scholar
Blake, EA, Kodama, M, Yunokawa, M, et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol 2015; 186C: 97105.Google Scholar
Grimm, D, Woelber, L, Trillsch, F, Keller-v Amsberg, G, Mahner, S. Clinical management of epithelial ovarian cancer during pregnancy. Eur J Cancer 2014; 50: 963–71.Google Scholar
Regan, MA, Rosenzweig, BA. Vulvar carcinoma in pregnancy: a case report and literature review. Am J Perinatol 1993; 10: 334–5.Google Scholar
Maw, RD. Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report. BJOG 2004; 111: 1475.Google Scholar
Nelson, EL, Stockdale, CK. Vulvar and vaginal HPV disease. Obstet Gynecol Clin North Am 2013; 40: 359–76.Google Scholar
Carinelli, SG, Cefis, F, Merlo, D. Epithelial neoplasia of the endometrium in pregnancy. A case report. Tumori 1987; 73: 175–80.Google Scholar
Fine, BA, Baker, TR, Hempling, RE, Intengan, M. Pregnancy coexisting with serous papillary adenocarcinoma involving both uterus and ovary. Gynecol Oncol 1994; 53: 369–72.Google Scholar
Ojomo, EO, Ezimokhai, M, Reale, FR, Nwabineli, NJ. Recurrent postpartum haemorrhage caused by endometrial carcinoma co-existing with endometrioid carcinoma of the ovary in a full term pregnancy. Br J Obstet Gynaecol 1993; 100: 489–91.Google Scholar
Vaccarello, L, Apte, SM, Copeland, LJ, Boutselis, JG, Rubin, SC. Endometrial carcinoma associated with pregnancy: a report of three cases and review of the literature. Gynecol Oncol 1999; 74: 118–22.Google Scholar
Antonelli, NM, Dotters, DJ, Katz, VL, Kuller, JA. Cancer in pregnancy: a review of the literature. Part II. Obstet Gynecol Surv 1996; 51: 135–42.Google Scholar
Antonelli, NM, Dotters, DJ, Katz, VL, Kuller, JA. Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv 1996; 51: 125–34.Google Scholar
Sebire, NJ, Jauniaux, E. Fetal and placental malignancies: prenatal diagnosis and management. Ultrasound Obstet Gynecol 2009; 33: 235–44.Google Scholar
Altman, JF, Lowe, L, Redman, B, et al. Placental metastasis of maternal melanoma. J Am Acad Dermatol 2003; 49: 1150–4.Google Scholar
Dessolle, L, Dalmon, C, Roche, B, Darai, E. [Placental metastases from maternal malignancies: review of the literature]. J Gynecol Obstet Biol Reprod (Paris) 2007; 36: 344–53.Google Scholar
Eltorky, M, Khare, VK, Osborne, P, Shanklin, DR. Placental metastasis from maternal carcinoma: a report of three cases. J Reprod Med 1995; 40: 399403.Google Scholar

References

United Network for Organ Sharing. History. https://www.unos.org/transplantation/history (accessed March 2017).Google Scholar
Murray, JE, Reid, DE, Harrison, JH, Merrill, JP. Successful pregnancies after human renal transplantation. N Engl J Med 1963; 269: 341–3.Google Scholar
Organ Procurement and Transplantation Network, Scientific Registry of Transplant Recipients. OPTN/SRTR Annual Data Report 2015. Am J Transplant 2017; 17 (Suppl S1): 1564. http://onlinelibrary.wiley.com/doi/10.1111/ajt.2017.17.issue-S1/issuetoc (accessed March 2017).Google Scholar
Bartlett, ST. Laproscopic donor nephrectomy after seven years. Am J Transplant 2002; 2: 896–7.Google Scholar
Moritz, MJ, Armenti, VT. Organ transplantation. In Jarrell, BE, Carabasi, RA (eds), National Medical Series for Independent Study: Surgery. Philadelphia, PA: Lippincott Williams & Wilkins, 2000, pp. 461–77.Google Scholar
Armenti, VT, Moritz, MJ, Davison, JM. Drug safety issues in pregnancy following transplantation and immunosuppression. Drug Saf 1998; 19: 219–32.Google Scholar
Fraser, FC, Fainstat, TD. The production of congenital defects in the offspring of pregnant mice treated with cortisone: a progress report. Pediatrics 1951; 8: 527–33.Google Scholar
Oren, D, Nulman, I, Makhija, M, Ito, S, Koren, G. Using corticosteroids during pregnancy: are topical, inhaled, or systemic agents associated with risk? Can Fam Physician 2004; 50: 1083–5.Google Scholar
Park-Wyllie, L, Mazzotta, P, Pastuszak, A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.Google Scholar
Cleary, BJ, Kallen, B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res A Clin Mol Teratol 2009; 85: 647–54.Google Scholar
Davison, JM. Dialysis, transplantation, and pregnancy. Am J Kidney Dis 1991; 17: 127–32.Google Scholar
Leb, DE, Weisskopf, B, Kanovitz, BS. Chromosome aberrations in the child of a kidney transplant recipient. Arch Intern Med 1971; 128: 441–4.Google Scholar
Mason, RJ, Thomson, AW, Whiting, PH, et al. Cyclosporine-induced feto-toxicity in the rat. Transplantation 1985; 39: 912.Google Scholar
Pickrell, MD, Sawers, R, Michael, J. Pregnancy after renal transplantation: severe intrauterine growth retardation during treatment with cyclosporin A. Br Med J 1988; 296: 825.Google Scholar
Paziana, K, Del Monaco, M, Cardonick, E, et al. Ciclosporin use during pregnancy. Drug Saf 2013; 36: 279–94.Google Scholar
Farley, DE, Shelby, J, Alexander, D, Scott, JR. The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. Transplantation 1991; 52: 106–10.Google Scholar
Jain, A, Venkataramanan, R, Fung, JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997; 64: 559–65.Google Scholar
Kainz, A, Harabacz, I, Cowlrick, IS, Gadgil, S, Hagiwara, D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000; 70: 1718–21.Google Scholar
National Transplantation Pregnancy Registry (NTPR). 2014 Annual Report: Gift of Life Institute. Philadelphia, PA: NTPR, 2015.Google Scholar
Genentech USA Inc. Mycophenolate mofetil package insert. South San Francisco, CA, 2013.Google Scholar
Novartis Pharmaceuticals. Mycophenolic acid package insert. East Hanover, NJ, 2013.Google Scholar
Sifontis, NM, Coscia, LA, Constantinescu, S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006; 82: 1698–702.Google Scholar
Le Ray, C, Coulomb, A, Elefant, E, Frydman, R, Audibert, F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 2004; 103: 1091–4.Google Scholar
Anderka, MT, Lin, AE, Abuelo, DN, Mitchell, AA, Rasmussen, SA. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 2009; 149A: 1241–8.Google Scholar
Klieger-Grossmann, C, Chitayat, D, Lavign, S, et al. Prenatal exposure to mycophenolate mofetil: an updated estimate. J Obstet Gynaecol Can 2010; 32: 794–7.Google Scholar
Hoeltzenbein, M, Elefant, E, Vial, T, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 2012; 158A: 588–96.Google Scholar
Coscia, LA, Armenti, DP, King, RW, et al. Update on the teratogenicity of maternal mycophenolate mofetil. J Pediatr Genet 2015; 4: 42–5.Google Scholar
EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17 (Suppl 4): 50–5.Google Scholar
Jones, A, Clary, MJ, McDermott, E, et al. Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products. Prog Transplant 2013; 23: 153–7.Google Scholar
Kim, M, Rostas, S, Gabardi, S. Mycophenolate fetal toxicity and risk evaluation and mitigation strategies. Am J Transplant 2013; 13: 1383–9.]Google Scholar
Pfizer. Sirolimus package insert. Philadelphia, PA, 2014.Google Scholar
Chu, SH, Liu, KL, Chiang, YJ, Wang, HH, Lai, PC. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transplant Proc 2008; 40: 2446–8.Google Scholar
Keller, F, Wiesner, S, Bunjes, D, Hartmann, B, Schmitt, M. Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation. Ann Transplant 2012; 17: 52–8.Google Scholar
Novartis Pharmaceuticals. Everolimus package insert. East Hanover, NJ, 2013.Google Scholar
Veroux, M, Corona, D, Veroux, P. Pregnancy under everolimus-based immunosuppression. Transpl Int 2011; 24(12): e115–17.Google Scholar
Carta, P, Zanazzi, M, Minetti, EE. Unplanned pregnancies in kidney transplanted patients treated with everolimus: three case reports. Transpl Int 2015; 28: 370–2.Google Scholar
Heeman, U, Viklicky, O. The role of belatacept in transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agents. Clin Transplant 2013; 27: E3–11.Google Scholar
Bristol-Myers Squibb Company. Belatacept package insert. Princeton, NJ, 2013.Google Scholar
Combs, J, Kagan, A, Boelkins, M, et al. Belatacept during pregnancy in renal transplant recipients: two case reports. Am J Transplant 2018; 18: 2079–82. doi: 10.1111/ajt.14911.Google Scholar
Davison, JM, Lind, T, Uldall, PR. Planned pregnancy in a renal transplant recipient. Br J Obstet Gynaecol 1976; 83: 518–27.Google Scholar
McKay, DB, Josephson, MA, Armenti, VT, et al.; Women’s Health Committee of the American Society of Transplantation. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005; 5: 1592–9.Google Scholar
First, MR, Combs, CA, Weiskittel, P, Miodovnik, M. Lack of effect of pregnancy on renal allograft survival or function. Transplantation 1995; 59: 472–6.Google Scholar
Sturgiss, SN, Davison, JM. Effect of pregnancy on the long-term function of renal allografts: an update. Am J Kidney Dis 1995; 26: 54–6.Google Scholar
Rahamimov, R, Ben-Haroush, A, Wittenberg, C, et al. Pregnancy in renal transplant recipients: long-term effect on patient and graft survival. A single-center experience. Transplantation 2006; 81(5):660664.Google Scholar
Guazzelli, CA, Torlini, MR, Sanches, TF, Barbieri, M, Pestana, JO. Contraceptive counseling and use among 197 female kidney transplant recipients. Transplantation 2008; 86: 669–72.Google Scholar
Xu, L, Yang, Y, Shi, JG, et al. Unwanted pregnancy among Chinese renal transplant recipients. Eur J Contracept Reprod Health Care 2011; 16: 270–6.Google Scholar
Ghazizadeh, S, Lessan-Pezeshki, M, Khatami, M, et al. Unwanted pregnancy among kidney transplant recipients in Iran. Transplant Proc 2005; 37: 3085–7.Google Scholar
Curtis, KM, Jamieson, DJ, Peterson, HB, Marchbanks, PA. Adaptation of the World Health Organization’s medical eligibility criteria for contraceptive use for use in the United States. Contraception 2010; 82: 39.Google Scholar
Krajewski, C, Sucato, G. Reproductive health care after transplantation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1222–34.Google Scholar
Curtis, KM, Tepper, NK, Jatlaoui, TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65 (RR-3): 1104. https://www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm (accessed March 2017).Google Scholar
Kosola, S, Lampela, H, Lauronen, J, et al. General health, health related quality of life and sexual health after pediatric liver transplantation: a nationwide study. Am J Transplant 2012; 12: 420–7.Google Scholar
Constantinescu, S, Gomez-Lobo, V, Davison, JM, Moritz, MJ, Armenti, VT. Pregnancy and contraception in transplantation. In Kirk, AD, Knechtle, SJ, Larsen, CP, Pearson, TC, Webber, SA (eds), The Textbook of Organ Transplantation. London: Wiley-Blackwell, 2014, pp. 1161–78.Google Scholar
Zerner, J, Doil, KL, Drewry, J, Leeber, DA. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 1981; 26: 99102.Google Scholar
Bahamondes, MV, Hidalgo, MM, Bahamondes, L, Monteiro, I. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine device in nulligravidas. Contraception 2011; 84: e11–16.Google Scholar
Davison, JM. Pregnancy in renal allograft recipients: problems, prognosis and practicalities. Ballieres Clin Obstet Gynaecol 1994; 8: 501–25.Google Scholar
Davison, JM. Renal disorders in pregnancy. Curr Opin Obstet Gynecol 2001; 13: 109–14.Google Scholar
Armenti, VT, Ahlswede, KM, Ahlswede, BA, et al. National Transplantation Pregnancy Registry: outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994; 57: 502–6.Google Scholar
Davison, JM, Redman, CW. Pregnancy post-transplant: the establishment of a UK registry. Br J Obstet Gynaecol 1997; 104: 1106–7.Google Scholar
Sibanda, N, Briggs, JD, Davison, JM, Johnson, RJ, Rudge, CJ. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation 2007; 83: 1301–7.Google Scholar
Bramham, K, Nelson-Piercy, C, Gao, H, et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin J Am Soc Nephrol 2013; 8: 290–8.Google Scholar
Mohamed-Ahmed, O, Nelson-Piercy, C, Bramham, K, et al. Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study. PLoS One 2014; 9: e89151. doi: 10.1371/journal.pone.0089151.Google Scholar
Wyld, ML, Clayton, PA, Jesudason, S, Chadban, SJ, Alexander, SI. Pregnancy outcomes for kidney transplant recipients. Am J Transplant 2013; 13: 3173–82.Google Scholar
Coscia, LA, Cardonick, EH, Moritz, MJ, Armenti, VT. Multiple gestations in female kidney transplant recipients maintained on calcineurin inhibitors. Am J Transplant 2003; 3 (Suppl 5): 563, Abs. 1603.Google Scholar
Norrman, E, Bergh, C, Wennerholm, UB. Pregnancy outcome and long-term follow-up after in vitro fertilization in women with renal transplantation. Hum Reprod 2015; 30: 205–13.Google Scholar
Scheurrer, U, Rimoldi, SF, Rexhaj, E, et al. Systemic and pulmonary vascular dysfunction in children conceived by assisted reproduction techniques. Circulation 2012; 125: 1890–6.Google Scholar
Rexhaj, E, Paoloni-Giacobino, A, Rimoldi, SF. Mice generated by in vitro fertilisation exhibit vascular dysfunction and shortened lifespan. J Clin Invest 2014; 123: 5052–60.Google Scholar
Oz, BB, Hackman, R, Einarson, T, Koren, G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71: 1051–5.Google Scholar
Scott, JR, Branch, DW, Holman, J. Autoimmune and pregnancy complications in the daughter of a kidney transplant patient. Transplantation 2002; 73: 815–16.Google Scholar
Pilarski, LM, Yacyshyn, BR, Lavarovits, AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or azathioprine in utero. Transplantation 1994; 57: 133–44.Google Scholar
Di Paolo, S, Schena, A, Morrone, LF, et al. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated kidney transplant recipients: analysis of lymphocyte suppopulation and immunoglobulin serum levels. Transplantation 2000; 69: 2049–54.Google Scholar
Stanley, CW, Gottlieb, R, Zager, R, et al. Developmental wellbeing in offspring of women receiving cyclosporine post-renal transplant. Transplant Proc 1999; 31: 241–2.Google Scholar
Nulman, I, Sgro, M, Barrera, M, et al. Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant. Pediatr Drugs 2010; 12: 113–22.Google Scholar
Chotiner, R. Investigation of cognitive and physical developmental abilities of young children exposed to tacrolimus and cyclosporine in utero. PhD thesis, Temple University, 2011. http://digital.library.temple.edu/cdm/compoundobject/collection/p245801coll10/id/142947/rec/1 (accessed March 2017).Google Scholar
Armenti, VT, Moritz, MJ, Davison, JM. Pregnancy. In Fine, RN, Webber, SA, Oltoff, KM, Kelly, DA, Harmon, WE (eds), Pediatric Solid Organ Transplantation, 2nd edn. Malden, MA: Blackwell, 2007, pp. 425–36.Google Scholar
Deshpande, N, Coscia, LA, Gomez-Lobo, V, Moritz, MJ, Armenti, VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol 2013; 6: 116–25.Google Scholar
Josephson, MA, McKay, DB. Women and transplantation: fertility, sexuality, pregnancy, contraception. Adv Chronic Kidney Dis 2013; 20: 433–40.Google Scholar
Parhar, KS, Gibson, PS, Coffin, CS. Pregnancy following liver transplantation: Review of the outcomes and recommendations for management. Can J Gastroenterol 2012; 26: 621–6.Google Scholar
Ramirez, CB, Doria, C, Moritz, MJ, et al. Contraception and pregnancy. In Neuberger, J, Ferguson, J, Newsome, P (eds), Liver Transplantation: Clinical Assessment and Management. Oxford: Wiley-Blackwell, 2013, pp. 274–82.Google Scholar
Mastrobattista, JM, Gomez-Lobo, V. Pregnancy after solid organ transplantation. Obstet Gynecol 2008; 112: 919–32.Google Scholar
McGrory, CH, Groshek, MA, Sollinger, HW, Moritz, MJ, Armenti, VT. Pregnancy outcomes in female pancreas-kidney recipients. Transplant Proc 1999; 31: 652–3.Google Scholar
Cowan, SW, Davison, JM, Doria, C, Moritz, MJ, Armenti, VT. Pregnancy after cardiac transplantation. Cardiol Clin 2012; 30: 441–52.Google Scholar
Shaner, J, Coscia, LA, Constantinescu, S, et al. Pregnancy after lung transplantation. Progress in Transplantation 2012; 22: 134–40.Google Scholar
Wuthrich, RP, Cicvara, S, Ambuhl, PM, Binswanger, U. Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation. Nephrol Dial Transplant 2000; 15: 1228–31.Google Scholar
Sifontis, NM, Coscia, LA, Lundgren, MP, et al. Pregnancy outcomes in solid organ transplant recipients with a switch from a mycophenolic acid product to azathioprine prior to conception. Am J Transplant 2013; 13 (Suppl 5): 161, Abs. 416.Google Scholar
Constantinescu, S, Axelrod, P, Coscia, L, Moritz, MJ, Armenti, VT. Pregnancy outcomes in kidney recipients who discontinued mycophenolic acid products prior to conception. J Am Soc Nephrol 2013; 24S: 861A.Google Scholar
Cooper, WO, Hernandez-Diaz, S, Arbogast, PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443–51.Google Scholar
Hiremath, S, Fergusson, D, Doucette, S, Mulay, AV, Knoll, GA. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7: 2350–60.Google Scholar
Hyde, C, Thornton, S. Does screening for preeclampsia make sense? BJOG 2013; 120: 1168–70.Google Scholar
Sibai, BM. First-trimester screening with combined clinical factors, biophysical and biomarkers to predict preterm preeclampsia and hypertensive disorders: are they ready for clinical use? BJOG 2015; 122: 282–3.Google Scholar
Conte, D, Fraquell, M, Prati, D, Colucci, A, Minola, E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751–5.Google Scholar
Wong, SY, Remington, JS. Toxoplasmosis in pregnancy. Clin Infect Dis 1994; 18: 853–62.Google Scholar
Moritz, MJ, Coscia, LA, Armenti, D, Constantinescu, S. Cholestasis of pregnancy in liver transplant recipients. Am J Obstet Gynecol 2016; 214: S275.Google Scholar
Williams, D. Long-term complications of preeclampsia. Semin Nephrol 2011; 31: 111–22.Google Scholar
Ananth, CV, Cleary, KM. Preeclampsia and cardiovascular disease: more questions than answers? BJOG 2013; 120:920–3.Google Scholar
Davis, EF, Lazdam, M, Lewandowski, AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012; 129: e1552–61.Google Scholar
Nyberg, G, Haljamäe, U, Frisenette-Fich, C, Wennergren, M, Kjellmer, I. Breast-feeding during treatment with cyclosporine. Transplantation 1998; 65: 253–5.Google Scholar
Constantinescu, S, Pai, A, Coscia, LA, et al. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1163–73.Google Scholar
Bramham, K, Chusney, G, Lee, J, Lightstone, L, Nelson-Piercy, C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol 2013; 8: 563–7.Google Scholar
Rudolph, J, Schweizer, RT, Bartus, SA. Pregnancy in renal transplant patients. Transplantation 1979; 27: 26–9.Google Scholar
Kozlowska-Boszko, B, Lao, M, Gaciong, Z, et al. Chronic rejection as a risk factor for deterioration of renal allograft function following pregnancy. Transplant Proc 1997; 29: 1522–3.Google Scholar
Coscia, LA, Constantinescu, S, Davison, JM, Moritz, MJ, Armenti, VT. Immunosuppressive drugs and fetal outcome. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1174–87.Google Scholar
Armenti, VT, Jarrell, BE, Radomski, JS, et al. National Transplantation Pregnancy Registry (NTPR): cyclosporine dosing and pregnancy outcome in female renal transplant recipients. Transplant Proc 1996; 28: 2111–12.Google Scholar
Blume, C, Pischke, S, von Versen-Höynck, F, Günter, HH, Gross, MM. Pregnancies in liver and kidney transplant recipients: a review of the current literature and recommendation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1123–36.Google Scholar
Brännström, M, Johannesson, L, Bokström, H, et al. Livebirth after uterus transplantation. Lancet 2015; 385: 607–16.Google Scholar
Brännström, M, Bokström, H, Dahm-Kähler, P, et al. One uterus bridging three generations: first live birth after mother-to-daughter uterus transplantation. Fertil Steril 2016; 106: 261–6.Google Scholar
Ejzenberg, D, Andraus, W, Baratelli Carelli Mendes, LR, et al. Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility. Lancet 2019; 392: 2697–704.Google Scholar
Jones, BP, Saso, S, Bracewell-Milnes, T, et al. Human uterine transplantation: a review of outcomes from the first 45 cases. BJOG 2019; 126: 1310–19.Google Scholar
Kvarnström, N, Järvholm, S, Johannesson, L, et al. Live donors of the initial observational study of uterus transplantation-psychological and medical follow-up until 1 year after surgery in the 9 cases. Transplantation 2017; 101: 664.Google Scholar
Petrini, C, Gainotti, S, Morresi, A, Nanni Costa, A. Ethical issues in uterine transplantation: psychological implications and informed consent. Transplant Proc 2017; 49: 707.Google Scholar
Testa, G, Koon, EC, Johannesson, L. Living donor uterus transplant and surrogacy: Ethical analysis according to the principle of equipoise. Am J Transplant 2017; 17: 912–16.Google Scholar

References

Van Hook, JW. Trauma in pregnancy. Clin Obstet Gynecol 2002; 45: 414–24.Google Scholar
Kuo, C, Jamieson, DJ, McPheeters, ML, et al. Injury hospitalizations of pregnant women in the United States, 2002. Am J Obstet Gynecol 2007; 196: 161.e1–6.Google Scholar
Periyayanagam, U, Crandall, M. The cost of injury: hospital charges for pregnant trauma patients, 1999 to 2003. Am J Surg 2014:208: 130–5.Google Scholar
Drost, TF, Rosemurgy, AS, Sherman, HF, et al. Major trauma in pregnant women: maternal/fetal outcome. J Trauma 1990; 30: 574–8.Google Scholar
Scorpio, RJ, Esposito, TJ, Smith, LG, Gens, DR. Blunt trauma during pregnancy: factors affecting fetal outcome. J Trauma 1992; 32: 213–16.Google Scholar
Schiff, MA, Holt, VL. The injury severity score in pregnant trauma patients: predicting placental abruption and fetal death. J Trauma 2002; 53: 946–9.Google Scholar
World Health Organization. Global and Regional Estimates of Violence Against Women: Prevalence and Health Effects of Intimate Partner Violence and Non-Partner Sexual Violence. Geneva: WHO, 2013.Google Scholar
El Kady, D, Gilbert, WM, Anderson, J, et al. Trauma during pregnancy: an analysis of maternal and fetal outcomes. Am J Obstet Gynecol 2004; 190: 1661–8.Google Scholar
Sperry, JL, Casey, BM, McIntire, DD, et al. Long-term fetal outcomes in pregnant trauma patients. Am J Surg 2006; 192: 715–21.Google Scholar
Weiss, HB, Sauber-Schatz, EK, Cook, LJ. The epidemiology of pregnancy-associated emergency department injury visits and their impact on birth outcomes. Accid Anal Prev 2008; 40: 1088–95.Google Scholar
Cotton, BA, Jerome, R, Collier, BR, et al. Guidelines for prehospital fluid resuscitation in the injured patient. J Trauma 2009; 67: 389402. http://www.east.org/education/practice-management-guidelines/prehospital-fluid-resuscitation-in-the-injured-patient (accessed March 2017).Google Scholar
Goodwin, TM, Breen, MT. Pregnancy outcome and fetomaternal hemorrhage after noncatastrophic trauma. Am J Obstet Gynecol 1990; 162: 665–71.Google Scholar
Baker, SP, O’Neill, B, Haddon, W, Long, WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14: 187–96.Google Scholar
Cahill, AG, Bastek, JA, Stamilio, DM. Minor trauma in pregnancy: is the evaluation unwarranted? Am J Obstet Gynecol 2008; 198: 208.e1–5.Google Scholar
Tanizaki, S, Maeda, S, Matano, H, et al. Elevated maternal serum α-fetoprotein after minor trauma during pregnancy may predict adverse fetal outcomes. J Trauma Acute Care Surg 2014; 77: 510–13.Google Scholar
Pearlman, MD, Tintinalli, JE, Lorenz, RP. Blunt trauma during pregnancy. N Engl J Med 1991; 323: 1609–13.Google Scholar
Sihler, KC, Napolitano, LM. Massive transfusion: new insights. Chest 2009; 136: 1654–67.Google Scholar
Esposito, TJ. Trauma during pregnancy. Emerg Med Clin North Am 1994; 12: 167–99.Google Scholar
Pearlman, MD, Tintinalli, JF. Evaluation and treatment of the gravida and fetus following trauma during pregnancy. Obstet Gynecol Clin North Am 1991; 18: 371–81.Google Scholar
Smith, RS, Bottoms, SF. Ultrasonographic prediction of neonatal survival in extremely low-birth-weight infants. Am J Obstet Gynecol 1993; 169: 490–3.Google Scholar
Knottenbelt, JD. Low initial hemoglobin levels in trauma patients: an important indicator of ongoing hemorrhage. J Trauma 1991; 31: 1396–9.Google Scholar
Sahdev, P, Garramone, RR, Schwartz, RJ, et al. Evaluation of liver function tests in screening for intra-abdominal injuries. Ann Emerg Med 1991; 20: 838–41.Google Scholar
American College of Obstetricians and Gynecologists (ACOG). Guidelines for Diagnostic Imaging During Pregnancy. ACOG Committee Opinion No. 229. Washington, DC: ACOG, 2004.Google Scholar
Hoff, WS, Holevar, M, Nagy, KK, et al. Practice management guidelines for the evaluation of blunt abdominal trauma: the EAST Practice Management Guidelines Work Group. J Trauma 2002; 53: 602–15. http://www.east.org/education/practice-management-guidelines/blunt-abdominal-trauma,-evaluation-of (accessed March 2017).Google Scholar
Rothenberger, DA, Quattlebaum, FW, Zabel, J, Fischer, RP. Diagnostic peritoneal lavage for blunt trauma in pregnant women. Am J Obstet Gynecol 1977; 129: 479–81.Google Scholar
Goodwin, H, Holmes, JF, Wisner, DH. Abdominal ultrasound examination in pregnant blunt trauma patients. J Trauma 2001; 50: 689–94.Google Scholar
Brown, MA, Sirlin, CB, Farahmand, N, et al. Screening sonography in pregnant patients with blunt abdominal trauma. J Ultrasound Med 2005; 24: 175–81.Google Scholar
Geerts, WH, Code, KI, Jay, RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331: 1601–6.Google Scholar
Guyatt, GH, Akl, EA, Crowther, M, Gutterman, DD, Schuünemann, HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): 7S47S.Google Scholar
Guillamondegui, OD, Gunter, OL, Bonadies, JA, et al. Practice management guidelines for stress ulcer prophylaxis. EAST Practice Management Guidelines Committee, 2008. https://www.east.org/education/practice-management-guidelines/stress-ulcer-prophylaxis (accessed March 2017).Google Scholar
Klinich, KD, Flannagan, CA, Rupp, JD, et al. Fetal outcome in motor-vehicle crashes: effects of crash characteristics and maternal restraint. Am J Obstet Gynecol 2008; 198: 450.e1–9.Google Scholar
Pearlman, MD. Motor vehicle crashes, pregnancy loss and preterm labor. Int J Gynecol Obstet 1997; 57: 127–32.Google Scholar
Dahmus, MA, Sibai, BM. Blunt abdominal trauma: are there any predictive factors for abruptio placentae or maternal-fetal distress? Am J Obstet Gynecol 1993; 169: 1054–9.Google Scholar
El Kady, D, Gilbert, WM, Xing, G, Smith, LH. Maternal and neonatal outcomes of assaults during pregnancy. Obstet Gynecol 2005; 105: 357–63.Google Scholar
El Kady, D, Gilbert, WM, Xing, G, Smith, LH. Association of maternal fractures with adverse perinatal outcomes. Am J Obstet Gynecol 2006; 195: 711–16.Google Scholar
Leggon, RE, Wood, C, Indeck, MC. Pelvic fractures in pregnancy: influencing maternal and fetal outcomes. J Trauma 2002; 3: 796804.Google Scholar
Amorosa, LF, Amorosa, JH, Wellman, DS, Helfet, DL. Management of pelvic injuries in pregnancy. Orthop Clin N Am 2013; 44: 301–15.Google Scholar
Hyde, LK, Cook, LJ, Olson, LM, et al. Effect of motor vehicle crashes on adverse fetal outcome. Obstet Gynecol 2003; 102: 279–86.Google Scholar
Williams, JK, McClain, L, Rosemurgy, AS, Colorado, NM. Evaluation of blunt abdominal trauma in the third trimester of pregnancy: maternal and fetal considerations. Obstet Gynecol 1990; 75: 33–7.Google Scholar
American College of Obstetricians and Gynecologists (ACOG). Obstetric Aspects of Trauma Management. ACOG Educational Bulletin No. 251). Washington, DC: ACOG, 1998.Google Scholar
Theodorou, DA, Velmahos, GC, Souter, I, et al. Fetal death after trauma in pregnancy. Am Surg 2000; 66: 809–12.Google Scholar
Curet, MJ, Schermer, CR, Demarest, GB, et al. Predictors of outcome in trauma during pregnancy: identification of patients who can be monitored for less than 6 hours. J Trauma 2000; 49: 1825.Google Scholar
Dhanraj, D, Lambers, D. The incidence of positive Kleihauer–Betke test in low-risk pregnancies and maternal trauma patients. Am J Obstet Gynecol 2004; 190: 1461–3.Google Scholar
Muench, MV, Baschat, AA, Reddy, UM, et al. Kleihauer–Betke testing is important in all cases of maternal trauma. J Trauma 2004; 57: 1094–8.Google Scholar
Rubod, C, Deruelle, P, Le Goueff, F, et al. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol 2007; 110: 256–60.Google Scholar
Huissoud, C, Divry, V, Dupont, C, et al. Large fetomaternal hemorrhage: prenatal predictive factors for perinatal outcome. Am J Perinatol 2009; 26: 227–33.Google Scholar
Pearlman, MD, Phillips, ME. Safety belt use during pregnancy. Obstet Gynecol 1996; 88: 1026–9.Google Scholar
Manoogian, S. Comparison of pregnant and non-pregnant occupant crash and injury characteristics based on national crash data. Accid Anal Prev 2015; 74: 6976.Google Scholar
McGwin, G, Willey, P, Ware, A, et al. A focused educational intervention can promote the proper application of seat belts during pregnancy. J Trauma 2004; 56: 1016–21.Google Scholar
Schiff, MA, Mack, CD, Kauffman, RP et al. The effect of air bags on pregnancy outcomes in Washington state. Obstet Gynecol 2010; 115: 8592Google Scholar
Sakala, EP, Kort, DD. Management of stab wounds to the pregnant uterus: a case report and a review of the literature. Obstet Gynecol Surv 1988; 43: 319–24.Google Scholar
Buchsbaum, HJ. Diagnosis and management of abdominal gunshot wounds during pregnancy. J Trauma 1975; 15: 425–30.Google Scholar
Sela, HY, Shveiky, D, Laufer, N, et al. Pregnant women injured in terror-related multiple casualty incidents: injuries and outcomes. J Trauma 2008; 64: 727–32.Google Scholar
Yıldız, MK, Ozkan, E, Odabaşı, HM, et al. Analysis of 120 patients with abdominal stab wound focusing on diagnostic role of fast. Int J Clin Exp Med 2014; 7: 1386–90.Google Scholar
Petrone, P, Talving, P, Browder, T, et al. Abdominal injuries in pregnancy: a 155-month study at two level 1 trauma centers. Injury 2011; 42: 47–9.Google Scholar
Franger, AL, Buchsbaum, HJ, Peaceman, AM. Abdominal gunshot wounds in pregnancy. Am J Obstet Gynecol 1989; 160: 1124– 8.Google Scholar
Carugno, JA, Rodriguez, A, Brito, J, Cabrera, C. Gunshot wound to the gravid uterus with non-lethal fetal injury. J Emerg Med 2008; 35: 43–5.Google Scholar
Tsutsumi, S, Ueta, T, Shiba, K, et al. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury: results in spinal injuries center. Spine 2006; 26: 2992–6.Google Scholar
Walters, BC, Hadley, MN, Hurlbert, RJ, et al. Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery. 2013; 60 (Suppl 1): 8291.Google Scholar
Pacheco, LD, Gei, AF, Vanhook, JW, Saade, GR, Hankins, GD. Burns in pregnancy. Obstet Gynecol 2005; 106: 1210–12.Google Scholar
Akhtar, MA, Mulawkar, PM, Kulkarni, HR. Burns in pregnancy: effect on maternal and fetal outcomes. Burns 1994; 20: 351–5.Google Scholar
Maghsoudi, H, Samnia, R, Garadaghi, A, Kianvar, H. Burns in pregnancy. Burns 2006; 32: 246–50.Google Scholar
Alharbi, Z, Piatkowski, A, Dembinski, R, et al. Treatment of burns in the first 24 hours: simple and practical guide by answering 10 questions in a step-by-step form. World J Emerg Surg 2012; 7: 13. http://wjes.biomedcentral.com/articles/10.1186/1749-7922-7-13 (accessed March 2017).Google Scholar
Kasten, KR, Makley, AT, Kagan, RJ. Update on the critical care management of severe burns. J Intensive Care Med 2011; 26: 223–36.Google Scholar
Paratz, JD, Stockton, K, Paratz, ED, et al. Burn resuscitation: hourly urine output versus alternative endpoints: a systematic review. Shock 2014; 42: 295306.Google Scholar
Roderique, EJ, Gebre-giorgis, AA, Stewart, DH, Feldman, MJ, Pozez, AL. Smoke inhalation injury in a pregnant patient: a literature review of the evidence and current best practices in the setting of a classic case. J Burn Care Res 2012; 33: 624–33.Google Scholar
Van Hoesen, KB, Camporesi, EM, Moon, RE, et al. Should hyperbaric oxygen be used to treat the pregnant patient for acute carbon monoxide poisoning? A case report and literature review. JAMA 1989; 261: 1039–43.Google Scholar
Polko, LE, McMahon, MJ. Burns in pregnancy. Obstet Gynecol Surv 1998; 53: 50–6.Google Scholar
Takeda, K, Sowa, Y, Numajiri, T, Nishino, K. Expansion abdominoplasty for a pregnant woman with severe abdominal wall contracture due to a major burn during childhood: a case report. Ann Plast Surg 2013; 70: 643–6.Google Scholar
Webb, JC, Baack, BR, Osler, TM, et al. A pregnancy complicated by mature abdominal burns scarring and its surgical solution: a case report. J Burn Care Rehabil 1995; 16: 276–9.Google Scholar
Fatovich, DM. Electric shock in pregnancy. J Emerg Med 1993; 11: 175–7.Google Scholar
Garcia Gutierre, JJ, Melendez, J, Torrero, JV, et al. Lightning injuries in a pregnant woman: a case report and review of the literature. Burns 2005; 31: 1045–9.Google Scholar
Einarson, A, Bailey, B, Inocencion, G, et al. Accidental electric shock in pregnancy: a prospective cohort study. Am J Obstet Gynecol 1997; 176: 678–81.Google Scholar
Fish, RM. Electric injury: Part III. Cardiac monitoring indications, the pregnant patient and lightning. J Emerg Med 2000; 18: 181–7.Google Scholar
Sparic, R, Malvasi, A, Nejkovic, L, Tinelli, A. Electric shock in pregnancy: a review. J Matern Fetal Neonatal Med 2016; 29: 317–23.Google Scholar
Vanden Hoek, TL, Morrison, LJ, Shuster, M, et al. Part 12: Cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122 (suppl): S829–61. http://circ.ahajournals.org/content/122/18_suppl_3/S829.full (accessed March 2017).Google Scholar
Lipman, S, Cohen, S, Einav, S, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the management of cardiac arrest in pregnancy. Anesth Analg 2014; 118: 1003–16.Google Scholar
Katz, V. Perimortem cesarean delivery: its role in maternal mortality. Semin Perinatol 2012; 36: 6872.Google Scholar

References

Cox, JL, Murray, D, Chapman, G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993; 163: 2731.Google Scholar
Joint Commissioning Panel for Mental Health. Guidance for Commissioners of Perinatal Mental Health Services. Volume Two: Practical Mental Health Commissioning. London: JCPMH, 2012. http://www.rcpsych.ac.uk/pdf/perinatal_web.pdf (accessed March 2017).Google Scholar
Confidential Enquiries into Maternal Deaths. Why Mothers Die 2000–2002: The Sixth Report of the Confidential Enquiries into Maternal Deaths in the UK. London: Royal College of Obstetricians and Gynaecologists, 2004.Google Scholar
Lewis, G, Clutton-Brock, T, Cooper, G, et al. Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer – 2003 to 2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London, CEMACH, 2007.Google Scholar
Cantwell, R, Clutton-Brock, T, Cooper, G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eight Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl 1): 1203.Google Scholar
Knight, M, Bunch, K, Tuffnell, D, et al. Saving Lives, Improving Mothers’ Care: Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014–16. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2018.Google Scholar
National Institute for Health and Care Excellence (NICE). Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance. Clinical Guideline 192. London: NICE, 2014 (updated February 2020). www.nice.org.uk/guidance/cg192 (accessed February 2020).Google Scholar
Scottish Intercollegiate Guidelines Network. Management of Perinatal Mood Disorders: A National Clinical Guideline. SIGN 127. Edinburgh: SIGN, 2012. http://sign.ac.uk/guidelines/fulltext/127 (accessed March 2017).Google Scholar
NHS England. NHS Five Year Forward View. London: NHS, 2014.Google Scholar
NHS England. The NHS Long Term Plan. London: NHS, 2019. www.longtermplan.nhs.uk (accessed February 2020).Google Scholar
Oates, M. Suicide: the leading cause of maternal death. Br J Psychiatry 2003; 183: 279–81.Google Scholar
Stein, A, Pearson, RM, Goodman, SH. Effects of perinatal mental disorders on the fetus and child. Lancet 2014; 384: 1800–17.Google Scholar
McAllister-Williams, RH, Baldwin, DS, Cantwell, R, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017; 31: 519–52. doi: 10.1177/0269881117699361.Google Scholar
Di Florio, A, Forty, L, Gordon-Smith, K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 2013; 70: 168–75.Google Scholar
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Publishing, 2013.Google Scholar
Gavin, NI, Gaynes, BN, Lohr, KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005; 106: 1071–83.Google Scholar
Henshaw, C, Foreman, D, Cox, J. Postnatal blues: a risk factor for postnatal depression. J Psychosom Obstet Gynaecol 2004; 25: 267–72.Google Scholar
Parsons, CE, Young, KS, Rochat, TJ, Kringelbach, ML, Stein, A. Postnatal depression and its effects on child development: a review of evidence from low- and middle-income countries. Br Med Bull 2012; 101: 5779.Google Scholar
O’Hara, MW, Swain, AM. Rates and risk of postpartum depression – a meta-analysis. Int Rev Psychiatry 1996; 8: 8798.Google Scholar
Munk-Olsen, T, Laursen, TM, Pedersen, CB, Mors, O, Mortensen, PB. New parents and mental disorders: a population-based register study. JAMA 2006; 296: 2582–9.Google Scholar
Josefsson, A, Angelsiöö, L, Berg, G, et al. Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. Obstet Gynecol 2002; 99: 223–8.Google Scholar
Cooper, C, Jones, L, Dunn, E, et al. Clinical presentation of postnatal and non-postnatal depressive episodes. Psychol Med 2007; 37: 1273–80.Google Scholar
Nylen, KJ, Williamson, JA, O’Hara, MW, Watson, D, Engeldinger, J. Validity of somatic symptoms as indicators of depression in pregnancy. Arch Womens Ment Health 2013; 16: 18.Google Scholar
Dayan, J, Creveuil, C, Dreyfus, M, et al. Developmental model of depression applied to prenatal depression: role of present and past life events, past emotional disorders and pregnancy stress. PLoS One 2010; 22: e12942.Google Scholar
Forty, L, Jones, L, Macgregor, S, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry 2006; 163: 1549–53.Google Scholar
Forman, ND, Videbech, P, Hedegaard, M, Dalby Salvig, J, Secher, NJ. Postpartum depression: identification of women at risk. BJOG 2000; 107: 1210–17.Google Scholar
Brockington, IF, Aucamp, HM, Fraser, C. Severe disorders of the mother–infant relationship: definitions and frequency. Arch Womens Ment Health 2006; 9: 243–51.Google Scholar
Howard, LM, Oram, S, Galley, H, Trevillion, K, Feder, G. Domestic violence and perinatal mental disorders: a systematic review and meta-analysis. PLoS Med 2013; 10: e1001452.Google Scholar
Talge, NM, Neal, C, Glover, V. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007; 48: 245–61.Google Scholar
Brown, AS, van Os, J, Driessens, C, Hoek, HW, Susser, ES. Further evidence of relation between prenatal famine and major affective disorder. Am J Psychiatry 2000; 157: 190–5.Google Scholar
Grigoriadis, S, VonderPorten, EH, Mamisashvili, L, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74: e321–41.Google Scholar
Grote, NK, Bridge, JA, Gavin, AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012–24.Google Scholar
Pearson, RM, Evans, J, Kounali, D, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry 2013 Dec; 70: 1312–19. doi: 10.1001/jamapsychiatry.2013.2163.Google Scholar
O’Donnell, KJ, Glover, V, Barker, ED, O’Connor, TG. The persisting effect of maternal mood in pregnancy on childhood psychopathology. Dev Psychopathol 2014; 26: 393403. doi: 10.1017/S0954579414000029.Google Scholar
Capron, LE, Glover, V, Pearson, RM, et al. Associations of maternal and paternal antenatal mood with offspring anxiety disorder at age 18 years. J Affect Disord 2015; 187: 20–6. doi: 10.1016/j.jad.2015.08.012.Google Scholar
Cohen, LS, Altshuler, LL, Harlow, BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499507.Google Scholar
Ross, LE, Grigoriadis, S, Mamisashvili, L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 2013; 70: 436–43.Google Scholar
Huybrechts, KF, Palmsten, K, Avorn, J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014; 370: 2397–407.Google Scholar
Grigoriadis, S, VonderPorten, EH, Mamisashvili, L, et al. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry 2013; 74: e293308.Google Scholar
Bérard, A, Iessa, N, Chaabane, S, et al. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol 2016; 81: 589604. doi: 10.1111/bcp.12849.Google Scholar
Hemels, ME, Einarson, A, Koren, G, Lanctôt, KL, Einarson, TR. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 2005; 39: 803–9.Google Scholar
Yonkers, KA, Blackwell, KA, Glover, J, Forray, A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol 2014; 10: 369–92.Google Scholar
Grigoriadis, S, Vonderporten, EH, Mamisashvili, L, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ 2014; 348: f6932.Google Scholar
Masarwa, R, Bar-Oz, B, Gorelik, E, et al. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Am J Obstet Gynecol 2019; 220: 57.e157.e13. doi: 10.1016/j.ajog.2018.08.030.Google Scholar
Croen, LA, Grether, JK, Yoshida, CK, Odouli, R, Hendrick, V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011; 68: 1104–12.Google Scholar
Man, KK, Tong, HH, Wong, LY, et al. Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies. Neurosci Biobehav Rev 2015; 49: 82–9.Google Scholar
Kaplan, YC, Keskin-Arslan, E, Acar, S, Sozmen, K. Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies. Br J Clin Pharmacol 2017; 83: 2798–806. doi: 10.1111/bcp.13382.Google Scholar
Hviid, A, Melbye, M, Pasternak, B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 2013; 369: 2406–15.Google Scholar
Vega, ML, Newport, GC, Bozhdaraj, D, et al. Implementation of advanced methods for reproductive pharmacovigilance in autism: a meta-analysis of the effects of prenatal antidepressant exposure. Am J Psychiatry 2020; 177: 506–17. https://doi.org/10.1176/appi.ajp.2020.18070766.Google Scholar
Clements, CC, Castro, VM, Blumenthal, SR, et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry 2015; 20: 727–34.Google Scholar
Grigoriadis, S, VonderPorten, EH, Mamisashvili, L, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74: e309–20.Google Scholar
Fenger-Grøn, J, Thomsen, M, Andersen, KS, Nielsen, RG. Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review. Dan Med Bull 2011; 58: A4303.Google Scholar
Klinger, G, Frankenthal, D, Merlob, P, et al. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. J Perinatol. 2011; 31: 615–20.Google Scholar
Kim, DR, Epperson, N, Paré, E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt) 2011; 20: 255–61.Google Scholar
Pompili, M, Dominici, G, Giordano, G, et al. Electroconvulsive treatment during pregnancy: a systematic review. Expert Rev Neurother 2014; 14: 1377–90.Google Scholar
Leiknes, KA, Cooke, MJ, Jarosch-von Schweder, L, Harboe, I, Høie, B. Electroconvulsive treatment during pregnancy: a systematic review. Arch Womens Ment Health 2015; 18: 139.Google Scholar
Dennis, CL, Dowswell, T. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev 2013; (2): CD001134.Google Scholar
Sockol, LE, Epperson, CN, Barber, JP. Preventing postpartum depression: a meta-analytic review. Clin Psychol Rev 2013; 33: 1205–17.Google Scholar
Dennis, CL, Hodnett, E. Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database Syst Rev 2007; (4): CD006116.Google Scholar
Molyneaux, E, Howard, LM, McGeown, HR, Karia, AM, Trevillion, K. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2014; (9): CD002018.Google Scholar
Sinyor, M, Schaffer, A, Levitt, A. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry 2010; 55: 126–35.Google Scholar
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799808.Google Scholar
Semkovska, M, McLoughlin, DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68: 568–77.Google Scholar
Murrough, JW, Iosifescu, DV, Chang, LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013; 170: 1134–42.Google Scholar
Gaynes, BN, Lloyd, SW, Lux, L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry 2014; 75: 477–89.Google Scholar
National Institute for Health and Care Excellence (NICE). Bipolar Disorder: Assessment and Management. Clinical Guideline 185. London: NICE, 2014. https://www.nice.org.uk/guidance/cg185 (accessed March 2017).Google Scholar
Dierckx, B, Heijnen, WT, van den Broek, WW, Birkenhager, TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord 2012; 14: 146–50.Google Scholar
Judd, LL, Akiskal, HS, Schettler, PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530–7.Google Scholar
Merikangas, KR, Akiskal, HS, Angst, J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2007; 64 (5): 543–52.Google Scholar
Yonkers, KA, Vigod, S, Ross, LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 2011; 117: 961–77.Google Scholar
Viguera, AC, Tondo, L, Koukopoulos, AE, et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 2011; 168: 1179–85.Google Scholar
Jones, I, Craddock, N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 2001; 158: 913–17.Google Scholar
Jablensky, AV, Morgan, V, Zubrick, SR, Bower, C, Yellachich, LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162: 7991.Google Scholar
Bodén, R, Lundgren, M, Brandt, L, et al. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ. 2012; 345: e7085.Google Scholar
Freeman, MP. Bipolar disorder and pregnancy: risks revealed. Am J Psychiatry 2007; 164: 1771–3.Google Scholar
National Institute for Health and Care Excellence (NICE). Antenatal and Postnatal Mental Health: Quality statement 1: Valproate. London: NICE, 2016. www.nice.org.uk/guidance/qs115/chapter/Quality-statement-1-Valproate (accessed February 2020).Google Scholar
Kendell, RE, Chalmers, JC, Platz, C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150: 662–73.Google Scholar
Epstein, RA, Bobo, WV, Shelton, RC, et al. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf 2013; 22: 794801.Google Scholar
Gentile, S. Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull 2010; 36: 518–44.Google Scholar
Einarson, A, Boskovic, R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009; 15: 183–92.Google Scholar
Damkier, P, Videbech, P. The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs 2018; 32: 351–66. doi: 10.1007/s40263-018-0517-5.Google Scholar
Boden, R, Lundgren, M, Brandt, L, Reutfors, J, Kieler, H. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 2012; 69: 715–21. doi: 10.1001/archgenpsychiatry.2011.1870.Google Scholar
Ellfolk, M, Leinonen, MK, Gissler, M, et al. Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol 2020; 76: 107–15. https://doi.org/10.1007/s00228-019-02769-z.Google Scholar
Vigod, SN, Gomes, T, Wilton, AS, Taylor, VH, Ray, JG. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015; 350: h2298. doi: 10.1136/bmj.h2298.Google Scholar
Galbally, M, Frayne, J, Watson, SJ, Morgan, V, Snellen, M. The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: a multicentre study. Aust N Z J Obstet Gynaecol 2020; 60: 63–9. https://doi.org/10.1111/ajo.12986.Google Scholar
Viguera, AC, Nonacs, R, Cohen, LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157: 179–84.Google Scholar
Viguera, AC, Whitfield, T, Baldessarini, RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164: 1817–24.Google Scholar
Nora, JJ, Nora, AH, Toews, WH. Letter: lithium, Ebstein’s anomaly, and other congenital heart defects. Lancet 1974; 2: 594–5.Google Scholar
Yacobi, S, Ornoy, A. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci 2008; 45: 95106.Google Scholar
McKnight, RF, Adida, M, Budge, K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012; 379: 721–8.Google Scholar
Gutgesell, H. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017; 377: 893. doi: 10.1056/NEJMc1708919.Google Scholar
Kozma, C. Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: another clinical report and a review of the literature. Am J Med Genet A 2005; 132A: 441–4.Google Scholar
Meador, K, Reynolds, MW, Crean, S, Fahrbach, K, Probst, C.Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008; 81: 113.Google Scholar
Jentink, J, Bakker, MK, Nijenhuis, CM, Wilffert, B, de Jong-van den Berg, LT. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiol Drug Saf 2010; 19: 803–7.Google Scholar
Medicines and Healthcare products Regulatory Agency. Valproate use by women and girls. 2018. www.gov.uk/guidance/valproate-use-by-women-and-girls (accessed February 2020).Google Scholar
McCorry, D, Bromley, R. Does in utero exposure of antiepileptic drugs lead to failure to reach full cognitive potential? Seizure 2015; 28: 51–6.Google Scholar
Tomson, T, Battino, D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012; 11: 803–13.Google Scholar
Bergink, V, Burgerhout, KM, Koorengevel, KM, et al. Treatment of psychosis and mania in the postpartum period. Am J Psychiatry 2015; 172: 115–23.Google Scholar
Lawson, A, Murphy, KE, Sloan, E, Uleryk, E, Dalfen, A. The relationship between sleep and postpartum mental disorders: a systematic review. J Affect Disord 2015; 176: 6577.Google Scholar
Chandra, PS, Bhargavaraman, RP, Raghunandan, VN, Shaligram, D. Delusions related to infant and their association with mother–infant interactions in postpartum psychotic disorders. Arch Womens Ment Health 2006; 9: 285–8.Google Scholar
Di Florio, A, Jones, L, Forty, L, et al. Mood disorders and parity: a clue to the aetiology of the postpartum trigger. J Affect Disord 2014; 152–154: 334–39.Google Scholar
Blackmore, ER, Jones, I, Doshi, M, et al. Obstetric variables associated with bipolar affective puerperal psychosis. Br J Psychiatry 2006; 188:32–6.Google Scholar
Heron, J, Robertson Blackmore, E, McGuinness, M, Craddock, N, Jones, I. No “latent period” in the onset of bipolar affective puerperal psychosis. Arch Womens Ment Health 2007; 10: 7981.Google Scholar
Heron, J, McGuinness, M, Blackmore, ER, Craddock, N, Jones, I. Early postpartum symptoms in puerperal psychosis. BJOG 2008; 115: 348–53.Google Scholar
Jones, I, Smith, S. Puerperal psychosis: identifying and caring for women at risk. Adv Psychiatr Treat 2009; 15: 411–18.Google Scholar
Doucet, S, Jones, I, Letourneau, N, Dennis, CL, Blackmore, ER. Interventions for the prevention and treatment of postpartum psychosis: a systematic review. Arch Womens Ment Health 2010; 14: 8998.Google Scholar
Focht, A, Kellner, CH. Electroconvulsive therapy (ECT) in the treatment of postpartum psychosis. J ECT. 2012; 28: 31–3.Google Scholar
Robertson, E, Jones, I, Haque, S, Holder, R, Craddock, N. Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis. Br J Psychiatry 2005; 186: 258–9.Google Scholar
Blackmore, ER, Rubinow, DR, O’Connor, TG, et al. Reproductive outcomes and risks of subsequent illness in women diagnosed with postpartum psychosis. Bipolar Disord 2013; 15: 394404.Google Scholar
Blanchard, JJ, Kring, AM, Horan, WP, Gur, R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull 2011; 37: 291–9.Google Scholar
Judd, F, Komiti, A, Sheehan, P, et al. Adverse obstetric and neonatal outcomes in women with severe mental illness: to what extent can they be prevented? Schizophr Res 2014; 157: 305–9.Google Scholar
Howard, LM. Fertility and pregnancy in women with psychotic disorders. Eur J Obstet Gynecol Reprod Biol 2005; 119: 310.Google Scholar
Taylor, CL, Stewart, R, Ogden, J, et al. The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses. BMC Psychiatry 2015; 15: 88.Google Scholar
Vigod, SN, Kurdyak, PA, Dennis, CL, et al. Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study. BJOG 2014; 121: 566–74.Google Scholar
Bennedsen, BE, Mortensen, PB, Olesen, AV, Henriksen, TB, Frydenberg, M. Obstetric complications in women with schizophrenia. Schizophr Res 2001; 47: 167–75.Google Scholar
Miller, LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 1997; 23: 623–35.Google Scholar
Matevosyan, NR. Pregnancy and postpartum specifics in women with schizophrenia: a meta-study. Arch Gynecol Obstet 2011; 283: 141–7.Google Scholar
Henriksson, KM, McNeil, TF. Health and development in the first 4 years of life in offspring of women with schizophrenia and affective psychoses: Well-Baby Clinic information. Schizophr Res 2004; 70: 3948.Google Scholar
Bundy, H, Stahl, D, MacCabe, JH. A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatr Scand 2011; 123: 98106.Google Scholar
Vigod, SN, Seeman, MV, Ray, JG, et al. Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996–2009): a population-based study in Ontario, Canada. Schizophr Res 2012; 139: 169–75.Google Scholar
Mehta, TM, Van Lieshout, RJ. A review of the safety of clozapine during pregnancy and lactation. Arch Womens Ment Health 2017; 20: 19. doi: 10.1007/s00737-016-0670-0.Google Scholar
Kenny, M, Conroy, S, Pariante, CM, Seneviratne, G, Pawlby, S. Mother–infant interaction in mother and baby unit patients: before and after treatment. J Psychiatr Res 2013; 47: 1192–8.Google Scholar
Leucht, S, Tardy, M, Komossa, K, et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2012; (5): CD008016.Google Scholar
Heron, J, O’Connor, TG, Evans, J, Golding, J, Glover, V. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 2004; 80: 6573.Google Scholar
Matthey, S, Barnett, B, Howie, P, Kavanagh, DJ. Diagnosing postpartum depression in mothers and fathers: whatever happened to anxiety? J Affect Disord 2003; 74: 139–47.Google Scholar
Zhang, S, Ding, Z, Liu, H, et al. Association between mental stress and gestational hypertension/preeclampsia: a meta-analysis. Obstet Gynecol Surv 2013; 68: 825–34.Google Scholar
Goodman, JH, Chenausky, KL, Freeman, MP. Anxiety disorders during pregnancy: a systematic review. J Clin Psychiatry 2014; 75: e1153–84.Google Scholar
Ding, XX, Wu, YL, Xu, SJ, et al. Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies. J Affect Disord 2014; 159: 103–10.Google Scholar
Littleton, HL, Breitkopf, CR, Berenson, AB. Correlates of anxiety symptoms during pregnancy and association with perinatal outcomes: a meta-analysis. Am J Obstet Gynecol 2007; 196: 424–32.Google Scholar
O’Connor, TG, Heron, J, Golding, J, Beveridge, M, Glover, V. Maternal antenatal anxiety and children’s behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry 2002; 180: 502–8.Google Scholar
Pemberton, CK, Neiderhiser, JM, Leve, LD, et al. Influence of parental depressive symptoms on adopted toddler behaviors: an emerging developmental cascade of genetic and environmental effects. Dev Psychopathol 2010; 22: 803–18.Google Scholar
Timpano, KR, Abramowitz, JS, Mahaffey, BL, Mitchell, MA, Schmidt, NB. Efficacy of a prevention program for postpartum obsessive-compulsive symptoms. J Psychiatr Res 2011; 45: 1511–17.Google Scholar
Milgrom, J, Schembri, C, Ericksen, J, Ross, J, Gemmill, AW. Towards parenthood: an antenatal intervention to reduce depression, anxiety and parenting difficulties. J Aff ect Disord 2011; 130: 385–94.Google Scholar
National Institute for Health and Care Excellence (NICE). Generalised Anxiety Disorder and Panic Disorder in Adults. Clinical Guideline 192. London: NICE, 2011. www.nice.org.uk/guidance/cg113 (accessed February 2020).Google Scholar
Okun, M, Ebert, R, Saini, B. A review of sleep-promoting medications used in pregnancy. Am J Obstet Gynecol 2015; 212: 428–41. doi: 10.1016/j.ajog.2014.10.1106.Google Scholar
Bellantuono, C, Tofani, S, Di Sciascio, G, et al. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry 2013; 35: 38. doi: 10.1016/j.genhosppsych.2012.09.003.Google Scholar
Enato, E, Moretti, M, Koren, G. The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can 2011; 33: 46–8.Google Scholar
Oberlander, TF, Warburton, W, Misri, S, et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008; 83: 6876.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×